"AHC","PY","nTotDoc","meanAUPerArt","meanAU_IN_PerArt","meanArtWith_AU_IN_FIRST","meanArtWith_AU_IN_LAST","meanArtWith_AU_IN_CORR","mean_articles_per_internal_author","mean_articles_per_internal_first_author","mean_articles_per_internal_last_author","mean_articles_per_internal_corresponding_author","ArtOA","singleAuArt","Q1_nSJR","Q2_nSJR","Q3_nSJR","Q4_nSJR","Q1_percSJR","Q2_percSJR","Q3_percSJR","Q4_percSJR","meanTCperArt","mean_NTC","meanCitationTrend","InternCoauthorship","AffCoauthorship","GC_AUIN_wFractional","GC_AUIN_FIRSTname","GC_AUIN_LASTname","GC_AUIN_CORRESP","top_AU","top_AU_freq","top_AU_wFract","top_AU_freq_wFract","top_AUIN","top_AUIN_freq","top_AUIN_wFract","top_AUIN_freq_wFract","topAUbyCit","topAUbyCit_TC","topAUINbyCit","topAUINbyCit_TC","topAUINbyCit_norm_byYear","topAUINbyCit_TC_norm_byYear","topConcept_L0","topFreq_L0","topConcept_L1","topFreq_L1","topConcept_L2","topFreq_L2","topConcept_L3","topFreq_L3","topConcept_L4","topFreq_L4","topMESH","topMESH_n","topprimary_topic.display_name","topprimary_topic.display_name_n","topDE","topDE_n","topTI_TM","topTI_TM_n","topAB_TM","topAB_TM_n","nDoc_wALTM","percDoc_wALTM","altmetric_score_thirdQu","cited_by_accounts_count_thirdQu","cited_by_fbwalls_count_thirdQu","cited_by_feeds_count_thirdQu","cited_by_gplus_count_thirdQu","cited_by_msm_count_thirdQu","cited_by_patents_count_thirdQu","cited_by_peer_review_sites_count_thirdQu","cited_by_policies_count_thirdQu","cited_by_posts_count_thirdQu","cited_by_rdts_count_thirdQu","cited_by_rh_count_thirdQu","cited_by_tweeters_count_thirdQu","cited_by_videos_count_thirdQu","cited_by_wikipedia_count_thirdQu","cohorts.com_thirdQu","cohorts.doc_thirdQu","cohorts.pub_thirdQu","cohorts.sci_thirdQu","readers.citeulike_thirdQu","readers.connotea_thirdQu","readers.mendeley_thirdQu","readers_count_thirdQu","n_patentsDistinct","nPatentStatus_Abandoned","nPatentStatus_Granted","nPatentStatus_N/A","nPatentStatus_Pending","nPatentStatus_Active","nPatentStatus_Not-in-force","nPatentStatus_Expired - Fee Related","nPatentStatus_Withdrawn","nPatentStatus_Ceased","nPatentStatus_Revoked","nPatentStatus_Expired - Lifetime","nPatentPubType_Application","nPatentPubType_Grant","nPatentPubType_N/A","avg_citations_Patent","avg_Inventors_Patent","inventor_per_AUIN_100","avg_InstitutesInvolved_Patent","nPatent_singleInventor","n_Patents_CoAff","n_Jurisdiction_distinct","nJurisd_AU","nJurisd_CA","nJurisd_EP","nJurisd_IN","nJurisd_CN","nJurisd_US","nJurisd_DE","nJurisd_ES","nJurisd_IT","nJurisd_AT","nJurisd_BR","nJurisd_WO","nJurisd_JP","nJurisd_DK","nJurisd_IL","nJurisd_PT","nJurisd_PL","nJurisd_FR","nJurisd_SA","nJurisd_MY","nJurisd_KR","nJurisd_NL","nJurisd_CO","nJurisd_SM","nJurisd_SI","nJurisd_HR","nJurisd_RU","nJurisd_EA","nJurisd_MX","nJurisd_HK","nPatentKC_A1","nPatentKC_A","nPatentKC_A2","nPatentKC_B1","nPatentKC_D1","nPatentKC_T3","nPatentKC_B2","nPatentKC_T1","nPatentKC_A3","nPatentKC_C","nPatentKC_B","nPatentKC_C2","nPatentKC_C0","nPatentKC_A8","nPatentKC_E","nPatentKC_T4","nPatentKC_D0","nPatentKC_T2","nPatentKC_A0","nPatentKC_B8","nPatentKC_A4","nPatentKC_T8","nPatentKC_C1","nPatentKC_U1","nPatentKC_T5","nPatentKC_B3","nPatentKC_T7","nPatentKC_A9","top_Inventor names_Patent","top_Inventor names_Patent_n","top_Original assignee names_Patent","top_Original assignee names_Patent_n","top_Fields of Research (ANZSRC 2020)_Patent","top_Fields of Research (ANZSRC 2020)_Patent_n","top_RCDC Categories_Patent","top_RCDC Categories_Patent_n","top_HRCS RAC Categories_Patent","top_HRCS RAC Categories_Patent_n","top_IPCR_Patent","top_IPCR_Patent_n","top_CPC_Patent","top_CPC_Patent_n","n_clTrial","avg_durationYear_clTrial","avg_participants_clTrial","clTrial_perAUIN_100","nClTrial_w_AltmScore","cl_AltmS_rel","avg_sponsor_clTrial","nclTrialPhase_Phase 1","nclTrialPhase_Phase 1/2","nclTrialPhase_Phase 2","nclTrialPhase_Phase 2/3","nclTrialPhase_Phase 3","nclTrialPhase_Phase 3/4","nclTrialPhase_Phase 4","nclTrialPhase_N/A","nclTrialPhase_Post Authorisation Studies","nclTrial_StudyType_Interventional","nclTrial_StudyType_Observational","nclTrial_StudyType_Other","nclTrial_StudyType_Expanded access","nclTrial_StudyType_Active surveillance","nclTrial_StudyType_Non-interventional","nclTrial_StudyType_RCT","nclTrial_StudyType_CCT","nclTrial_Gender_All","nclTrial_Gender_Female","nclTrial_Gender_Male","nclTrial_Registry_ClinicalTrials.gov","nclTrial_Registry_EU-CTR","nclTrial_Registry_ENCePP","nclTrial_Registry_ISRCTN","nclTrial_Registry_ANZCTR","nclTrial_Registry_GCTR","nclTrial_Registry_PACTR","nclTrial_Registry_CTRI","nclTrial_Registry_ReBEC","nclTrial_Registry_UMIN-CTR","top_funder_country","top_funder_country_n","top_Fields of Research (ANZSRC 2020)_clTrial","top_Fields of Research (ANZSRC 2020)_clTrial_n","top_RCDC Categories_clTrial","top_RCDC Categories_clTrial_n","top_HRCS HC Categories_clTrial","top_HRCS HC Categories_clTrial_n","top_HRCS RAC Categories_clTrial","top_HRCS RAC Categories_clTrial_n","top_Cancer Types_clTrial","top_Cancer Types_clTrial_n","top_CSO Categories_clTrial","top_CSO Categories_clTrial_n","n_grants","avg_funding_EUR","avg_funding_EUR_perOrganization","avg_durationYear_grant","avg_Organization_per_grant","avg_countries_per_grant","perc_grant_internationalColl","avg_ResultingPublications_per_grant","totFundingOrgbyActivedGrant","avgPubByActivedFundingGrant_1000","top_Research Organization - standardized_Grants","top_Research Organization - standardized_n_Grants","top_Funder_Grants","top_Funder_n_Grants","top_Funder Group_Grants","top_Funder Group_n_Grants","top_Program_Grants","top_Program_n_Grants","top_Fields of Research (ANZSRC 2020)_Grants","top_Fields of Research (ANZSRC 2020)_n_Grants","top_RCDC Categories_Grants","top_RCDC Categories_n_Grants","top_HRCS HC Categories_Grants","top_HRCS HC Categories_n_Grants","top_HRCS RAC Categories_Grants","top_HRCS RAC Categories_n_Grants","top_Cancer Types_Grants","top_Cancer Types_n_Grants","top_CSO Categories_Grants","top_CSO Categories_n_Grants","top_Units of Assessment_Grants","top_Units of Assessment_n_Grants","top_Sustainable Development Goals_Grants","top_Sustainable Development Goals_n_Grants","n_dataset","top_Repository_Dataset","top_Repository_Dataset_n","top_Fields of Research (ANZSRC 2020)_Dataset","top_Fields of Research (ANZSRC 2020)_Dataset_n","top_RCDC Categories_Dataset","top_RCDC Categories_Dataset_n","top_HRCS HC Categories_Dataset","top_HRCS HC Categories_Dataset_n","top_HRCS RAC Categories_Dataset","top_HRCS RAC Categories_Dataset_n","top_Health Research Areas_Dataset","top_Health Research Areas_Dataset_n","top_Broad Research Areas_Dataset","top_Broad Research Areas_Dataset_n","top_Cancer Types_Dataset","top_Cancer Types_Dataset_n","top_Sustainable Development Goals_Dataset","top_Sustainable Development Goals_Dataset_n"
"IRCCS_GASLINI",2000,152,8.18421052631579,2.73026315789474,0.467105263157895,0.407894736842105,0.467105263157895,1.52205882352941,1.18333333333333,1.40909090909091,1.18333333333333,0.276315789473684,2,72,23,9,33,0.47,0.15,0.06,0.22,39.2,0.864837897307838,NA,0.361842105263158,0.80921052631579,0.38,0.346,0.375,0.355,"FRANCESCO FRASSONI;VITO PISTOIA;CLAUDIO GAMBINI;ROBERTO RAVAZZOLO;MIRELLA FILOCAMO;GIORGIO DINI;GIAN MARCO GHIGGERI;ANDREA BACIGALUPO;BRUNO DE BERNARDI;ROSANNA GATTI;ANGELA PISTORIO;ISABELLA CECCHERINI;RAFFAELLA MAZZOTTI;CARLO MINETTI;GIOVANNI A. ROSSI;PAOLO PICCO;CLAUDIO GRANATA;MAJA DI ROCCO;GIANLUCA CARIDI;EDOARDO LANINO","8;8;6;6;6;6;5;5;5;5;4;4;4;4;4;4;4;4;4;4","FABRIZIO DE BENEDETTI;MIRELLA FILOCAMO;D. GAZZOLO;ANGELO RAVELLI;M. DIROCCO;FRANCESCO FRASSONI;ROSANNA GATTI;CLAUDIO GAMBINI;VITO PISTOIA;ANDREA ROSSI;G. SERRA;ROBERTO RAVAZZOLO;R. CERONE;RAFFAELLA MAZZOTTI;GLORIA BONUCCELLI;MASSIMO MAZZELLA;ALBERTO MARTINI;GIOVANNI A. ROSSI;GIORGIO DINI;RICCARDO HAUPT","1.14;1.08;1;1;1;0.96;0.93;0.91;0.89;0.87;0.83;0.82;0.73;0.71;0.71;0.67;0.64;0.6;0.59;0.58","FRANCESCO FRASSONI;VITO PISTOIA;CLAUDIO GAMBINI;ROBERTO RAVAZZOLO;MIRELLA FILOCAMO;GIORGIO DINI;GIAN MARCO GHIGGERI;BRUNO DE BERNARDI;ROSANNA GATTI;ANGELA PISTORIO;ISABELLA CECCHERINI;RAFFAELLA MAZZOTTI;CARLO MINETTI;GIOVANNI A. ROSSI;PAOLO PICCO;CLAUDIO GRANATA;MAJA DI ROCCO;GIANLUCA CARIDI;EDOARDO LANINO;R. CERONE","8;8;6;6;6;6;5;5;5;4;4;4;4;4;4;4;4;4;4;4","MIRELLA FILOCAMO;D. GAZZOLO;ANGELO RAVELLI;M. DIROCCO;FRANCESCO FRASSONI;ROSANNA GATTI;CLAUDIO GAMBINI;VITO PISTOIA;ANDREA ROSSI;ROBERTO RAVAZZOLO;R. CERONE;RAFFAELLA MAZZOTTI;GLORIA BONUCCELLI;MASSIMO MAZZELLA;ALBERTO MARTINI;GIOVANNI A. ROSSI;GIORGIO DINI;RICCARDO HAUPT;CARLO MINETTI;BRUNO DE BERNARDI","1.08;1;1;1;0.96;0.93;0.91;0.89;0.87;0.82;0.73;0.71;0.71;0.67;0.64;0.6;0.59;0.58;0.57;0.56","CARLO MINETTI;FABRIZIO DE BENEDETTI;MICHAEL P. LISANTI;ANGELO RAVELLI;VITO PISTOIA;GIAN MARCO GHIGGERI;ROMANO TENCONI;PAOLO PICCO;GIANLUCA CARIDI;MAJA DI ROCCO;FRANCESCO SCOLARI;ALI G. GHARAVI;ANITA FARHI;ANTONIO AMOROSO;BATTISTA FABIO VIOLA;BRUCE A. JULIAN;CAROL NELSON‐WILLIAMS;CRISTINA CANOVA;FRANCESCO PAOLO SCHENA;GIOVANNI M. FRASCÀ","466;454;452;433;414;393;393;390;384;359;339;319;319;319;319;319;319;319;319;319","CARLO MINETTI;ANGELO RAVELLI;VITO PISTOIA;GIAN MARCO GHIGGERI;GIANLUCA CARIDI;PAOLO PICCO;MAJA DI ROCCO;MAURA VALLE;PAOLA FACCHETTI;ANNA CORCIONE;IRMA AIROLDI;E BONIOLI;ROBERTA GUGLIELMINO;ANTONELLA BONCOMPAGNI;FEDERICA SOTGIA;SANDRO DALLORSO;MARCO SERI;DANIELA VOLONTÉ;FERRUCCIO GALBIATI;JEFFREY B. CHU","466;433;408;393;384;381;359;308;302;261;258;229;217;206;202;190;175;153;153;153","FRANCESCO FRASSONI;VITO PISTOIA;GIORGIO DINI;MIRELLA FILOCAMO;ROBERTO RAVAZZOLO;GIAN MARCO GHIGGERI;ANGELA PISTORIO;MAJA DI ROCCO;ROSANNA GATTI;CARLO MINETTI;EDOARDO LANINO;GIANLUCA CARIDI;GIOVANNI A. ROSSI;GLORIA BONUCCELLI;IRMA AIROLDI;ISABELLA CECCHERINI;MICHELA SILVESTRI;R. CERONE;RAFFAELLA MAZZOTTI;SANDRO DALLORSO","8;8;6;6;6;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4","MEDICINE;BIOLOGY;CHEMISTRY;COMPUTER SCIENCE;PSYCHOLOGY;MATHEMATICS;PHYSICS;ENGINEERING;ART;PHILOSOPHY;SOCIOLOGY","112;90;15;9;8;7;6;3;1;1;1","INTERNAL MEDICINE;GENETICS;IMMUNOLOGY;BIOCHEMISTRY;PEDIATRICS;SURGERY;MOLECULAR BIOLOGY;PATHOLOGY;CELL BIOLOGY;ENDOCRINOLOGY;GASTROENTEROLOGY;INTENSIVE CARE MEDICINE;ONCOLOGY;MICROBIOLOGY;RADIOLOGY;CANCER RESEARCH;VIROLOGY;ANESTHESIA;ENVIRONMENTAL HEALTH;ORGANIC CHEMISTRY;PSYCHIATRY","76;62;43;29;28;27;24;24;15;15;14;12;10;9;9;8;7;6;6;6;6","GENE;DISEASE;TRANSPLANTATION;IMMUNE SYSTEM;ANTIGEN;CELL CULTURE;RECEPTOR;ANTIBODY;BONE MARROW;IN VITRO;CANCER;STEM CELL;PREGNANCY;SIGNAL TRANSDUCTION;ANTIBIOTICS;ASTHMA;DIABETES MELLITUS;ENZYME;POPULATION;VIRUS","48;17;16;12;11;11;11;10;10;10;8;8;7;7;6;6;6;6;6;6","MUTATION;ALLELE;EXON;NEUROBLASTOMA;T CELL;GENOTYPE;PHENOTYPE;CHROMOSOME;GENE EXPRESSION;RNA;B CELL;GRAFT-VERSUS-HOST DISEASE;CYTOTOXIC T CELL;FETUS;GENOMIC DNA;HEMATOPOIETIC STEM CELL TRANSPLANTATION;HUMAN LEUKOCYTE ANTIGEN;INTRON;LOCUS (GENETICS);CD8;CLONE (JAVA METHOD);CUMULATIVE INCIDENCE;CYCLOPHOSPHAMIDE;EOSINOPHIL;GENE REARRANGEMENT;GENOME;GLUCOCEREBROSIDASE;METASTASIS;MUTANT;PERIPHERAL BLOOD MONONUCLEAR CELL;STREPTOCOCCUS PNEUMONIAE;TRANSFECTION;TYROSINE PHOSPHORYLATION","19;14;13;9;9;8;8;6;6;6;5;5;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3","MISSENSE MUTATION;COMPOUND HETEROZYGOSITY;RNA SPLICING;ALTERNATIVE SPLICING;GERMINAL CENTER;HAPLOTYPE;PROMOTER;GERMLINE MUTATION;T-CELL RECEPTOR;CAVEOLIN 3;CD3;CD40;GENE MUTATION;GENETIC HETEROGENEITY;GENOTYPE-PHENOTYPE DISTINCTION;KARYOTYPE;NEPHRONOPHTHISIS;OLIGOARTHRITIS;PERIPHERAL T-CELL LYMPHOMA;POINT MUTATION;PRIMARY TUMOR;PSEUDOGENE;REPORTER GENE","6;5;5;4;4;4;4;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HUMANS;FEMALE;MALE;CHILD;CHILD, PRESCHOOL;ADOLESCENT;;NEUROBLASTOMA;INFANT;ADULT;ANIMALS;ITALY;MOLECULAR SEQUENCE DATA;T-LYMPHOCYTES;LYMPHOCYTE ACTIVATION;MUTATION;INFANT, NEWBORN;MEMBRANE GLYCOPROTEINS;PROTO-ONCOGENE PROTEINS;BONE MARROW TRANSPLANTATION","117;64;59;51;36;30;28;27;25;22;17;16;15;15;14;14;12;12;12;11","NEUROBLASTOMA RESEARCH AND TREATMENT;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;METABOLIC DISORDERS AND BIOCHEMICAL GENETICS;NATURAL KILLER CELLS IN IMMUNITY;HEMATOPOIETIC STEM CELL BIOLOGY;HIRSCHSPRUNG DISEASE AND ENTERIC NERVOUS SYSTEM DEVELOPMENT;THERAPEUTIC ADVANCES IN CYSTIC FIBROSIS RESEARCH;ASTHMA;BIOLOGICAL ROLE OF CAVEOLAE IN CELLULAR PROCESSES;EFFICACY AND RESISTANCE IN CML TREATMENT;HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS AND RELATED DISORDERS;HEPATITIS C INFECTION AND TREATMENT;MANAGEMENT AND EPIDEMIOLOGY OF PNEUMONIA;EPIDEMIOLOGY AND TREATMENT OF CHILDHOOD LEUKEMIA;FUNCTIONS AND REGULATION OF RNA EDITING BY ADARS;GENETIC AND MOLECULAR STUDIES OF CONNECTIVE TISSUE DISORDERS;GENOMIC REARRANGEMENTS AND COPY NUMBER VARIATIONS;GLOBAL PREVALENCE AND TREATMENT OF GLAUCOMA;GLYCOGEN METABOLISM AND MYOCLONIC DISORDERS;MOLECULAR MECHANISMS OF OSTEOCLAST DIFFERENTIATION AND BONE REMODELING","8;7;7;7;6;4;4;3;3;3;3;3;3;2;2;2;2;2;2;2","NEUROBLASTOMA;GLUCOCEREBROSIDASE MUTATIONS;COMPOUND HETEROZYGOSITY;GENOMIC DNA;INBORN ERRORS OF METABOLISM;NK CELL RECEPTORS;NONSENSE MUTATION;RET GENE;ABNORMALITY;ADOLESCENT AND YOUNG ADULT ONCOLOGY;CAVEOLIN;CHILDHOOD CANCER SURVIVOR STUDY;CHILDHOOD PNEUMONIA;CLONE (JAVA METHOD);CORD BLOOD;CUMULATIVE INCIDENCE;GAUCHER DISEASE;GENE REARRANGEMENT;GENETIC LINKAGE;HEMATOPOIETIC CELL TRANSPLANTATION","8;6;5;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3","BONE MARROW;MARROW TRANSPLANTATION;STEM CELL;ADHESION MOLECULE;DISEASE TYPE;HEMATOPOIETIC STEM;IDIOPATHIC ARTHRITIS;JUVENILE IDIOPATHIC;RET PROTO-ONCOGENE;TYPE III;ACTIVATION EVIDENCE;ACUTE LYMPHOBLASTIC;B-MEDIATED NK;CARDIAC INVOLVEMENT;CELL ACTIVATION;CELL TRANSPLANT;CELL TRANSPLANTATION;CHILDHOOD CANCER;CHILDREN RECEIVING;CHRONIC MYELOID;CORD BLOOD;CYSTIC FIBROSIS;ELASTIN-BINDING PROTEIN;EPITHELIAL CELLS;FUNCTIONAL CHARACTERIZATION;GAUCHER DISEASE;GENE MUTATIONS;GENETIC COUNSELING;GENETIC HETEROGENEITY;GM-GANGLIOSIDOSIS PATIENTS","7;7;5;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","PUBMED SCOPUS;CROSSREF PUBMED;LISANTI MP;BIOL CHEM;SCHERER PE;CELL BIOL;CHEM -ABSTRACT;TANG Z-L;BIOL -CROSSREF;PEDIATRIC CLINIC;DI DIAGNOSI;DI MALATTIE;DIAGNOSI PRE;ISTITUTO GGASLINISEARCH;LABORATORIO DI;MALATTIE METABOLICHE;METABOLICHE ISTITUTO;PE TANG;POSTNATALE DI;CLINIC UNIVERSITY;FUSION PROTEIN;CENTER LYMPHOMA;CHEM -CROSSREF;FOLLICULAR CENTER;FUSION PROTEINS;KOHTZ DS;LODISH HF;SONG KS;GERMINAL CENTER;SKELETAL MUSCLE","56;39;34;27;23;19;19;18;17;14;12;12;12;12;12;12;12;12;12;10;9;8;8;8;8;8;8;8;7;7",22,0.14,3,2,0,0,0,0,2,0,1,2,0,0,1,0,1.5,0,0,1,0,0,0,38,38,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,8,163,0.81,0,0,24,0,0,0,0,2,0,0,0,0,2,0,0,0,0,0,0,0,2,0,0,2,0,0,0,0,0,0,0,0,0,"Germany;United Kingdom","1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS","2;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;PATIENT SAFETY;PEDIATRIC;RARE DISEASES;ARTHRITIS;AUTOIMMUNE DISEASE;CANCER;NEUROBLASTOMA;NEUROSCIENCES;ORPHAN DRUG;PEDIATRIC CANCER","2;2;2;2;2;1;1;1;1;1;1;1","CANCER;INFLAMMATORY AND IMMUNE SYSTEM","1;1","6.1 PHARMACEUTICALS;6.4 SURGERY","2;1","NEUROBLASTOMA","1","4.3 TECHNOLOGY AND/OR MARKER TESTING IN A CLINICAL SETTING;5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","1;1",4,163631.25,94275.08,3,1.75,1,0.5,5.5,111619.277777778,1.36177193605047,"ISTITUTO GIANNINA GASLINI;IRCCS OSPEDALE SAN RAFFAELE;POLICLINICO SAN MATTEO FONDAZIONE;SAPIENZA UNIVERSITY OF ROME","4;1;1;1","TELETHON FOUNDATION;EUROPEAN COMMISSION","3;1","COALITION S;EC & ERC - EUROPEAN UNION","1;1","TELETHON GRANT PROJECTS - 2000 (PROGRAM);CON - COORDINATION OF RESEARCH ACTIONS (FUNDING SCHEME);FP5-LIFE QUALITY - SPECIFIC PROGRAMME FOR RESEARCH, TECHNOLOGICAL DEVELOPMENT AND DEMONSTRATION ON ""QUALITY OF LIFE AND MANAGEMENT OF LIVING RESOURCES"", 1998-2002 (PROGRAMME);TELETHON FELLOWSHIPS FOR ITALIAN SCIENTISTS IN ITALY - 1999 (PROGRAM)","2;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;3105 GENETICS;48 LAW AND LEGAL STUDIES;4805 LEGAL SYSTEMS;49 MATHEMATICAL SCIENCES;50 PHILOSOPHY AND RELIGIOUS STUDIES;5003 PHILOSOPHY","2;1;1;1;1;1;1;1","AUTOIMMUNE DISEASE;LUPUS;RARE DISEASES","1;1;1","INFLAMMATORY AND IMMUNE SYSTEM;MUSCULOSKELETAL","1;1","5.1 PHARMACEUTICALS;6.1 PHARMACEUTICALS","1;1",NA,NA,NA,NA,"A01 CLINICAL MEDICINE","1",NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_GASLINI",2001,192,7.55208333333333,2.68229166666667,0.484375,0.375,0.479166666666667,1.90740740740741,1.13414634146341,1.56521739130435,1.15,0.239583333333333,4,80,23,14,57,0.42,0.12,0.07,0.3,56.32,1.23253916542971,NA,0.380208333333333,0.791666666666667,0.434,0.366,0.376,0.359,"NICOLINO RUPERTO;LORENZO MORETTA;ALBERTO MARTINI;ROBERTO BIASSONI;FRANCESCO PERFUMO;ALESSANDRO MORETTA;ELIO CASTAGNOLA;CLAUDIO GAMBINI;RICCARDO HAUPT;ROBERTO CUSANO;EDOARDO LANINO;JEANNE M. LANDGRAF;ROBERTA BIANCHERI;MICHELA FALCO;CRISTINA BOTTINO;LINO NOBILI;MARCO SERI;G. SERRA;ROBERTO RAVAZZOLO;ALBERTO GARAVENTA","25;10;9;8;8;8;7;7;7;6;6;6;6;5;5;5;5;5;5;5","NICOLINO RUPERTO;MICHELA SILVESTRI;ELIO CASTAGNOLA;ALBERTO MARTINI;RICCARDO HAUPT;LORENZO MORETTA;CLAUDIO GAMBINI;ROBERTA BIANCHERI;VANDERSON ROCHA;MOHAMAD MAGHNIE;ANDREA ROSSI;G. B. FERRARA;EZIO FULCHERI;FRANCESCO PERFUMO;PAOLO TORTORI‐DONATI;ALESSANDRO MORETTA;GIACOMO PONGIGLIONE;P PERUTELLI;STEFANIA VIOLA;ROBERTO BIASSONI","3.39;1.77;1.64;1.56;1.2;1.15;1.13;1.06;1;1;1;1;0.93;0.89;0.88;0.86;0.83;0.83;0.83;0.83","NICOLINO RUPERTO;LORENZO MORETTA;ALBERTO MARTINI;ROBERTO BIASSONI;FRANCESCO PERFUMO;ALESSANDRO MORETTA;ELIO CASTAGNOLA;CLAUDIO GAMBINI;RICCARDO HAUPT;ROBERTO CUSANO;EDOARDO LANINO;ROBERTA BIANCHERI;MICHELA FALCO;CRISTINA BOTTINO;LINO NOBILI;MARCO SERI;G. SERRA;ROBERTO RAVAZZOLO;ALBERTO GARAVENTA;VITO PISTOIA","25;10;9;8;8;8;7;7;7;6;6;6;5;5;5;5;5;5;5;5","NICOLINO RUPERTO;MICHELA SILVESTRI;ELIO CASTAGNOLA;ALBERTO MARTINI;RICCARDO HAUPT;LORENZO MORETTA;CLAUDIO GAMBINI;ROBERTA BIANCHERI;VANDERSON ROCHA;MOHAMAD MAGHNIE;ANDREA ROSSI;G. B. FERRARA;EZIO FULCHERI;FRANCESCO PERFUMO;PAOLO TORTORI‐DONATI;ALESSANDRO MORETTA;GIACOMO PONGIGLIONE;P PERUTELLI;ROBERTO BIASSONI;G. SERRA","3.39;1.77;1.64;1.56;1.2;1.15;1.13;1.06;1;1;1;1;0.93;0.89;0.88;0.86;0.83;0.83;0.83;0.79","MASSIMO MAZZELLA;EPHRAT LEVY‐LAHAD;F. DAGNA BRICARELLI;FRANCESCA FARAVELLI;FRED RAMSDELL;GEOFFREY C BYRNE;JANE PEAKE;JEAN‐LAURENT CASANOVA;L PERRONI;MARK MCEUEN;MARK W. APPLEBY;MARY E. BRUNKOW;NEIL R.M. BUIST;OLIVIER GOULET;ROBERT S. WILDIN;SEAN PROLL;LORENZO MORETTA;ROBERTO BIASSONI;ALESSANDRO MORETTA;CRISTINA BOTTINO","1909;1821;1821;1821;1821;1821;1821;1821;1821;1821;1821;1821;1821;1821;1821;1821;1253;1118;1051;857","MASSIMO MAZZELLA;LORENZO MORETTA;VANDERSON ROCHA;ALBERTO MARTINI;CLAUDIA CANTONI;NICOLINO RUPERTO;ANGELA PISTORIO;STEFANIA MARCENARO;CARLO MINETTI;GIORGIO GIMELLI;ANGELO RAVELLI;CLARA MALATTIA;LUISA FRANCO;MARINA NANNI;M. G. BAGLIETTO;MARCO SERI;FRANCESCO PERFUMO;ROBERTA BIANCHERI;GIOVANNI CANDIANO;ANDREA ROSSI","1909;1253;774;511;498;473;463;460;448;416;390;347;343;329;312;283;277;267;244;241","NICOLINO RUPERTO;LORENZO MORETTA;ALBERTO MARTINI;FRANCESCO PERFUMO;RICCARDO HAUPT;CLAUDIO GAMBINI;ROBERTO CUSANO;ELIO CASTAGNOLA;MARCO SERI;ROBERTO RAVAZZOLO;MICHELA SILVESTRI;ROBERTA BIANCHERI;R GUSMANO;ALBERTO GARAVENTA;ANDREA ROSSI;BRUNO DE BERNARDI;EDOARDO LANINO;ELENA BATTISTINI;FABIO CORSOLINI;FABRIZIO GINEVRI","24;10;9;8;7;6;6;6;5;5;5;5;5;4;4;4;4;4;4;4","MEDICINE;BIOLOGY;CHEMISTRY;PSYCHOLOGY;PHYSICS;COMPUTER SCIENCE;MATHEMATICS;PHILOSOPHY;ENGINEERING;HISTORY;ECONOMICS;POLITICAL SCIENCE;ART;BUSINESS;GEOGRAPHY;SOCIOLOGY","144;88;28;14;9;8;6;6;4;3;2;2;1;1;1;1","INTERNAL MEDICINE;PATHOLOGY;GENETICS;BIOCHEMISTRY;IMMUNOLOGY;PEDIATRICS;PSYCHIATRY;SURGERY;CELL BIOLOGY;PHYSICAL THERAPY;MOLECULAR BIOLOGY;NURSING;ENDOCRINOLOGY;GASTROENTEROLOGY;CANCER RESEARCH;ANESTHESIA;ANATOMY;AUDIOLOGY;DERMATOLOGY;FAMILY MEDICINE;INTENSIVE CARE MEDICINE;ORGANIC CHEMISTRY;RADIOLOGY","93;56;53;48;47;37;37;37;31;28;27;25;20;13;12;11;9;7;7;7;7;7;7","GENE;HEALTH ASSESSMENT;PSYCHOSOCIAL;QUALITY OF LIFE (HEALTHCARE);ARTHRITIS;DISEASE;RECEPTOR;IN VITRO;TRANSPLANTATION;ANTIBODY;IMMUNE SYSTEM;BONE MARROW;CELL;ANTIGEN;CELL CULTURE;ENZYME;CHEMOTHERAPY;AMINO ACID;EPILEPSY;STEM CELL","42;24;24;24;22;19;18;17;16;15;13;12;12;10;10;10;8;7;7;7","JUVENILE RHEUMATOID ARTHRITIS;MUTATION;T CELL;CYTOTOXIC T CELL;CHROMOSOME;NEUROBLASTOMA;ALLELE;BONE MARROW TRANSPLANTATION;MONOCLONAL ANTIBODY;PHENOTYPE;B CELL;CLONE (JAVA METHOD);GENOTYPE;CD34;CD8;CYCLOPHOSPHAMIDE;CYTOTOXICITY;GENE DUPLICATION;HAEMATOPOIESIS;HEMATOPOIETIC STEM CELL TRANSPLANTATION;MAJOR HISTOCOMPATIBILITY COMPLEX;SPIROMETRY","19;11;10;9;7;7;6;6;6;6;5;5;5;4;4;4;4;4;4;4;4;4","NATURAL KILLER CELL;INTERLEUKIN 21;CYTOLYSIS;MISSENSE MUTATION;ANTIGEN-PRESENTING CELL;EXHALED NITRIC OXIDE;KARYOTYPE;BONE MARROW TRANSPLANT;CD38;CD40;GENOTYPE-PHENOTYPE DISTINCTION;INTERLEUKIN 12;MHC CLASS I;ONCOGENE;ANEUPLOIDY;CD3;DIFFUSING CAPACITY;DNA METHYLATION;FLUORESCENCE IN SITU HYBRIDIZATION;FOCAL SEGMENTAL GLOMERULOSCLEROSIS;GENETICALLY MODIFIED MOUSE;GERMLINE MUTATION;IFOSFAMIDE;LOSS OF HETEROZYGOSITY;METHYLTRANSFERASE;MUCOPOLYSACCHARIDOSIS TYPE II;NKG2D;POINT MUTATION;PRENATAL DIAGNOSIS;RNA SPLICING;SLEEP SPINDLE;TOTAL BODY IRRADIATION;VINCRISTINE","9;8;7;6;5;4;4;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HUMANS;FEMALE;MALE;CHILD;ADOLESCENT;ARTHRITIS, JUVENILE;CHILD, PRESCHOOL;INFANT;QUALITY OF LIFE;DISABILITY EVALUATION;PSYCHOMETRICS;RECEPTORS, IMMUNOLOGIC;REPRODUCIBILITY OF RESULTS;SURVEYS AND QUESTIONNAIRES;ANIMALS;CROSS-CULTURAL COMPARISON;CULTURAL CHARACTERISTICS;HEALTH STATUS;LANGUAGE;ADULT","158;99;95;75;56;54;40;29;26;25;25;25;25;25;24;24;24;24;24;22","HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS AND RELATED DISORDERS;NATURAL KILLER CELLS IN IMMUNITY;HEMATOPOIETIC STEM CELL BIOLOGY;NEUROBLASTOMA RESEARCH AND TREATMENT;ASTHMA;HIRSCHSPRUNG DISEASE AND ENTERIC NERVOUS SYSTEM DEVELOPMENT;EPILEPSY AND SEIZURES;LYSOSOMAL CALCIUM SIGNALING IN PHYSIOLOGY AND PATHOLOGY;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;MANAGEMENT OF FEBRILE NEUTROPENIA IN CANCER PATIENTS;ROLE OF HOMOCYSTEINE IN HEALTH AND DISEASE;SUPPORTING HEALTH CARE TRANSITION FROM ADOLESCENCE TO ADULTHOOD;EPIDEMIOLOGY AND MANAGEMENT OF CONGENITAL HEART DISEASE;MOLECULAR MECHANISMS OF INFLAMMASOME ACTIVATION AND REGULATION;REGULATORY T CELL DEVELOPMENT AND FUNCTION;THERAPEUTIC ADVANCES IN CYSTIC FIBROSIS RESEARCH;ACUTE MYELOID LEUKEMIA;BRANCHIAL ANOMALIES AND THYROID ABNORMALITIES;CHEMICAL GLYCOBIOLOGY AND THERAPEUTIC APPLICATIONS;CLASSIFICATION AND TREATMENT OF HISTIOCYTIC DISORDERS","25;11;6;6;5;5;4;4;4;4;4;4;3;3;3;3;2;2;2;2","HEALTH ASSESSMENT;JUVENILE IDIOPATHIC ARTHRITIS;PEDIATRIC QUALITY OF LIFE INVENTORY;JUVENILE RHEUMATOID ARTHRITIS;NK CELL ACTIVATION;SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS;NK CELL DEVELOPMENT;NK CELL RECOGNITION;NK CELL THERAPY;HEMATOPOIETIC CELL TRANSPLANTATION;NEUROBLASTOMA;NK CELL RECEPTORS;CLONE (JAVA METHOD);LYMPHOKINE-ACTIVATED KILLER CELL;MEMORY T CELLS;NK-92;NONSENSE MUTATION;ADOLESCENT AND YOUNG ADULT ONCOLOGY;BACTEREMIA;BONE MARROW TRANSPLANT","24;21;20;19;9;9;8;8;8;6;6;6;5;4;4;4;4;3;3;3","ASSESSMENT QUESTIONNAIRE;CHILD HEALTH;CHILDHOOD HEALTH;HEALTH ASSESSMENT;HEALTH QUESTIONNAIRE;QUESTIONNAIRE CHAQ;QUESTIONNAIRE CHQ;BONE MARROW;MARROW TRANSPLANTATION;NITRIC OXIDE;NK CELLS;HUMAN NK;CELLS REQUIREMENT;CYTOTOXICITY RECEPTORS;EXHALED NITRIC;HEAVY CHAIN;HUMAN TONSILLAR;NATURAL CYTOTOXICITY;STEM CELL;TONSILLAR SUBEPITHELIAL;TYPE II;VITRO STIMULATION;ASTHMATIC CHILDREN;BRANCHIO-OTO-RENAL SYNDROME;CELL HISTIOCYTOSIS;CELL PROLIFERATION;CELL TRANSPLANTATION;CENTRAL VENOUS;COMPLICATIONS RELATED;CONGENITAL INTRAHEPATIC","24;24;24;24;24;24;24;9;7;5;5;4;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2","PUBMED SCOPUS;CROSSREF PUBMED;BIOL CHEM;CHEM -ABSTRACT;LISANTI MP;PH DOMAIN;SKELETAL MUSCLE;DE FLORA;PLASMA MEMBRANE;CAVEOLIN- NULL;MUSCLE FIBERS;CELL BIOL;PUBMED GOOGLE;BIOL -CROSSREF;NULL MICE;ACAD SCI;NATL ACAD;PROC NATL;SCHERER PE;PH DOMAINS;CAVEOLIN- EXPRESSION;DBL PH;AS-LOX CELLS;GEF ACTIVITY;T-TUBULE SYSTEM;DH DOMAIN;BRICARELLI FD;CAVEOLIN- PROTEIN;SCIENCE -CROSSREF;TARGET CELLS","241;158;81;80;63;53;41;35;33;29;29;28;28;27;27;26;26;26;26;24;22;20;19;19;19;18;17;17;17;17",27,0.14,6,4,0,1,0,1,4.75,1,1,4,0,1,1,0,3,0,1,1,0,0,0,52,52,1,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,2,0.39,2,0,1,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,"GAZZOLO DIEGO;MICHETTI FABRIZIO","1;1","ISTITUTO GIANNINA GASLINI;MICHETTI FABRIZIO","1;1",NA,NA,NA,NA,NA,NA,"A23C11/06;A23C9/15;A23L1/305;A23L33/00","1;1;1;1","A23C11/065;A23C9/1512;A23L33/17;A23L33/40;Y10S426/801","1;1;1;1;1",2,7.5,150,0.82,0,0,49.5,0,0,0,0,1,0,1,0,0,2,0,0,0,0,0,0,0,2,0,0,2,0,0,0,0,0,0,0,0,0,"United States","1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES","2;2","CLINICAL RESEARCH;RARE DISEASES;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;PATIENT SAFETY","2;2;1;1",NA,NA,"6.1 PHARMACEUTICALS","2",NA,NA,NA,NA,5,385502.8,169850.99,4.2,2.8,1.4,0.4,12.5,285887.016468254,0.67159398272751,"ISTITUTO GIANNINA GASLINI;CLAUDE BERNARD UNIVERSITY LYON 1;DÉLÉGATION PARIS 11;EUROPEAN INSTITUTE OF ONCOLOGY;NATIONAL AGENCY FOR NEW TECHNOLOGIES, ENERGY AND SUSTAINABLE ECONOMIC DEVELOPMENT;TELETHON INSTITUTE OF GENETICS AND MEDICINE;UNIVERSITY OF FREIBURG;UNIVERSITY OF PADUA;UNIVERSITY OF PAVIA;UNIVERSITY OF PISA","5;1;1;1;1;1;1;1;1;1","TELETHON FOUNDATION;EUROPEAN COMMISSION","4;1","COALITION S;EC & ERC - EUROPEAN UNION","1;1","TELETHON GRANT PROJECTS - 2001 (PROGRAM);CSC - COST-SHARING CONTRACTS (FUNDING SCHEME);FP5-LIFE QUALITY - SPECIFIC PROGRAMME FOR RESEARCH, TECHNOLOGICAL DEVELOPMENT AND DEMONSTRATION ON ""QUALITY OF LIFE AND MANAGEMENT OF LIVING RESOURCES"", 1998-2002 (PROGRAMME);TELETHON CAREER AWARD - 2000 (PROGRAM);TELETHON RESEARCH SERVICES AND FACILITIES - 2000 (PROGRAM)","2;1;1;1;1","31 BIOLOGICAL SCIENCES;32 BIOMEDICAL AND CLINICAL SCIENCES;3105 GENETICS;3101 BIOCHEMISTRY AND CELL BIOLOGY;3107 MICROBIOLOGY;3202 CLINICAL SCIENCES;42 HEALTH SCIENCES","4;4;2;1;1;1;1","GENETICS;RARE DISEASES;CLINICAL RESEARCH;CANCER;CHARCOT-MARIE-TOOTH DISEASE;CYSTIC FIBROSIS;HEMATOLOGY;KIDNEY DISEASE;LUNG;NEURODEGENERATIVE;NEUROSCIENCES;ORPHAN DRUG;PEDIATRIC;PERIPHERAL NEUROPATHY","3;3;2;1;1;1;1;1;1;1;1;1;1;1","CANCER;CONGENITAL;NEUROLOGICAL;RENAL AND UROGENITAL","1;1;1;1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;1.1 NORMAL BIOLOGICAL DEVELOPMENT AND FUNCTIONING;2.6 RESOURCES AND INFRASTRUCTURE (AETIOLOGY)","3;1;1","COLON AND RECTAL CANCER","1","1.3 CANCER INITIATION: ONCOGENES AND TUMOR SUPPRESSOR GENES;2.2 ENDOGENOUS FACTORS IN THE ORIGIN AND CAUSE OF CANCER","1;1","A01 CLINICAL MEDICINE;A03 ALLIED HEALTH PROFESSIONS, DENTISTRY, NURSING AND PHARMACY;A05 BIOLOGICAL SCIENCES","3;1;1",NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_GASLINI",2002,195,8.15384615384615,3.14871794871795,0.517948717948718,0.430769230769231,0.548717948717949,1.76657060518732,1.31168831168831,1.47368421052632,1.3375,0.312820512820513,7,92,38,8,38,0.47,0.19,0.04,0.19,49.59,0.898967391670426,NA,0.287179487179487,0.805128205128205,0.451,0.356,0.38,0.394,"ROBERTO RAVAZZOLO;MARCO SERI;VITO PISTOIA;ISABELLA CECCHERINI;CLAUDIO GAMBINI;DIEGO GAZZOLO;FABRIZIO MICHETTI;FEDERICA SABATINI;LORENZO MORETTA;CHIARA MESSINA;ROBERTO CUSANO;GIORGIO DINI;CARLO MINETTI;FRANCO LOCATELLI;GIOVANNI A. ROSSI;PAOLO PICCO;GIAN MARCO GHIGGERI;VINCENZO JASONNI;MARCO GATTORNO;FRANCESCO PERFUMO","12;11;10;9;9;8;7;7;7;7;7;7;6;6;6;6;6;6;6;6","FRANCESCO PERFUMO;DIEGO GAZZOLO;G TABORELLI;CLAUDIO GAMBINI;FABRIZIO MICHETTI;VITO PISTOIA;E DE;FEDERICA SABATINI;ROBERTO RAVAZZOLO;ISABELLA CECCHERINI;R GUSMANO;ANNA CORCIONE;ALBERTO MARTINI;MICHELA SILVESTRI;GIOVANNI A. ROSSI;L FOUILLARD;ROSSI GA;MARCO SERI;LORENZO MORETTA;PAOLO PICCO","1.55;1.52;1.49;1.37;1.35;1.33;1.25;1.17;1.16;1.16;1.14;1.12;1.08;1.05;1.01;1;1;0.95;0.95;0.92","ROBERTO RAVAZZOLO;MARCO SERI;VITO PISTOIA;ISABELLA CECCHERINI;CLAUDIO GAMBINI;DIEGO GAZZOLO;FABRIZIO MICHETTI;FEDERICA SABATINI;LORENZO MORETTA;CHIARA MESSINA;ROBERTO CUSANO;GIORGIO DINI;CARLO MINETTI;FRANCO LOCATELLI;GIOVANNI A. ROSSI;PAOLO PICCO;GIAN MARCO GHIGGERI;VINCENZO JASONNI;MARCO GATTORNO;FRANCESCO PERFUMO","12;11;10;9;9;8;7;7;7;7;7;7;6;6;6;6;6;6;6;6","FRANCESCO PERFUMO;DIEGO GAZZOLO;G TABORELLI;CLAUDIO GAMBINI;FABRIZIO MICHETTI;VITO PISTOIA;E DE;FEDERICA SABATINI;ROBERTO RAVAZZOLO;ISABELLA CECCHERINI;R GUSMANO;ANNA CORCIONE;ALBERTO MARTINI;MICHELA SILVESTRI;GIOVANNI A. ROSSI;ROSSI GA;MARCO SERI;LORENZO MORETTA;PAOLO PICCO;MIRELLA FILOCAMO","1.55;1.52;1.49;1.37;1.35;1.33;1.25;1.17;1.16;1.16;1.14;1.12;1.08;1.05;1.01;1;0.95;0.95;0.92;0.9","LORENZO MORETTA;CHIARA FOLLI;LUIS J. V. GALIETTA;A. S. VERKMAN;HONG YANG;JAY R. THIAGARAJAH;NITIN D. SONAWANE;TONGHUI MA;CHRISTIAN MÜNZ;GIOVANNI MELIOLI;GUIDO FERLAZZO;MING L. TSANG;RALPH M. STEINMAN;FRANCO LOCATELLI;CHIARA MESSINA;ANDREA PESSION;ROBERTO RAVAZZOLO;CARLO MINETTI;FRANCA FAGIOLI;ALESSANDRO MORETTA","1623;1361;1361;1177;1177;1177;1177;1177;982;982;982;982;982;764;499;478;410;380;380;377","LORENZO MORETTA;CHIARA FOLLI;LUIS J. V. GALIETTA;ALESSANDRO MORETTA;FRANCO LOCATELLI;EDOARDO LANINO;FRANCESCO FRASSONI;ROBERTO RAVAZZOLO;DIEGO GAZZOLO;MICHELA FALCO;ROBERTO BIASSONI;GIAN MARCO GHIGGERI;GIOVANNI A. ROSSI;CRISTINA BOTTINO;FABRIZIO GINEVRI;GIORGIO GIMELLI;ANTONIA MORETTA;BRUNO GRIDELLI;DANIELA MONTAGNA;FAUSTO BALDANTI","1623;1361;1361;359;354;343;340;328;318;287;287;269;269;268;265;259;256;256;256;256","CLAUDIO GAMBINI;VITO PISTOIA;ROBERTO RAVAZZOLO;DIEGO GAZZOLO;LORENZO MORETTA;ISABELLA CECCHERINI;MIRELLA FILOCAMO;GIORGIO DINI;PAOLO PICCO;VINCENZO JASONNI;FRANCESCO PERFUMO;A. BARABINO;CHIARA FOLLI;FEDERICA SABATINI;GIAN MARCO GHIGGERI;GIOVANNI A. ROSSI;GIROLAMO MATTIOLI;LUIS J. V. GALIETTA;MARCO GATTORNO;MARCO SERI","9;9;8;8;7;7;6;6;6;6;6;5;5;5;5;5;5;5;5;5","MEDICINE;BIOLOGY;CHEMISTRY;PHYSICS;MATHEMATICS;COMPUTER SCIENCE;PHILOSOPHY;PSYCHOLOGY;ECONOMICS;ENGINEERING;MATERIALS SCIENCE;SOCIOLOGY","150;124;29;16;6;3;2;2;1;1;1;1","INTERNAL MEDICINE;GENETICS;IMMUNOLOGY;BIOCHEMISTRY;PATHOLOGY;SURGERY;ENDOCRINOLOGY;PEDIATRICS;CELL BIOLOGY;GASTROENTEROLOGY;MOLECULAR BIOLOGY;ANATOMY;CANCER RESEARCH;CARDIOLOGY;ENVIRONMENTAL HEALTH;DERMATOLOGY;RADIOLOGY;OPTICS;INTENSIVE CARE MEDICINE;OBSTETRICS;ONCOLOGY;PHARMACOLOGY;VIROLOGY","99;84;54;43;33;32;31;27;25;21;18;17;12;11;11;10;10;8;7;6;6;6;6","GENE;DISEASE;PREGNANCY;IN VITRO;RECEPTOR;IMMUNE SYSTEM;TRANSPLANTATION;ANTIGEN;LEUKEMIA;ENZYME;POPULATION;CELL CULTURE;CHEMOTHERAPY;ANTIBODY;ARTHRITIS;BONE MARROW;CANCER;STEM CELL;VIRUS;ASTHMA;INCIDENCE (GEOMETRY);SECRETION;UMBILICAL CORD","52;25;23;21;16;15;14;13;13;11;11;10;9;8;8;8;8;7;7;6;6;6;6","MUTATION;FETUS;PHENOTYPE;GENOTYPE;CYTOTOXIC T CELL;ALLELE;NEUROBLASTOMA;HEMATOPOIETIC STEM CELL TRANSPLANTATION;HUMAN LEUKOCYTE ANTIGEN;T CELL;GESTATION;GESTATIONAL AGE;CHROMOSOME;CODING REGION;EXON;LYMPHOBLASTIC LEUKEMIA;CD8;CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR;CHROMOSOMAL TRANSLOCATION;EOSINOPHIL;GENE EXPRESSION;GRAFT-VERSUS-HOST DISEASE;HAEMATOPOIESIS;MAJOR HISTOCOMPATIBILITY COMPLEX;MUTANT","22;16;14;11;10;9;9;8;8;8;7;7;6;6;6;6;5;5;4;4;4;4;4;4;4","ACUTE LYMPHOCYTIC LEUKEMIA;GERMLINE MUTATION;HAPLOTYPE;INTERLEUKIN 21;NATURAL KILLER CELL;CYTOLYSIS;PRENATAL DIAGNOSIS;AMNIOTIC FLUID;BREAKPOINT;FOCAL SEGMENTAL GLOMERULOSCLEROSIS;INTERLEUKIN 12;KARYOTYPE;PLACENTA;UMBILICAL ARTERY;AMNION;ASPARAGINASE;CAVEOLIN 3;COLECTOMY;COMPOUND HETEROZYGOSITY;CYTOGENETICS;DUCTUS VENOSUS;EOSINOPHIL CATIONIC PROTEIN;FETAL GROWTH;FIRST TRIMESTER;FLUORESCENCE IN SITU HYBRIDIZATION;FRAMESHIFT MUTATION;GENETIC HETEROGENEITY;GENOTYPING;HEREDITARY SPASTIC PARAPLEGIA;HOMEOBOX;INTERRUPTED AORTIC ARCH;LYMPHEDEMA;METHYLENETETRAHYDROFOLATE REDUCTASE;MISSENSE MUTATION;NATURAL KILLER T CELL;POINT MUTATION;SINGLE-NUCLEOTIDE POLYMORPHISM;T-CELL RECEPTOR;TOTAL BODY IRRADIATION","5;5;5;5;5;4;4;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HUMANS;FEMALE;MALE;CHILD;ADOLESCENT;CHILD, PRESCHOOL;ADULT;INFANT;ANIMALS;ITALY;PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;DNA;MUTATION;;ARTHRITIS, JUVENILE;RNA, MESSENGER;ABNORMALITIES, MULTIPLE;TREATMENT OUTCOME;BRAIN;FIBROBLASTS","162;95;77;64;47;42;34;30;27;27;26;25;25;23;22;22;21;20;19;19","NATURAL KILLER CELLS IN IMMUNITY;HEMATOPOIETIC STEM CELL BIOLOGY;NEUROBLASTOMA RESEARCH AND TREATMENT;HIRSCHSPRUNG DISEASE AND ENTERIC NERVOUS SYSTEM DEVELOPMENT;NEONATAL LUNG DEVELOPMENT AND RESPIRATORY MORBIDITY;HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS AND RELATED DISORDERS;THERAPEUTIC ADVANCES IN CYSTIC FIBROSIS RESEARCH;ACUTE MYELOID LEUKEMIA;ASTHMA;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;BIOLOGICAL ROLE OF CAVEOLAE IN CELLULAR PROCESSES;GLOBAL PREVALENCE AND TREATMENT OF GLAUCOMA;ROLE OF HOMOCYSTEINE IN HEALTH AND DISEASE;S100 PROTEINS: STRUCTURE, FUNCTION, AND PATHOLOGY;BIOLOGICAL AND SYNTHETIC HYDROGENASES: MECHANISMS AND APPLICATIONS;DIAGNOSIS AND MANAGEMENT OF GASTROESOPHAGEAL REFLUX DISEASE;EFFICACY AND RESISTANCE IN CML TREATMENT;EPIDEMIOLOGY AND PATHOGENESIS OF RESPIRATORY VIRAL INFECTIONS;EPIDEMIOLOGY AND TREATMENT OF CHILDHOOD LEUKEMIA;GENETIC BASIS OF NEUROPATHIES AND RELATED DISORDERS","9;7;7;6;6;5;5;4;4;4;3;3;3;3;2;2;2;2;2;2","NK CELL RECOGNITION;NK CELL ACTIVATION;NEUROBLASTOMA;CODING REGION;HEMATOPOIETIC CELL TRANSPLANTATION;NK CELL DEVELOPMENT;TREATMENT OUTCOMES;ACUTE LYMPHOCYTIC LEUKEMIA;NK CELL RECEPTORS;PATHOGENESIS;CFTR;GLUCOCEREBROSIDASE MUTATIONS;JUVENILE IDIOPATHIC ARTHRITIS;LYMPHOKINE-ACTIVATED KILLER CELL;SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS;BREAKPOINT;CAVEOLIN;CHOLERA TOXIN;FETAL DNA ANALYSIS;GENOMIC DNA","9;8;7;6;6;6;6;5;5;5;4;4;4;4;4;3;3;3;3;3","NATURAL KILLER;ACUTE LYMPHOBLASTIC;JUVENILE IDIOPATHIC;MYELOID LEUKEMIA;STEM CELL;ACUTE MYELOID;BLOCKS CHOLERA;CELL TRANSPLANTATION;CFTR INHIBITOR;CHOLERA TOXININDUCED;CORD BLOOD;FLUID SECRETION;GRAFT-VERSUS-HOST DISEASE;HEMATOPOIETIC STEM;HIGH-THROUGHPUT SCREENING;IDIOPATHIC ARTHRITIS;INHIBITOR IDENTIFIED;INTESTINAL FLUID;ITALIAN PATIENTS;LYMPHOBLASTIC LEUKEMIA;MULTIPLE LETTERS;NEPHROTIC SYNDROME;NITRIC OXIDE;NK CELLS;PRENATAL DIAGNOSIS;RESPIRATORY SYNCYTIAL;RISK FACTORS;SB PROTEIN;SCREENING BLOCKS;SYNCYTIAL VIRUS","6;5;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3","PUBMED SCOPUS;CROSSREF PUBMED;LISANTI MP;MUSCLE FIBERS;NK CELLS;PLASMA MEMBRANE;BIOL CHEM;GGTCC HAPLOTYPE;CAVEOLIN- DEFICIENCY;CELL SURFACE;CHEM -CROSSREF;SCHERER PE;ACUTE LYMPHOBLASTIC;CYSTIC FIBROSIS;GENET -CROSSREF;NK CELL;RET PROTO-ONCOGENE;AUTOSOMAL DOMINANT;CAVEOLIN GENE;GPI-LINKED PROTEINS;HLA CLASS;LGMD-C MUSCLE;CAVEOLIN- GENE;GENE FAMILY;LYMPHOBLASTIC LEUKAEMIA;RET GENE;SKELETAL MUSCLE;T-TUBULE SYSTEM;CAVEOLAE FORMATION;DE NOVO","64;49;31;25;19;18;16;16;14;14;14;14;12;11;11;11;11;10;10;10;10;10;9;9;9;9;9;9;8;8",38,0.19,3,3,0,1,0,0,5.25,0,1.5,3,0,1,1.5,0,2,0,0,1.5,0,0,0,51,51,2,1,0,2,0,0,0,0,1,0,0,0,2,0,2,103,2.75,1.79,1,0,0,3,0,0,0,0,0,1,1,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"JASONNI VINCENZO;MARTUCCIELLO GIUSEPPE;PINI PRATO ALESSIO;BECCHETTI STELVIO;PARODI VALTER;PRATO ALESSIO PINI","3;3;2;1;1;1","ISTITUTO GIANNINA GASLINI;INSTITUTO GIANNINA GASLINI;ISTITUTO GIANNINA GASLINI GENU","2;1;1","40 ENGINEERING;4012 FLUID MECHANICS AND THERMAL ENGINEERING;49 MATHEMATICAL SCIENCES;4902 MATHEMATICAL PHYSICS","3;1;1;1","CLINICAL RESEARCH","1",NA,NA,"A61B10/00;A61B10/02;A61F","3;3;1","A61B10/0266;A61B10/0283","3;3",1,24,3300,0.32,1,1,126,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,NA,NA,"32 BIOMEDICAL AND CLINICAL SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS","1;1;1;1","CANCER;CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;NEUROBLASTOMA;NEUROSCIENCES;PEDIATRIC;PREVENTION;RARE DISEASES","1;1;1;1;1;1;1;1","CANCER","1","6.2 CELLULAR AND GENE THERAPIES;6.4 SURGERY;6.5 RADIOTHERAPY AND OTHER NON-INVASIVE THERAPIES","1;1;1","NEUROBLASTOMA","1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","1",8,851349.62,111992.29,3.71428571428571,8.125,4.875,0.5,11.4285714285714,485051.44265873,0.402019214562355,"ISTITUTO GIANNINA GASLINI;DÉLÉGATION PARIS 11;SEMMELWEIS UNIVERSITY;UNIVERSITY HOSPITAL IN MOTOL;AARHUS UNIVERSITY HOSPITAL;AZIENDA OSPEDALIERA DI PADOVA;BAMBINO GESÙ CHILDREN'S HOSPITAL;CHARITÉ - UNIVERSITY MEDICINE BERLIN;CHILDREN'S HOSPITAL AGIA SOPHIA;CHILDREN'S MEMORIAL HEALTH INSTITUTE;CLAUDE BERNARD UNIVERSITY LYON 1;CUKUROVA UNIVERSITY;EGE UNIVERSITY;ERASMUS UNIVERSITY ROTTERDAM;ESSEN UNIVERSITY HOSPITAL;FRENCH NATIONAL CENTRE FOR SCIENTIFIC RESEARCH;GHENT UNIVERSITY HOSPITAL;HACETTEPE UNIVERSITY;HANNOVER MEDICAL SCHOOL;HOSPITAL DE SÃO JOÃO","8;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","EUROPEAN COMMISSION;TELETHON FOUNDATION","5;3","COALITION S;EC & ERC - EUROPEAN UNION","5;5","FP5-LIFE QUALITY - SPECIFIC PROGRAMME FOR RESEARCH, TECHNOLOGICAL DEVELOPMENT AND DEMONSTRATION ON ""QUALITY OF LIFE AND MANAGEMENT OF LIVING RESOURCES"", 1998-2002 (PROGRAMME);CSC - COST-SHARING CONTRACTS (FUNDING SCHEME);FP5-HUMAN POTENTIAL - PROGRAMME FOR RESEARCH, TECHNOLOGICAL DEVELOPMENT AND DEMONSTRATION ON ""IMPROVING THE HUMAN RESEARCH POTENTIAL AND THE SOCIO-ECONOMIC KNOWLEDGE BASE"" (1998-2002) (PROGRAMME);SC - HIGH LEVEL SCIENTIFIC CONFERENCE (FUNDING SCHEME);TELETHON GRANT PROJECTS - 2001 (PROGRAM);TELETHON GRANT PROJECTS - 2002 (PROGRAM);TELETHON RESEARCH SERVICES AND FACILITIES - 2001 (PROGRAM);THN - THEMATIC NETWORK CONTRACTS (FUNDING SCHEME)","4;3;1;1;1;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;3202 CLINICAL SCIENCES;3101 BIOCHEMISTRY AND CELL BIOLOGY;3102 BIOINFORMATICS AND COMPUTATIONAL BIOLOGY;3105 GENETICS;3206 MEDICAL BIOTECHNOLOGY;3208 MEDICAL PHYSIOLOGY;43 HISTORY, HERITAGE AND ARCHAEOLOGY","5;2;2;1;1;1;1;1;1","PEDIATRIC;GENETICS;RARE DISEASES;BIOTECHNOLOGY;BRAIN DISORDERS;CLINICAL RESEARCH;NEUROSCIENCES;AGING;BIOMEDICAL IMAGING;CANCER;CARDIOVASCULAR;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;CYSTIC FIBROSIS;DUCHENNE/ BECKER MUSCULAR DYSTROPHY;EPILEPSY;GENE THERAPY;HUMAN GENOME;HYPERTENSION;INTELLECTUAL AND DEVELOPMENTAL DISABILITIES (IDD);KIDNEY DISEASE","5;3;3;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1","CARDIOVASCULAR;CONGENITAL;GENERIC HEALTH RELEVANCE;MUSCULOSKELETAL;NEUROLOGICAL;RESPIRATORY","1;1;1;1;1;1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;1.1 NORMAL BIOLOGICAL DEVELOPMENT AND FUNCTIONING;5.2 CELLULAR AND GENE THERAPIES;6.1 PHARMACEUTICALS","4;1;1;1","LUNG CANCER;NEUROBLASTOMA","1;1","4.4 RESOURCES AND INFRASTRUCTURE RELATED TO DETECTION, DIAGNOSIS, OR PROGNOSIS;5.3 SYSTEMIC THERAPIES - DISCOVERY AND DEVELOPMENT;5.7 RESOURCES AND INFRASTRUCTURE RELATED TO TREATMENT AND THE PREVENTION OF RECURRENCE","1;1;1","A01 CLINICAL MEDICINE;A06 AGRICULTURE, VETERINARY AND FOOD SCIENCE;B11 COMPUTER SCIENCE AND INFORMATICS","4;1;1",NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_GASLINI",2003,204,8.80882352941176,3.25980392156863,0.5,0.401960784313726,0.524509803921569,1.91091954022989,1.29113924050633,1.51851851851852,1.27380952380952,0.294117647058824,6,101,36,17,39,0.5,0.18,0.08,0.19,57.2,1.08064133622613,NA,0.333333333333333,0.803921568627451,0.448,0.411,0.409,0.423,"LORENZO MORETTA;ALESSANDRO MORETTA;FRANCESCO PERFUMO;GIOVANNI A. ROSSI;FEDERICA SABATINI;CLAUDIO GAMBINI;GIAN MARCO GHIGGERI;MICHELA SILVESTRI;CARLO MINETTI;CLAUDIA CANTONI;MIRCO PONZONI;PAOLO TOMÀ;MARCO DI DUCA;DIEGO GAZZOLO;GIANLUCA CARIDI;MARIA GRAZIA CALEVO;MIRELLA FILOCAMO;FABRIZIO MICHETTI;FRANCESCO SCOLARI;MATTEO BRUSCHETTINI","15;13;12;10;9;9;9;9;8;7;7;7;7;7;7;7;7;6;6;6","PAOLO TOMÀ;LORENZO MORETTA;CARLO MINETTI;ALESSANDRO MORETTA;FEDERICA SABATINI;MICHELA SILVESTRI;GIOVANNI A. ROSSI;CLAUDIO GAMBINI;GIULIANA CANGEMI;DIEGO GAZZOLO;MARIA GRAZIA CALEVO;MIRELLA FILOCAMO;PAOLA GRISERI;FABIO LUIGI MASSIMO RICCIARDOLO;CARLO DUFOUR;FRANCESCO PERFUMO;MARIO LITUANIA;MARCO DI DUCA;FABRIZIO MICHETTI;MATTEO BRUSCHETTINI","2;1.91;1.76;1.47;1.34;1.34;1.32;1.28;1.17;1.06;1.04;1;1;1;1;0.99;0.91;0.89;0.89;0.89","LORENZO MORETTA;ALESSANDRO MORETTA;FRANCESCO PERFUMO;GIOVANNI A. ROSSI;FEDERICA SABATINI;CLAUDIO GAMBINI;GIAN MARCO GHIGGERI;MICHELA SILVESTRI;CARLO MINETTI;CLAUDIA CANTONI;MIRCO PONZONI;PAOLO TOMÀ;MARCO DI DUCA;DIEGO GAZZOLO;GIANLUCA CARIDI;MARIA GRAZIA CALEVO;MIRELLA FILOCAMO;MATTEO BRUSCHETTINI;G. SERRA;ROBERTO RAVAZZOLO","15;13;12;10;9;9;9;9;8;7;7;7;7;7;7;7;7;6;6;6","PAOLO TOMÀ;LORENZO MORETTA;CARLO MINETTI;ALESSANDRO MORETTA;FEDERICA SABATINI;MICHELA SILVESTRI;GIOVANNI A. ROSSI;CLAUDIO GAMBINI;GIULIANA CANGEMI;DIEGO GAZZOLO;MARIA GRAZIA CALEVO;MIRELLA FILOCAMO;PAOLA GRISERI;FABIO LUIGI MASSIMO RICCIARDOLO;CARLO DUFOUR;FRANCESCO PERFUMO;MARIO LITUANIA;MARCO DI DUCA;MATTEO BRUSCHETTINI;G. SERRA","2;1.91;1.76;1.47;1.34;1.34;1.32;1.28;1.17;1.06;1.04;1;1;1;1;0.99;0.91;0.89;0.89;0.85","ALESSANDRO MORETTA;LORENZO MORETTA;CLAUDIA CANTONI;MASSIMO VITALE;ROBERTA CASTRICONI;CRISTINA BOTTINO;MARIELLA DELLA CHIESA;EMANUELA MARCENARO;GIAN MARCO GHIGGERI;ROMANA CONTE;MARINA NANNI;MIRCO PONZONI;BARBARA CARNEMOLLA;DANIELA PENDE;JESSICA GRASSI;MARC LOPEZ;NICOLAS REYMOND;PAOLA RIVERA;STEFANIA MARCENARO;ROBERTO BIASSONI","2978;2909;1842;1817;1727;1618;1001;971;939;938;904;828;816;816;816;816;816;816;816;776","LORENZO MORETTA;CLAUDIA CANTONI;CRISTINA BOTTINO;ALESSANDRO MORETTA;GIAN MARCO GHIGGERI;MARINA NANNI;MIRCO PONZONI;STEFANIA MARCENARO;MARIELLA DELLA CHIESA;MASSIMO VITALE;ROBERTA CASTRICONI;FRANCESCO PERFUMO;ROBERTO BIASSONI;EMANUELA MARCENARO;ROMANA CONTE;CLAUDIO GAMBINI;GIANLUCA CARIDI;CHIARA BRIGNOLE;DANILO MARIMPIETRI;FABIO PASTORINO","2909;1842;1618;938;915;904;828;816;744;744;744;684;681;635;635;602;566;552;552;552","LORENZO MORETTA;FRANCESCO PERFUMO;CLAUDIO GAMBINI;GIOVANNI A. ROSSI;FEDERICA SABATINI;MICHELA SILVESTRI;GIAN MARCO GHIGGERI;CARLO MINETTI;MIRCO PONZONI;CLAUDIA CANTONI;MARCO DI DUCA;MIRELLA FILOCAMO;ROBERTO RAVAZZOLO;GIANLUCA CARIDI;MARIA GRAZIA CALEVO;PAOLO TOMÀ;ROSA SALE;DIEGO GAZZOLO;GIORGIO DINI;LAURA D. SERPERO","15;11;9;9;9;9;8;7;7;7;7;7;6;6;6;6;6;5;5;5","MEDICINE;BIOLOGY;CHEMISTRY;PHYSICS;MATHEMATICS;ENGINEERING;COMPUTER SCIENCE;ECONOMICS;SOCIOLOGY;PHILOSOPHY;PSYCHOLOGY;BUSINESS;GEOGRAPHY;GEOLOGY;POLITICAL SCIENCE","146;128;35;10;7;5;4;3;3;2;2;1;1;1;1","INTERNAL MEDICINE;GENETICS;BIOCHEMISTRY;IMMUNOLOGY;PATHOLOGY;SURGERY;CELL BIOLOGY;PEDIATRICS;MOLECULAR BIOLOGY;ENDOCRINOLOGY;CANCER RESEARCH;GASTROENTEROLOGY;RADIOLOGY;ANATOMY;ANESTHESIA;ENVIRONMENTAL HEALTH;PSYCHIATRY;VIROLOGY;INTENSIVE CARE MEDICINE;NEUROSCIENCE;OBSTETRICS;PHARMACOLOGY","92;79;63;56;36;35;33;32;28;24;17;17;13;9;9;9;9;7;6;6;6;6","GENE;IN VITRO;DISEASE;RECEPTOR;PREGNANCY;ENZYME;IMMUNE SYSTEM;ANTIBODY;CELL CULTURE;ASTHMA;CHEMOTHERAPY;CANCER;CYTOKINE;POPULATION;VIRUS;APOPTOSIS;CELL;STEM CELL;TRANSPLANTATION;ALTERNATIVE MEDICINE;ANTIGEN;KIDNEY;LUNG","64;29;25;23;20;17;16;15;14;13;12;9;9;9;9;8;8;8;8;7;7;7;7","MUTATION;FETUS;CYTOTOXIC T CELL;CYTOTOXICITY;NEUROBLASTOMA;PHENOTYPE;ALLELE;T CELL;CD8;EXON;SPIROMETRY;HAEMATOPOIESIS;MONOCLONAL ANTIBODY;RESPIRATORY DISEASE;GENE EXPRESSION;GENOTYPE;TRANSFECTION;BREAST CANCER;CHROMOSOME;CYTOCHROME C OXIDASE;HEMATOPOIETIC STEM CELL TRANSPLANTATION;HUMAN LEUKOCYTE ANTIGEN;MESSENGER RNA;MYOCLONIC EPILEPSY;REFLUX","20;18;13;11;11;10;8;8;7;7;7;6;6;6;5;5;5;4;4;4;4;4;4;4;4","INTERLEUKIN 21;MISSENSE MUTATION;NATURAL KILLER CELL;CYTOLYSIS;EXHALED NITRIC OXIDE;INTERLEUKIN 12;PRENATAL DIAGNOSIS;AMNIOTIC FLUID;BRONCHIAL HYPERRESPONSIVENESS;CD3;FOCAL SEGMENTAL GLOMERULOSCLEROSIS;CD40;DIFFUSING CAPACITY;GENE MUTATION;METHACHOLINE;PROMOTER;RETINOID;VESICOURETERAL REFLUX;ANEUPLOIDY;APIGENIN;BASIC FIBROBLAST GROWTH FACTOR;BK VIRUS;CAVEOLIN;CAVEOLIN 3;CD86;COMPOUND HETEROZYGOSITY;CTL*;FAS LIGAND;FIRST TRIMESTER;FRAMESHIFT MUTATION;GERMLINE MUTATION;HAPLOTYPE;HEMORRHAGIC CYSTITIS;IN UTERO;KARYOTYPE;LEIGH DISEASE;LYMPHEDEMA;METHYLENETETRAHYDROFOLATE REDUCTASE;MITOCHONDRIAL MYOPATHY;MUCOPOLYSACCHARIDOSIS TYPE II;NKG2D;ONCOGENE;PODOCYTE;SINGLE-STRAND CONFORMATION POLYMORPHISM;STEM CELL FACTOR;SYNOVIAL FLUID;TRANSLATION (BIOLOGY)","7;7;7;6;6;5;5;4;4;4;4;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HUMANS;FEMALE;MALE;CHILD;ADOLESCENT;CHILD, PRESCHOOL;ADULT;ITALY;NEUROBLASTOMA;RECEPTORS, IMMUNOLOGIC;KILLER CELLS, NATURAL;ANIMALS;INFANT;ASTHMA;MUTATION;INFANT, NEWBORN;;INTERFERON-GAMMA;MUSCLE, SKELETAL;CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR","169;93;90;58;50;44;34;34;34;33;31;30;30;26;26;24;23;20;20;18","NATURAL KILLER CELLS IN IMMUNITY;ASTHMA;NEUROBLASTOMA RESEARCH AND TREATMENT;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;PATHOPHYSIOLOGY OF GLOMERULAR DISEASES AND NEPHROTIC SYNDROMES;THERAPEUTIC ADVANCES IN CYSTIC FIBROSIS RESEARCH;MITOCHONDRIAL DYNAMICS AND REACTIVE OXYGEN SPECIES REGULATION;EPIDEMIOLOGY AND TREATMENT OF CHILDHOOD LEUKEMIA;EPILEPSY AND SEIZURES;GENETIC BASIS OF NEUROPATHIES AND RELATED DISORDERS;GLYCOGEN METABOLISM AND MYOCLONIC DISORDERS;HEPATITIS C INFECTION AND TREATMENT;PEDIATRIC URINARY TRACT INFECTIONS;POLYOMAVIRUS-ASSOCIATED CARCINOGENESIS AND CLINICAL MANIFESTATIONS;ROLE OF HOMOCYSTEINE IN HEALTH AND DISEASE;S100 PROTEINS: STRUCTURE, FUNCTION, AND PATHOLOGY;ALLERGIC RHINITIS AND ITS IMPACT ON ASTHMA;BIOLOGICAL METHANE UTILIZATION AND METABOLISM;BIOLOGICAL ROLE OF CAVEOLAE IN CELLULAR PROCESSES;CHARGE SYNDROME AND RELATED GENETIC DISORDERS","17;11;9;5;5;5;4;3;3;3;3;3;3;3;3;3;2;2;2;2","NK CELL RECOGNITION;NK CELL ACTIVATION;NK CELL RECEPTORS;NK CELL DEVELOPMENT;NEUROBLASTOMA;ASTHMA;NK CELL THERAPY;S100 PROTEINS;COUGH REFLEX SENSITIVITY;LYMPHOKINE-ACTIVATED KILLER CELL;PRENATAL DIAGNOSIS;NEPHROLOGY;NK CELL EDUCATION;TREATMENT;BRONCHIAL HYPERRESPONSIVENESS;INFLAMMATION;LYSOSOMAL STORAGE DISORDERS;MYOCLONIC EPILEPSY;CD16;CFTR","15;14;14;13;11;10;9;7;6;6;6;5;5;5;4;4;4;4;3;3","SB PROTEIN;DENDRITIC CELLS;EXHALED NITRIC;NITRIC OXIDE;NATURAL CYTOTOXICITY;NATURAL KILLER;CYTOTOXICITY RECEPTORS;FOLLOW-UP STUDY;HUMAN NEUROBLASTOMA;NK CELL;STEM CELL;BONE MARROW;BRONCHIAL EPITHELIAL;CELL TRANSPLANTATION;CYSTIC FIBROSIS;EPITHELIAL CELLS;HUMAN NATURAL;HUMAN NK;LONG-TERM FOLLOW-UP;MARROW TRANSPLANTATION;MYOCLONIC EPILEPSY;RECEPTOR NKP;SEVERE MYOCLONIC;ACUTE LEUKEMIA;ACUTE LYMPHOBLASTIC;ALLERGIC RHINITIS;AMNIOTIC FLUID;ANTISENSE PEPTIDE;AUTOLOGOUS DENDRITIC;AUTOSOMAL DOMINANT","7;6;6;6;5;5;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2","PUBMED SCOPUS;CROSSREF PUBMED;BIOL CHEM;SKELETAL MUSCLE;CHEM -ABSTRACT;PLASMA MEMBRANE;LISANTI MP;LAD II;CHEM -CROSSREF;NK CELLS;VAN ETTEN;ETTEN JL;ACAD SCI;MDX MICE;MUSCULAR DYSTROPHY;NATL ACAD;PUBMED GOOGLE;NK CELL;HALTIWANGER RS;DE FLORA;MUSCLE FIBERS;CELL LINES;REDUCTASE ACTIVITY;SCHERER PE;CYSTIC FIBROSIS;DEFECTIVE ΔF-CFTR;HLA CLASS;MUSCLE CELLS;NUCLEOTIDE SUGARS;PROC NATL","197;147;66;50;40;38;37;32;26;24;24;23;20;20;20;20;20;18;17;16;16;15;15;15;14;13;13;12;12;12",53,0.26,3.5,5,1,0,0,1,9,1,1,5,0,0,2.5,0,4,0,1,1.75,0,0,0,46,46,4,0,1,4,0,0,0,0,0,0,0,0,1,0,4,5,2.4,1.8,1.2,0,1,2,0,0,1,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,"GAZZOLO DIEGO;MICHETTI FABRIZIO;BECCHETTI STELVIO;BOTTONE LAURA;JASONNI VINCENZO;LI PIRA GIUSEPPINA;MANCA FABRIZIO;MARTUCCIELLO GIUSEPPE;PARODI VALTER;PINI PRATO ALESSIO","2;2;1;1;1;1;1;1;1;1","ISTITUTO GIANNINA GASLINI;MICHETTI FABRIZIO","5;1","32 BIOMEDICAL AND CLINICAL SCIENCES;49 MATHEMATICAL SCIENCES;3213 PAEDIATRICS;4901 APPLIED MATHEMATICS","2;2;1;1",NA,NA,NA,NA,"A23C11/06;A23C9/15;A23L1/305;A23L33/00;A23C9/152;A23L1/29;A61B/;A61B10/00;A61B10/02;A61F","2;2;2;2;1;1;1;1;1;1","A23C11/065;A23C9/1512;A23L33/17;A23L33/40;Y10S426/801;A61B10/0266;A61B10/0283;A61K2039/5154;A61K2039/5158;A61K2039/53","2;2;2;2;2;1;1;1;1;1",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,68000,68000,3,1,1,0,3.5,471336.998214286,0.432811344691542,"ISTITUTO GIANNINA GASLINI","2","TELETHON FOUNDATION","2",NA,NA,"TELETHON - UILDM CLINICAL GRANT PROJECTS - 2003 (PROGRAM);TELETHON RESEARCH SERVICES AND FACILITIES - 2002 (PROGRAM)","1;1","31 BIOLOGICAL SCIENCES;3105 GENETICS;32 BIOMEDICAL AND CLINICAL SCIENCES;42 HEALTH SCIENCES;4207 SPORTS SCIENCE AND EXERCISE","1;1;1;1;1","BIOENGINEERING;BRAIN DISORDERS;CLINICAL RESEARCH;GENETIC TESTING;GENETICS;INTELLECTUAL AND DEVELOPMENTAL DISABILITIES (IDD);MUSCULAR DYSTROPHY;PEDIATRIC;PREVENTION;RARE DISEASES;REHABILITATION","1;1;1;1;1;1;1;1;1;1;1","MUSCULOSKELETAL","1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;2.6 RESOURCES AND INFRASTRUCTURE (AETIOLOGY);4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;7.3 MANAGEMENT AND DECISION MAKING","1;1;1;1",NA,NA,NA,NA,"A01 CLINICAL MEDICINE;B12 ENGINEERING","1;1",NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_GASLINI",2004,225,8.65777777777778,2.74666666666667,0.333333333333333,0.346666666666667,0.337777777777778,1.75862068965517,1.13636363636364,1.35087719298246,1.13432835820896,0.386666666666667,4,121,53,18,23,0.54,0.24,0.08,0.1,62.14,1.32066845008091,NA,0.32,0.848888888888889,0.425,0.403,0.439,0.415,"LORENZO MORETTA;ALESSANDRO MORETTA;GIORGIO CIPRANDI;VITO PISTOIA;ROBERTO RAVAZZOLO;R. GIACCHINO;GIORGIO DINI;ANGELA PISTORIO;FEDERICO PREFUMO;MARIA CRISTINA MINGARI;MANLIO MILANESE;DANIELA PENDE;ANDREA VIZZACCARO;EDOARDO LANINO;ALBERTO GARAVENTA;IGNAZIO CIRILLO;A. BARABINO;MARIA ANGELA TOSCA;CLAUDIO GAMBINI;CARLO BELLINI","19;15;11;11;10;8;8;7;7;7;7;7;7;7;7;7;7;6;6;6","LORENZO MORETTA;GIORGIO CIPRANDI;ALESSANDRO MORETTA;ROBERTO RAVAZZOLO;ANDREA VIZZACCARO;IGNAZIO CIRILLO;GIOVANNI A. ROSSI;GIUSEPPINA LI PIRA;MANLIO MILANESE;FEDERICO PREFUMO;MARIA ANGELA TOSCA;MARCO GATTORNO;VITO PISTOIA;FRANCESCO LO‐COCO;D. PALADINI;A. BARABINO;CARLO BELLINI;PAOLO VOLPE;M. MARASINI;ALBERTO MARTINI","2.39;2.24;1.82;1.58;1.52;1.52;1.5;1.4;1.38;1.22;1.22;1.17;1.16;1;0.96;0.92;0.9;0.85;0.85;0.84","LORENZO MORETTA;ALESSANDRO MORETTA;VITO PISTOIA;ROBERTO RAVAZZOLO;R. GIACCHINO;GIORGIO DINI;ANGELA PISTORIO;FEDERICO PREFUMO;MARIA CRISTINA MINGARI;DANIELA PENDE;ANDREA VIZZACCARO;EDOARDO LANINO;ALBERTO GARAVENTA;IGNAZIO CIRILLO;A. BARABINO;MARIA ANGELA TOSCA;CLAUDIO GAMBINI;CARLO BELLINI;RICCARDO HAUPT;CRISTINA BOTTINO","19;15;11;10;8;8;7;7;7;7;7;7;7;7;7;6;6;6;6;6","LORENZO MORETTA;ALESSANDRO MORETTA;ROBERTO RAVAZZOLO;ANDREA VIZZACCARO;IGNAZIO CIRILLO;GIOVANNI A. ROSSI;GIUSEPPINA LI PIRA;FEDERICO PREFUMO;MARIA ANGELA TOSCA;MARCO GATTORNO;VITO PISTOIA;FRANCESCO LO‐COCO;D. PALADINI;A. BARABINO;CARLO BELLINI;M. MARASINI;ALBERTO MARTINI;CLAUDIO CELENTANO;GIORGIO DINI;MARIA ANGELA TOSCA","2.39;1.82;1.58;1.52;1.52;1.5;1.4;1.22;1.22;1.17;1.16;1;0.96;0.92;0.9;0.85;0.84;0.82;0.8;0.78","ALESSANDRO MORETTA;BARBARA CARNEMOLLA;LORENZO MORETTA;LUCIANO ZARDI;GIAN MARCO GHIGGERI;GIOVANNI CANDIANO;LUCA MUSANTE;MAURIZIO BRUSCHI;LAURA SANTUCCI;PAOLA ORECCHIA;PIER GIORGIO RIGHETTI;CRISTINA BOTTINO;DANIELA PENDE;EDOARDO LANINO;MICHELA FALCO;NICOLINO RUPERTO;MARIA CRISTINA MINGARI;ALESSANDRA DONDERO;ROBERTA CASTRICONI;CLAUDIA CANTONI","2329;2281;2241;2001;1983;1902;1902;1902;1886;1886;1886;1160;1086;1078;959;958;814;792;792;748","LORENZO MORETTA;LUCIANO ZARDI;GIAN MARCO GHIGGERI;GIOVANNI CANDIANO;LUCA MUSANTE;MAURIZIO BRUSCHI;LAURA SANTUCCI;ALESSANDRO MORETTA;CRISTINA BOTTINO;EDOARDO LANINO;MICHELA FALCO;CLAUDIA CANTONI;ANGELA PISTORIO;NICOLINO RUPERTO;MAJA DI ROCCO;STEFANIA MARCENARO;VITO PISTOIA;MARIA VALERIA CORRIAS;ROBERTA CASTRICONI;CLAUDIO BRUNO","2183;2001;1983;1902;1902;1902;1886;1183;1160;1078;913;748;650;595;591;573;568;529;507;492","LORENZO MORETTA;MARIA ANGELA TOSCA;VITO PISTOIA;GIORGIO DINI;ROBERTO RAVAZZOLO;FEDERICO PREFUMO;EDOARDO LANINO;A. BARABINO;CLAUDIO GAMBINI;ANGELA PISTORIO;CRISTINA BOTTINO;ALBERTO GARAVENTA;CARLO BELLINI;GIAN MARCO GHIGGERI;GIUSEPPE MORREALE;R. GIACCHINO;RICCARDO HAUPT;FABRIZIO GINEVRI;MIRELLA FILOCAMO;ALESSANDRO MORETTA","17;9;9;8;8;7;7;6;6;6;6;5;5;5;5;5;5;5;5;4","MEDICINE;BIOLOGY;CHEMISTRY;PHYSICS;COMPUTER SCIENCE;PSYCHOLOGY;MATHEMATICS;SOCIOLOGY;ART;ENGINEERING;MATERIALS SCIENCE;PHILOSOPHY;ECONOMICS;ENVIRONMENTAL SCIENCE;GEOGRAPHY;POLITICAL SCIENCE;BUSINESS;GEOLOGY;HISTORY","146;129;37;22;11;7;5;4;3;3;3;3;2;2;2;2;1;1;1","INTERNAL MEDICINE;GENETICS;IMMUNOLOGY;BIOCHEMISTRY;SURGERY;MOLECULAR BIOLOGY;PEDIATRICS;PATHOLOGY;CELL BIOLOGY;CANCER RESEARCH;GASTROENTEROLOGY;ENDOCRINOLOGY;ENVIRONMENTAL HEALTH;ANATOMY;ORGANIC CHEMISTRY;ANESTHESIA;RADIOLOGY;VIROLOGY;OPTICS;PSYCHIATRY","99;81;67;62;40;35;34;29;27;25;20;17;16;14;13;12;12;11;9;9","GENE;IN VITRO;RECEPTOR;DISEASE;IMMUNE SYSTEM;PREGNANCY;ANTIBODY;ANTIGEN;CELL CULTURE;ENZYME;POPULATION;ALLERGY;TRANSPLANTATION;ASTHMA;CELL;CYTOKINE;KIDNEY;CHEMOTHERAPY;INCIDENCE (GEOMETRY);STEM CELL","46;34;29;24;20;19;18;17;17;14;14;13;13;12;11;11;10;9;9;9","CYTOTOXIC T CELL;CD8;MUTATION;T CELL;FETUS;GENOTYPE;CYTOTOXICITY;NEUROBLASTOMA;CHROMOSOME;ALLELE;GENE EXPRESSION;HUMAN LEUKOCYTE ANTIGEN;EXON;KIDNEY TRANSPLANTATION;MONOCLONAL ANTIBODY;ALLERGIC INFLAMMATION;CHEMOKINE;GESTATION;GESTATIONAL AGE;TRANSFECTION","18;16;13;13;12;11;10;10;8;7;7;7;6;6;6;5;5;5;5;5","INTERLEUKIN 21;NATURAL KILLER CELL;PRENATAL DIAGNOSIS;INTERLEUKIN 12;NKG2D;CTL*;CYTOLYSIS;FLUORESCENCE IN SITU HYBRIDIZATION;FOCAL SEGMENTAL GLOMERULOSCLEROSIS;HAPLOTYPE;CD3;CHEMOKINE RECEPTOR;DNA METHYLATION;IL-2 RECEPTOR;KARYOTYPE;ONCOGENE;ACTIN CYTOSKELETON;ACUTE LYMPHOCYTIC LEUKEMIA;BRONCHIAL HYPERREACTIVITY;CD38;CYTOGENETICS;FUSION PROTEIN;HOLOPROSENCEPHALY;IMMUNODOMINANCE;JUVENILE MYELOMONOCYTIC LEUKEMIA;METHACHOLINE;MISOPROSTOL;MISSENSE MUTATION;MULTIPLEX POLYMERASE CHAIN REACTION;NATURAL KILLER T CELL;NECTIN;PERFORIN;POINT MUTATION;PROMOTER;SYNOVIAL FLUID;TUMOR SUPPRESSOR GENE","12;12;6;5;5;4;4;4;4;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HUMANS;FEMALE;MALE;CHILD;ADOLESCENT;CHILD, PRESCHOOL;;KILLER CELLS, NATURAL;ADULT;ANIMALS;INTERFERON-GAMMA;NEUROBLASTOMA;ASTHMA;ITALY;ANTIBODIES, MONOCLONAL;MICE;INFANT;RECEPTORS, IMMUNOLOGIC;ARTHRITIS, JUVENILE;MUTATION","168;82;76;60;47;46;45;45;43;39;39;36;29;28;27;25;24;23;21;21","NATURAL KILLER CELLS IN IMMUNITY;ASTHMA;NEUROBLASTOMA RESEARCH AND TREATMENT;HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS AND RELATED DISORDERS;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;ALLERGIC RHINITIS AND ITS IMPACT ON ASTHMA;EPIDEMIOLOGY AND MANAGEMENT OF CYTOMEGALOVIRUS INFECTION;HEMATOPOIETIC STEM CELL BIOLOGY;IMMUNOBIOLOGY OF DENDRITIC CELLS;PATHOPHYSIOLOGY OF GLOMERULAR DISEASES AND NEPHROTIC SYNDROMES;COPPER AND ZINC IN HEALTH AND DISEASE;EPIDEMIOLOGY AND MANAGEMENT OF CONGENITAL HEART DISEASE;GENETICS AND TREATMENT OF INFLAMMATORY BOWEL DISEASE;HEMOGLOBIN FUNCTION AND REGULATION IN VERTEBRATES;KIDNEY TRANSPLANTATION;LYSOSOMAL CALCIUM SIGNALING IN PHYSIOLOGY AND PATHOLOGY;PEDIATRIC CANCER AND QUALITY OF LIFE;PRENATAL ANEUPLOIDY DIAGNOSIS AND SCREENING TECHNIQUES;THERAPEUTIC ADVANCES IN CYSTIC FIBROSIS RESEARCH;ACUTE MYELOID LEUKEMIA","19;11;10;6;6;5;4;4;4;4;3;3;3;3;3;3;3;3;3;2","NK CELL RECOGNITION;NK CELL ACTIVATION;NK CELL DEVELOPMENT;NK CELL RECEPTORS;NEUROBLASTOMA;NK CELL THERAPY;LYMPHOKINE-ACTIVATED KILLER CELL;ALLERGIC INFLAMMATION;JUVENILE IDIOPATHIC ARTHRITIS;NKG2D;SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS;COUGH REFLEX SENSITIVITY;CTL*;HEMATOPOIETIC CELL TRANSPLANTATION;IMMUNOSUPPRESSION;NASAL LAVAGE;NK-92;PEDIATRIC GASTROENTEROLOGY;POLLEN ALLERGY;PRENATAL DIAGNOSIS","17;16;14;14;11;11;10;5;5;5;5;4;4;4;4;4;4;4;4;4","ALLERGIC RHINITIS;NATURAL KILLER;IDIOPATHIC ARTHRITIS;JUVENILE IDIOPATHIC;SEASONAL ALLERGIC;BONE MARROW;HUMAN NATURAL;HUMAN NEUROBLASTOMA;ITALIAN PATIENTS;KILLER CELLS;NEUROBLASTOMA CELLS;RISK EFTS;ACUTE LYMPHOBLASTIC;CELL LINES;CELL TRANSPLANTATION;CEREBROSPINAL FLUID;DENDRITIC CELLS;HUMAN NK;LYMPHOBLASTIC LEUKEMIA;MARROW TRANSPLANTATION;NK CELL;PERENNIAL ALLERGIC;PERIPHERAL BLOOD;STEM CELL;ACUTE GRAFT-VERSUS-HOST;ALLOGENEIC BONE;ANTISENSE OLIGONUCLEOTIDES;ASSOCIAZIONE ITALIANA;ASTHMATIC CHILDREN;ATPB GENE","9;9;7;7;5;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2","PUBMED SCOPUS;CROSSREF PUBMED;NK CELLS;BIOL CHEM;CHEM -ABSTRACT;CELL LINES;DE FLORA;PUBMED GOOGLE;NK CELL;BUTYL ISOCYANIDE;LUKACS GL;WILD TYPE;CD CELLS;CF MICE;PROTEIN MATRIX;TYPE MICE;XE SITE;BONE MARROW;CB MNC;GALIETTA LJ;HEME DISTAL;IODIDE INFLUX;LJ VERKMAN;POLLEN SEASON;STROMAL CELLS;Å NA;ACR PEDIATRIC;AMINO ACID;NASAL PDS;SCIENCE -CROSSREF","113;83;39;33;33;32;26;22;18;16;16;15;13;13;13;13;13;12;11;11;11;11;11;11;11;11;10;10;10;10",53,0.24,6,8,0,0,0,1,10,1,1,8,0,1,1,0,3,0,0,1,0,0,0,89,90,3,1,2,2,0,0,0,0,0,0,0,0,4,0,1,7.5,2.8,2.29,2,0,3,5,1,1,0,0,0,1,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"ALLEN THERESA M;CORTI ANGELO;LI PIRA GIUSEPPINA;MANCA FABRIZIO;PONZONI MIRCO;BOTTONE LAURA;BOTTONE, LAURA;GAZZOLO DIEGO;MICHETTI FABRIZIO","2;2;2;2;2;1;1;1;1","ISTITUTO GIANNINA GASLINI;FABRIZIO MICHETTI;FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR;G GASLINI CHILDRENS HOSPITAL;INDIVIDUAL;INSTITUTO GIANNINA GASLINI;LI PIRA GIUSEPPINA;MANCA FABRIZIO;UNIVERSITY OF ALBERTA","2;1;1;1;1;1;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;49 MATHEMATICAL SCIENCES;3206 MEDICAL BIOTECHNOLOGY;3207 MEDICAL MICROBIOLOGY;4904 PURE MATHEMATICS","4;2;1;1;1","BIOTECHNOLOGY;BREAST CANCER;CANCER","1;1;1","5.1 PHARMACEUTICALS;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS","2;1","A61K38/10;A61K31/00;A61K31/704;A61K38/00;A61K38/08;A61K38/16;A61K39/00;A61K9/127;C07K14/045;G01N33/569","3;2;2;2;2;2;2;2;2;2","A61K2039/5154;A61K2039/5158;A61K2039/53;A61K31/00;A61K31/704;A61K38/08;A61K38/10;A61K38/162;A61K39/00;A61K9/127","2;2;2;2;2;2;2;2;2;2",2,0,140,0.64,0,0,1,0,0,2,0,0,0,0,0,0,1,0,0,0,0,0,0,0,2,0,0,1,1,0,0,0,0,0,0,0,0,"United Kingdom","1","32 BIOMEDICAL AND CLINICAL SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS","2;1;1;1","CLINICAL RESEARCH;RARE DISEASES;CANCER;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;HEMATOLOGY;NEUROBLASTOMA;NEUROSCIENCES;PATIENT SAFETY;PEDIATRIC;PEDIATRIC CANCER;STEM CELL RESEARCH","2;2;1;1;1;1;1;1;1;1;1","CANCER","1","6.4 SURGERY;7.3 MANAGEMENT AND DECISION MAKING","1;1","LEUKEMIA / LEUKAEMIA;NEUROBLASTOMA","1;1","4.3 TECHNOLOGY AND/OR MARKER TESTING IN A CLINICAL SETTING;5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","1;1",4,3560125,244485.81,4,11.25,5.25,0.75,13.5,611698.071474359,0.367828526020507,"ISTITUTO GIANNINA GASLINI;AMSTERDAM UMC LOCATION VUMC;ANTHONY NOLAN;AUTONOMOUS UNIVERSITY OF MADRID;BAMBINO GESÙ CHILDREN'S HOSPITAL;BAYER (GERMANY);CANCER RESEARCH UK;CATHOLIC UNIVERSITY OF THE SACRED HEART;CHARLES UNIVERSITY;DÉLÉGATION PARIS 11;DÉLÉGATION PROVENCE ET CORSE;ETH ZURICH;EUROPEAN SCHOOL OF HAEMATOLOGY;FEDERAL MEDICAL-BIOLOGICAL AGENCY;FONDAZIONE ISTITUTO NEUROLOGICO NAZIONALE CASIMIRO MONDINO;HEIDELBERG UNIVERSITY;HELIOS KLINIKUM ERFURT;HELMHOLTZ ZENTRUM MÜNCHEN;HOSPITAL DE CLÍNICAS UNIVERSIDADE FEDERAL DO PARANÁ;INNATE PHARMA (FRANCE)","4;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","EUROPEAN COMMISSION;TELETHON FOUNDATION","2;2","COALITION S;EC & ERC - EUROPEAN UNION","2;2","FP6-2002-LIFESCIHEALTH (CALL FOR PROPOSAL);FP6-LIFESCIHEALTH - LIFE SCIENCES, GENOMICS AND BIOTECHNOLOGY FOR HEALTH: THEMATIC PRIORITY 1 UNDER THE FOCUSING AND INTEGRATING COMMUNITY RESEARCH PROGRAMME 2002-2006. (PROGRAMME);IIF - MARIE CURIE ACTIONS-INCOMING INTERNATIONAL FELLOWSHIPS (FUNDING SCHEME);IP - INTEGRATED PROJECT (FUNDING SCHEME);TELETHON - UILDM CLINICAL GRANT PROJECTS - 2003 (PROGRAM);TELETHON GRANT PROJECTS - 2004 (PROGRAM)","2;2;1;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;3105 GENETICS;3202 CLINICAL SCIENCES;3204 IMMUNOLOGY;3211 ONCOLOGY AND CARCINOGENESIS","4;1;1;1;1;1","CLINICAL RESEARCH;PEDIATRIC;RARE DISEASES;BIOTECHNOLOGY;CANCER;CONGENITAL STRUCTURAL ANOMALIES;GENETICS;NEURODEGENERATIVE;NEUROSCIENCES;ORPHAN DRUG;PREVENTION;REGENERATIVE MEDICINE;SPINAL MUSCULAR ATROPHY;STEM CELL RESEARCH;STEM CELL RESEARCH - NONEMBRYONIC - HUMAN;STEM CELL RESEARCH - NONEMBRYONIC - NON-HUMAN;TRANSPLANTATION","2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CANCER;NEUROLOGICAL","2;1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;5.2 CELLULAR AND GENE THERAPIES;5.1 PHARMACEUTICALS","2;2;1","NOT SITE-SPECIFIC CANCER;HODGKIN'S DISEASE;LEUKEMIA / LEUKAEMIA;MYELOMA;NON-HODGKIN'S LYMPHOMA","2;1;1;1;1","5.3 SYSTEMIC THERAPIES - DISCOVERY AND DEVELOPMENT","2","A01 CLINICAL MEDICINE;A04 PSYCHOLOGY, PSYCHIATRY AND NEUROSCIENCE","3;1","3 GOOD HEALTH AND WELL BEING","1",0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_GASLINI",2005,237,8.38818565400844,2.92827004219409,0.430379746835443,0.40506329113924,0.455696202531646,1.88679245283019,1.17241379310345,1.53968253968254,1.21348314606742,0.371308016877637,8,118,50,28,26,0.5,0.21,0.12,0.11,57.56,1.08721434848534,NA,0.383966244725738,0.856540084388186,0.47,0.38,0.393,0.429,"ANGELA PISTORIO;LORENZO MORETTA;ALBERTO MARTINI;GIORGIO CIPRANDI;ROBERTO RAVAZZOLO;ELIO CASTAGNOLA;FRANCO LOCATELLI;ANGELO RAVELLI;ANDREA VIZZACCARO;IGNAZIO CIRILLO;ANGELO CLAUDIO MOLINARI;GIOVANNI A. ROSSI;NICOLINO RUPERTO;MIRELLA FILOCAMO;GIORGIO DINI;ALESSANDRO MORETTA;MARIA ANGELA TOSCA;ISABELLA CECCHERINI;CARLO MINETTI;ENRICO MILLO","13;12;12;11;11;9;9;9;9;9;8;8;8;8;8;8;7;7;7;7","ELIO CASTAGNOLA;GIORGIO CIPRANDI;NAZZARENO DIMASI;ROBERTO RAVAZZOLO;ALBERTO MARTINI;ELENA BATTISTINI;LORENZO MORETTA;NICOLINO RUPERTO;ARIEL MUNITZ;ROBERTO BIASSONI;ANGELO CLAUDIO MOLINARI;ANGELA PISTORIO;ANDREA VIZZACCARO;IGNAZIO CIRILLO;ANGELO RAVELLI;GIOVANNI A. ROSSI;MARIA ANGELA TOSCA;BRUNO DE BERNARDI;FRANCESCA FIOREDDA;ISABELLA CECCHERINI","1.95;1.94;1.75;1.68;1.62;1.54;1.54;1.53;1.48;1.45;1.45;1.44;1.44;1.44;1.44;1.36;1.3;1.23;1.21;1.19","ANGELA PISTORIO;LORENZO MORETTA;ALBERTO MARTINI;ROBERTO RAVAZZOLO;ELIO CASTAGNOLA;ANGELO RAVELLI;ANGELO CLAUDIO MOLINARI;GIOVANNI A. ROSSI;NICOLINO RUPERTO;MIRELLA FILOCAMO;GIORGIO DINI;ALESSANDRO MORETTA;MARIA ANGELA TOSCA;ISABELLA CECCHERINI;CARLO MINETTI;ENRICO MILLO;RICCARDO HAUPT;FABRIZIO GINEVRI;MICHELA SILVESTRI;CLAUDIO GAMBINI","13;12;12;11;9;9;8;8;8;8;8;8;7;7;7;7;7;7;7;6","ELIO CASTAGNOLA;NAZZARENO DIMASI;ROBERTO RAVAZZOLO;ALBERTO MARTINI;ELENA BATTISTINI;LORENZO MORETTA;NICOLINO RUPERTO;ARIEL MUNITZ;ROBERTO BIASSONI;ANGELO CLAUDIO MOLINARI;ANGELA PISTORIO;ANGELO RAVELLI;GIOVANNI A. ROSSI;MARIA ANGELA TOSCA;BRUNO DE BERNARDI;FRANCESCA FIOREDDA;ISABELLA CECCHERINI;OLGA ZEGARRA‐MORAN;MIRELLA FILOCAMO;FEDERICO ZARA","1.95;1.75;1.68;1.62;1.54;1.54;1.53;1.48;1.45;1.45;1.44;1.44;1.36;1.3;1.23;1.21;1.19;1.18;1.1;1.07","LORENZO MORETTA;ANDREA CAPOBIANCO;GRAZIA MARIA SPAGGIARI;ALESSANDRO MORETTA;ALBERTO MARTINI;MARIA CRISTINA MINGARI;S. BECCHETTI;NICOLINO RUPERTO;OLGA ZEGARRA‐MORAN;LUIS J. V. GALIETTA;MIRELLA FILOCAMO;ANGELO RAVELLI;NICOLETTA PEDEMONTE;ANGELA PISTORIO;MARIELLA DELLA CHIESA;HIROFUMI OHASHI;HIROSHI KAWAME;KENJI KUROSAWA;KUMI KATO;SHIGEO KURE","2310;1273;1273;1136;1121;1121;1016;927;871;853;829;820;739;710;668;643;643;643;643;643","LORENZO MORETTA;ANDREA CAPOBIANCO;GRAZIA MARIA SPAGGIARI;MARIA CRISTINA MINGARI;S. BECCHETTI;OLGA ZEGARRA‐MORAN;LUIS J. V. GALIETTA;MIRELLA FILOCAMO;NICOLINO RUPERTO;ANGELA PISTORIO;ALBERTO MARTINI;ANGELO RAVELLI;ALESSANDRO MORETTA;DANIELA PENDE;EMANUELA CACI;MARIA ANGELA TOSCA;GIOVANNI A. ROSSI;ROBERTO RAVAZZOLO;MARIELLA DELLA CHIESA;MASSIMO VITALE","2310;1273;1273;1016;1016;871;853;829;752;710;687;643;640;640;576;480;437;421;383;383","ANGELA PISTORIO;LORENZO MORETTA;MARIA ANGELA TOSCA;ROBERTO RAVAZZOLO;ALBERTO MARTINI;GIOVANNI A. ROSSI;MIRELLA FILOCAMO;ELIO CASTAGNOLA;ISABELLA CECCHERINI;ANGELO CLAUDIO MOLINARI;ANGELO RAVELLI;ENRICO MILLO;MICHELA SILVESTRI;NICOLINO RUPERTO;CARLO MINETTI;FABRIZIO GINEVRI;RICCARDO HAUPT;GIORGIO DINI;VITO PISTOIA;ELENA BATTISTINI","13;12;11;11;8;8;8;8;7;7;7;7;7;7;6;6;6;6;6;5","MEDICINE;BIOLOGY;CHEMISTRY;PHYSICS;COMPUTER SCIENCE;PSYCHOLOGY;SOCIOLOGY;ECONOMICS;PHILOSOPHY;POLITICAL SCIENCE;MATHEMATICS;ENGINEERING;BUSINESS;MATERIALS SCIENCE","175;135;41;14;10;6;6;5;4;4;3;2;1;1","INTERNAL MEDICINE;GENETICS;IMMUNOLOGY;BIOCHEMISTRY;PATHOLOGY;SURGERY;MOLECULAR BIOLOGY;PEDIATRICS;CELL BIOLOGY;ENDOCRINOLOGY;GASTROENTEROLOGY;CANCER RESEARCH;PHARMACOLOGY;ORGANIC CHEMISTRY;ENVIRONMENTAL HEALTH;NEUROSCIENCE;PSYCHIATRY;PHYSICAL THERAPY;ONCOLOGY;OPTICS","122;89;87;62;40;37;30;29;28;26;23;19;16;12;11;10;10;9;8;8","GENE;IN VITRO;DISEASE;IMMUNE SYSTEM;ANTIBODY;RECEPTOR;ASTHMA;TRANSPLANTATION;CELL CULTURE;POPULATION;ARTHRITIS;CHEMOTHERAPY;CYTOKINE;ALLERGY;CANCER;LUNG;ANTIGEN;ENZYME;PREGNANCY;CELL;KIDNEY","67;34;32;30;24;20;19;16;14;13;12;12;12;11;11;11;10;10;10;8;8","MUTATION;CYTOTOXIC T CELL;ALLELE;CD8;T CELL;NEUROBLASTOMA;EOSINOPHIL;RESPIRATORY DISEASE;GENOTYPE;MUTANT;GENE EXPRESSION;CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR;CELL CYCLE;JUVENILE RHEUMATOID ARTHRITIS;ALLERGEN;AUTOANTIBODY;CHROMOSOME;CYCLOPHOSPHAMIDE;EXON;FETUS;GESTATIONAL AGE;HEMATOPOIETIC STEM CELL TRANSPLANTATION;IMMUNOTHERAPY;INNATE IMMUNE SYSTEM;KIDNEY TRANSPLANTATION;MONOCLONAL ANTIBODY;NASAL LAVAGE;PERIPHERAL BLOOD MONONUCLEAR CELL;TRANSCRIPTION FACTOR;TRANSFECTION","21;18;14;13;13;11;10;10;9;9;8;7;6;6;5;5;5;5;5;5;5;5;5;5;5;5;5;5;5;5","INTERLEUKIN 21;INTERLEUKIN 12;MISSENSE MUTATION;CTL*;BRONCHIAL HYPERREACTIVITY;CYTOLYSIS;KARYOTYPE;METHACHOLINE;TOTAL BODY IRRADIATION;ANTI-NUCLEAR ANTIBODY;CHEMOKINE RECEPTOR;FOCAL SEGMENTAL GLOMERULOSCLEROSIS;GENE MUTATION;GERMLINE MUTATION;HAPLOTYPE;IL-2 RECEPTOR;MHC CLASS I;NATURAL KILLER CELL;OLIGOARTHRITIS;ONCOGENE;PERFORIN;PRENATAL DIAGNOSIS;PROBAND;SINGLE-NUCLEOTIDE POLYMORPHISM","7;6;6;5;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3","HUMANS;MALE;FEMALE;CHILD;CHILD, PRESCHOOL;ADULT;ADOLESCENT;ANIMALS;NEUROBLASTOMA;ARTHRITIS, JUVENILE;;INFANT;NEOPLASMS;KILLER CELLS, NATURAL;RHINITIS, ALLERGIC, PERENNIAL;INFLAMMATION;ASTHMA;MICE;CYTOKINES;MUTATION","189;115;111;71;52;48;47;42;38;34;32;32;32;27;27;25;23;23;22;22","NATURAL KILLER CELLS IN IMMUNITY;HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS AND RELATED DISORDERS;ALLERGIC RHINITIS AND ITS IMPACT ON ASTHMA;NEUROBLASTOMA RESEARCH AND TREATMENT;THERAPEUTIC ADVANCES IN CYSTIC FIBROSIS RESEARCH;ASTHMA;HIRSCHSPRUNG DISEASE AND ENTERIC NERVOUS SYSTEM DEVELOPMENT;PEDIATRIC CANCER AND QUALITY OF LIFE;EPIDEMIOLOGY AND TREATMENT OF CHILDHOOD LEUKEMIA;GLYCOGEN METABOLISM AND MYOCLONIC DISORDERS;HEPATITIS C INFECTION AND TREATMENT;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;PATHOPHYSIOLOGY OF GLOMERULAR DISEASES AND NEPHROTIC SYNDROMES;EPIDEMIOLOGY AND MANAGEMENT OF CYTOMEGALOVIRUS INFECTION;GENETICS AND PATHOGENESIS OF TYPE 1 DIABETES;GLIOMAS;HEMATOPOIETIC STEM CELL BIOLOGY;KIDNEY TRANSPLANTATION;MULTIPOTENT MESENCHYMAL STEM CELLS;PATHOGENESIS AND TREATMENT OF SYSTEMIC SCLEROSIS","13;12;10;10;9;8;6;5;4;4;4;4;4;3;3;3;3;3;3;3","NEUROBLASTOMA;NK CELL RECOGNITION;JUVENILE IDIOPATHIC ARTHRITIS;NK CELL ACTIVATION;SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS;NK CELL DEVELOPMENT;TREATMENT;CFTR;NK CELL RECEPTORS;PATHOGENESIS;CHLORIDE CHANNEL;JUVENILE RHEUMATOID ARTHRITIS;POLLEN ALLERGY;ALLERGIC INFLAMMATION;CTL*;HEMATOPOIETIC CELL TRANSPLANTATION;NASAL LAVAGE;NK CELL THERAPY;TREATMENT OUTCOMES;BRONCHIAL HYPERREACTIVITY","10;10;9;9;9;8;8;7;7;7;6;6;6;5;5;5;5;5;5;4","IDIOPATHIC ARTHRITIS;JUVENILE IDIOPATHIC;ALLERGIC RHINITIS;CYSTIC FIBROSIS;BONE MARROW;STEM CELL;ACUTE LYMPHOBLASTIC;CONDUCTANCE REGULATOR;DENDRITIC CELLS;FIBROSIS TRANSMEMBRANE;ITALIAN CHILDREN;MESENCHYMAL STEM;TRANSMEMBRANE CONDUCTANCE;CELL TRANSPLANTATION;DIABETES MELLITUS;DISEASE ACTIVITY;KILLER CELL;MARROW TRANSPLANTATION;NK CELL;NK CELLS;PULMONARY FUNCTION;STEM CELLS;TYPE DIABETES;VON WILLEBRAND;ALI VACCINATION;ALLERGEN CHALLENGE;ALLERGIC INFLAMMATION;APLASTIC ANEMIA;ASTHMA CHARACTERISTICS;BLOOD LEVELS","10;10;8;8;5;5;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2","NK CELLS;PEDIATRIC SPECIALISTS;CLINICAL TRIALS;CLINICAL TRIAL;AUTOLOGOUS EBV-SPECIFIC;DISEASE ACTIVITY;PERIPHERAL BLOOD;CORE SET;ALLERGIC RHINITIS;CTL LINES;IRCCS POLICLINICO;MATTEO PAVIA;SPECIALISTS AGREED;EBV DNA;NK CELL;TRANSPLANT IMMUNOLOGY;TRIAL DESIGN;DC MATURATION;EBV-SPECIFIC CTL;EBV-SPECIFIC CTLS;HEMATOLOGYONCOLOGY IRCCS;HR CI;NERVOUS SYSTEM;PAVIA ITALYSEARCH;PEDIATRIC HEMATOLOGYONCOLOGY;CELL LINES;DESIGN ISSUES;EBV-RELATED PTLD;PEDIATRIC NEPHROLOGY;ADULT SPECIALISTS","38;22;21;16;13;13;13;12;10;10;10;10;10;9;9;9;9;8;8;8;8;8;8;8;8;7;7;7;7;6",49,0.21,6,5,0,0,0,3,9,1,1,6,0,1,1,0,3,0,0,1,1,0,0,70,70,1,0,0,1,0,0,1,0,0,0,0,2,0,3,1,0,2,1.14,1.25,0,1,4,0,0,1,0,0,0,1,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"GAZZOLO DIEGO;MICHETTI FABRIZIO","4;4","ISTITUTO GIANNINA GASLINI;ISTITUTO GIANNINA GASLINI GENU;MICHETTI FABRIZIO","3;1;1","30 AGRICULTURAL, VETERINARY AND FOOD SCIENCES;49 MATHEMATICAL SCIENCES;3006 FOOD SCIENCES;31 BIOLOGICAL SCIENCES;3102 BIOINFORMATICS AND COMPUTATIONAL BIOLOGY;32 BIOMEDICAL AND CLINICAL SCIENCES;44 HUMAN SOCIETY;4410 SOCIOLOGY;4901 APPLIED MATHEMATICS","3;2;1;1;1;1;1;1;1",NA,NA,NA,NA,"A23C11/06;A23C9/15;A23C9/152;A23L1/29;A23L1/305;A23L33/00","4;4;4;4;4;4","A23C11/065;A23C9/1512;A23L33/17;A23L33/40;Y10S426/801","4;4;4;4;4",10,5,148.67,3.01,0,0,5.4,1,0,3,1,5,0,0,0,0,3,0,0,0,0,0,0,0,10,0,0,3,7,0,0,0,0,0,0,0,0,"Germany;Italy","2;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;3107 MICROBIOLOGY;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3204 IMMUNOLOGY;3212 OPHTHALMOLOGY AND OPTOMETRY;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;44 HUMAN SOCIETY;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY","8;3;1;1;1;1;1;1;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;PEDIATRIC;RARE DISEASES;CANCER;HEMATOLOGY;PREVENTION;STEM CELL RESEARCH;ARTHRITIS;AUTOIMMUNE DISEASE;CYSTIC FIBROSIS;DIABETES;IMMUNIZATION;LUNG;NEUROBLASTOMA;NEUROSCIENCES;NUTRITION;ORPHAN DRUG;REGENERATIVE MEDICINE;STEM CELL RESEARCH - NONEMBRYONIC - HUMAN","4;4;3;3;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1","CANCER;CONGENITAL;INFLAMMATORY AND IMMUNE SYSTEM","2;2;2","6.1 PHARMACEUTICALS;5.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES;7.1 INDIVIDUAL CARE NEEDS","4;1;1;1","NEUROBLASTOMA;ANAL CANCER;LEUKEMIA / LEUKAEMIA;NOT SITE-SPECIFIC CANCER","2;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","2",6,1068050,187941.92,4,4.5,2.5,0.5,10.5,724902.145337995,0.326940679544403,"ISTITUTO GIANNINA GASLINI;IMPERIAL COLLEGE LONDON;ANTONI VAN LEEUWENHOEK HOSPITAL;COMENIUS UNIVERSITY;ERASMUS MC;FRAUNHOFER SOCIETY;HÔPITAL RENÉ HUGUENIN;INSTITUT GUSTAVE ROUSSY;INTERNATIONAL AGENCY FOR RESEARCH ON CANCER;IRCCS OSPEDALE SAN RAFFAELE;LUDWIG-MAXIMILIANS-UNIVERSITÄT MÜNCHEN;LUND UNIVERSITY;OZ BIOSCIENCES (FRANCE);RECHTS DER ISAR HOSPITAL;ROYAL MARSDEN HOSPITAL;SAPIENZA UNIVERSITY OF ROME;SWANSEA UNIVERSITY;UNIVERSITY OF BIRMINGHAM;UNIVERSITY OF CAMBRIDGE;UNIVERSITY OF GENOA","6;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","TELETHON FOUNDATION;EUROPEAN COMMISSION","4;2","COALITION S;EC & ERC - EUROPEAN UNION","2;2","TELETHON GRANT PROJECTS - 2005 (PROGRAM);STREP - SPECIFIC TARGETED RESEARCH PROJECT (FUNDING SCHEME);EURATOMCALL2004-FIXEDDEADLINE (CALL FOR PROPOSAL);FP6-2003-LIFESCIHEALTH-I (CALL FOR PROPOSAL);FP6-EURATOM-RADPROT - THEMATIC PRIORITY - RADIATION PROTECTION AS PART OF THE SPECIFIC FRAMEWORK PROGRAMME FOR THE EUROPEAN ATOMIC ENERGY COMMUNITY, WITHIN THE MULTI-ANNUAL FRAMEWORK PROGRAMME 2002-2006. (PROGRAMME);FP6-LIFESCIHEALTH - LIFE SCIENCES, GENOMICS AND BIOTECHNOLOGY FOR HEALTH: THEMATIC PRIORITY 1 UNDER THE FOCUSING AND INTEGRATING COMMUNITY RESEARCH PROGRAMME 2002-2006. (PROGRAMME);TELETHON RESEARCH SERVICES AND FACILITIES - 2004 (PROGRAM)","3;2;1;1;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;3105 GENETICS;3208 MEDICAL PHYSIOLOGY;3211 ONCOLOGY AND CARCINOGENESIS;34 CHEMICAL SCIENCES;3404 MEDICINAL AND BIOMOLECULAR CHEMISTRY;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS","6;3;3;1;1;1;1;1;1","GENETICS;PEDIATRIC;BIOTECHNOLOGY;RARE DISEASES;BRAIN DISORDERS;CLINICAL RESEARCH;CYSTIC FIBROSIS;GENETIC TESTING;LUNG;NEURODEGENERATIVE;NEUROSCIENCES;PREVENTION;BIOENGINEERING;BREAST CANCER;CANCER;EPILEPSY;HUMAN GENOME;NANOTECHNOLOGY;ORPHAN DRUG","5;4;3;3;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1","NEUROLOGICAL;CANCER;CONGENITAL","2;1;1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;2.2 FACTORS RELATING TO THE PHYSICAL ENVIRONMENT;2.6 RESOURCES AND INFRASTRUCTURE (AETIOLOGY);5.1 PHARMACEUTICALS;6.1 PHARMACEUTICALS","4;1;1;1;1","BREAST CANCER","1","2.1 EXOGENOUS FACTORS IN THE ORIGIN AND CAUSE OF CANCER;2.2 ENDOGENOUS FACTORS IN THE ORIGIN AND CAUSE OF CANCER;2.3 INTERACTIONS OF GENES AND/OR GENETIC POLYMORPHISMS WITH EXOGENOUS AND/OR ENDOGENOUS FACTORS;2.4 RESOURCES AND INFRASTRUCTURE RELATED TO ETIOLOGY;6.2 SURVEILLANCE","1;1;1;1;1","A01 CLINICAL MEDICINE;A02 PUBLIC HEALTH, HEALTH SERVICES AND PRIMARY CARE;A03 ALLIED HEALTH PROFESSIONS, DENTISTRY, NURSING AND PHARMACY;A04 PSYCHOLOGY, PSYCHIATRY AND NEUROSCIENCE","4;1;1;1","3 GOOD HEALTH AND WELL BEING","1",0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_GASLINI",2006,260,8.91153846153846,2.98846153846154,0.423076923076923,0.411538461538462,0.45,2.03403141361257,1.20879120879121,1.48611111111111,1.31460674157303,0.361538461538462,5,116,73,28,30,0.45,0.28,0.11,0.12,37.83,0.740719329693207,NA,0.323076923076923,0.880769230769231,0.446,0.435,0.441,0.446,"CARLO MINETTI;FEDERICO ZARA;ANDREA ROSSI;GIAN MARCO GHIGGERI;FEDERICO PREFUMO;ROBERTO RAVAZZOLO;PASQUALE STRIANO;ISABELLA CECCHERINI;RICCARDO HAUPT;GIORGIO CIPRANDI;ENRICO BERTINI;VITO PISTOIA;DENISE CASSANDRINI;CLAUDIO BRUNO;PAOLO NOZZA;MARIA LUISA GARRÈ;IGNAZIO CIRILLO;GIOVANNI CANDIANO;STEFANO PARODI;LORENZO MORETTA","17;17;15;14;12;12;10;9;9;9;9;9;9;9;8;8;8;7;7;7","FEDERICO PREFUMO;ANDREA ROSSI;GIORGIO CIPRANDI;MARIA VALERIA CORRIAS;PAOLO NOZZA;CARLO MINETTI;ROBERTO RAVAZZOLO;GIAN MARCO GHIGGERI;NAZZARENO DIMASI;FEDERICO ZARA;IGNAZIO CIRILLO;G. SERRA;GIAN LUIGI MARSEGLIA;ISABELLA CECCHERINI;GIUSEPPINA LI PIRA;FABRIZIO MANCA;VITO PISTOIA;LORENZO MORETTA;ALESSIO PINI PRATO;EVELYN M.L. SKLAR","2.13;1.81;1.72;1.69;1.6;1.58;1.53;1.45;1.42;1.41;1.39;1.33;1.19;1.17;1.13;1.13;1.12;1.06;1.04;1","CARLO MINETTI;FEDERICO ZARA;ANDREA ROSSI;GIAN MARCO GHIGGERI;FEDERICO PREFUMO;ROBERTO RAVAZZOLO;PASQUALE STRIANO;ISABELLA CECCHERINI;RICCARDO HAUPT;VITO PISTOIA;DENISE CASSANDRINI;CLAUDIO BRUNO;PAOLO NOZZA;MARIA LUISA GARRÈ;GIOVANNI CANDIANO;STEFANO PARODI;LORENZO MORETTA;GIANLUCA CARIDI;MARIA VALERIA CORRIAS;FRANCESCO PERFUMO","17;17;15;14;12;12;10;9;9;9;9;9;8;8;7;7;7;7;7;7","FEDERICO PREFUMO;ANDREA ROSSI;MARIA VALERIA CORRIAS;PAOLO NOZZA;CARLO MINETTI;ROBERTO RAVAZZOLO;GIAN MARCO GHIGGERI;NAZZARENO DIMASI;FEDERICO ZARA;G. SERRA;ISABELLA CECCHERINI;GIUSEPPINA LI PIRA;FABRIZIO MANCA;VITO PISTOIA;LORENZO MORETTA;ALESSIO PINI PRATO;EVELYN M.L. SKLAR;STEFANIA FONTANA;RICCARDO HAUPT;MARIA LUISA GARRÈ","2.13;1.81;1.69;1.6;1.58;1.53;1.45;1.42;1.41;1.33;1.17;1.13;1.13;1.12;1.06;1.04;1;1;0.99;0.98","FEDERICO ZARA;CARLO MINETTI;LORENZO MORETTA;GIAN MARCO GHIGGERI;CLAUDIO BRUNO;ANDREA ROSSI;ALBERTO MARTINI;ENRICO BERTINI;ROBERTO RAVAZZOLO;PASQUALE STRIANO;VITO PISTOIA;ISABELLA CECCHERINI;ALESSANDRO MORETTA;ANNALISA PEZZOLO;MICHAEL P. LISANTI;DOMÉNICO RIBATTI;MIRCO PONZONI;SIMONA CARLOMAGNO;MARIELLA DELLA CHIESA;MICHELE CILLI","950;811;805;740;547;545;543;538;527;522;502;487;484;438;426;411;410;410;409;406","LORENZO MORETTA;GIAN MARCO GHIGGERI;CARLO MINETTI;FEDERICO ZARA;ROBERTO RAVAZZOLO;VITO PISTOIA;ANNALISA PEZZOLO;CLAUDIO BRUNO;MICHAEL P. LISANTI;ANDREA ROSSI;MIRCO PONZONI;ALESSANDRO MORETTA;MARIELLA DELLA CHIESA;GABRIELLA PAGNAN;DANILO MARIMPIETRI;CHIARA BRIGNOLE;DANIELA DI PAOLO;FABIO PASTORINO;ISABELLA CECCHERINI;R. GAGGERO","805;712;690;657;476;453;434;426;426;418;410;409;409;390;388;368;368;368;365;364","ANDREA ROSSI;GIAN MARCO GHIGGERI;FEDERICO PREFUMO;FEDERICO ZARA;CARLO MINETTI;ROBERTO RAVAZZOLO;RICCARDO HAUPT;CLAUDIO BRUNO;MIRELLA FILOCAMO;STEFANO PARODI;ARMANDO CAMA;FRANCESCO PERFUMO;LORENZO MORETTA;MARIA LUISA GARRÈ;MARIA VALERIA CORRIAS;PAOLO NOZZA;VITO PISTOIA;ISABELLA CECCHERINI;MAJA DI ROCCO;GIANLUCA CARIDI","15;13;12;12;12;10;9;8;7;7;7;7;7;7;7;7;7;6;6;6","MEDICINE;BIOLOGY;CHEMISTRY;PHYSICS;COMPUTER SCIENCE;ENGINEERING;MATHEMATICS;PSYCHOLOGY;PHILOSOPHY;SOCIOLOGY;ECONOMICS;MATERIALS SCIENCE;POLITICAL SCIENCE;BUSINESS;GEOGRAPHY","203;159;21;18;14;8;7;7;4;3;2;2;2;1;1","INTERNAL MEDICINE;GENETICS;IMMUNOLOGY;PATHOLOGY;SURGERY;PEDIATRICS;BIOCHEMISTRY;CELL BIOLOGY;ENDOCRINOLOGY;RADIOLOGY;MOLECULAR BIOLOGY;CANCER RESEARCH;ANATOMY;PSYCHIATRY;GASTROENTEROLOGY;ANESTHESIA;ENVIRONMENTAL HEALTH;ONCOLOGY;CARDIOLOGY;INTENSIVE CARE MEDICINE","120;118;62;50;49;42;38;36;33;31;30;29;22;22;18;12;12;11;10;10","GENE;DISEASE;IMMUNE SYSTEM;IN VITRO;PREGNANCY;CANCER;CELL CULTURE;MAGNETIC RESONANCE IMAGING;POPULATION;RECEPTOR;ASTHMA;EPILEPSY;KIDNEY;TRANSPLANTATION;ANTIBODY;ANTIGEN;LESION;APOPTOSIS;CHEMOTHERAPY;STEM CELL","77;26;25;19;18;16;15;12;12;12;11;11;11;11;10;9;9;8;8;8","MUTATION;PHENOTYPE;GENE EXPRESSION;NEUROBLASTOMA;T CELL;CYTOTOXIC T CELL;ALLELE;FETUS;GENOTYPE;CD8;INNATE IMMUNE SYSTEM;BREAST CANCER;CHROMOSOME;MUTANT;PROTEINURIA;TRANSCRIPTION FACTOR;AUTOIMMUNITY;EXON;HAEMATOPOIESIS;IMMUNITY;RNA;SPIROMETRY","25;17;13;13;13;12;11;10;10;9;7;6;6;6;6;6;5;5;5;5;5;5","MISSENSE MUTATION;HAPLOTYPE;INTERLEUKIN 21;PRENATAL DIAGNOSIS;PROMOTER;ANTIGEN-PRESENTING CELL;FOCAL SEGMENTAL GLOMERULOSCLEROSIS;GENETIC HETEROGENEITY;INTERLEUKIN 12;PERFORIN;RNA SPLICING;ADOPTIVE CELL TRANSFER;COMPOUND HETEROZYGOSITY;CTL*;CYTOLYSIS;FRAMESHIFT MUTATION;MAMMARY GLAND;NATURAL KILLER CELL;PODOCYTE;POINT MUTATION;PROBAND","12;5;5;5;5;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3","HUMANS;FEMALE;MALE;CHILD;CHILD, PRESCHOOL;ADULT;;ADOLESCENT;NEUROBLASTOMA;MUTATION;INFANT;ANIMALS;ITALY;KILLER CELLS, NATURAL;RNA, MESSENGER;MEMBRANE PROTEINS;CRANIOPHARYNGIOMA;PITUITARY NEOPLASMS;MAGNETIC RESONANCE IMAGING;MICE","195;115;108;86;60;57;49;49;46;41;35;34;34;28;25;24;23;22;20;20","NEUROBLASTOMA RESEARCH AND TREATMENT;NATURAL KILLER CELLS IN IMMUNITY;ALLERGIC RHINITIS AND ITS IMPACT ON ASTHMA;DIAGNOSIS AND MANAGEMENT OF PITUITARY DISORDERS;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;PATHOPHYSIOLOGY OF GLOMERULAR DISEASES AND NEPHROTIC SYNDROMES;ASTHMA;IMMUNOBIOLOGY OF DENDRITIC CELLS;INSULIN-LIKE GROWTH FACTORS IN HEALTH AND DISEASE;LYMPHANGIOGENESIS IN CANCER METASTASIS AND DISEASE;BIOLOGICAL ROLE OF CAVEOLAE IN CELLULAR PROCESSES;EPIDEMIOLOGY AND TREATMENT OF CHILDHOOD LEUKEMIA;EPILEPSY AND SEIZURES;HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS AND RELATED DISORDERS;HIRSCHSPRUNG DISEASE AND ENTERIC NERVOUS SYSTEM DEVELOPMENT;MOLECULAR BASIS OF RETT SYNDROME AND RELATED DISORDERS;CILIOPATHIES: GENETIC DISORDERS INVOLVING PRIMARY CILIA;DIAGNOSIS AND MANAGEMENT OF HEREDITARY HEMORRHAGIC TELANGIECTASIA;FUNCTIONS AND REGULATION OF RNA EDITING BY ADARS;GENE THERAPY FOR SPINAL MUSCULAR ATROPHY","13;9;7;6;6;6;5;5;5;5;4;4;4;4;4;4;3;3;3;3","NEUROBLASTOMA;NK CELL ACTIVATION;CRANIOPHARYNGIOMAS;NK CELL DEVELOPMENT;NK CELL RECOGNITION;NK CELL THERAPY;NONSENSE MUTATION;CRANIOPHARYNGIOMA;T CELL IMMUNITY;MATERNAL PLASMA DNA SEQUENCING;POLLEN ALLERGY;PRENATAL DIAGNOSIS;RHINOMANOMETRY;STROKE (ENGINE);SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS;TREATMENT OUTCOMES;ADOPTIVE CELL TRANSFER;CAVEOLIN;CHROMATIN IMMUNOPRECIPITATION;CODING REGION","15;8;6;6;6;6;6;5;5;4;4;4;4;4;4;4;3;3;3;3","ITALIAN PATIENTS;GROWTH HORMONE;IMMUNE RESPONSE;NEUROBLASTOMA CELLS;PRENATAL DIAGNOSIS;ALLERGIC RHINITIS;DELETION SYNDROME;HORMONE DEFICIENCY;HUMAN NEUROBLASTOMA;MUSCULAR ATROPHY;MYOCLONIC EPILEPSY;NASAL AIRFLOW;NK CELLS;PERIPHERAL BLOOD;PRETERM NEONATES;PULMONARY ARTERIOVENOUS;SEVERE MYOCLONIC;SPINAL MUSCULAR;STEM CELL;SYSTEMIC LUPUS;ABDOMINAL WALL;ADVERSE EFFECTS;ALLOGENEIC STEM;ARTERIOVENOUS MALFORMATIONS;BENIGN FAMILIAL;BONE MARROW;BOWEL DISEASE;BREAST CANCER;BRONCHIAL HYPERREACTIVITY;CAUDAL REGRESSION","5;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2","PUBMED SCOPUS;CROSSREF PUBMED;LISANTI MP;MAMMARY EPITHELIAL;BREAST CANCER;PESTELL RG;RG LISANTI;NK CELLS;EPITHELIAL CELLS;BIOL CHEM;GENET -CROSSREF;NPHP DEL;HUMAN BREAST;PUBMED GOOGLE;MAMMARY GLAND;CELL LINES;CHEM -CROSSREF;MP CAVEOLIN-;MULLER WJ;NPHS PROMOTER;DS RAZANI;EPITHELIAL CELL;GENE EXPRESSION;NEPHROTIC SYNDROME;PARK DS;CAVEOLIN- GENE;BREAST CANCERS;IGA NEPHROPATHY;GROWTH FACTOR;CHOPRA NG","218;170;68;50;45;43;35;34;33;32;32;30;28;28;26;23;23;22;22;21;19;19;19;19;19;18;17;17;16;15",42,0.16,3.44,3,1,1,0,0,7,1,1,4,0,1,1,1,2,0,0,1,1,0,0,54.5,54.5,2,0,0,0,0,0,0,0,1,0,0,1,1,1,0,0,2.5,0.64,3,0,1,2,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,"ALLEN THERESA M;CORTI ANGELO;GAZZOLO DIEGO;MICHETTI FABRIZIO;PONZONI MIRCO","1;1;1;1;1","FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR;G GASLINI CHILDREN'S HOSPITAL;GASLINI CHILDREN S HOSPITAL G;ISTITUTO GIANNINA GASLINI;SAN RAFFAELE CENTRO FOND;UNIVERSITY OF ALBERTA","1;1;1;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3206 MEDICAL BIOTECHNOLOGY;3213 PAEDIATRICS","4;1;1","BIOTECHNOLOGY;BREAST CANCER;CANCER;ORPHAN DRUG;RARE DISEASES","1;1;1;1;1","5.1 PHARMACEUTICALS","1","A23C11/06;A23C9/15;A23C9/152;A23L1/305;A23L33/00;A61K31/00;A61K31/704;A61K38/00;A61K38/08;A61K38/10","1;1;1;1;1;1;1;1;1;1","A23C11/065;A23C9/1512;A23L33/17;A23L33/40;A61K31/00;A61K31/704;A61K38/08;A61K38/10;A61K9/127;A61P35/00","1;1;1;1;1;1;1;1;1;1",9,7.33,391,2.65,1,0.11,5.11,0,0,5,0,3,0,1,0,0,3,0,0,0,0,0,0,0,9,0,0,3,6,0,0,0,0,0,0,0,0,"United States;United Kingdom","2;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;3107 MICROBIOLOGY;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3207 MEDICAL MICROBIOLOGY;30 AGRICULTURAL, VETERINARY AND FOOD SCIENCES;3009 VETERINARY SCIENCES","8;4;3;3;2;2;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;PEDIATRIC;ARTHRITIS;AUTOIMMUNE DISEASE;COMPARATIVE EFFECTIVENESS RESEARCH;LUPUS;NEUROSCIENCES;RARE DISEASES","3;3;3;2;2;2;1;1;1","INFLAMMATORY AND IMMUNE SYSTEM;INFECTION;RESPIRATORY;REPRODUCTIVE HEALTH AND CHILDBIRTH","3;2;2;1","6.1 PHARMACEUTICALS;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;5.1 PHARMACEUTICALS","3;1;1","NOT SITE-SPECIFIC CANCER;BLOOD CANCER;LEUKEMIA / LEUKAEMIA","3;2;2","6.1 PATIENT CARE AND SURVIVORSHIP ISSUES;5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","2;1",3,4896685.33,528368.53,3.66666666666667,7,4.33333333333333,0.666666666666667,18.6666666666667,1010613.68819514,0.257269422566733,"ISTITUTO GIANNINA GASLINI;ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS;BAMBINO GESÙ CHILDREN'S HOSPITAL;BASF (FRANCE);CHARITÉ - UNIVERSITY MEDICINE BERLIN;DÉLÉGATION PARIS 11;EUROPEAN GENETICS FOUNDATION;EUROPEAN ORGANIZATION FOR NUCLEAR RESEARCH;GRIFOLS (SPAIN);MEDICAL UNIVERSITY PLEVEN;NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS;SIEMENS (GERMANY);UNIVERSITY COLLEGE LONDON;UNIVERSITY OF ALCALÁ;UNIVERSITY OF BASILICATA;UNIVERSITY OF GENOA;UNIVERSITY OF MANCHESTER;UNIVERSITY OF MODENA AND REGGIO EMILIA;UNIVERSITY OF THE WEST OF ENGLAND","3;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","EUROPEAN COMMISSION;TELETHON FOUNDATION","2;1","COALITION S;EC & ERC - EUROPEAN UNION","2;2","FP6-2004-IST-4 (CALL FOR PROPOSAL);FP6-2004-LIFESCIHEALTH-5 (CALL FOR PROPOSAL);FP6-IST - INFORMATION SOCIETY TECHNOLOGIES: THEMATIC PRIORITY UNDER THE SPECIFIC PROGRAMME ""INTEGRATING AND STRENGTHENING THE EUROPEAN RESEARCH AREA"" (2002-2006). (PROGRAMME);FP6-LIFESCIHEALTH - LIFE SCIENCES, GENOMICS AND BIOTECHNOLOGY FOR HEALTH: THEMATIC PRIORITY 1 UNDER THE FOCUSING AND INTEGRATING COMMUNITY RESEARCH PROGRAMME 2002-2006. (PROGRAMME);IP - INTEGRATED PROJECT (FUNDING SCHEME);STREP - SPECIFIC TARGETED RESEARCH PROJECT (FUNDING SCHEME);TELETHON GRANT PROJECTS - 2006 (PROGRAM)","1;1;1;1;1;1;1","31 BIOLOGICAL SCIENCES;3101 BIOCHEMISTRY AND CELL BIOLOGY;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;46 INFORMATION AND COMPUTING SCIENCES;4605 DATA MANAGEMENT AND DATA SCIENCE","2;2;1;1;1;1","BIOTECHNOLOGY;BRAIN DISORDERS;CLINICAL RESEARCH;EPILEPSY;GENETICS;HEALTH SERVICES;NEURODEGENERATIVE;NEUROSCIENCES;PEDIATRIC;PREVENTION","1;1;1;1;1;1;1;1;1;1","GENERIC HEALTH RELEVANCE;NEUROLOGICAL","3;1","1.1 NORMAL BIOLOGICAL DEVELOPMENT AND FUNCTIONING;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;5.1 PHARMACEUTICALS","1;1;1","NOT SITE-SPECIFIC CANCER","1","1.1 NORMAL FUNCTIONING;1.3 CANCER INITIATION: ONCOGENES AND TUMOR SUPPRESSOR GENES","1;1","A01 CLINICAL MEDICINE;B11 COMPUTER SCIENCE AND INFORMATICS;B12 ENGINEERING","1;1;1","3 GOOD HEALTH AND WELL BEING","1",1,"PUBLIC LIBRARY OF SCIENCE","1","32 BIOMEDICAL AND CLINICAL SCIENCES;3204 IMMUNOLOGY","2;1","AUTOIMMUNE DISEASE;BIOTECHNOLOGY;CLINICAL RESEARCH;DIGESTIVE DISEASES;INFECTIOUS DISEASES;NUTRITION","1;1;1;1;1;1","INFLAMMATORY AND IMMUNE SYSTEM","1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS","1","BIOMEDICAL","1","BASIC SCIENCE","1",NA,NA,NA,NA
"IRCCS_GASLINI",2007,248,9.91532258064516,3.05645161290323,0.399193548387097,0.411290322580645,0.471774193548387,1.98950131233596,1.17857142857143,1.52238805970149,1.21875,0.370967741935484,0,132,50,23,26,0.53,0.2,0.09,0.1,57.93,1.09768571998561,NA,0.403225806451613,0.866935483870968,0.454,0.428,0.411,0.436,"CARLO MINETTI;LORENZO MORETTA;ALBERTO MARTINI;CLAUDIO BRUNO;FEDERICO ZARA;ANGELO RAVELLI;ROBERTA BIANCHERI;ANGELA PISTORIO;ROBERTO RAVAZZOLO;ANDREA ROSSI;MIRELLA FILOCAMO;DENISE CASSANDRINI;RENATA LORINI;GIAN MARCO GHIGGERI;MARIA GRAZIA CALEVO;ENRICO BERTINI;ALESSANDRO MORETTA;MOHAMAD MAGHNIE;FRANCO LOCATELLI;MARIA CRISTINA MINGARI","16;16;15;15;12;11;11;10;10;10;9;9;8;8;8;8;8;7;7;7","LORENZO MORETTA;ALBERTO MARTINI;CARLO MINETTI;MIRELLA FILOCAMO;CLAUDIO BRUNO;GIAN MARCO GHIGGERI;ANGELO RAVELLI;MARIA GRAZIA CALEVO;GIORGIO CIPRANDI;FEDERICO ZARA;ANDREA ROSSI;ROBERTA BIANCHERI;RENATA LORINI;ANGELA PISTORIO;ROBERTO RAVAZZOLO;MAJA DI ROCCO;MOHAMAD MAGHNIE;IGNAZIO CIRILLO;DENISE CASSANDRINI;LUIS J. V. GALIETTA","1.89;1.8;1.65;1.48;1.39;1.37;1.36;1.22;1.16;1.16;1.11;1.08;1.08;1.05;1.04;1.01;1;0.96;0.94;0.94","CARLO MINETTI;LORENZO MORETTA;ALBERTO MARTINI;CLAUDIO BRUNO;FEDERICO ZARA;ANGELO RAVELLI;ROBERTA BIANCHERI;ANGELA PISTORIO;ROBERTO RAVAZZOLO;ANDREA ROSSI;MIRELLA FILOCAMO;DENISE CASSANDRINI;RENATA LORINI;GIAN MARCO GHIGGERI;MARIA GRAZIA CALEVO;ALESSANDRO MORETTA;MOHAMAD MAGHNIE;MARIA CRISTINA MINGARI;CLAUDIO GAMBINI;VINCENZO JASONNI","16;16;15;15;12;11;11;10;10;10;9;9;8;8;8;8;7;7;7;7","LORENZO MORETTA;ALBERTO MARTINI;CARLO MINETTI;MIRELLA FILOCAMO;CLAUDIO BRUNO;GIAN MARCO GHIGGERI;ANGELO RAVELLI;MARIA GRAZIA CALEVO;FEDERICO ZARA;ANDREA ROSSI;ROBERTA BIANCHERI;RENATA LORINI;ANGELA PISTORIO;ROBERTO RAVAZZOLO;MAJA DI ROCCO;MOHAMAD MAGHNIE;DENISE CASSANDRINI;LUIS J. V. GALIETTA;MARIA CRISTINA MINGARI;ALBERTO GARAVENTA","1.89;1.8;1.65;1.48;1.39;1.37;1.36;1.22;1.16;1.11;1.08;1.08;1.05;1.04;1.01;1;0.94;0.94;0.91;0.9","LORENZO MORETTA;MARCO GATTORNO;ANTONIO LANZAVECCHIA;DAVID JARROSSAY;EVA V. ACOSTA RODRÍGUEZ;FEDERICA SALLUSTO;GIORGIO NAPOLITANI;JENS GEGINAT;LAURA RIVINO;ALBERTO MARTINI;MARIA CRISTINA MINGARI;ANGELO RAVELLI;FLAVIO BECCHETTI;ANDREA CAPOBIANCO;GRAZIA MARIA SPAGGIARI;HEBA ABDELRAZIK;NICOLINO RUPERTO;VITO PISTOIA;ALESSANDRO MORETTA;ANGELA PISTORIO","2377;2287;1765;1765;1765;1765;1765;1765;1765;1649;1473;1211;1081;1063;1063;1063;1022;928;910;847","MARCO GATTORNO;LORENZO MORETTA;FLAVIO BECCHETTI;HEBA ABDELRAZIK;VITO PISTOIA;ANGELA PISTORIO;ALBERTO MARTINI;NICOLINO RUPERTO;ANGELO RAVELLI;CARLO MINETTI;LIZZIA RAFFAGHELLO;MICHELA FALCO;ROBERTO RAVAZZOLO;GABRIELLE LUI;CLAUDIO BRUNO;PASQUALE STRIANO;ELISA MERELLO;FABRIZIO GINEVRI;MICHELA CIONI;FEDERICO ZARA","2287;2100;1081;1063;928;807;751;742;678;645;607;484;466;456;427;417;395;384;384;383","CLAUDIO BRUNO;CARLO MINETTI;LORENZO MORETTA;FEDERICO ZARA;ALBERTO MARTINI;ANDREA ROSSI;ANGELA PISTORIO;ROBERTA BIANCHERI;ANGELO RAVELLI;GIAN MARCO GHIGGERI;MARIA GRAZIA CALEVO;MIRELLA FILOCAMO;ROBERTO RAVAZZOLO;CLAUDIO GAMBINI;MOHAMAD MAGHNIE;RENATA LORINI;VITO PISTOIA;ALESSIO PINI PRATO;DENISE CASSANDRINI;MAJA DI ROCCO","17;14;14;11;10;9;9;9;9;8;8;8;8;7;7;7;7;6;6;6","MEDICINE;BIOLOGY;CHEMISTRY;PHYSICS;COMPUTER SCIENCE;ENGINEERING;MATHEMATICS;PSYCHOLOGY;BUSINESS;ECONOMICS;PHILOSOPHY;POLITICAL SCIENCE;GEOGRAPHY;MATERIALS SCIENCE;SOCIOLOGY","178;147;31;14;8;8;8;6;4;3;3;3;1;1;1","INTERNAL MEDICINE;GENETICS;IMMUNOLOGY;BIOCHEMISTRY;PATHOLOGY;CELL BIOLOGY;SURGERY;PEDIATRICS;ENDOCRINOLOGY;MOLECULAR BIOLOGY;CANCER RESEARCH;GASTROENTEROLOGY;PSYCHIATRY;INTENSIVE CARE MEDICINE;RADIOLOGY;ANESTHESIA;ANATOMY;DERMATOLOGY;NEUROSCIENCE;PHYSICAL THERAPY","116;98;65;56;44;39;38;37;35;28;23;21;17;15;15;14;13;12;12;12","GENE;DISEASE;IN VITRO;IMMUNE SYSTEM;RECEPTOR;ANTIBODY;ANTIGEN;ARTHRITIS;DIABETES MELLITUS;STEM CELL;CELL CULTURE;BONE MARROW;CANCER;CELL;CYTOKINE;ENZYME;RHEUMATOLOGY;TRANSPLANTATION;ANTIBIOTICS;APOPTOSIS;CHEMOTHERAPY;GLYCOGEN;MAGNETIC RESONANCE IMAGING;POPULATION","82;32;27;22;16;15;10;10;10;10;9;8;8;8;8;8;8;8;7;7;7;7;7;7","MUTATION;PHENOTYPE;CYTOTOXIC T CELL;T CELL;EXON;MUTANT;ALLELE;CHROMOSOME;HEMATOPOIETIC STEM CELL TRANSPLANTATION;CD8;NEUROBLASTOMA;CHROMOSOMAL TRANSLOCATION;CYTOTOXICITY;GENE EXPRESSION;GENOME;GLYCOGEN STORAGE DISEASE;HAEMATOPOIESIS;INTRON;CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR;INTERLEUKIN;LOCUS (GENETICS);MAJOR HISTOCOMPATIBILITY COMPLEX;MUSCLE BIOPSY;RNA;SEROLOGY;TRANSCRIPTION FACTOR","27;19;16;10;9;8;7;7;7;6;6;5;5;5;5;5;5;5;4;4;4;4;4;4;4;4","MISSENSE MUTATION;BREAKPOINT;INTERLEUKIN 21;INTERLEUKIN 12;NKG2D;KARYOTYPE;CD40;COMPOUND HETEROZYGOSITY;FRAMESHIFT MUTATION;RNA SPLICING;GENE MUTATION;INTERLEUKIN 15;MHC CLASS I;NATURAL KILLER CELL;PENETRANCE;PERFORIN;CASPOFUNGIN;CAVEOLIN 3;CHEMOKINE RECEPTOR;CHROMOSOME 15;CORONAVIRUS DISEASE 2019 (COVID-19);CTL*;DIFFUSING CAPACITY;GERMLINE MOSAICISM;GLYCOGEN BRANCHING ENZYME;GLYCOGEN DEBRANCHING ENZYME;GLYCOGEN STORAGE DISEASE TYPE II;GROWTH HORMONE DEFICIENCY;HIPPOCAMPAL SCLEROSIS;MICROARRAY;MITOCHONDRIAL ENCEPHALOMYOPATHY;MUTATION TESTING;PITUITARY STALK;PROBAND;SINGLE-STRAND CONFORMATION POLYMORPHISM;SUBLINGUAL IMMUNOTHERAPY;TRANSACTIVATION","8;7;7;6;6;5;4;4;4;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HUMANS;MALE;FEMALE;CHILD;CHILD, PRESCHOOL;ADOLESCENT;;ADULT;INFANT;ANIMALS;ITALY;MUTATION;KILLER CELLS, NATURAL;MICE;NEUROBLASTOMA;ARTHRITIS, JUVENILE;MIDDLE AGED;DNA MUTATIONAL ANALYSIS;RECEPTORS, IMMUNOLOGIC;BRAIN","185;102;95;78;53;52;44;43;43;37;36;35;32;24;24;23;22;21;21;20","NATURAL KILLER CELLS IN IMMUNITY;HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS AND RELATED DISORDERS;HIRSCHSPRUNG DISEASE AND ENTERIC NERVOUS SYSTEM DEVELOPMENT;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;GLYCOGEN METABOLISM AND MYOCLONIC DISORDERS;THERAPEUTIC ADVANCES IN CYSTIC FIBROSIS RESEARCH;ASTHMA;HEMATOPOIETIC STEM CELL BIOLOGY;EPILEPSY AND SEIZURES;FUNCTIONS AND REGULATION OF RNA EDITING BY ADARS;GENOMIC REARRANGEMENTS AND COPY NUMBER VARIATIONS;NEUROBLASTOMA RESEARCH AND TREATMENT;ALLERGIC RHINITIS AND ITS IMPACT ON ASTHMA;BIOLOGICAL ROLE OF CAVEOLAE IN CELLULAR PROCESSES;COCHLEAR NEUROPATHY AND HEARING LOSS MECHANISMS;DEVELOPMENT AND DISORDERS OF FETAL BRAIN;DIAGNOSIS AND MANAGEMENT OF FUNGAL INFECTIONS;IMMUNOBIOLOGY OF DENDRITIC CELLS;INSULIN-LIKE GROWTH FACTORS IN HEALTH AND DISEASE;MECHANICAL VENTILATION IN RESPIRATORY FAILURE AND ARDS","15;9;7;7;6;6;5;5;4;4;4;4;3;3;3;3;3;3;3;3","NK CELL ACTIVATION;NK CELL DEVELOPMENT;NK CELL RECOGNITION;NK CELL THERAPY;SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS;NK CELL RECEPTORS;JUVENILE IDIOPATHIC ARTHRITIS;TREATMENT;BREAKPOINT;GLYCOGEN STORAGE DISEASES;NKG2D;GLYCOGEN;LYMPHOKINE-ACTIVATED KILLER CELL;NEUROBLASTOMA;NK CELL EDUCATION;TREATMENT OUTCOMES;COMPOUND HETEROZYGOSITY;DIABETES;HEMATOPOIETIC CELL TRANSPLANTATION;JANUS KINASE 3","15;13;13;12;10;9;8;8;7;7;6;5;5;5;5;5;4;4;4;4","NK CELLS;IDIOPATHIC ARTHRITIS;JUVENILE IDIOPATHIC;NK CELL;ITALIAN PATIENTS;STEM CELL;STEM CELLS;BONE MARROW;CELL TRANSPLANTATION;HEMATOPOIETIC STEM;MESENCHYMAL STEM;MOLECULAR ANALYSIS;NATURAL KILLER;STORAGE DISEASE;ALLERGIC RHINITIS;ALLOGENEIC HEMATOPOIETIC;CELL LINES;CELL PHENOTYPE;CELLS INHIBIT;CHIMPANZEE NK;CONSERVED NK;CYSTIC FIBROSIS;DIFFERENTIAL NKP;GLYCOGEN STORAGE;HIRSCHSPRUNGS DISEASE;HIV--INFECTED ANIMALS;HUMAN NEUROBLASTOMA;LONG-TERM HIV--INFECTED;NKP INDUCIBILITY;PATIENTS AFFECTED","8;7;7;6;5;5;5;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3","PUBMED SCOPUS;CROSSREF PUBMED;NK CELLS;DIABETES MELLITUS;NATRIURETIC PEPTIDE;TYPE DIABETES;CFTR INHIBITORS;CELL LINES;PUBMED GOOGLE;URINARY TRACT;CFTR INHIBITION;DIABETES CARE;GENOVA ITALYSEARCH;COELIAC DISEASE;GASLINI INSTITUTE;NK CELL;C-TYPE NATRIURETIC;CYSTIC FIBROSIS;DIAGNOSI PRE-POSTNATALE;INTESTINAL FLUID;MALATTIE METABOLICHE;NEPHROL -CROSSREF;PRE-POSTNATALE MALATTIE;RENAL HYPODYSPLASIA;SOC NEPHROL;BONE MARROW;INT -CROSSREF;AUTOSOMAL DOMINANT;CONTRIBUTED EQUALLY;GENET -CROSSREF","80;73;48;24;24;24;18;16;16;16;15;14;14;13;13;13;12;12;12;12;12;12;12;12;12;11;11;10;10;10",52,0.21,9,4.5,5,1.25,1,1,5.5,1,1.5,4.5,0,1,3,0,2.75,1,1,7,1,0,0,83,83,3,0,0,1,0,0,0,1,1,0,0,0,2,1,0,3.5,2.33333333333333,0.92,2,0,2,3,0,0,1,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"ALLEN, THERESA, M.;CORTI, ANGELO;GAZZOLO DIEGO;LI PIRA GIUSEPPINA;MANCA FABRIZIO;MICHETTI FABRIZIO;PONZONI, MIRCO","1;1;1;1;1;1;1","ISTITUTO GIANNINA GASLINI;CENTRO BIOTECNOLOGIE AVANZATE;FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR;G GASLINI CHILDREN S HOSPITAL;THE GOVERNORS OF THE UNIVERSITY OF ALBERTA","2;1;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;49 MATHEMATICAL SCIENCES;3101 BIOCHEMISTRY AND CELL BIOLOGY;3204 IMMUNOLOGY;3206 MEDICAL BIOTECHNOLOGY;4904 PURE MATHEMATICS","4;2;2;1;1;1;1","BIOTECHNOLOGY;BREAST CANCER;CANCER;ORPHAN DRUG;RARE DISEASES","2;1;1;1;1","5.1 PHARMACEUTICALS","1","A23C11/00;A23C11/06;A23C9/00;A23C9/15;A23L1/305;A23L33/00;A61K;A61K31/00;A61K31/135;A61K31/437","1;1;1;1;1;1;1;1;1;1","A23C11/065;A23C9/1512;A23L33/17;A23L33/40;A61K31/00;A61K31/704;A61K38/08;A61K38/10;A61K9/127;G01N33/505","1;1;1;1;1;1;1;1;1;1",6,0,0,1.78,0,0,1,0,0,3,0,0,0,3,0,0,0,0,0,0,0,0,0,0,5,1,0,0,6,0,0,0,0,0,0,0,0,NA,NA,"32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;30 AGRICULTURAL, VETERINARY AND FOOD SCIENCES;3009 VETERINARY SCIENCES;31 BIOLOGICAL SCIENCES;3107 MICROBIOLOGY;3211 ONCOLOGY AND CARCINOGENESIS;42 HEALTH SCIENCES;4202 EPIDEMIOLOGY","4;2;1;1;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES","1;1","CANCER;CONGENITAL;RESPIRATORY","1;1;1","6.1 PHARMACEUTICALS;5.1 PHARMACEUTICALS","3;1","NOT SITE-SPECIFIC CANCER","1","5.3 SYSTEMIC THERAPIES - DISCOVERY AND DEVELOPMENT","1",6,2130754.83,205777.61,4,8.33333333333333,3,0.666666666666667,70,1137151.11615213,0.218088868293229,"ISTITUTO GIANNINA GASLINI;FONDAZIONE ISTITUTO NEUROLOGICO NAZIONALE CASIMIRO MONDINO;UNIVERSITY OF PADUA;BAMBINO GESÙ CHILDREN'S HOSPITAL;BIOCODEX (FRANCE);CASA SOLLIEVO DELLA SOFFERENZA;CATHOLIC UNIVERSITY OF THE SACRED HEART;CF CONSULTING FINANZIAMENTI UNIONE EUROPEA;CHARITÉ - UNIVERSITY MEDICINE BERLIN;ENTE OSPEDALIERO OSPEDALI GALLIERA;EPILEPSY IRELAND;FONDAZIONE IRCCS CA' GRANDA OSPEDALE MAGGIORE POLICLINICO;HOSPITAL UNIVERSITARIO FUNDACIÓN JIMÉNEZ DÍAZ;HUNGARIAN ACADEMY OF SCIENCES;INNSBRUCK MEDICAL UNIVERSITY;INSERM;ISTANBUL UNIVERSITY;ISTITUTI CLINICI DI PERFEZIONAMENTO;ISTITUTO NEUROLOGICO CARLO BESTA;JOHANNES GUTENBERG UNIVERSITY OF MAINZ","6;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","TELETHON FOUNDATION;EUROPEAN COMMISSION","4;2","COALITION S;EC & ERC - EUROPEAN UNION","2;2","TELETHON GRANT PROJECTS - 2007 (PROGRAM);EIF - MARIE CURIE ACTIONS-INTRA-EUROPEAN FELLOWSHIPS (FUNDING SCHEME);FP6-2005-LIFESCIHEALTH-6 (CALL FOR PROPOSAL);FP6-2006-MOBILITY-4 (CALL FOR PROPOSAL);FP6-LIFESCIHEALTH - LIFE SCIENCES, GENOMICS AND BIOTECHNOLOGY FOR HEALTH: THEMATIC PRIORITY 1 UNDER THE FOCUSING AND INTEGRATING COMMUNITY RESEARCH PROGRAMME 2002-2006. (PROGRAMME);FP6-MOBILITY - HUMAN RESOURCES AND MOBILITY IN THE SPECIFIC PROGRAMME FOR RESEARCH, TECHNOLOGICAL DEVELOPMENT AND DEMONSTRATION ""STRUCTURING THE EUROPEAN RESEARCH AREA"" UNDER THE SIXTH FRAMEWORK PROGRAMME 2002-2006 (PROGRAMME);IP - INTEGRATED PROJECT (FUNDING SCHEME);TELETHON - UILDM CLINICAL GRANT PROJECTS - 2006 (PROGRAM);TELETHON NETWORK OF GENETIC BIOBANKS - 2007 (PROGRAM)","2;1;1;1;1;1;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;3105 GENETICS;3202 CLINICAL SCIENCES;3209 NEUROSCIENCES;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","5;2;2;2;1;1","RARE DISEASES;BRAIN DISORDERS;GENETICS;CLINICAL RESEARCH;NEUROSCIENCES;PEDIATRIC;ARTHRITIS;AUTOIMMUNE DISEASE;EPILEPSY;INTELLECTUAL AND DEVELOPMENTAL DISABILITIES (IDD);KIDNEY DISEASE;MUSCULAR DYSTROPHY;NEURODEGENERATIVE;ORPHAN DRUG","5;3;3;2;2;2;1;1;1;1;1;1;1;1","INFLAMMATORY AND IMMUNE SYSTEM;NEUROLOGICAL","2;2","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;1.1 NORMAL BIOLOGICAL DEVELOPMENT AND FUNCTIONING;5.1 PHARMACEUTICALS","5;2;2",NA,NA,NA,NA,"A01 CLINICAL MEDICINE;A03 ALLIED HEALTH PROFESSIONS, DENTISTRY, NURSING AND PHARMACY;A04 PSYCHOLOGY, PSYCHIATRY AND NEUROSCIENCE","4;1;1",NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_GASLINI",2008,274,10.6459854014599,3.41240875912409,0.430656934306569,0.394160583941606,0.452554744525547,2.27250608272506,1.28260869565217,1.58823529411765,1.29166666666667,0.481751824817518,2,134,93,19,17,0.49,0.34,0.07,0.06,63.97,1.16575492110408,NA,0.397810218978102,0.886861313868613,0.456,0.449,0.492,0.454,"ALBERTO MARTINI;ANGELO RAVELLI;ANGELA PISTORIO;NICOLINO RUPERTO;EDOARDO LANINO;PASQUALE STRIANO;LORENZO MORETTA;MAURA FARACI;GIORGIO DINI;STEFANIA VIOLA;GIOVANNI FILOCAMO;SILVIA MAGNI‐MANZONI;MARCO GATTORNO;GIUSEPPE MORREALE;GIAN MARCO GHIGGERI;GIORGIO CIPRANDI;ROBERTO RAVAZZOLO;VITO PISTOIA;SALVATORE STRIANO;ANTONELLA BUONCOMPAGNI","32;24;23;15;14;14;13;13;13;11;10;10;10;9;9;9;9;9;9;8","ANGELA PISTORIO;ALBERTO MARTINI;GIORGIO DINI;ANGELO RAVELLI;PASQUALE STRIANO;GIORGIO CIPRANDI;LORENZO MORETTA;MAURA FARACI;ANDREA ROSSI;EDOARDO LANINO;IGNAZIO CIRILLO;VITO PISTOIA;SALVATORE STRIANO;NICOLINO RUPERTO;MICHELE TORRE;MARCO GATTORNO;ROBERTO RAVAZZOLO;VINCENZO JASONNI;GIUSEPPE MORREALE;RENATA LORINI","3.19;2.75;2.22;1.97;1.95;1.95;1.68;1.51;1.5;1.43;1.32;1.21;1.1;1.1;1.09;1.09;1.04;0.98;0.97;0.94","ALBERTO MARTINI;ANGELO RAVELLI;ANGELA PISTORIO;NICOLINO RUPERTO;EDOARDO LANINO;PASQUALE STRIANO;LORENZO MORETTA;MAURA FARACI;GIORGIO DINI;STEFANIA VIOLA;GIOVANNI FILOCAMO;MARCO GATTORNO;GIUSEPPE MORREALE;GIAN MARCO GHIGGERI;ROBERTO RAVAZZOLO;VITO PISTOIA;SALVATORE STRIANO;ANTONELLA BUONCOMPAGNI;MIRELLA FILOCAMO;ALESSANDRO CONSOLARO","32;24;23;15;14;14;13;13;13;11;10;10;9;9;9;9;9;8;8;7","ANGELA PISTORIO;ALBERTO MARTINI;GIORGIO DINI;ANGELO RAVELLI;PASQUALE STRIANO;LORENZO MORETTA;MAURA FARACI;ANDREA ROSSI;EDOARDO LANINO;VITO PISTOIA;SALVATORE STRIANO;NICOLINO RUPERTO;MICHELE TORRE;MARCO GATTORNO;ROBERTO RAVAZZOLO;VINCENZO JASONNI;GIUSEPPE MORREALE;RENATA LORINI;STEFANIA VIOLA;GIAN MARCO GHIGGERI","3.19;2.75;2.22;1.97;1.95;1.68;1.51;1.5;1.43;1.21;1.1;1.1;1.09;1.09;1.04;0.98;0.97;0.94;0.94;0.9","FRANCO LOCATELLI;MARIA ESTER BERNARDO;FRANCESCO FRASSONI;GIORGIO DINI;EDOARDO LANINO;ANDREA BACIGALUPO;BERIT SUNDBERG;HELENE ROELOFS;IAN A. LEWIS;KATARINA LE BLANC;LYNNE M. BALL;MATS REMBERGER;OLLE RINGDÉN;R. MAARTEN EGELER;WILLEM E. FIBBE;ALBERTO MARTINI;ROBERTO RAVAZZOLO;LUIS J. V. GALIETTA;OLGA ZEGARRA‐MORAN;GIORGIO GIMELLI","3100;2974;2938;2889;2852;2607;2607;2607;2607;2607;2607;2607;2607;2607;2607;2246;1534;1359;1359;1348","GIORGIO DINI;EDOARDO LANINO;ALBERTO MARTINI;ROBERTO RAVAZZOLO;LUIS J. V. GALIETTA;OLGA ZEGARRA‐MORAN;GIORGIO GIMELLI;EMANUELA CACI;LORENZO MORETTA;ANTONELLA CAPUTO;NICOLETTA PEDEMONTE;CRISTINA BARSANTI;ELVIRA SONDO;LORETTA FERRERA;ULRICH PFEFFER;GIOVANNA BIANCHI;LIZZIA RAFFAGHELLO;NICOLINO RUPERTO;PASQUALE STRIANO;MARCO GATTORNO","2889;2847;1792;1395;1359;1359;1348;1326;1311;1286;1226;1186;1186;1186;1186;1130;1130;1129;995;916","ALBERTO MARTINI;ANGELA PISTORIO;ANGELO RAVELLI;EDOARDO LANINO;GIORGIO DINI;LORENZO MORETTA;NICOLINO RUPERTO;PASQUALE STRIANO;STEFANIA VIOLA;MAURA FARACI;GIOVANNI FILOCAMO;GIAN MARCO GHIGGERI;GIUSEPPE MORREALE;VITO PISTOIA;ALESSANDRO CONSOLARO;A. LOY;CLARA MALATTIA;MARCO GATTORNO;RICCARDO HAUPT;ANTONELLA BUONCOMPAGNI","24;23;19;13;13;13;13;11;10;10;9;9;8;8;7;7;7;7;7;7","MEDICINE;BIOLOGY;CHEMISTRY;PHYSICS;COMPUTER SCIENCE;PSYCHOLOGY;MATHEMATICS;ENGINEERING;PHILOSOPHY;ECONOMICS;MATERIALS SCIENCE;SOCIOLOGY;ART;GEOGRAPHY;GEOLOGY;HISTORY;POLITICAL SCIENCE","221;155;29;21;9;9;8;4;4;3;3;2;1;1;1;1;1","INTERNAL MEDICINE;GENETICS;IMMUNOLOGY;SURGERY;PEDIATRICS;BIOCHEMISTRY;PATHOLOGY;CELL BIOLOGY;ENDOCRINOLOGY;GASTROENTEROLOGY;MOLECULAR BIOLOGY;CANCER RESEARCH;ANESTHESIA;PHYSICAL THERAPY;RADIOLOGY;MICROBIOLOGY;OPTICS;VIROLOGY;DERMATOLOGY;ONCOLOGY;PHARMACOLOGY;PSYCHIATRY","155;118;71;63;48;46;45;28;28;24;22;21;17;15;14;13;12;12;11;10;10;10","GENE;DISEASE;RHEUMATOLOGY;ARTHRITIS;TRANSPLANTATION;IMMUNE SYSTEM;JUVENILE;ANTIBODY;CELL CULTURE;IN VITRO;STEM CELL;BONE MARROW;CHEMOTHERAPY;VIRUS;ANTIGEN;EPILEPSY;RECEPTOR;CANCER;CYSTIC FIBROSIS;ALTERNATIVE MEDICINE;BACTERIA;INCIDENCE (GEOMETRY)","75;41;30;28;26;25;18;17;15;14;14;13;13;13;12;12;12;11;11;10;10;10","MUTATION;PHENOTYPE;HEMATOPOIETIC STEM CELL TRANSPLANTATION;ALLELE;NEUROBLASTOMA;T CELL;GENOTYPE;CYTOTOXIC T CELL;EXON;PSEUDOMONAS AERUGINOSA;CHROMOSOME;FETUS;HAEMATOPOIESIS;TRANSFECTION;HUMAN LEUKOCYTE ANTIGEN;MUTANT;ANAKINRA;CYCLOPHOSPHAMIDE;ETOPOSIDE;GENE EXPRESSION;MONOCLONAL ANTIBODY;RHINOMANOMETRY","30;17;15;13;12;12;9;8;8;8;7;7;7;7;6;6;5;5;5;5;5;5","INTERLEUKIN 21;MISSENSE MUTATION;INTERLEUKIN 12;ALLELE FREQUENCY;FRAMESHIFT MUTATION;ALTERNATIVE SPLICING;CHEMOKINE RECEPTOR;COMPARATIVE GENOMIC HYBRIDIZATION;GENE MUTATION;GENOTYPE-PHENOTYPE DISTINCTION;HERPESVIRIDAE;MICROARRAY;POINT MUTATION;PROBAND;BK VIRUS;BREAKPOINT;CALPASTATIN;CARBOPLATIN;CAVEOLIN 3;COMPOUND HETEROZYGOSITY;COPY-NUMBER VARIATION;CXCL1;CXCL10;CYTOLYSIS;DNA MICROARRAY;FILGRASTIM;FLUORESCENCE IN SITU HYBRIDIZATION;FOCAL SEGMENTAL GLOMERULOSCLEROSIS;GENETIC HETEROGENEITY;HAPLOTYPE;HEMATOPOIETIC CELL;IFOSFAMIDE;KARYOTYPE;MICROARRAY ANALYSIS TECHNIQUES;MUTANT PROTEIN;NATURAL KILLER CELL;PRENATAL DIAGNOSIS;RNA SPLICING;SYNOVIAL FLUID","6;6;5;4;4;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HUMANS;MALE;FEMALE;CHILD;;ADOLESCENT;CHILD, PRESCHOOL;ADULT;INFANT;HEMATOPOIETIC STEM CELL TRANSPLANTATION;ITALY;NEUROBLASTOMA;MUTATION;ANIMALS;MIDDLE AGED;KILLER CELLS, NATURAL;RHINITIS, ALLERGIC, PERENNIAL;DNA MUTATIONAL ANALYSIS;MONOCYTES;TREATMENT OUTCOME","195;115;105;83;73;57;57;55;45;37;36;33;32;31;30;28;24;22;22;22","HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS AND RELATED DISORDERS;NATURAL KILLER CELLS IN IMMUNITY;NEUROBLASTOMA RESEARCH AND TREATMENT;THERAPEUTIC ADVANCES IN CYSTIC FIBROSIS RESEARCH;ALLERGIC RHINITIS AND ITS IMPACT ON ASTHMA;EPIDEMIOLOGY AND MANAGEMENT OF CYTOMEGALOVIRUS INFECTION;GENOMIC REARRANGEMENTS AND COPY NUMBER VARIATIONS;HEMATOPOIETIC STEM CELL BIOLOGY;HIRSCHSPRUNG DISEASE AND ENTERIC NERVOUS SYSTEM DEVELOPMENT;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;MOLECULAR MECHANISMS OF INFLAMMASOME ACTIVATION AND REGULATION;MINIMALLY INVASIVE REPAIR OF PECTUS EXCAVATUM;MOLECULAR MECHANISMS OF KIDNEY DEVELOPMENT AND DISEASE;MULTIPOTENT MESENCHYMAL STEM CELLS;CHRONIC KIDNEY DISEASE AND DIALYSIS TREATMENT;EMERGENCY DEPARTMENT CROWDING;GLYCOGEN METABOLISM AND MYOCLONIC DISORDERS;MANAGEMENT AND EPIDEMIOLOGY OF PNEUMONIA;MANAGEMENT OF FEBRILE NEUTROPENIA IN CANCER PATIENTS;METABOLIC REPROGRAMMING IN CANCER BIOLOGY","28;10;10;9;7;6;5;5;5;5;5;4;4;4;3;3;3;3;3;3","JUVENILE IDIOPATHIC ARTHRITIS;SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS;NK CELL RECOGNITION;NK CELL ACTIVATION;NK CELL DEVELOPMENT;HEMATOPOIETIC CELL TRANSPLANTATION;NEUROBLASTOMA;PATHOGENESIS;NK CELL RECEPTORS;NK CELL THERAPY;POLLEN ALLERGY;RHINOMANOMETRY;TREATMENT OUTCOMES;APLASTIC ANEMIA;ASTHMA;CYSTIC FIBROSIS;EPILEPSY;IMMUNOSUPPRESSION;JUVENILE RHEUMATOID ARTHRITIS;MESENCHYMAL STEM CELLS","23;23;11;10;10;9;9;8;6;6;5;5;5;4;4;4;4;4;4;4","IDIOPATHIC ARTHRITIS;JUVENILE IDIOPATHIC;STEM CELL;ARTHRITIS JIA;CELL TRANSPLANTATION;CYSTIC FIBROSIS;PSEUDOMONAS AERUGINOSA;ALLERGIC RHINITIS;NK CELLS;ITALIAN PATIENTS;NATURAL KILLER;BONE MARROW;CF PATIENTS;CHILDREN RECEIVING;DISEASE ACTIVITY;HEMATOPOIETIC STEM;ITALIAN CHILDREN;LUPUS ERYTHEMATOSUS;MARROW TRANSPLANTATION;PECTUS EXCAVATUM;PEDIATRIC PATIENTS;SYSTEMIC LUPUS;DENDRITIC CELLS;EMERGENCY DEPARTMENT;FUNCTIONAL CHARACTERIZATION;HEMOPOIETIC STEM;ITALIAN ASSOCIATION;ITALIAN STUDY;JUVENILE SYSTEMIC;KILLER CELLS","22;22;11;10;8;7;7;6;6;5;5;4;4;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3","NK CELLS;PERITONEAL DIALYSIS;PUBMED SCOPUS;MALATTIE METABOLICHE;PD SOLUTIONS;METABOLICHE IRCCS;CROSSREF PUBMED;SPUTUM CULTURE;CF PATIENTS;STROMAL CELLS;SOC NEPHROL;MESENCHYMAL STROMAL;MESOTHELIAL CELL;PARIETAL CELLS;ALLERGIC RHINITIS;BURLO GAROFOLO;DI MALATTIE;DIAGNOSI PRE-POSTNATALE;GENOVA ITALYSEARCH;GGASLINI GENOVA;IRCCS BURLO;IRCCS GGASLINI;PRE-POSTNATALE MALATTIE;UNITÀ DI;CAPILLARY LOOP;COQ CG;GENE EXPRESSION;IPEX SYNDROME;NEPHROL -CROSSREF;PERITONEAL MEMBRANE","31;26;21;20;19;18;16;16;13;13;12;11;11;11;10;10;10;10;10;10;10;10;10;10;9;9;9;9;9;9",59,0.22,6,5,4,1.75,2,1.75,5,1,1,5,1,1,2.5,1,2.5,1,5.5,2,2,0,0,100.5,100.5,2,3,0,1,0,0,0,0,0,0,0,0,4,0,0,1,2.75,1.18,3.75,0,3,4,1,1,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"LUNARDI CLAUDIO;PUCCETTI ANTONIO;ZANONI GIOVANNA;LI PIRA GIUSEPPINA;MANCA FABRIZIO","3;3;3;1;1","UNIVERSITA DEGLI STUDI DI VERONA;CENTRO DI BIOTECNOLOGIE AVANZATE AND ISTITUTO GIANNINA GASLINI;DEGLI STUDI DI VERONA, UNIVERSITY OF;ISTITUTO G GASLINI;ISTITUTO G. GASLINI;ISTITUTO GIANNINA GASLINI;LUNARDI CLAUDIO;LUNARDI, CLAUDIO;PUCCETTI ANTONIO;PUCCETTI, ANTONIO","2;1;1;1;1;1;1;1;1;1","31 BIOLOGICAL SCIENCES;32 BIOMEDICAL AND CLINICAL SCIENCES;3101 BIOCHEMISTRY AND CELL BIOLOGY;3204 IMMUNOLOGY","4;4;3;1","AUTOIMMUNE DISEASE;CLINICAL RESEARCH;DIGESTIVE DISEASES;NUTRITION","2;2;2;2","1.1 NORMAL BIOLOGICAL DEVELOPMENT AND FUNCTIONING","1","A61K38/00;C07K14/14;C07K14/47;C40B30/06","3;3;3;1","A61K2039/53;A61K38/00;A61K39/12;A61K39/15;C07K14/005;C07K14/4713;C07K16/10;C07K16/18;C07K16/2896;C07K16/40","3;3;3;3;3;3;3;3;3;3",12,7,45.33,3.27,2,0.17,15,1,0,7,1,1,0,1,1,0,3,1,0,0,0,0,0,0,11,0,1,4,8,0,0,0,0,0,0,0,0,"United States","1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3204 IMMUNOLOGY;3211 ONCOLOGY AND CARCINOGENESIS;3213 PAEDIATRICS;30 AGRICULTURAL, VETERINARY AND FOOD SCIENCES;3009 VETERINARY SCIENCES;44 HUMAN SOCIETY","11;4;2;2;2;2;1;1;1","PEDIATRIC;CLINICAL RESEARCH;RARE DISEASES;HEMATOLOGY;KIDNEY DISEASE;PATIENT SAFETY;ARTHRITIS;AUTOIMMUNE DISEASE;CANCER;CHILDHOOD LEUKEMIA;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;ORGAN TRANSPLANTATION;ORPHAN DRUG;PEDIATRIC CANCER;PEDIATRIC RESEARCH INITIATIVE;TRANSPLANTATION","4;3;3;2;2;2;1;1;1;1;1;1;1;1;1;1","INFLAMMATORY AND IMMUNE SYSTEM;RENAL AND UROGENITAL","2;2","6.1 PHARMACEUTICALS;5.1 PHARMACEUTICALS;5.2 CELLULAR AND GENE THERAPIES","3;1;1","LEUKEMIA / LEUKAEMIA","2","5.3 SYSTEMIC THERAPIES - DISCOVERY AND DEVELOPMENT;5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","2;2",5,1333547.2,255297.98,3.6,4,2.6,0.6,10.75,1411282.50156879,0.194149647356514,"ISTITUTO GIANNINA GASLINI;DÉLÉGATION PARIS 11;CHARITÉ - UNIVERSITY MEDICINE BERLIN;KAROLINSKA INSTITUTET;POLICLINICO SAN MATTEO FONDAZIONE;PRONTO DIAGNOSTICS (ISRAEL);RESEARCH CENTER BORSTEL - LEIBNIZ LUNG CENTER;UNIVERSITY COLLEGE LONDON;UNIVERSITY HOSPITAL OF MONTPELLIER;UNIVERSITY MEDICAL CENTER FREIBURG;UNIVERSITY MEDICAL CENTER HAMBURG-EPPENDORF;UNIVERSITY OF BRESCIA;UNIVERSITY OF CAMBRIDGE;UNIVERSITY OF LEEDS;UNIVERSITY OF PARMA","5;2;1;1;1;1;1;1;1;1;1;1;1;1;1","EUROPEAN COMMISSION;TELETHON FOUNDATION","3;2","COALITION S;EC & ERC - EUROPEAN UNION","3;3","CP-FP - SMALL OR MEDIUM-SCALE FOCUSED RESEARCH PROJECT (FUNDING SCHEME);FP7-HEALTH - SPECIFIC PROGRAMME ""COOPERATION"": HEALTH (PROGRAMME);FP7-HEALTH-2007-A (CALL FOR PROPOSAL);TELETHON GRANT PROJECTS - 2008 (PROGRAM);FP7-PEOPLE - SPECIFIC PROGRAMME ""PEOPLE"" IMPLEMENTING THE SEVENTH FRAMEWORK PROGRAMME OF THE EUROPEAN COMMUNITY FOR RESEARCH, TECHNOLOGICAL DEVELOPMENT AND DEMONSTRATION ACTIVITIES (2007 TO 2013) (PROGRAMME);FP7-PEOPLE-2007-2-1-IEF (CALL FOR PROPOSAL);MC-IEF - INTRA-EUROPEAN FELLOWSHIPS (IEF) (FUNDING SCHEME)","2;2;2;2;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;3204 IMMUNOLOGY;3101 BIOCHEMISTRY AND CELL BIOLOGY;3105 GENETICS;3202 CLINICAL SCIENCES","5;2;2;1;1;1","CLINICAL RESEARCH;GENETICS;PREVENTION;RARE DISEASES;PEDIATRIC;BIODEFENSE;CONGENITAL STRUCTURAL ANOMALIES;EMERGING INFECTIOUS DISEASES;HUMAN GENOME;INFECTIOUS DISEASES;KIDNEY DISEASE;NEUROSCIENCES;SPINA BIFIDA;UROLOGIC DISEASES;VACCINE RELATED","3;3;3;3;2;1;1;1;1;1;1;1;1;1;1","INFLAMMATORY AND IMMUNE SYSTEM;GENERIC HEALTH RELEVANCE;RENAL AND UROGENITAL","2;1;1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;1.1 NORMAL BIOLOGICAL DEVELOPMENT AND FUNCTIONING","5;2","KIDNEY CANCER;NOT SITE-SPECIFIC CANCER","1;1","1.1 NORMAL FUNCTIONING;1.2 CANCER INITIATION: ALTERATIONS IN CHROMOSOMES;1.4 CANCER PROGRESSION AND METASTASIS;2.2 ENDOGENOUS FACTORS IN THE ORIGIN AND CAUSE OF CANCER","1;1;1;1","A01 CLINICAL MEDICINE","5",NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_GASLINI",2009,279,10.6559139784946,3.03584229390681,0.32258064516129,0.362007168458781,0.372759856630824,1.98823529411765,1.2,1.71186440677966,1.26829268292683,0.369175627240143,11,139,74,25,29,0.5,0.27,0.09,0.1,50.21,1.08548389033893,NA,0.340501792114695,0.878136200716846,0.516,0.399,0.42,0.423,"LORENZO MORETTA;GIAN MARCO GHIGGERI;ANGELA PISTORIO;ALBERTO MARTINI;VITO PISTOIA;PASQUALE STRIANO;RENATA LORINI;GIORGIO CIPRANDI;FRANCO LOCATELLI;RICCARDO HAUPT;ALESSANDRO MORETTA;ADELE D’AMICO;STEFANO PARODI;ANGELO RAVELLI;GIAN LUIGI MARSEGLIA;ANDREA ROSSI;MIRELLA FILOCAMO;MARA DE AMICI;GIOVANNI CANDIANO;MIRCO PONZONI","17;14;13;12;12;11;10;10;9;9;9;8;8;8;8;8;8;7;7;7","LUIS J. V. GALIETTA;LORENZO MORETTA;GIORGIO CIPRANDI;ALBERTO MARTINI;MIRELLA FILOCAMO;ANGELA PISTORIO;GIAN LUIGI MARSEGLIA;MIRCO PONZONI;RENATA LORINI;MAJA DI ROCCO;MARIA ANGELA TOSCA;GIAN MARCO GHIGGERI;CARLO DUFOUR;MARA DE AMICI;MARIA GRAZIA CALEVO;PASQUALE STRIANO;ANTONELLA PALMIERI;GIUSEPPE D’ANNUNZIO;GIOVANNI A. ROSSI;ANDREA ROSSI","2.76;2.01;1.97;1.91;1.84;1.68;1.58;1.56;1.51;1.46;1.41;1.4;1.38;1.38;1.35;1.33;1.15;1.13;1.1;1.09","LORENZO MORETTA;GIAN MARCO GHIGGERI;ANGELA PISTORIO;ALBERTO MARTINI;VITO PISTOIA;PASQUALE STRIANO;RENATA LORINI;RICCARDO HAUPT;STEFANO PARODI;ANGELO RAVELLI;ANDREA ROSSI;MIRELLA FILOCAMO;GIOVANNI CANDIANO;MIRCO PONZONI;GIOVANNI A. ROSSI;CLAUDIO GAMBINI;VINCENZO JASONNI;MARIA GRAZIA CALEVO;FRANCESCO SCOLARI;FEDERICO ZARA","17;14;13;12;12;11;10;9;8;8;8;8;7;7;7;7;7;7;7;7","LUIS J. V. GALIETTA;LORENZO MORETTA;ALBERTO MARTINI;MIRELLA FILOCAMO;ANGELA PISTORIO;MIRCO PONZONI;RENATA LORINI;MAJA DI ROCCO;MARIA ANGELA TOSCA;GIAN MARCO GHIGGERI;CARLO DUFOUR;MARIA GRAZIA CALEVO;PASQUALE STRIANO;ANTONELLA PALMIERI;GIUSEPPE D’ANNUNZIO;GIOVANNI A. ROSSI;ANDREA ROSSI;LIZZIA RAFFAGHELLO;GIOVANNI MELIOLI;ARMANDO CAMA","2.76;2.01;1.91;1.84;1.68;1.56;1.51;1.46;1.41;1.4;1.38;1.35;1.33;1.15;1.13;1.1;1.09;1.08;1;1","LORENZO MORETTA;GIAN MARCO GHIGGERI;GIORGIO DINI;ANNA SUREDA;ALESSANDRO MORETTA;FLAVIO BECCHETTI;ALOÏS GRATWOHL;ANDRÉ TICHELLI;DIETGER NIEDERWIESER;JAKOB PASSWEG;VANDERSON ROCHA;STEFANO PARODI;GRAZIA MARIA SPAGGIARI;HEBA ABDELRAZIK;ANDREA VELARDI;RICCARDO HAUPT;GIANLUCA CARIDI;ELISABETTA TRAGGIAI;MARIA CRISTINA MINGARI;PASQUALE STRIANO","1841;875;860;825;788;772;749;749;749;749;749;741;715;715;707;638;606;585;581;557","LORENZO MORETTA;GIAN MARCO GHIGGERI;GIORGIO DINI;FLAVIO BECCHETTI;STEFANO PARODI;GRAZIA MARIA SPAGGIARI;RICCARDO HAUPT;HEBA ABDELRAZIK;ELISABETTA TRAGGIAI;PASQUALE STRIANO;MAJA DI ROCCO;VITO PISTOIA;ANTONELLA TRIVELLI;CLAUDIO BRUNO;GIROLAMO MATTIOLI;FEDERICO ZARA;CLAUDIA CANTONI;MIRCO PONZONI;ANTONIO PUCCETTI;MARZIA DOLCINO","1841;875;853;772;741;715;638;633;538;512;504;465;463;458;458;449;420;403;387;387","LORENZO MORETTA;GIAN MARCO GHIGGERI;ANGELA PISTORIO;VITO PISTOIA;PASQUALE STRIANO;RICCARDO HAUPT;RENATA LORINI;MARIA ANGELA TOSCA;MIRELLA FILOCAMO;STEFANO PARODI;LUIS J. V. GALIETTA;ALBERTO MARTINI;CLAUDIO BRUNO;FEDERICO ZARA;GIOVANNI A. ROSSI;GIOVANNI CANDIANO;MIRCO PONZONI;ANDREA ROSSI;ANGELO RAVELLI;CARLO MINETTI","17;14;13;11;10;9;8;8;8;8;7;7;7;7;7;7;7;6;6;6","MEDICINE;BIOLOGY;CHEMISTRY;PHYSICS;COMPUTER SCIENCE;ENGINEERING;PSYCHOLOGY;MATHEMATICS;ECONOMICS;MATERIALS SCIENCE;PHILOSOPHY;POLITICAL SCIENCE;SOCIOLOGY;ART;GEOGRAPHY;GEOLOGY;HISTORY","223;154;31;21;11;11;10;7;5;4;4;4;4;2;1;1;1","INTERNAL MEDICINE;GENETICS;IMMUNOLOGY;SURGERY;PEDIATRICS;BIOCHEMISTRY;PATHOLOGY;CANCER RESEARCH;CELL BIOLOGY;PSYCHIATRY;ENVIRONMENTAL HEALTH;MOLECULAR BIOLOGY;ENDOCRINOLOGY;GASTROENTEROLOGY;ANESTHESIA;ONCOLOGY;INTENSIVE CARE MEDICINE;PALEONTOLOGY;OPTICS;COMPUTATIONAL BIOLOGY;PHARMACOLOGY","146;107;66;59;55;46;39;33;28;26;24;24;18;17;16;15;13;12;11;10;10","GENE;DISEASE;IMMUNE SYSTEM;CELL CULTURE;POPULATION;IN VITRO;RECEPTOR;ANTIBODY;EPILEPSY;TRANSPLANTATION;CANCER;PREGNANCY;STEM CELL;ANTIGEN;INCIDENCE (GEOMETRY);ANGIOGENESIS;KIDNEY;COHORT;ALLERGY;BONE MARROW;CYTOKINE;ENZYME;LUNG;STAGE (STRATIGRAPHY)","67;32;28;23;22;21;21;20;16;16;15;15;13;11;11;10;10;9;8;8;8;8;8;8","MUTATION;T CELL;NEUROBLASTOMA;PHENOTYPE;CYTOTOXIC T CELL;HEMATOPOIETIC STEM CELL TRANSPLANTATION;CD8;EXON;GENOTYPE;ALLELE;FETUS;GENE EXPRESSION;CHROMOSOME;CYTOTOXICITY;HAEMATOPOIESIS;IMMUNOTHERAPY;MUTANT;RNA;ALLERGEN;CHEMOKINE;HUMAN LEUKOCYTE ANTIGEN;MONOCLONAL ANTIBODY;PROTEINURIA","20;17;16;12;11;11;10;9;9;8;7;7;6;6;6;6;6;6;5;5;5;5;5","CHEMOKINE RECEPTOR;INTERLEUKIN 12;INTERLEUKIN 21;ALTERNATIVE SPLICING;ANTIGEN-PRESENTING CELL;MISSENSE MUTATION;ACUTE LYMPHOCYTIC LEUKEMIA;CD3;CD40;CYTOLYSIS;FANCONI ANEMIA;FOCAL SEGMENTAL GLOMERULOSCLEROSIS;IL-2 RECEPTOR;NATURAL KILLER CELL;PODOCYTE;RNA SPLICING;SINGLE-NUCLEOTIDE POLYMORPHISM;SUBLINGUAL IMMUNOTHERAPY;ADOPTIVE CELL TRANSFER;ASPARAGINASE;BK VIRUS;BONE MARROW FAILURE;BUSULFAN;CASPASE;CD38;CD86;COMPARATIVE GENOMIC HYBRIDIZATION;GENETIC HETEROGENEITY;GROWTH HORMONE DEFICIENCY;HEPATIC VENO-OCCLUSIVE DISEASE;KARYOTYPE;LYMPHANGIOGENESIS;LYMPHEDEMA;MEMBRANOUS NEPHROPATHY;METHYLENETETRAHYDROFOLATE REDUCTASE;NATURAL KILLER T CELL;NKG2D;NORETHISTERONE;ONCOGENE;PENETRANCE;POINT MUTATION;POLYMORPHISM (COMPUTER SCIENCE);PRENATAL DIAGNOSIS;PROBAND;RIBOSOME;SYNOVIAL FLUID;VESICOURETERAL REFLUX;WILD TYPE","5;5;5;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HUMANS;FEMALE;MALE;CHILD;CHILD, PRESCHOOL;ADOLESCENT;ADULT;;NEUROBLASTOMA;INFANT;KILLER CELLS, NATURAL;YOUNG ADULT;ITALY;RHINITIS, ALLERGIC, SEASONAL;INFANT, NEWBORN;MIDDLE AGED;ANIMALS;EPILEPSY;TREATMENT OUTCOME;BIOMARKERS","212;129;118;90;72;71;66;58;51;45;44;35;32;32;30;30;26;26;26;25","NATURAL KILLER CELLS IN IMMUNITY;NEUROBLASTOMA RESEARCH AND TREATMENT;ALLERGIC RHINITIS AND ITS IMPACT ON ASTHMA;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;EPILEPSY AND SEIZURES;HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS AND RELATED DISORDERS;HEMATOPOIETIC STEM CELL BIOLOGY;PATHOPHYSIOLOGY OF GLOMERULAR DISEASES AND NEPHROTIC SYNDROMES;DIAGNOSIS AND MANAGEMENT OF ENDOMETRIOSIS;MINIMALLY INVASIVE REPAIR OF PECTUS EXCAVATUM;MOLECULAR MECHANISMS OF MUSCLE REGENERATION AND ATROPHY;EPIDEMIOLOGY AND TREATMENT OF CHILDHOOD LEUKEMIA;HIRSCHSPRUNG DISEASE AND ENTERIC NERVOUS SYSTEM DEVELOPMENT;LYMPHOID NEOPLASMS;MASS SPECTROMETRY TECHNIQUES WITH PROTEINS;PEDIATRIC URINARY TRACT INFECTIONS;POLYOMAVIRUS-ASSOCIATED CARCINOGENESIS AND CLINICAL MANIFESTATIONS;PRENATAL ANEUPLOIDY DIAGNOSIS AND SCREENING TECHNIQUES;ROLE OF LONG NONCODING RNAS IN CANCER AND DEVELOPMENT;THERAPEUTIC ADVANCES IN CYSTIC FIBROSIS RESEARCH","16;16;9;9;6;6;5;5;4;4;4;3;3;3;3;3;3;3;3;3","NEUROBLASTOMA;NK CELL ACTIVATION;NK CELL RECOGNITION;NK CELL DEVELOPMENT;NK CELL THERAPY;JUVENILE IDIOPATHIC ARTHRITIS;NK CELL RECEPTORS;PATHOGENESIS;SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS;CHILDHOOD CANCER SURVIVOR STUDY;ETIOLOGY;MINIMAL RESIDUAL DISEASE;TREATMENT OUTCOMES;ACUTE LYMPHOBLASTIC LEUKEMIA;ALLERGEN-SPECIFIC IMMUNOTHERAPY;APLASTIC ANEMIA;CHLORIDE CHANNEL;CONGENITAL MUSCULAR DYSTROPHY;EPILEPSY;GAUCHER DISEASE","18;15;15;13;12;8;6;6;6;5;5;5;5;4;4;4;4;4;4;4","NK CELLS;STEM CELL;ALLERGIC RHINITIS;CELL TRANSPLANTATION;HEMATOPOIETIC STEM;IDIOPATHIC ARTHRITIS;JUVENILE IDIOPATHIC;NATURAL KILLER;NK CELL;CHLORIDE CHANNEL;DISSEMINATED NEUROBLASTOMA;GAUCHER DISEASE;ITALIAN PATIENTS;ACUTE LYMPHOBLASTIC;CELL LINES;CONGENITAL MUSCULAR;DIABETES MELLITUS;GROWTH HORMONE;HUMAN NEUROBLASTOMA;LONG-TERM RESULTS;LYMPHOBLASTIC LEUKEMIA;MYOCLONIC EPILEPSY;NORETHISTERONE ACETATE;POOR PROGNOSIS;STEM CELLS;ALLERGEN EXPOSURE;ALLOGENEIC HEMATOPOIETIC;ALLOREACTIVE NK;AMBULATORY ASSESSMENT;ANTI-LEUKEMIA ACTIVITY","9;9;6;6;6;6;6;5;5;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2","PUBMED SCOPUS;CROSSREF PUBMED;NK CELLS;NK CELL;GWA STUDIES;CELL LINES;ENDOMETRIAL TISSUE;GENET -CROSSREF;ENDOMETRIOTIC LESIONS;CDB GR;PERIPHERAL BLOOD;GENE EXPRESSION;SUSCEPTIBILITY LOCI;GENOME-WIDE ASSOCIATION;ILIL PATHWAY;RISK FACTORS;CONTROL SUBJECTS;STEM CELL;CD CELLS;FLOW CYTOMETRY;INACTIVE DISEASE;PLP GENE;CD SUSCEPTIBILITY;GENOMIC CONTROL;GWA STUDY;HLA CLASS;INFLAMMATORY BOWEL;JOINT COUNTS;MELANOMA CELLS;POLAND SYNDROME","63;48;46;22;21;19;16;16;14;13;13;12;12;11;11;11;10;10;9;9;9;9;8;8;8;8;8;8;8;8",52,0.19,6,4.25,2,1,0,1,4,1,2,5,0,1,1.5,1,3,0,1,1,1,0,0,95.25,95.25,2,1,0,1,0,0,0,1,0,0,0,0,2,1,0,11.6666666666667,2.33333333333333,0.83,2.66666666666667,1,3,2,0,0,0,0,0,2,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"ALLEN THERESA M;CORTI ANGELO;PONZONI MIRCO;ORIENTI ISABELLA","2;2;2;1","FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR;ISTITUTO GIANNINA GASLINI;UNIVERSITY OF ALBERTA;G GASLINI CHILDREN'S HOSPITAL;ORIENTI ISABELLA","2;2;2;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3206 MEDICAL BIOTECHNOLOGY;34 CHEMICAL SCIENCES","5;3;1","BIOTECHNOLOGY;BREAST CANCER;CANCER;ORPHAN DRUG;RARE DISEASES","2;2;2;2;2","5.1 PHARMACEUTICALS","2","A61K31/00;A61K31/704;A61K38/08;A61K38/10;A61K9/127;A61K31/12;A61K31/135;A61K31/437;A61K31/44;A61K31/496","2;2;2;2;2;1;1;1;1;1","A61K31/00;A61K31/704;A61K38/08;A61K38/10;A61K9/127;A61P35/00;A61K31/12;A61K47/543;A61K47/6951;B82Y5/00","2;2;2;2;2;2;1;1;1;1",13,6.67,464.71,3.47,1,0.08,22.15,0,0,4,1,5,0,0,3,0,4,3,0,0,0,0,0,0,12,1,0,7,6,0,0,0,0,0,0,0,0,"Germany;Italy","2;2","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3211 ONCOLOGY AND CARCINOGENESIS;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;42 HEALTH SCIENCES;31 BIOLOGICAL SCIENCES;3207 MEDICAL MICROBIOLOGY;3215 REPRODUCTIVE MEDICINE;4201 ALLIED HEALTH AND REHABILITATION SCIENCE","13;12;2;2;2;2;1;1;1;1","CLINICAL RESEARCH;PEDIATRIC;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;PEDIATRIC RESEARCH INITIATIVE;CANCER;INFECTIOUS DISEASES;KIDNEY DISEASE;PATIENT SAFETY;PREVENTION;RARE DISEASES;STEM CELL RESEARCH;ARTHRITIS;AUTOIMMUNE DISEASE;BIOTECHNOLOGY;CARDIOVASCULAR;CHRONIC LIVER DISEASE AND CIRRHOSIS;CHRONIC PAIN;CONDITIONS AFFECTING THE EMBRYONIC AND FETAL PERIODS;DIGESTIVE DISEASES;HEART DISEASE","8;5;4;3;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1","RENAL AND UROGENITAL;CANCER;CARDIOVASCULAR;INFECTION;INFLAMMATORY AND IMMUNE SYSTEM;MUSCULOSKELETAL;NEUROLOGICAL;REPRODUCTIVE HEALTH AND CHILDBIRTH","3;2;2;2;1;1;1;1","6.1 PHARMACEUTICALS;2.4 SURVEILLANCE AND DISTRIBUTION;6.4 SURGERY;6.5 RADIOTHERAPY AND OTHER NON-INVASIVE THERAPIES;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;2.2 FACTORS RELATING TO THE PHYSICAL ENVIRONMENT;7.3 MANAGEMENT AND DECISION MAKING","7;2;2;2;1;1;1","BONE CANCER, OSTEOSARCOMA / MALIGNANT FIBROUS HISTIOCYTOMA;LUNG CANCER;NERVOUS SYSTEM;SARCOMA","2;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;5.5 COMBINATIONS OF LOCALIZED AND SYSTEMIC THERAPIES;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES","2;1;1",2,6151244.5,450646.53,4,9,5.5,1,52,1111622.2217611,0.250984547212443,"ISTITUTO GIANNINA GASLINI;BEN-GURION UNIVERSITY OF THE NEGEV;INSTITUT GUSTAVE ROUSSY;INSTITUTE FOR RESEARCH IN BIOMEDICINE;INSTITUTE OF MOLECULAR BIOTECHNOLOGY;NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS;NEWCASTLE UNIVERSITY;PALACKÝ UNIVERSITY, OLOMOUC;RESEARCH CENTER BORSTEL - LEIBNIZ LUNG CENTER;UNIVERSITY OF BIRMINGHAM;UNIVERSITY OF BRISTOL;UNIVERSITY OF COLOGNE;UNIVERSITY OF GENOA;UNIVERSITY OF OXFORD;UNIVERSITY OF RIJEKA;UNIVERSITY OF VIENNA;WEIZMANN INSTITUTE OF SCIENCE","2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","EUROPEAN COMMISSION;TELETHON FOUNDATION","1;1","COALITION S;EC & ERC - EUROPEAN UNION","1;1","CP-IP - LARGE-SCALE INTEGRATING PROJECT (FUNDING SCHEME);FP7-HEALTH - SPECIFIC PROGRAMME ""COOPERATION"": HEALTH (PROGRAMME);FP7-HEALTH-2007-B (CALL FOR PROPOSAL);TELETHON GRANT PROJECTS - 2009 (PROGRAM)","1;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS","2;1;1","BRAIN DISORDERS;CANCER;GENETICS;PEDIATRIC;PREVENTION","1;1;1;1;1","CANCER;INFLAMMATORY AND IMMUNE SYSTEM","1;1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS","1","COLON AND RECTAL CANCER","1",NA,NA,"A01 CLINICAL MEDICINE;A03 ALLIED HEALTH PROFESSIONS, DENTISTRY, NURSING AND PHARMACY","1;1",NA,NA,5,"PUBLIC LIBRARY OF SCIENCE","5","31 BIOLOGICAL SCIENCES;3102 BIOINFORMATICS AND COMPUTATIONAL BIOLOGY;32 BIOMEDICAL AND CLINICAL SCIENCES;3105 GENETICS;3204 IMMUNOLOGY;46 INFORMATION AND COMPUTING SCIENCES;4612 SOFTWARE ENGINEERING","6;3;3;2;1;1;1","GENETICS;BIOTECHNOLOGY","3;2","INFLAMMATORY AND IMMUNE SYSTEM","1","1.1 NORMAL BIOLOGICAL DEVELOPMENT AND FUNCTIONING;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS","1;1","BIOMEDICAL","1","CLINICAL MEDICINE AND SCIENCE","1","NOT SITE-SPECIFIC CANCER","1",NA,NA
"IRCCS_GASLINI",2010,233,10.5278969957082,3.24034334763948,0.334763948497854,0.360515021459227,0.399141630901288,1.9686684073107,1.16417910447761,1.37704918032787,1.24,0.450643776824034,2,119,61,23,12,0.51,0.26,0.1,0.05,54.78,1.21212888883097,NA,0.454935622317597,0.879828326180258,0.464,0.375,0.419,0.433,"ALBERTO MARTINI;ANGELA PISTORIO;LORENZO MORETTA;NICOLINO RUPERTO;GIORGIO CIPRANDI;GIAN MARCO GHIGGERI;MARCO GATTORNO;ISABELLA CECCHERINI;VITO PISTOIA;MIRELLA FILOCAMO;MARIA CRISTINA MINGARI;ANGELO RAVELLI;ALBERTO GARAVENTA;ELIO CASTAGNOLA;CLAUDIO GAMBINI;VINCENZO JASONNI;FEDERICO ZARA;ELISABETTA TRAGGIAI;MARIA ANGELA TOSCA;MARA DE AMICI","17;15;14;14;11;10;10;9;9;9;8;8;8;7;7;7;7;7;7;6","GIORGIO CIPRANDI;LORENZO MORETTA;NICOLINO RUPERTO;GIAN LUIGI MARSEGLIA;MARIA ANGELA TOSCA;MARA DE AMICI;ANGELA PISTORIO;MARCO GATTORNO;FEDERICO ZARA;ALBERTO MARTINI;PASQUALE STRIANO;ALBERTO GARAVENTA;DOMENICOTTI;MICHELA SILVESTRI;MIRELLA FILOCAMO;GIAN MARCO GHIGGERI;ROBERTO RAVAZZOLO;GIOVANNI A. ROSSI;ANDREA ROSSI;ELIO CASTAGNOLA","2.74;2.06;1.74;1.53;1.52;1.45;1.37;1.24;1.24;1.18;1.09;1.04;1;0.99;0.93;0.91;0.9;0.89;0.87;0.86","ALBERTO MARTINI;ANGELA PISTORIO;LORENZO MORETTA;NICOLINO RUPERTO;GIAN MARCO GHIGGERI;MARCO GATTORNO;ISABELLA CECCHERINI;VITO PISTOIA;MIRELLA FILOCAMO;ANGELO RAVELLI;ALBERTO GARAVENTA;ELIO CASTAGNOLA;CLAUDIO GAMBINI;VINCENZO JASONNI;FEDERICO ZARA;ELISABETTA TRAGGIAI;MARIA ANGELA TOSCA;ALESSIO PINI PRATO;STEFANO AVANZINI;GIROLAMO MATTIOLI","17;15;14;14;10;10;9;9;9;8;8;7;7;7;7;7;7;6;6;6","LORENZO MORETTA;NICOLINO RUPERTO;MARIA ANGELA TOSCA;ANGELA PISTORIO;MARCO GATTORNO;FEDERICO ZARA;ALBERTO MARTINI;PASQUALE STRIANO;ALBERTO GARAVENTA;MICHELA SILVESTRI;MIRELLA FILOCAMO;GIAN MARCO GHIGGERI;ROBERTO RAVAZZOLO;GIOVANNI A. ROSSI;ANDREA ROSSI;ELIO CASTAGNOLA;VITO PISTOIA;VINCENZO JASONNI;PAOLO NOZZA;RENATA BOCCIARDI","2.06;1.74;1.52;1.37;1.24;1.24;1.18;1.09;1.04;0.99;0.93;0.91;0.9;0.89;0.87;0.86;0.81;0.79;0.74;0.74","ALBERTO MARTINI;NICOLINO RUPERTO;ANGELA PISTORIO;SEZA ÖZEN;S. M. IUSAN;ANTONELLA BUONCOMPAGNI;DONATO RIGANTE;FLÁVIO SZTAJNBOK;YOSEF UZIEL;A. I. ESTRELLA;ALEXANDRE BÉLOT;ALMA NUNZIA OLIVIERI;ANUELA KONDI;AYŞİN BAKKALOĞLU;CHRIS PRUUNSILD;CLAUDIA SENGLER;CLÓVIS A. SILVA;CÂLIN LAZAR;D. DJEDDI;DIMITRINA MIHAYLOVA","2833;2429;2162;1591;1452;1364;1349;1294;1294;1237;1237;1237;1237;1237;1237;1237;1237;1237;1237;1237","ALBERTO MARTINI;ANGELA PISTORIO;NICOLINO RUPERTO;S. M. IUSAN;ANTONELLA BUONCOMPAGNI;ANUELA KONDI;M. G. ALPIGIANI;SILVIA PEDERZOLI;ISABELLA CECCHERINI;LORENZO MORETTA;MARCO GATTORNO;CLAUDIA CANTONI;ANGELO RAVELLI;GIAN MARCO GHIGGERI;ELISABETTA TRAGGIAI;MIRELLA FILOCAMO;LIZZIA RAFFAGHELLO;EDOARDO LANINO;VITO PISTOIA;GIOVANNA BIANCHI","2391;2162;2123;1452;1364;1237;1237;1237;1098;944;786;608;555;518;488;483;432;419;401;387","ANGELA PISTORIO;LORENZO MORETTA;ALBERTO MARTINI;NICOLINO RUPERTO;MARIA ANGELA TOSCA;MARCO GATTORNO;MIRELLA FILOCAMO;ALBERTO GARAVENTA;GIAN MARCO GHIGGERI;ISABELLA CECCHERINI;VITO PISTOIA;ELISABETTA TRAGGIAI;ANDREA ROSSI;FEDERICO ZARA;PASQUALE STRIANO;ANGELO RAVELLI;ELIO CASTAGNOLA;GIOVANNI A. ROSSI;MICHELA SILVESTRI;PAOLO NOZZA","15;13;13;11;10;9;9;8;8;8;8;7;6;6;6;6;6;6;6;6","MEDICINE;BIOLOGY;CHEMISTRY;COMPUTER SCIENCE;PHYSICS;PSYCHOLOGY;SOCIOLOGY;MATHEMATICS;ECONOMICS;ENGINEERING;POLITICAL SCIENCE;ART;PHILOSOPHY","176;141;22;10;10;7;6;5;3;3;2;1;1","INTERNAL MEDICINE;GENETICS;IMMUNOLOGY;BIOCHEMISTRY;PATHOLOGY;SURGERY;CELL BIOLOGY;PEDIATRICS;CANCER RESEARCH;MOLECULAR BIOLOGY;ENDOCRINOLOGY;GASTROENTEROLOGY;PSYCHIATRY;RADIOLOGY;INTENSIVE CARE MEDICINE;ONCOLOGY;PHYSICAL THERAPY;ENVIRONMENTAL HEALTH;MICROBIOLOGY;NEUROSCIENCE;OPTICS;PHARMACOLOGY;VIROLOGY","123;92;64;50;44;42;39;33;32;28;26;15;14;13;10;9;8;7;7;7;7;7;7","GENE;DISEASE;IMMUNE SYSTEM;CANCER;RECEPTOR;ANTIBODY;CELL CULTURE;CHEMOTHERAPY;IN VITRO;STEM CELL;PREGNANCY;CYTOKINE;INFLAMMATION;KIDNEY;POPULATION;ALLERGY;COHORT;EPILEPSY;APOPTOSIS;ARTHRITIS;CELL;INCIDENCE (GEOMETRY);PROSPECTIVE COHORT STUDY;RESPIRATORY SYSTEM;RHEUMATOLOGY;TRANSPLANTATION","74;32;24;22;19;18;18;17;15;11;10;9;9;9;9;8;8;8;7;7;7;7;7;7;7;7","MUTATION;PHENOTYPE;NEUROBLASTOMA;GENE EXPRESSION;GENOTYPE;BREAST CANCER;CYTOTOXIC T CELL;EXON;ALLELE;DOWNREGULATION AND UPREGULATION;HAEMATOPOIESIS;IMMUNOGLOBULIN E;CHROMOSOMAL TRANSLOCATION;CHROMOSOME;FETUS;T CELL;TRANSCRIPTION FACTOR;ALLERGEN;CYCLOPHOSPHAMIDE;METASTASIS;MUTANT","25;18;14;13;13;9;9;9;8;8;7;7;6;6;6;6;6;5;5;5;5","MISSENSE MUTATION;COMPOUND HETEROZYGOSITY;BREAKPOINT;DNA METHYLATION;FRAMESHIFT MUTATION;NATURAL KILLER CELL;ONCOGENE;ANTIGEN-PRESENTING CELL;CYTOGENETICS;EXHALED NITRIC OXIDE;INDOLEAMINE 2,3-DIOXYGENASE;INTERLEUKIN 12;INTERLEUKIN 21;POINT MUTATION;POLYARTERITIS NODOSA;SINGLE-NUCLEOTIDE POLYMORPHISM;SYSTEMIC VASCULITIS;ACUTE LYMPHOCYTIC LEUKEMIA;ALLERGIC RESPONSE;ANEUPLOIDY;BRONCHIAL HYPERREACTIVITY;CD40;CHEMOKINE RECEPTOR;CONGENITAL CENTRAL HYPOVENTILATION SYNDROME;CORONAVIRUS DISEASE 2019 (COVID-19);CYTOLYSIS;FLUORESCENCE IN SITU HYBRIDIZATION;GASTRULATION;GENETIC HETEROGENEITY;GENOME INSTABILITY;HAPLOTYPE;HENOCH-SCHONLEIN PURPURA;HEREDITARY SPASTIC PARAPLEGIA;INNATE LYMPHOID CELL;KARYOTYPE;KRABBE DISEASE;LYMPHEDEMA;OLIGOARTHRITIS;PLACENTA;PODOCYTE;PROBAND;RNA SPLICING;SMALL INTERFERING RNA;VINCRISTINE","9;7;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HUMANS;FEMALE;MALE;CHILD;CHILD, PRESCHOOL;ADOLESCENT;INFANT;NEUROBLASTOMA;;ANIMALS;MUTATION;ADULT;ITALY;KILLER CELLS, NATURAL;ARTHRITIS, JUVENILE;INFANT, NEWBORN;MICE;CELL PROLIFERATION;CYTOKINES;RNA, MESSENGER","189;115;106;76;64;53;41;41;32;32;32;31;28;24;22;22;21;20;20;20","NEUROBLASTOMA RESEARCH AND TREATMENT;NATURAL KILLER CELLS IN IMMUNITY;HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS AND RELATED DISORDERS;ALLERGIC RHINITIS AND ITS IMPACT ON ASTHMA;ASTHMA;EPILEPSY AND SEIZURES;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;THERAPEUTIC ADVANCES IN CYSTIC FIBROSIS RESEARCH;GENOMIC REARRANGEMENTS AND COPY NUMBER VARIATIONS;MOLECULAR MECHANISMS OF INFLAMMASOME ACTIVATION AND REGULATION;MOLECULAR MECHANISMS OF KIDNEY DEVELOPMENT AND DISEASE;CLASSIFICATION AND MANAGEMENT OF VASCULITIDES;FUNCTIONS AND REGULATION OF RNA EDITING BY ADARS;HIRSCHSPRUNG DISEASE AND ENTERIC NERVOUS SYSTEM DEVELOPMENT;METABOLIC DISORDERS AND BIOCHEMICAL GENETICS;MULTIPOTENT MESENCHYMAL STEM CELLS;PATHOPHYSIOLOGY OF GLOMERULAR DISEASES AND NEPHROTIC SYNDROMES;PEDIATRIC URINARY TRACT INFECTIONS;ACUTE MYELOID LEUKEMIA;CHRONIC KIDNEY DISEASE AND DIALYSIS TREATMENT","13;11;10;9;6;5;5;5;4;4;4;3;3;3;3;3;3;3;2;2","NEUROBLASTOMA;NK CELL ACTIVATION;NK CELL DEVELOPMENT;NK CELL RECOGNITION;SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS;JUVENILE IDIOPATHIC ARTHRITIS;COMPOUND HETEROZYGOSITY;NK CELL RECEPTORS;NK CELL THERAPY;REGIMEN;TREATMENT;BREAKPOINT;CFTR;DIAGNOSIS;NK CELL EDUCATION;POLLEN ALLERGY;PROINFLAMMATORY CYTOKINE;ALLERGEN IMMUNOTHERAPY;ALLERGEN-SPECIFIC IMMUNOTHERAPY;ASTHMA","13;12;12;11;10;8;7;7;6;6;5;4;4;4;4;4;4;3;3;3","IDIOPATHIC ARTHRITIS;JUVENILE IDIOPATHIC;ALLERGIC RHINITIS;NK CELLS;DENDRITIC CELLS;HUMAN NATURAL;MESENCHYMAL STEM;STEM CELL;STEM CELLS;CELL TRANSPLANTATION;CYTOKINE PRODUCTION;GENE EXPRESSION;HEMATOPOIETIC STEM;KILLER CELL;LYMPHOBLASTIC LEUKEMIA;NATURAL KILLER;REPLACEMENT THERAPY;ALCAM MOLECULES;ALLERGEN EXPOSURE;APLASTIC ANEMIA;ARTERITIS ANKARA;ASSOCIAZIONE ITALIANA;BACTERIAL LYSATES;BRONCHIAL HYPERREACTIVITY;CD SUPSUP;CDSUPSUP NK;CELL GROWTH;CELLS INHIBIT;CENTRAL HYPOVENTILATION;CHILDHOOD POLYARTERITIS","7;7;5;5;4;4;4;4;4;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2","NK CELLS;STAGE III;ENDOTHELIAL CELLS;NK CELL;CD NK;PATIENTS RECEIVING;STEM CELL;SYSTEMIC SCLEROSIS;CELL LINES;CELL SURFACE;CELL TRANSPLANTATION;CIRCLE VAS;DENDRITIC CELLS;GENE EXPRESSION;GERMINAL CENTRE;GH DEFICIENCY;MEDIAN AGE;NUMBERED CIRCLE;PERIPHERAL BLOOD;ALLERGIC PATIENTS;BACTERIAL LYSATES;CIRCULATING ENDOTHELIAL;CX CL;GENETIC TESTING;HEMATOPOIETIC STEM;INFLIXIMAB MGKG;JIA PATIENTS;MGKG MTX;VENTRICULAR OUTFLOW;BINDING SITE","31;14;12;11;8;8;8;8;7;7;7;7;7;7;7;7;7;7;7;6;6;6;6;6;6;6;6;6;6;5",49,0.21,6,3,1,1.25,1,1,3.5,1,1,3,0,1,4.25,1.75,1,0,2,2.75,1,0,0,92,92,1,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,3,0.4,2,0,1,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"LUNARDI CLAUDIO;PUCCETTI ANTONIO;ZANONI GIOVANNA","1;1;1","ISTITUTO GIANNINA GASLINI;UNIVERSITA DEGLI STUDI DI VERONA","1;1","31 BIOLOGICAL SCIENCES;3101 BIOCHEMISTRY AND CELL BIOLOGY;32 BIOMEDICAL AND CLINICAL SCIENCES","1;1;1","AUTOIMMUNE DISEASE;CLINICAL RESEARCH;DIGESTIVE DISEASES;NUTRITION","1;1;1;1",NA,NA,"C07H21/04;C07K16/00;C07K7/08;C12N15/63;C12N5/00;G01N33/53","1;1;1;1;1;1","A61K2039/53;A61K38/00;A61K39/12;A61K39/15;C07K14/005;C07K14/4713;C07K16/10;C07K16/18;C07K16/2896;C07K16/40","1;1;1;1;1;1;1;1;1;1",10,4.5,97.88,2.79,2,0.2,19.4,0,0,3,2,1,0,1,3,0,5,3,0,0,0,0,0,0,10,0,0,8,2,0,0,0,0,0,0,0,0,"United States;France;Portugal","2;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3212 OPHTHALMOLOGY AND OPTOMETRY;31 BIOLOGICAL SCIENCES;3213 PAEDIATRICS;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;39 EDUCATION;3904 SPECIALIST STUDIES IN EDUCATION;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY","10;7;2;1;1;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;PEDIATRIC;EYE DISEASE AND DISORDERS OF VISION;NEURODEGENERATIVE;NEUROSCIENCES;BRAIN DISORDERS;DENTAL/ORAL AND CRANIOFACIAL DISEASE;DIABETES;GENETICS;INFANT MORTALITY;KIDNEY DISEASE;NUTRITION;PATIENT SAFETY;PERINATAL PERIOD - CONDITIONS ORIGINATING IN PERINATAL PERIOD;PRETERM, LOW BIRTH WEIGHT AND HEALTH OF THE NEWBORN;RARE DISEASES","8;6;4;2;2;2;1;1;1;1;1;1;1;1;1;1;1","EYE;METABOLIC AND ENDOCRINE;RENAL AND UROGENITAL;REPRODUCTIVE HEALTH AND CHILDBIRTH","1;1;1;1","6.1 PHARMACEUTICALS;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;5.1 PHARMACEUTICALS;6.4 SURGERY","6;1;1;1;1",NA,NA,NA,NA,4,1693806.5,177017,3.5,10.25,2.75,0.75,34.5,1124152.33539747,0.20726728279012,"ISTITUTO GIANNINA GASLINI;BAMBINO GESÙ CHILDREN'S HOSPITAL;CATHOLIC UNIVERSITY OF THE SACRED HEART;UNIVERSITY OF MESSINA;UNIVERSITY OF PADUA;UNIVERSITY OF TURIN;ACADEMIC MEDICAL CENTER;DÉLÉGATION PARIS 11;EUROPEAN LEUKODYSTROPHY ASSOCIATION;FONDAZIONE IRCCS CA' GRANDA OSPEDALE MAGGIORE POLICLINICO;FONDAZIONE ISTITUTO NEUROLOGICO NAZIONALE CASIMIRO MONDINO;FRANCE EUROPE INNOVATION;INSTITUT D'INVESTIGACIÓ BIOMÉDICA DE BELLVITGE;IRCCS OSPEDALE SAN RAFFAELE;ISTITUTO NEUROLOGICO CARLO BESTA;MAX PLANCK SOCIETY;MEDICAL UNIVERSITY OF VIENNA;ROCHE (FRANCE);UNIVERSITY COLLEGE LONDON;UNIVERSITY HOSPITAL BONN","4;3;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1","TELETHON FOUNDATION;EUROPEAN COMMISSION","3;1","COALITION S;EC & ERC - EUROPEAN UNION","1;1","TELETHON - UILDM CLINICAL GRANT PROJECTS - 2009 (PROGRAM);CP-FP - SMALL OR MEDIUM-SCALE FOCUSED RESEARCH PROJECT (FUNDING SCHEME);FP7-HEALTH - SPECIFIC PROGRAMME ""COOPERATION"": HEALTH (PROGRAMME);FP7-HEALTH-2009-SINGLE-STAGE (CALL FOR PROPOSAL);TELETHON GRANT PROJECTS - 2010 (PROGRAM)","2;1;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;3101 BIOCHEMISTRY AND CELL BIOLOGY;3206 MEDICAL BIOTECHNOLOGY;3208 MEDICAL PHYSIOLOGY;42 HEALTH SCIENCES;4201 ALLIED HEALTH AND REHABILITATION SCIENCE","3;2;1;1;1;1;1","BRAIN DISORDERS;CLINICAL RESEARCH;GENETICS;NEUROSCIENCES;ORPHAN DRUG;RARE DISEASES;AUTOIMMUNE DISEASE;BIOTECHNOLOGY;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;CYSTIC FIBROSIS;DUCHENNE/ BECKER MUSCULAR DYSTROPHY;INTELLECTUAL AND DEVELOPMENTAL DISABILITIES (IDD);LUNG;MUSCULAR DYSTROPHY;NEURODEGENERATIVE;PEDIATRIC","2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1","CONGENITAL;MUSCULOSKELETAL","1;1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;5.1 PHARMACEUTICALS;7.3 MANAGEMENT AND DECISION MAKING","1;1;1",NA,NA,NA,NA,"A01 CLINICAL MEDICINE;A04 PSYCHOLOGY, PSYCHIATRY AND NEUROSCIENCE;A05 BIOLOGICAL SCIENCES","2;1;1",NA,NA,9,"PUBLIC LIBRARY OF SCIENCE","9","32 BIOMEDICAL AND CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3101 BIOCHEMISTRY AND CELL BIOLOGY;3105 GENETICS;3203 DENTISTRY;3204 IMMUNOLOGY;38 ECONOMICS;3801 APPLIED ECONOMICS;51 PHYSICAL SCIENCES;5110 SYNCHROTRONS AND ACCELERATORS","13;4;3;1;1;1;1;1;1;1;1","GENETICS;BIOTECHNOLOGY;AUTOIMMUNE DISEASE;BIODEFENSE;BREAST CANCER;CANCER;DIGESTIVE DISEASES;EMERGING INFECTIOUS DISEASES;HEMATOLOGY;HUMAN GENOME;INFECTIOUS DISEASES;PREVENTION;VACCINE RELATED","4;3;1;1;1;1;1;1;1;1;1;1;1","CANCER;CONGENITAL;INFLAMMATORY AND IMMUNE SYSTEM;ORAL AND GASTROINTESTINAL","2;1;1;1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;1.1 NORMAL BIOLOGICAL DEVELOPMENT AND FUNCTIONING;5.1 PHARMACEUTICALS","3;1;1","BIOMEDICAL;HEALTH SERVICES & SYSTEMS","2;1","BASIC SCIENCE","3","BREAST CANCER;NOT SITE-SPECIFIC CANCER;PANCREATIC CANCER","1;1;1",NA,NA
"IRCCS_GASLINI",2011,279,12.0035842293907,3.4336917562724,0.405017921146953,0.422939068100358,0.491039426523298,2.10549450549451,1.17708333333333,1.84375,1.24545454545455,0.505376344086022,3,125,88,34,19,0.45,0.32,0.12,0.07,44.83,1.05400946867846,NA,0.433691756272401,0.888888888888889,0.493,0.402,0.441,0.414,"ALBERTO MARTINI;MARCO GATTORNO;ANGELO RAVELLI;VITO PISTOIA;NICOLINO RUPERTO;ANGELA PISTORIO;CARLO DUFOUR;ANDREA ROSSI;LORENZO MORETTA;VALERIA CAPRA;GIOVANNI MELIOLI;GIORGIO CIPRANDI;ISABELLA CECCHERINI;GIAN MARCO GHIGGERI;CARLO MINETTI;ALESSANDRO CONSOLARO;GIOVANNI A. ROSSI;FABIO MORANDI;VINCENZO JASONNI;LUIS J. V. GALIETTA","26;18;14;14;12;11;11;11;10;10;10;10;9;9;7;7;7;7;7;7","ALBERTO MARTINI;GIORGIO CIPRANDI;GIOVANNI MELIOLI;MARIA ANGELA TOSCA;MARCO GATTORNO;LORENZO MORETTA;NICOLINO RUPERTO;VITO PISTOIA;CARLO DUFOUR;ANDREA ROSSI;MICHELE TORRE;ANGELO RAVELLI;ALESSIO SIGNORI;LUIS J. V. GALIETTA;ANGELA PISTORIO;CARLO GANDOLFO;GIOVANNI A. ROSSI;CORRADO MURTAS;FABIO MORANDI;IGNAZIO CIRILLO","2.71;2.33;1.98;1.62;1.49;1.41;1.4;1.37;1.35;1.27;1.26;1.2;1.2;1.16;1.15;1.12;1.12;1.07;1.05;1","ALBERTO MARTINI;MARCO GATTORNO;ANGELO RAVELLI;VITO PISTOIA;NICOLINO RUPERTO;ANGELA PISTORIO;CARLO DUFOUR;ANDREA ROSSI;LORENZO MORETTA;VALERIA CAPRA;GIOVANNI MELIOLI;ISABELLA CECCHERINI;GIAN MARCO GHIGGERI;CARLO MINETTI;ALESSANDRO CONSOLARO;GIOVANNI A. ROSSI;FABIO MORANDI;VINCENZO JASONNI;LUIS J. V. GALIETTA;MARIA LUISA GARRÈ","26;18;14;14;12;11;11;11;10;10;10;9;9;7;7;7;7;7;7;7","ALBERTO MARTINI;GIOVANNI MELIOLI;MARIA ANGELA TOSCA;MARCO GATTORNO;LORENZO MORETTA;NICOLINO RUPERTO;VITO PISTOIA;CARLO DUFOUR;ANDREA ROSSI;MICHELE TORRE;ANGELO RAVELLI;LUIS J. V. GALIETTA;ANGELA PISTORIO;CARLO GANDOLFO;GIOVANNI A. ROSSI;CORRADO MURTAS;FABIO MORANDI;VALERIA CAPRA;MARIA VALERIA CORRIAS;CARLO MINETTI","2.71;1.98;1.62;1.49;1.41;1.4;1.37;1.35;1.27;1.26;1.2;1.16;1.15;1.12;1.12;1.07;1.05;0.95;0.93;0.87","LORENZO MORETTA;GIAN MARCO GHIGGERI;FRANCESCO SCOLARI;PIETRO RAVANI;LORETO GESUALDO;ALESSANDRO MORETTA;ALBERTO MARTINI;JEAN‐LAURENT CASANOVA;ALESSANDRO PLEBANI;CARLO DUFOUR;LANDINO ALLEGRI;ALI G. GHARAVI;ANGELO RAVELLI;RICCARDO MAGISTRONI;ALESSANDRO AMORE;BRUCE A. JULIAN;JAN NOVÁK;LICIA PERUZZI;ROSANNA COPPO;GIORGIO GIMELLI","1216;1211;1059;888;863;810;807;803;801;772;761;759;683;683;681;681;681;681;681;671","LORENZO MORETTA;GIAN MARCO GHIGGERI;CARLO DUFOUR;GIORGIO GIMELLI;MICHAELA CALVILLO;ELISABETTA TRAGGIAI;MONICA BODRIA;VALERIA CAPRA;FRANCESCA LUGANI;MARCO GATTORNO;NICOLINO RUPERTO;MAJA DI ROCCO;ANDREA ROSSI;ANGELA PISTORIO;VITO PISTOIA;LUIS J. V. GALIETTA;MICHELA CASSANELLO;ANGELO RAVELLI;SABRINA CHIESA;MIRELLA FILOCAMO","1216;1190;772;671;664;658;648;615;570;542;473;465;455;446;438;410;396;379;377;372","MARCO GATTORNO;ALBERTO MARTINI;VITO PISTOIA;ANGELA PISTORIO;ANDREA ROSSI;CARLO DUFOUR;NICOLINO RUPERTO;LORENZO MORETTA;ANGELO RAVELLI;VALERIA CAPRA;GIOVANNI MELIOLI;ISABELLA CECCHERINI;GIAN MARCO GHIGGERI;ALESSANDRO CONSOLARO;ARMANDO CAMA;FABIO MORANDI;GIOVANNI A. ROSSI;LUIS J. V. GALIETTA;MAJA DI ROCCO;MARIA ANGELA TOSCA","16;16;14;11;11;11;11;10;10;10;9;9;8;7;7;7;7;7;7;7","MEDICINE;BIOLOGY;CHEMISTRY;PHYSICS;PSYCHOLOGY;POLITICAL SCIENCE;ENGINEERING;COMPUTER SCIENCE;MATHEMATICS;ECONOMICS;PHILOSOPHY;BUSINESS;SOCIOLOGY;MATERIALS SCIENCE;GEOGRAPHY","225;160;38;23;11;9;7;6;6;4;4;3;3;2;1","INTERNAL MEDICINE;GENETICS;PEDIATRICS;IMMUNOLOGY;BIOCHEMISTRY;PATHOLOGY;CELL BIOLOGY;SURGERY;CANCER RESEARCH;ENDOCRINOLOGY;ENVIRONMENTAL HEALTH;GASTROENTEROLOGY;PSYCHIATRY;MOLECULAR BIOLOGY;ONCOLOGY;PHYSICAL THERAPY;RADIOLOGY;NEUROSCIENCE;INTENSIVE CARE MEDICINE;BIOINFORMATICS","165;112;71;68;55;47;43;42;30;24;24;24;22;21;19;17;14;12;11;10","GENE;DISEASE;CANCER;IMMUNE SYSTEM;RHEUMATOLOGY;RECEPTOR;POPULATION;STEM CELL;CELL CULTURE;ANTIBODY;TRANSPLANTATION;ARTHRITIS;IN VITRO;BONE MARROW;COHORT;JUVENILE;LEUKEMIA;ASTHMA;ENZYME;ANTIGEN;CHEMOTHERAPY;IMMUNOHISTOCHEMISTRY;INFLAMMATION;PREGNANCY","75;46;22;21;21;20;19;19;18;16;16;15;15;14;12;11;11;10;10;9;9;9;9;9","MUTATION;NEUROBLASTOMA;PHENOTYPE;GENOTYPE;EXON;T CELL;HAEMATOPOIESIS;ALLELE;FETUS;HEMATOPOIETIC STEM CELL TRANSPLANTATION;CD34;GENE EXPRESSION;RNA;SPIROMETRY;ANAKINRA;CD8;CYTOTOXIC T CELL;FAMILIAL MEDITERRANEAN FEVER;MUTANT;ALLERGEN;APLASTIC ANEMIA;CHEMOKINE;CLINICAL ENDPOINT;DNA REPAIR;HUMAN GENETICS;INFECTIOUS DISEASE (MEDICAL SPECIALTY);METASTASIS;NEUROPSYCHOLOGY;PERIPHERAL BLOOD MONONUCLEAR CELL;PLACEBO;PROTEINURIA;RESPIRATORY DISEASE;RITUXIMAB","28;14;14;11;10;10;9;8;8;7;6;6;6;6;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4;4;4","MISSENSE MUTATION;BONE MARROW FAILURE;COMPOUND HETEROZYGOSITY;CANAKINUMAB;CD3;CORONAVIRUS DISEASE 2019 (COVID-19);GENE MUTATION;INTERLEUKIN 21;NKG2D;ALTERNATIVE SPLICING;BRONCHODILATION;CONGENITAL CENTRAL HYPOVENTILATION SYNDROME;FANCONI ANEMIA;INTERLEUKIN 12;NATURAL KILLER CELL;ACUTE LYMPHOCYTIC LEUKEMIA;ALLELE FREQUENCY;ANAPLASTIC LYMPHOMA KINASE;ATYPICAL HEMOLYTIC UREMIC SYNDROME;BUTHIONINE SULFOXIMINE;CD38;CHEMOKINE RECEPTOR;COMPARATIVE GENOMIC HYBRIDIZATION;CYTOGENETICS;DIFFUSING CAPACITY;ECULIZUMAB;EXOME SEQUENCING;FEBRILE NEUTROPENIA;GENE EXPRESSION PROFILING;HETEROZYGOTE ADVANTAGE;HISTONE DEACETYLASE;IL-2 RECEPTOR;IMIPENEM;IMMUNOGLOBULIN M;LEUKAPHERESIS;LOSS OF HETEROZYGOSITY;MITOCHONDRIAL MYOPATHY;MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION;NATURAL KILLER T CELL;PLACENTA;PODOCYTE;PRENATAL DIAGNOSIS;RNA INTERFERENCE;SINGLE-NUCLEOTIDE POLYMORPHISM;SMALL INTERFERING RNA;TRANSCRIPTOME;TRPC6;VERBAL FLUENCY TEST","12;5;5;4;4;4;4;4;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HUMANS;MALE;FEMALE;CHILD;CHILD, PRESCHOOL;ADOLESCENT;;INFANT;NEUROBLASTOMA;ADULT;ITALY;MUTATION;KILLER CELLS, NATURAL;YOUNG ADULT;ANIMALS;RHINITIS, ALLERGIC, PERENNIAL;TREATMENT OUTCOME;ASTHMA;MIDDLE AGED;RHINITIS, ALLERGIC, SEASONAL","205;130;127;91;72;67;64;50;47;45;40;36;35;31;29;29;29;28;25;25","MOLECULAR MECHANISMS OF INFLAMMASOME ACTIVATION AND REGULATION;NEUROBLASTOMA RESEARCH AND TREATMENT;HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS AND RELATED DISORDERS;NATURAL KILLER CELLS IN IMMUNITY;ALLERGIC RHINITIS AND ITS IMPACT ON ASTHMA;PATHOPHYSIOLOGY OF GLOMERULAR DISEASES AND NEPHROTIC SYNDROMES;THERAPEUTIC ADVANCES IN CYSTIC FIBROSIS RESEARCH;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;ASTHMA;EPILEPSY AND SEIZURES;HEMATOPOIETIC STEM CELL BIOLOGY;MANAGEMENT OF FEBRILE NEUTROPENIA IN CANCER PATIENTS;METABOLIC DISORDERS AND BIOCHEMICAL GENETICS;CLINICAL MANAGEMENT OF TRACHEAL AND AIRWAY DISORDERS;DEVELOPMENT AND DISORDERS OF FETAL BRAIN;GENOMIC REARRANGEMENTS AND COPY NUMBER VARIATIONS;GLIOMAS;IMMUNOLOGICAL MECHANISMS IN PREGNANCY AND FETAL-MATERNAL INTERFACE;METABOLIC REPROGRAMMING IN CANCER BIOLOGY;MOLECULAR MECHANISMS OF DNA DAMAGE RESPONSE","14;14;11;10;9;7;7;6;5;5;4;4;4;3;3;3;3;3;3;3","NEUROBLASTOMA;SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS;NK CELL ACTIVATION;JUVENILE IDIOPATHIC ARTHRITIS;NK CELL DEVELOPMENT;NK CELL RECOGNITION;NK CELL THERAPY;ASTHMA;CHLORIDE CHANNEL;INFLAMMATION;NK CELL RECEPTORS;BONE MARROW FAILURE;COMPOUND HETEROZYGOSITY;HEMATOPOIETIC CELL TRANSPLANTATION;AIRWAY AFFERENT NERVES;APLASTIC ANEMIA;CANAKINUMAB;CFTR;CHILDHOOD CANCER;CLINICAL ENDPOINT","15;12;11;10;9;7;7;6;6;6;6;5;5;5;4;4;4;4;4;4","IDIOPATHIC ARTHRITIS;JUVENILE IDIOPATHIC;ALLERGIC RHINITIS;CYSTIC FIBROSIS;HEMATOPOIETIC STEM;NEPHROTIC SYNDROME;STEM CELL;BONE MARROW;DISEASE ACTIVITY;ITALIAN PATIENTS;PATIENTS TREATED;PERIODIC SYNDROME;PHASE II;STEM CELLS;SYSTEMIC JUVENILE;APLASTIC ANEMIA;CELL TRANSPLANTATION;CHLORIDE CHANNEL;CRYOPYRIN-ASSOCIATED PERIODIC;DENDRITIC CELLS;FANCONI ANEMIA;INACTIVE DISEASE;ITALIAN CHILDREN;KILLER CELLS;LEUKEMIA CELLS;LUPUS ERYTHEMATOSUS;LYMPHOBLASTIC LEUKEMIA;MOLECULAR CHARACTERIZATION;NATURAL KILLER;NEURAL TUBE","11;11;8;6;5;5;5;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3","PUBMED SCOPUS;CROSSREF PUBMED;NEPHROTIC SYNDROME;DIABETIC GASTROPARESIS;NK CELLS;GALIETTA LJ;BIOL CHEM;FIGURE FIGURE;ALTERNATIVE SPLICING;METABOTROPIC GLUTAMATE;PHYSIOL -CROSSREF;AUTOSOMAL RECESSIVE;SANDERS KM;WARD SM;CHEM -ABSTRACT;GENE EXPRESSION;MGLU RECEPTOR;NEPHROL -CROSSREF;CA-ACTIVATED CL;CANCER CELLS;GENET -CROSSREF;CELL LINES;CYSTIC FIBROSIS;SERUM LEVELS;FIGURE VIEWERDOWNLOAD;GLUTAMATE RECEPTORS;IMAGE FIGURE;MISSENSE MUTATIONS;PEDIATRIC PATIENTS;SOC NEPHROL","179;135;32;29;25;23;22;18;17;16;16;15;15;15;14;14;14;14;13;13;13;12;12;12;11;11;11;11;11;11",67,0.24,7.12,5,2.25,1,0,1,5,0,1,5,0,1,3,0,3.5,2,1,2,1,0,0,93,93,1,0,0,1,0,0,0,0,0,0,0,0,1,0,0,7,3,0.31,5,0,1,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"FRULLONI LUCA;LUNARDI CLAUDIO;PUCCETTI ANTONIO","1;1;1","FRULLONI LUCA;ISTITUTO G GASLINI;LUNARDI CLAUDIO;PUCCETTI ANTONIO;UNI DEGLI STUDI DI VERONA","1;1;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3204 IMMUNOLOGY","2;1",NA,NA,NA,NA,"G01N33/53;G01N33/564","1;1","G01N2800/067;G01N33/564","1;1",10,6.67,1217.8,2.33,2,0.2,29,0,0,2,0,3,0,1,4,0,6,4,0,0,0,0,0,0,10,0,0,10,0,0,0,0,0,0,0,0,0,"Italy;Germany;United States","4;2;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;31 BIOLOGICAL SCIENCES;3105 GENETICS;3213 PAEDIATRICS;42 HEALTH SCIENCES","10;7;3;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;RARE DISEASES;PEDIATRIC;CANCER;PEDIATRIC RESEARCH INITIATIVE;BRAIN DISORDERS;GENETICS;NEUROSCIENCES;PATIENT SAFETY;ARTHRITIS;AUTOIMMUNE DISEASE;BRAIN CANCER;CARDIOVASCULAR;INFECTIOUS DISEASES;KIDNEY DISEASE;NEUROBLASTOMA;ORPHAN DRUG;PEDIATRIC CANCER;PREVENTION","10;7;7;6;3;3;2;2;2;2;1;1;1;1;1;1;1;1;1;1","CANCER;INFLAMMATORY AND IMMUNE SYSTEM;RENAL AND UROGENITAL","3;1;1","6.1 PHARMACEUTICALS;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;5.1 PHARMACEUTICALS;6.4 SURGERY","8;1;1;1","BONE CANCER, OSTEOSARCOMA / MALIGNANT FIBROUS HISTIOCYTOMA;BRAIN TUMOR;LEUKEMIA / LEUKAEMIA;NEUROBLASTOMA;SARCOMA","1;1;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","2",4,6740906.5,382454.95,5.25,17.25,8.25,1,36.75,1091209.61269905,0.255679565825953,"ISTITUTO GIANNINA GASLINI;UNIVERSITY COLLEGE LONDON;ACADEMIC MEDICAL CENTER;ERASMUS MC;EUROPEAN SOCIETY FOR PAEDIATRIC ONCOLOGY;INSTITUT GUSTAVE ROUSSY;INTERNATIONAL AGENCY FOR RESEARCH ON CANCER;ST ANNA CHILDREN'S HOSPITAL;UNIVERSITY MEDICAL CENTER UTRECHT;UNIVERSITY OF BIRMINGHAM;UNIVERSITY OF MÜNSTER;ASKLEPIOS KLINIK SANKT AUGUSTIN;ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS;AUSTRIAN INSTITUTE OF TECHNOLOGY;BELFAST HEALTH AND SOCIAL CARE TRUST;BOYNE RESEARCH INSTITUTE;CATHOLIC UNIVERSITY OF THE SACRED HEART;CENTRE LÉON BÉRARD;CHARITÉ - UNIVERSITY MEDICINE BERLIN;CINECA","4;3;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1","EUROPEAN COMMISSION","4","COALITION S;EC & ERC - EUROPEAN UNION","4;4","FP7-HEALTH - SPECIFIC PROGRAMME ""COOPERATION"": HEALTH (PROGRAMME);CP-FP - SMALL OR MEDIUM-SCALE FOCUSED RESEARCH PROJECT (FUNDING SCHEME);FP7-HEALTH-2010-SINGLE-STAGE (CALL FOR PROPOSAL);FP7-HEALTH-2010-TWO-STAGE (CALL FOR PROPOSAL);FP7-HEALTH-2011-TWO-STAGE (CALL FOR PROPOSAL);NOE - NETWORK OF EXCELLENCE (FUNDING SCHEME)","4;3;2;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;3202 CLINICAL SCIENCES;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","3;2;2;1;1","CLINICAL RESEARCH;PATIENT SAFETY;PEDIATRIC;CANCER;PREVENTION;RARE DISEASES;ARTHRITIS;AUTOIMMUNE DISEASE;BRAIN DISORDERS;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;EPILEPSY;GENETICS;HEALTH SERVICES;HUMAN GENOME;NEURODEGENERATIVE;NEUROSCIENCES;ORPHAN DRUG;PEDIATRIC CANCER;PEDIATRIC RESEARCH INITIATIVE;RHEUMATOID ARTHRITIS","3;3;3;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CANCER;INFECTION;INFLAMMATORY AND IMMUNE SYSTEM;NEUROLOGICAL","2;1;1;1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;2.4 SURVEILLANCE AND DISTRIBUTION;4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES;4.5 RESOURCES AND INFRASTRUCTURE (DETECTION);5.1 PHARMACEUTICALS;5.9 RESOURCES AND INFRASTRUCTURE (TREATMENT DEVELOPMENT);6.1 PHARMACEUTICALS;6.9 RESOURCES AND INFRASTRUCTURE (TREATMENT EVALUATION)","1;1;1;1;1;1;1;1","NOT SITE-SPECIFIC CANCER;LEUKEMIA / LEUKAEMIA","3;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;5.7 RESOURCES AND INFRASTRUCTURE RELATED TO TREATMENT AND THE PREVENTION OF RECURRENCE;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES;6.2 SURVEILLANCE","1;1;1;1","A01 CLINICAL MEDICINE;A02 PUBLIC HEALTH, HEALTH SERVICES AND PRIMARY CARE;A03 ALLIED HEALTH PROFESSIONS, DENTISTRY, NURSING AND PHARMACY","2;1;1","3 GOOD HEALTH AND WELL BEING","3",1,"PUBLIC LIBRARY OF SCIENCE","1","31 BIOLOGICAL SCIENCES;3101 BIOCHEMISTRY AND CELL BIOLOGY;32 BIOMEDICAL AND CLINICAL SCIENCES","2;1;1","CANCER;HEMATOLOGY;RARE DISEASES","1;1;1",NA,NA,"1.1 NORMAL BIOLOGICAL DEVELOPMENT AND FUNCTIONING","1","BIOMEDICAL","1","BASIC SCIENCE","1","LEUKEMIA / LEUKAEMIA","1",NA,NA
"IRCCS_GASLINI",2012,281,12.0747330960854,2.90747330960854,0.352313167259786,0.298932384341637,0.448398576512456,2.13802083333333,1.19047619047619,1.51785714285714,1.25742574257426,0.466192170818505,4,154,60,29,18,0.55,0.21,0.1,0.06,57.89,1.38605569684656,5.47021276595744,0.487544483985765,0.921708185053381,0.507,0.443,0.437,0.449,"ALBERTO MARTINI;LORENZO MORETTA;ELIO CASTAGNOLA;GIOVANNI MELIOLI;NICOLINO RUPERTO;ANGELA PISTORIO;ANGELO RAVELLI;GIAN MARCO GHIGGERI;MARCO GATTORNO;ISABELLA CECCHERINI;GIOVANNI A. ROSSI;CLARA MALATTIA;MARIA CRISTINA MINGARI;ANDREAS H. GROLL;LUIS J. V. GALIETTA;FRANCESCO FRASSONI;ANDREA ROSSI;VITO PISTOIA;CLAUDIO GAMBINI;EMMANUEL ROILIDES","20;19;16;14;12;11;10;10;10;9;9;8;8;8;8;8;8;8;7;7","LORENZO MORETTA;GIOVANNI MELIOLI;ALBERTO MARTINI;CORRADO MURTAS;ELIO CASTAGNOLA;GIOVANNI A. ROSSI;IRMA AIROLDI;VITO PISTOIA;LUIS J. V. GALIETTA;GIORGIO CIPRANDI;ANDREA ROSSI;FABIO MORANDI;MARIA CRISTINA MINGARI;FRANCESCA FIOREDDA;CLAUDIA COCCO;ISABELLA CECCHERINI;MICHELA SILVESTRI;ANGELA PISTORIO;NICOLETTA PEDEMONTE;GIULIANA CANGEMI","3.06;2.31;2.29;2.25;1.53;1.44;1.33;1.29;1.28;1.27;1.26;1.23;1.14;1;1;0.99;0.97;0.93;0.85;0.85","ALBERTO MARTINI;LORENZO MORETTA;ELIO CASTAGNOLA;GIOVANNI MELIOLI;NICOLINO RUPERTO;ANGELA PISTORIO;ANGELO RAVELLI;GIAN MARCO GHIGGERI;MARCO GATTORNO;ISABELLA CECCHERINI;GIOVANNI A. ROSSI;CLARA MALATTIA;MARIA CRISTINA MINGARI;LUIS J. V. GALIETTA;FRANCESCO FRASSONI;ANDREA ROSSI;VITO PISTOIA;CLAUDIO GAMBINI;EMMANUEL ROILIDES;FEDERICO ZARA","20;19;16;14;12;11;10;10;10;9;9;8;8;8;8;8;8;7;7;7","LORENZO MORETTA;GIOVANNI MELIOLI;ALBERTO MARTINI;CORRADO MURTAS;ELIO CASTAGNOLA;GIOVANNI A. ROSSI;IRMA AIROLDI;VITO PISTOIA;LUIS J. V. GALIETTA;ANDREA ROSSI;FABIO MORANDI;MARIA CRISTINA MINGARI;FRANCESCA FIOREDDA;CLAUDIA COCCO;ISABELLA CECCHERINI;MICHELA SILVESTRI;ANGELA PISTORIO;NICOLETTA PEDEMONTE;GIULIANA CANGEMI;ROBERTO BANDETTINI","3.06;2.31;2.29;2.25;1.53;1.44;1.33;1.29;1.28;1.26;1.23;1.14;1;1;0.99;0.97;0.93;0.85;0.85;0.81","ELIO CASTAGNOLA;ANDREAS H. GROLL;EMMANUEL ROILIDES;ANDREW J. ULLMANN;BART JAN KULLBERG;CLAUDIO VISCOLI;CORNELIA LASS‐FLÖRL;HENRIK ELVANG JENSEN;JACQUES BILLÉ;JORGE GARBINO;MAIKEN CAVLING ARENDRUP;MALCOLM RICHARDSON;MATTEO BASSETTI;MURAT AKOVA;OLIVER A. CORNELY;OLIVIER LORTHOLARY;PAUL E. VERWEIJ;RAOUL HERBRECHT;SEVTAP ARIKAN-AKDAĞLI;WILLIAM HOPE","2881;2820;2487;2322;2322;2322;2322;2322;2322;2322;2322;2322;2322;2322;2322;2322;2322;2322;2322;2322","ELIO CASTAGNOLA;ALBERTO MARTINI;MARCO GATTORNO;LORENZO MORETTA;VITO PISTOIA;LIZZIA RAFFAGHELLO;GIOVANNA BIANCHI;GIAN MARCO GHIGGERI;NICOLINO RUPERTO;RICCARDO HAUPT;ANGELA PISTORIO;ALESSANDRO CONSOLARO;CLAUDIA CANTONI;ISABELLA CECCHERINI;CARLO DUFOUR;ANGELO RAVELLI;MAURA FARACI;MIRNA BALSAMO;CORRADO MURTAS;GIORGIO DINI","2868;2018;1433;1250;1175;1015;997;955;875;701;678;478;462;452;403;393;390;383;373;362","LORENZO MORETTA;ALBERTO MARTINI;ELIO CASTAGNOLA;GIOVANNI MELIOLI;NICOLINO RUPERTO;ANGELA PISTORIO;GIAN MARCO GHIGGERI;MARCO GATTORNO;GIOVANNI A. ROSSI;ISABELLA CECCHERINI;VITO PISTOIA;ANGELO RAVELLI;CLAUDIO BRUNO;FRANCESCO FRASSONI;LUIS J. V. GALIETTA;CLAUDIO GAMBINI;MARIA ANGELA TOSCA;ANDREA ROSSI;PASQUALE STRIANO;ALESSANDRO CONSOLARO","19;17;15;13;12;10;10;10;9;9;9;8;8;8;8;7;7;7;7;6","MEDICINE;BIOLOGY;CHEMISTRY;PHYSICS;COMPUTER SCIENCE;MATHEMATICS;PSYCHOLOGY;ENGINEERING;POLITICAL SCIENCE;MATERIALS SCIENCE;PHILOSOPHY;BUSINESS;ECONOMICS;GEOGRAPHY;HISTORY;SOCIOLOGY","220;161;34;21;17;13;11;7;6;3;3;2;2;2;2;2","INTERNAL MEDICINE;GENETICS;IMMUNOLOGY;BIOCHEMISTRY;PEDIATRICS;PATHOLOGY;CANCER RESEARCH;CELL BIOLOGY;SURGERY;ENDOCRINOLOGY;GASTROENTEROLOGY;INTENSIVE CARE MEDICINE;PSYCHIATRY;MOLECULAR BIOLOGY;ENVIRONMENTAL HEALTH;NEUROSCIENCE;RADIOLOGY;ANESTHESIA;MICROBIOLOGY;ONCOLOGY","153;101;81;62;59;43;36;36;35;28;23;23;20;19;16;16;16;13;13;13","GENE;DISEASE;IMMUNE SYSTEM;RECEPTOR;IN VITRO;TRANSPLANTATION;ANTIBODY;POPULATION;STEM CELL;CELL CULTURE;ARTHRITIS;CHEMOTHERAPY;BONE MARROW;EPILEPSY;ASTHMA;CANCER;ENZYME;MAGNETIC RESONANCE IMAGING;CELL;COHORT;CYTOKINE;INCIDENCE (GEOMETRY);INFLAMMATION","74;43;29;28;23;18;15;15;15;14;13;13;12;12;10;10;10;10;9;9;9;9;9","MUTATION;T CELL;MUTANT;CYTOTOXIC T CELL;NEUROBLASTOMA;PHENOTYPE;CD8;HAEMATOPOIESIS;HEMATOPOIETIC STEM CELL TRANSPLANTATION;CHROMOSOME;EXON;GENOTYPE;CHEMOKINE;IMMUNOTHERAPY;FLUCONAZOLE;GENE EXPRESSION;INNATE IMMUNE SYSTEM;MAPK/ERK PATHWAY;PROINFLAMMATORY CYTOKINE;SPIROMETRY","28;16;14;13;11;10;9;9;9;8;8;7;6;6;5;5;5;5;5;5","INTERLEUKIN 21;MISSENSE MUTATION;INTERLEUKIN 12;CD3;COMPOUND HETEROZYGOSITY;ALTERNATIVE SPLICING;BRONCHODILATION;CASPOFUNGIN;COPY-NUMBER VARIATION;DYSKINESIA;ECHINOCANDIN;MICAFUNGIN;MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION;NATURAL KILLER CELL;NKG2D;PERFORIN;PROBAND;SINGLE-NUCLEOTIDE POLYMORPHISM;ANTIGEN-PRESENTING CELL;BONE MARROW FAILURE;CANCER IMMUNOTHERAPY;CHEMOKINE RECEPTOR;COMPARATIVE GENOMIC HYBRIDIZATION;CONGENITAL CENTRAL HYPOVENTILATION SYNDROME;CYTOLYSIS;DIFFUSING CAPACITY;ECULIZUMAB;ENDOPLASMIC-RETICULUM-ASSOCIATED PROTEIN DEGRADATION;EXHALED NITRIC OXIDE;FANCONI ANEMIA;GANCICLOVIR;HEMATOPOIETIC CELL;HERPESVIRIDAE;HYPERGLYCINEMIA;IL-2 RECEPTOR;INVASIVE CANDIDIASIS;METABOTROPIC GLUTAMATE RECEPTOR;METABOTROPIC RECEPTOR;MICRODELETION SYNDROME;MUTANT PROTEIN;PANEL REACTIVE ANTIBODY;PENETRANCE;RECEPTOR ANTAGONIST;T-CELL RECEPTOR;UBIQUITIN LIGASE;WILD TYPE","10;10;7;5;5;3;3;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HUMANS;FEMALE;MALE;CHILD;ADOLESCENT;CHILD, PRESCHOOL;;INFANT;ADULT;NEUROBLASTOMA;INFANT, NEWBORN;MUTATION;ARTHRITIS, JUVENILE;YOUNG ADULT;MIDDLE AGED;KILLER CELLS, NATURAL;ANIMALS;CANDIDIASIS;ASTHMA;RETROSPECTIVE STUDIES","220;130;128;93;75;70;56;55;48;40;37;37;30;30;29;25;24;24;23;23","NEUROBLASTOMA RESEARCH AND TREATMENT;HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS AND RELATED DISORDERS;NATURAL KILLER CELLS IN IMMUNITY;DIAGNOSIS AND MANAGEMENT OF FUNGAL INFECTIONS;ASTHMA;EPILEPSY AND SEIZURES;FUNCTIONS AND REGULATION OF RNA EDITING BY ADARS;HEMATOPOIETIC STEM CELL BIOLOGY;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;MOLECULAR MECHANISMS OF INFLAMMASOME ACTIVATION AND REGULATION;MOLECULAR MECHANISMS OF KIDNEY DEVELOPMENT AND DISEASE;GENETIC BASIS OF PRIMARY IMMUNODEFICIENCY DISORDERS;GLIOMAS;THERAPEUTIC ADVANCES IN CYSTIC FIBROSIS RESEARCH;ALLERGIC RHINITIS AND ITS IMPACT ON ASTHMA;DEVELOPMENT AND DISORDERS OF FETAL BRAIN;EPIDEMIOLOGY AND MANAGEMENT OF CYTOMEGALOVIRUS INFECTION;EPIDEMIOLOGY AND TREATMENT OF CHILDHOOD LEUKEMIA;IMPROVING PATIENT SAFETY IN HEALTHCARE SETTINGS;MANAGEMENT OF FEBRILE NEUTROPENIA IN CANCER PATIENTS","16;14;13;8;7;7;6;6;6;6;5;4;4;4;3;3;3;3;3;3","NEUROBLASTOMA;NK CELL ACTIVATION;NK CELL DEVELOPMENT;NK CELL THERAPY;SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS;JUVENILE IDIOPATHIC ARTHRITIS;NK CELL RECOGNITION;NK CELL RECEPTORS;TREATMENT;COMPOUND HETEROZYGOSITY;HEMATOPOIETIC CELL TRANSPLANTATION;JANUS KINASE 3;LYMPHOKINE-ACTIVATED KILLER CELL;NK CELL IMMUNOTHERAPY;NONSENSE MUTATION;PATHOGENESIS;PROINFLAMMATORY CYTOKINE;APLASTIC ANEMIA;CFTR;ECHINOCANDIN","14;14;14;14;13;12;12;6;6;5;5;5;5;5;5;5;5;4;4;4","IDIOPATHIC ARTHRITIS;JUVENILE IDIOPATHIC;NK CELLS;STEM CELLS;CANDIDA DISEASES;ESCMID GUIDELINE;STEM CELL;APLASTIC ANEMIA;CELL TRANSPLANTATION;DISEASE ACTIVITY;MAGNETIC RESONANCE;MELANOMA CELLS;MYELOID LEUKEMIA;NATURAL KILLER;NEUROBLASTOMA PATIENTS;NEWBORN SCREENING;RESONANCE IMAGING;ACUTE MYELOID;BONE MARROW;CENTRAL HYPOVENTILATION;DUCHENNE MUSCULAR;GAUCHER DISEASE;GENE EXPRESSION;LEUKEMIA PATIENTS;MESENCHYMAL STEM;MUSCULAR DYSTROPHY;OBSERVATIONAL STUDY;PROSPECTIVE STUDY;ACCEPTABLE SYMPTOM;ACQUIRED APLASTIC","11;11;8;7;6;6;6;4;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;2;2","NK CELLS;DISEASE TRANSMISSION;TRANSMISSION EVENTS;INACTIVE DISEASE;BONE MARROW;NK CELL;RISK FACTORS;NB CELLS;STEM CELL;CELL LINES;PERIPHERAL BLOOD;DISEASE ACTIVITY;MYCN AMPLIFICATION;ORGAN DONORS;CUTOFF VALUES;GENE EXPRESSION;NB PATIENTS;ORGAN TRANSPLANTATION;POOR OUTCOME;PROTEIN EXPRESSION;PUBLIC HEALTH;TUMOR CELLS;ADVERSE EVENTS;AUTOINFLAMMATORY DISEASES;BEAS-B CELLS;DE NOVO;DNA DAMAGE;DONOR-DERIVED TRANSMISSION;INFECTIOUS DISEASES;MRNA EXPRESSION","43;20;19;18;16;16;13;12;12;11;11;10;10;10;9;9;9;9;9;9;9;9;8;8;8;8;8;8;8;8",114,0.41,5.11,4,1,1,2,1,4,0,1.5,4,2,1,3,26,2,2,1,3,1,0,0,79,79,2,0,0,2,0,0,0,0,1,0,0,0,2,0,1,4,3.66666666666667,1.34,2.66666666666667,0,2,3,0,0,1,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"PAGNAN GABRIELLA;PASTORINO FABIO;PERRI PATRIZIA;PONZONI MIRCO;FRULLONI LUCA;LUNARDI CLAUDIO;PUCCETTI ANTONIO","2;2;2;2;1;1;1","ISTITUTO GIANNINA GASLINI;PAGNAN GABRIELLA;PASTORINO FABIO;PERRI PATRIZIA;PONZONI MIRCO;UNIVERSITA DEGLI STUDI DI VERONA","3;1;1;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;3204 IMMUNOLOGY;3206 MEDICAL BIOTECHNOLOGY","4;1;1;1","BIOTECHNOLOGY;CANCER;GENE THERAPY;GENETICS","1;1;1;1",NA,NA,"A61K47/48;A61K9/127;A61P35/00;C07K16/30;G01N33/53;G01N33/564","1;1;1;1;1;1","A61K47/6851;A61K47/6913;A61K9/1271;A61P35/00;C07H21/02;C07K16/3084;G01N2800/067;G01N33/564","2;2;2;2;2;2;1;1",5,5,169.4,1.4,2,0.4,34.6,0,2,0,0,2,0,0,1,0,4,1,0,0,0,0,0,0,5,0,0,5,0,0,0,0,0,0,0,0,0,"Italy;United Kingdom;France;United States;Canada;Spain;Switzerland","9;4;2;2;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3204 IMMUNOLOGY;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;42 HEALTH SCIENCES;4201 ALLIED HEALTH AND REHABILITATION SCIENCE","4;4;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;KIDNEY DISEASE;RARE DISEASES;AUTOIMMUNE DISEASE;CANCER;IMMUNIZATION;NEUROBLASTOMA;NEUROSCIENCES;PEDIATRIC;PEDIATRIC CANCER;PREVENTION;SUBSTANCE MISUSE","4;3;3;3;1;1;1;1;1;1;1;1;1","CANCER;RENAL AND UROGENITAL","1;1","6.1 PHARMACEUTICALS;5.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES","4;1;1","NEUROBLASTOMA","1","5.3 SYSTEMIC THERAPIES - DISCOVERY AND DEVELOPMENT;5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","1;1",8,4039028.25,231935,4.375,30.125,6.5,0.75,133.875,1032117.04424397,0.272255943807065,"ISTITUTO GIANNINA GASLINI;KAROLINSKA INSTITUTET;UNIVERSITY COLLEGE LONDON;ACADEMIC MEDICAL CENTER;ATOMIC ENERGY AND ALTERNATIVE ENERGIES COMMISSION;BAMBINO GESÙ CHILDREN'S HOSPITAL;CATHOLIC UNIVERSITY OF THE SACRED HEART;FONDAZIONE ISTITUTO NEUROLOGICO NAZIONALE CASIMIRO MONDINO;FONDAZIONE STELLA MARIS;GLAXOSMITHKLINE (UNITED KINGDOM);ISTITUTO DELLE SCIENZE NEUROLOGICHE DI BOLOGNA;LEIDEN UNIVERSITY MEDICAL CENTER;LUND UNIVERSITY;NOVO NORDISK (DENMARK);QUEEN MARY UNIVERSITY OF LONDON;SHEBA MEDICAL CENTER;UNIVERSITY HOSPITAL OF BASEL;UNIVERSITY MEDICAL CENTER UTRECHT;UNIVERSITY OF CAMBRIDGE;UNIVERSITY OF CAMPANIA ""LUIGI VANVITELLI""","8;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","TELETHON FOUNDATION;EUROPEAN COMMISSION;MEDICAL RESEARCH COUNCIL","4;3;1","COALITION S;EC & ERC - EUROPEAN UNION;ICRP - INTERNATIONAL CANCER RESEARCH PARTNERSHIP;UKRI - UK RESEARCH AND INNOVATION","4;3;1;1","TELETHON - UILDM CLINICAL GRANT PROJECTS - 2011 (PROGRAM);TELETHON EXPLORATORY PROJECTS 2012 (PROGRAM);CP-FP - SMALL OR MEDIUM-SCALE FOCUSED RESEARCH PROJECT (FUNDING SCHEME);FP7-HEALTH - SPECIFIC PROGRAMME ""COOPERATION"": HEALTH (PROGRAMME);FP7-HEALTH-2012-INNOVATION-1 (CALL FOR PROPOSAL);FP7-JTI - SPECIFIC PROGRAMME ""COOPERATION"": JOINT TECHNOLOGY INITIATIVES (PROGRAMME);FP7-PEOPLE - SPECIFIC PROGRAMME ""PEOPLE"" IMPLEMENTING THE SEVENTH FRAMEWORK PROGRAMME OF THE EUROPEAN COMMUNITY FOR RESEARCH, TECHNOLOGICAL DEVELOPMENT AND DEMONSTRATION ACTIVITIES (2007 TO 2013) (PROGRAMME);FP7-PEOPLE-2011-ITN (CALL FOR PROPOSAL);IMI-JU-03-2010 (CALL FOR PROPOSAL);INTRAMURAL (PROJECT CATEGORY);JTI-CP-IMI - JOINT TECHNOLOGY INITIATIVES - COLLABORATIVE PROJECT (IMI) (FUNDING SCHEME);MC-ITN - NETWORKS FOR INITIAL TRAINING (ITN) (FUNDING SCHEME)","2;2;1;1;1;1;1;1;1;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;3101 BIOCHEMISTRY AND CELL BIOLOGY;3206 MEDICAL BIOTECHNOLOGY;3208 MEDICAL PHYSIOLOGY;3213 PAEDIATRICS;34 CHEMICAL SCIENCES;3404 MEDICINAL AND BIOMOLECULAR CHEMISTRY;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;48 LAW AND LEGAL STUDIES","6;3;1;1;1;1;1;1;1;1;1;1","RARE DISEASES;BRAIN DISORDERS;CLINICAL RESEARCH;INTELLECTUAL AND DEVELOPMENTAL DISABILITIES (IDD);MUSCULAR DYSTROPHY;PEDIATRIC;AUTOIMMUNE DISEASE;NEUROSCIENCES;ARTHRITIS;BIOTECHNOLOGY;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;DUCHENNE/ BECKER MUSCULAR DYSTROPHY;EYE DISEASE AND DISORDERS OF VISION;GENETICS;INFANT MORTALITY;PATIENT SAFETY;PERINATAL PERIOD - CONDITIONS ORIGINATING IN PERINATAL PERIOD;PRETERM, LOW BIRTH WEIGHT AND HEALTH OF THE NEWBORN;PREVENTION;REGENERATIVE MEDICINE","5;4;4;4;4;4;2;2;1;1;1;1;1;1;1;1;1;1;1;1","MUSCULOSKELETAL;GENERIC HEALTH RELEVANCE;INFLAMMATORY AND IMMUNE SYSTEM","4;1;1","5.1 PHARMACEUTICALS;1.1 NORMAL BIOLOGICAL DEVELOPMENT AND FUNCTIONING;1.5 RESOURCES AND INFRASTRUCTURE (UNDERPINNING);2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;2.6 RESOURCES AND INFRASTRUCTURE (AETIOLOGY);4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;4.5 RESOURCES AND INFRASTRUCTURE (DETECTION);5.9 RESOURCES AND INFRASTRUCTURE (TREATMENT DEVELOPMENT)","2;1;1;1;1;1;1;1","NOT SITE-SPECIFIC CANCER","3","1.5 RESOURCES AND INFRASTRUCTURE;2.4 RESOURCES AND INFRASTRUCTURE RELATED TO ETIOLOGY","1;1","A01 CLINICAL MEDICINE;A03 ALLIED HEALTH PROFESSIONS, DENTISTRY, NURSING AND PHARMACY;C21 SOCIOLOGY","6;1;1","4 QUALITY EDUCATION","1",15,"PUBLIC LIBRARY OF SCIENCE","15","32 BIOMEDICAL AND CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;31 BIOLOGICAL SCIENCES;3202 CLINICAL SCIENCES;3213 PAEDIATRICS;3102 BIOINFORMATICS AND COMPUTATIONAL BIOLOGY;3105 GENETICS;3204 IMMUNOLOGY;3209 NEUROSCIENCES;3212 OPHTHALMOLOGY AND OPTOMETRY;36 CREATIVE ARTS AND WRITING;40 ENGINEERING;4003 BIOMEDICAL ENGINEERING;42 HEALTH SCIENCES","23;4;3;3;3;1;1;1;1;1;1;1;1;1","PEDIATRIC;NEUROSCIENCES;RARE DISEASES;BIOTECHNOLOGY;CANCER;GENETICS;NEUROBLASTOMA;PEDIATRIC RESEARCH INITIATIVE;CLINICAL RESEARCH;PEDIATRIC CANCER;STEM CELL RESEARCH;STEM CELL RESEARCH - NONEMBRYONIC - HUMAN;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;EYE DISEASE AND DISORDERS OF VISION;REGENERATIVE MEDICINE;STEM CELL RESEARCH - NONEMBRYONIC - NON-HUMAN","8;5;5;4;4;3;3;3;2;2;2;2;1;1;1;1","CANCER;GENERIC HEALTH RELEVANCE;NEUROLOGICAL","3;1;1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;1.1 NORMAL BIOLOGICAL DEVELOPMENT AND FUNCTIONING;2.4 SURVEILLANCE AND DISTRIBUTION;5.1 PHARMACEUTICALS","4;2;1;1","BIOMEDICAL","6","BASIC SCIENCE;CLINICAL MEDICINE AND SCIENCE","4;3","NEUROBLASTOMA;EYE CANCER;MELANOMA","2;1;1",NA,NA
"IRCCS_GASLINI",2013,415,12.2024096385542,3.65783132530121,0.421686746987952,0.387951807228916,0.539759036144578,2.71454219030521,1.5,2.16216216216216,1.50675675675676,0.518072289156627,13,181,148,29,34,0.44,0.36,0.07,0.08,27.67,0.793071228845089,5.6613953488372,0.472289156626506,0.872289156626506,0.553,0.5,0.524,0.492,"ALBERTO MARTINI;MARCO GATTORNO;NICOLINO RUPERTO;ANGELO RAVELLI;ALESSANDRO CONSOLARO;ANGELA PISTORIO;JORDI ANTÓN;ANTONELLA INSALACO;SEZA ÖZEN;LUCA CANTARINI;ISABELLA CECCHERINI;PIERRE QUARTIER;LORENZO MORETTA;ISABELLE KONÉ‐PAUT;ANDREA ROSSI;JOOST FRENKEL;ERKAN DEMIRKAYA;FRANCO LOCATELLI;VITO PISTOIA;PASQUALE STRIANO","73;53;47;38;23;18;18;18;18;17;16;16;14;13;13;13;12;12;12;12","NICOLINO RUPERTO;ANGELO RAVELLI;ALBERTO MARTINI;MARCO GATTORNO;ELIO CASTAGNOLA;ALESSANDRO CONSOLARO;VITO PISTOIA;LORENZO MORETTA;ANGELA PISTORIO;GIORGIO GIMELLI;ANTONELLA INSALACO;ANDREA ROSSI;ISABELLA CECCHERINI;ELISA TASSANO;JORDI ANTÓN;MAJA DI ROCCO;GIAN MARCO GHIGGERI;GIORGIO CIPRANDI;LUCA A. RAMENGHI;PIERRE QUARTIER","8.05;6.59;6.57;6.12;4.12;2.42;2.16;1.53;1.52;1.48;1.48;1.46;1.45;1.44;1.36;1.27;1.27;1.26;1.22;1.13","ALBERTO MARTINI;MARCO GATTORNO;NICOLINO RUPERTO;ANGELO RAVELLI;ALESSANDRO CONSOLARO;ANGELA PISTORIO;JORDI ANTÓN;ANTONELLA INSALACO;SEZA ÖZEN;LUCA CANTARINI;ISABELLA CECCHERINI;PIERRE QUARTIER;LORENZO MORETTA;ISABELLE KONÉ‐PAUT;ANDREA ROSSI;JOOST FRENKEL;VITO PISTOIA;PASQUALE STRIANO;GIORGIO GIMELLI;ELIO CASTAGNOLA","73;53;47;38;23;18;18;18;18;17;16;16;14;13;13;13;12;12;11;11","NICOLINO RUPERTO;ANGELO RAVELLI;ALBERTO MARTINI;MARCO GATTORNO;ELIO CASTAGNOLA;ALESSANDRO CONSOLARO;VITO PISTOIA;LORENZO MORETTA;ANGELA PISTORIO;GIORGIO GIMELLI;ANTONELLA INSALACO;ANDREA ROSSI;ISABELLA CECCHERINI;ELISA TASSANO;JORDI ANTÓN;MAJA DI ROCCO;GIAN MARCO GHIGGERI;LUCA A. RAMENGHI;PIERRE QUARTIER;ROBERTA CAORSI","8.05;6.59;6.57;6.12;4.12;2.42;2.16;1.53;1.52;1.48;1.48;1.46;1.45;1.44;1.36;1.27;1.27;1.22;1.13;1.11","ALBERTO MARTINI;NICOLINO RUPERTO;LORENZO MORETTA;FRANCO LOCATELLI;PASQUALE STRIANO;MARCO GATTORNO;GIOVANNI MELIOLI;MARIA CRISTINA MINGARI;FEDERICO ZARA;GIAN MARCO GHIGGERI;CLAUDIO BRUNO;GIORGIO WALTER CANONICA;GIOVANNI PASSALACQUA;GABRIELLA PIETRA;CARLO MINETTI;ANDREA ROSSI;MARCO ZECCA;VITO PISTOIA;ENRICO BERTINI;ANGELA PISTORIO","1228;873;855;763;757;724;715;604;602;577;556;541;483;479;467;457;448;447;438;434","ALBERTO MARTINI;NICOLINO RUPERTO;LORENZO MORETTA;MARCO GATTORNO;GIOVANNI MELIOLI;FEDERICO ZARA;GIAN MARCO GHIGGERI;CLAUDIO BRUNO;CARLO MINETTI;ANGELO CLAUDIO MOLINARI;VITO PISTOIA;ANGELO RAVELLI;ANGELA PISTORIO;PASQUALE STRIANO;CARLO DUFOUR;ANDREA ROSSI;GIANLUCA CARIDI;FRANCESCO FRASSONI;FABIOLA BLENGIO;FEDERICA RAGGI","1101;871;855;724;715;602;577;556;467;405;403;391;388;339;333;324;319;315;304;304","ALBERTO MARTINI;MARCO GATTORNO;NICOLINO RUPERTO;ANGELO RAVELLI;ALESSANDRO CONSOLARO;ANGELA PISTORIO;CLAUDIO BRUNO;ISABELLA CECCHERINI;LORENZO MORETTA;ANDREA ROSSI;FEDERICO ZARA;GIAN MARCO GHIGGERI;GIORGIO GIMELLI;VITO PISTOIA;ELISA TASSANO;ROBERTA CAORSI;CARLO DUFOUR;MAJA DI ROCCO;MARTINA FINETTI;PAOLO PICCO","65;52;44;35;19;15;15;15;14;11;11;11;11;11;10;10;9;9;9;9","MEDICINE;BIOLOGY;CHEMISTRY;PHYSICS;COMPUTER SCIENCE;PSYCHOLOGY;SOCIOLOGY;POLITICAL SCIENCE;BUSINESS;PHILOSOPHY;MATHEMATICS;ENGINEERING;ECONOMICS;GEOGRAPHY;MATERIALS SCIENCE","356;234;34;29;20;16;10;8;7;6;5;4;3;2;1","INTERNAL MEDICINE;GENETICS;PEDIATRICS;IMMUNOLOGY;PATHOLOGY;SURGERY;BIOCHEMISTRY;CELL BIOLOGY;CANCER RESEARCH;PHYSICAL THERAPY;GASTROENTEROLOGY;PSYCHIATRY;RADIOLOGY;DERMATOLOGY;NEUROSCIENCE;ENVIRONMENTAL HEALTH;BIOINFORMATICS;INTENSIVE CARE MEDICINE;ENDOCRINOLOGY;FAMILY MEDICINE;NURSING;OPTICS","270;175;101;100;93;65;45;35;34;33;28;25;24;23;21;20;19;19;17;16;16;16","DISEASE;GENE;RHEUMATOLOGY;ARTHRITIS;JUVENILE;CELL CULTURE;RECEPTOR;ANTIBODY;IMMUNE SYSTEM;ALTERNATIVE MEDICINE;COHORT;CANCER;EPILEPSY;TRANSPLANTATION;POPULATION;CHEMOTHERAPY;IN VITRO;PREGNANCY;BONE MARROW;INCIDENCE (GEOMETRY);INFLAMMATION","101;96;73;50;28;27;27;25;25;22;22;20;20;19;18;17;17;17;16;16;16","MUTATION;PHENOTYPE;ANAKINRA;NEUROBLASTOMA;FAMILIAL MEDITERRANEAN FEVER;JUVENILE DERMATOMYOSITIS;GESTATIONAL AGE;HEMATOPOIETIC STEM CELL TRANSPLANTATION;PLACEBO;CYTOTOXIC T CELL;HAEMATOPOIESIS;ALLELE;CHROMOSOME;GENOTYPE;CLINICAL ENDPOINT;ETANERCEPT;EXON;HUMAN LEUKOCYTE ANTIGEN;MUTANT;CUMULATIVE INCIDENCE;FETUS","41;33;27;24;16;15;11;11;11;10;10;9;9;9;8;8;8;8;8;7;7","CANAKINUMAB;GENE MUTATION;MISSENSE MUTATION;PENETRANCE;CHEMOKINE RECEPTOR;FANCONI ANEMIA;HAPLOINSUFFICIENCY;COMPOUND HETEROZYGOSITY;COPY-NUMBER VARIATION;POINT MUTATION;ALTERNATIVE SPLICING;ARTICULAR CARTILAGE;CLINICAL PHENOTYPE;COMPARATIVE GENOMIC HYBRIDIZATION;GENETIC HETEROGENEITY;HAPLOTYPE;INTERLEUKIN 12;INTRAVENTRICULAR HEMORRHAGE;LYMPHEDEMA;NATURAL KILLER CELL;OLIGOARTHRITIS;PRENATAL DIAGNOSIS;PROBAND;PYRIN DOMAIN;SINGLE-NUCLEOTIDE POLYMORPHISM;VANCOMYCIN","18;9;8;8;5;5;5;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3","HUMANS;;FEMALE;MALE;CHILD;CHILD, PRESCHOOL;ADOLESCENT;NEUROBLASTOMA;INFANT;ADULT;ARTHRITIS, JUVENILE;MUTATION;ITALY;YOUNG ADULT;ANIMALS;KILLER CELLS, NATURAL;TREATMENT OUTCOME;BRAIN;INFANT, NEWBORN;ASTHMA","242;166;155;155;112;79;75;66;53;46;44;44;42;38;34;34;33;28;28;27","MOLECULAR MECHANISMS OF INFLAMMASOME ACTIVATION AND REGULATION;HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS AND RELATED DISORDERS;NEUROBLASTOMA RESEARCH AND TREATMENT;EPIDEMIOLOGY, CLASSIFICATION, AND CLINICAL FEATURES OF INFLAMMATORY MYOPATHIES;NATURAL KILLER CELLS IN IMMUNITY;HIRSCHSPRUNG DISEASE AND ENTERIC NERVOUS SYSTEM DEVELOPMENT;HEMATOPOIETIC STEM CELL BIOLOGY;ALLERGIC RHINITIS AND ITS IMPACT ON ASTHMA;EPILEPSY AND SEIZURES;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;MOLECULAR MECHANISMS OF MUSCLE REGENERATION AND ATROPHY;EPIDEMIOLOGY AND MANAGEMENT OF OCULAR INFLAMMATORY DISEASES;GENE THERAPY FOR SPINAL MUSCULAR ATROPHY;IMPACT OF CHILD CARE ON INFECTIOUS DISEASES;SUPPORTING HEALTH CARE TRANSITION FROM ADOLESCENCE TO ADULTHOOD;ACUTE MYELOID LEUKEMIA;ASTHMA;DEVELOPMENTAL PHARMACOLOGY IN PEDIATRIC DRUG USE;GENOMIC REARRANGEMENTS AND COPY NUMBER VARIATIONS;MOLECULAR MECHANISMS OF DNA DAMAGE RESPONSE","40;38;21;11;11;9;7;6;6;6;6;5;5;5;5;4;4;4;4;4","JUVENILE IDIOPATHIC ARTHRITIS;SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS;NEUROBLASTOMA;CANAKINUMAB;INFLAMMATION;JUVENILE DERMATOMYOSITIS;DERMATOMYOSITIS;NK CELL RECOGNITION;TREATMENT OUTCOMES;DISCONTINUATION;NK CELL ACTIVATION;NK CELL DEVELOPMENT;NK CELL THERAPY;CLINICAL ENDPOINT;CUMULATIVE INCIDENCE;HEMATOPOIETIC CELL TRANSPLANTATION;PATHOGENESIS;PENETRANCE;TREATMENT;HIRSCHSPRUNG DISEASE","44;42;23;18;16;15;10;10;10;9;9;9;9;8;8;8;8;8;8;7","IDIOPATHIC ARTHRITIS;JUVENILE IDIOPATHIC;DISEASE ACTIVITY;JUVENILE DERMATOMYOSITIS;SYSTEMIC JUVENILE;STEM CELL;CELL TRANSPLANTATION;MUSCULAR DYSTROPHY;FANCONI ANEMIA;HEMATOPOIETIC STEM;ALLERGIC RHINITIS;AUTOINFLAMMATORY DISEASES;DUCHENNE MUSCULAR;FAMILIAL MEDITERRANEAN;MEDITERRANEAN FEVER;NK CELLS;PERIPHERAL BLOOD;VERSUS PREDNISONE;ACTIVITY SCORE;APLASTIC ANEMIA;ARTHRITIS DISEASE;ARTHRITIS SJIA;BONE MARROW;BRADYKININ RECEPTORS;CLINICAL MANAGEMENT;DE NOVO;DIAGNOSTIC CRITERIA;EPILEPTIC ENCEPHALOPATHY;EUROFEVER REGISTRY;GAUCHER DISEASE","40;40;13;13;10;9;6;6;5;5;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3","PUBMED SCOPUS;CROSSREF PUBMED;NK CELLS;DE NOVO;NEPHROTIC SYNDROME;NEPHROL -CROSSREF;DISEASE ACTIVITY;FOCAL SEGMENTAL;IDIOPATHIC ARTHRITIS;JUVENILE IDIOPATHIC;NATURAL KILLER;AUTOINFLAMMATORY DISEASES;SOC NEPHROL;STEROID-RESISTANT NEPHROTIC;AUTOSOMAL DOMINANT;ARTHRITIS JIA;INTELLECTUAL DISABILITY;GENET -CROSSREF;NK CELL;STEM CELL;KILLER CELLS;NERVOUS SYSTEM;CELL LINES;CLINICAL FEATURES;DRAVET SYNDROME;GENETIC TESTING;MEDIAN AGE;PROSTATE CANCER;SEGMENTAL GLOMERULOSCLEROSIS;AUTOSOMAL RECESSIVE","75;57;36;27;26;22;21;20;20;20;19;18;17;17;16;14;13;12;12;12;11;11;10;10;10;10;10;10;10;9",125,0.3,4.75,4,2,1,1,2,3,1,1,5,0,1,4,0,1,1,1.25,3,2,0,0,67,67,1,1,0,0,0,0,0,0,0,0,0,0,1,0,0,1,4,0.26,1,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"PAGNAN GABRIELLA;PASTORINO FABIO;PERRI PATRIZIA;PONZONI MIRCO","1;1;1;1","ISTITUTO GIANNINA GASLINI","1","32 BIOMEDICAL AND CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;3206 MEDICAL BIOTECHNOLOGY","2;1;1","BIOTECHNOLOGY;GENE THERAPY;GENETICS","1;1;1",NA,NA,"C07H21/02","1","A61K47/6851;A61K47/6913;A61K9/1271;A61P35/00;C07H21/02;C07K16/3084","1;1;1;1;1;1",8,6.12,88.5,1.64,4,0.5,22,1,2,1,1,2,0,0,1,0,7,1,0,0,0,0,0,0,7,0,1,8,0,0,0,0,0,0,0,0,0,"Italy;Belgium;United States","5;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;30 AGRICULTURAL, VETERINARY AND FOOD SCIENCES;3204 IMMUNOLOGY;3212 OPHTHALMOLOGY AND OPTOMETRY;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS","7;4;1;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;PEDIATRIC;RARE DISEASES;AUTOIMMUNE DISEASE;NEUROSCIENCES;PATIENT SAFETY;ARTHRITIS;BRAIN DISORDERS;CANCER;DUCHENNE/ BECKER MUSCULAR DYSTROPHY;INTELLECTUAL AND DEVELOPMENTAL DISABILITIES (IDD);MUSCULAR DYSTROPHY;NEUROBLASTOMA;ORPHAN DRUG;PEDIATRIC CANCER;PEDIATRIC RESEARCH INITIATIVE;REGENERATIVE MEDICINE;STEM CELL RESEARCH;STEM CELL RESEARCH - NONEMBRYONIC - HUMAN","8;7;5;5;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1","INFLAMMATORY AND IMMUNE SYSTEM;NEUROLOGICAL","1;1","6.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;5.1 PHARMACEUTICALS;5.2 CELLULAR AND GENE THERAPIES","6;2;1;1;1","NEUROBLASTOMA;BONE CANCER, OSTEOSARCOMA / MALIGNANT FIBROUS HISTIOCYTOMA;BRAIN TUMOR;HODGKIN'S DISEASE;LEUKEMIA / LEUKAEMIA;SARCOMA","2;1;1;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;5.3 SYSTEMIC THERAPIES - DISCOVERY AND DEVELOPMENT","3;1",6,6393314.83,402075.65,5.5,14.5,5.66666666666667,1,131,1419060.0535874,0.292447101833974,"ISTITUTO GIANNINA GASLINI;UNIVERSITY COLLEGE LONDON;UNIVERSITÄTSKLINIKUM ERLANGEN;AMSTERDAM UMC LOCATION VUMC;BAMBINO GESÙ CHILDREN'S HOSPITAL;CHARITÉ - UNIVERSITY MEDICINE BERLIN;ERASMUS MC;VRIJE UNIVERSITEIT AMSTERDAM;ACADEMIC MEDICAL CENTER;ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS;ATOMIC ENERGY AND ALTERNATIVE ENERGIES COMMISSION;AZIENDA UNIVERSITARIA OSPEDALIERA CONSORZIALE - POLICLINICO BARI;BAKER IDI HEART AND DIABETES INSTITUTE;BIOMOLECULAR RESEARCH GENOMICS (ITALY);BOYNE RESEARCH INSTITUTE;CASA SOLLIEVO DELLA SOFFERENZA;CATHOLIC UNIVERSITY OF THE SACRED HEART;CEGAT (GERMANY);CENTRE HOSPITALIER UNIVERSITAIRE DE SAINT-ÉTIENNE;CF CONSULTING FINANZIAMENTI UNIONE EUROPEA","6;3;3;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1","EUROPEAN COMMISSION;TELETHON FOUNDATION","4;2","COALITION S;EC & ERC - EUROPEAN UNION","4;4","FP7-HEALTH - SPECIFIC PROGRAMME ""COOPERATION"": HEALTH (PROGRAMME);FP7-HEALTH-2013-INNOVATION-1 (CALL FOR PROPOSAL);CP-FP - SMALL OR MEDIUM-SCALE FOCUSED RESEARCH PROJECT (FUNDING SCHEME);CP - COLLABORATIVE PROJECT (GENERIC) (FUNDING SCHEME);CP-IP - LARGE-SCALE INTEGRATING PROJECT (FUNDING SCHEME);FP7-ICT - SPECIFIC PROGRAMME ""COOPERATION"": INFORMATION AND COMMUNICATION TECHNOLOGIES (PROGRAMME);FP7-ICT-2011-9 (CALL FOR PROPOSAL);TELETHON GRANT PROJECTS - 2013 (PROGRAM);TELETHON NETWORK OF GENETIC BIOBANKS - RENEWAL 2012 (PROGRAM)","3;3;2;1;1;1;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;3202 CLINICAL SCIENCES;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;3101 BIOCHEMISTRY AND CELL BIOLOGY;3105 GENETICS;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;46 INFORMATION AND COMPUTING SCIENCES;48 LAW AND LEGAL STUDIES;4807 PUBLIC LAW","3;2;2;2;2;1;1;1;1;1;1","CLINICAL RESEARCH;GENETICS;NEUROSCIENCES;BIOTECHNOLOGY;BRAIN DISORDERS;EPILEPSY;NEURODEGENERATIVE;PAIN RESEARCH;PEDIATRIC;PREVENTION;BIOENGINEERING;CANCER;CHRONIC PAIN;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;GENETIC TESTING;HEADACHES;MIGRAINES;PATIENT SAFETY;REHABILITATION;STEM CELL RESEARCH","4;4;3;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1","GENERIC HEALTH RELEVANCE;NEUROLOGICAL;CANCER","3;2;1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;1.5 RESOURCES AND INFRASTRUCTURE (UNDERPINNING);2.6 RESOURCES AND INFRASTRUCTURE (AETIOLOGY);4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES;5.1 PHARMACEUTICALS;6.1 PHARMACEUTICALS","2;1;1;1;1;1","NOT SITE-SPECIFIC CANCER","2","1.5 RESOURCES AND INFRASTRUCTURE;2.4 RESOURCES AND INFRASTRUCTURE RELATED TO ETIOLOGY;4.4 RESOURCES AND INFRASTRUCTURE RELATED TO DETECTION, DIAGNOSIS, OR PROGNOSIS;5.7 RESOURCES AND INFRASTRUCTURE RELATED TO TREATMENT AND THE PREVENTION OF RECURRENCE;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES","1;1;1;1;1","A01 CLINICAL MEDICINE;A03 ALLIED HEALTH PROFESSIONS, DENTISTRY, NURSING AND PHARMACY;A04 PSYCHOLOGY, PSYCHIATRY AND NEUROSCIENCE;B11 COMPUTER SCIENCE AND INFORMATICS","3;1;1;1","3 GOOD HEALTH AND WELL BEING","2",38,"PUBLIC LIBRARY OF SCIENCE","38","32 BIOMEDICAL AND CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3204 IMMUNOLOGY;3102 BIOINFORMATICS AND COMPUTATIONAL BIOLOGY;3101 BIOCHEMISTRY AND CELL BIOLOGY;3105 GENETICS;37 EARTH SCIENCES;49 MATHEMATICAL SCIENCES;4901 APPLIED MATHEMATICS;50 PHILOSOPHY AND RELIGIOUS STUDIES;51 PHYSICAL SCIENCES;3107 MICROBIOLOGY;3109 ZOOLOGY;3206 MEDICAL BIOTECHNOLOGY;3705 GEOLOGY;44 HUMAN SOCIETY;4403 DEMOGRAPHY;5003 PHILOSOPHY","47;17;10;6;4;3;2;2;2;2;2;2;2;1;1;1;1;1;1;1","GENETICS;CLINICAL RESEARCH;RARE DISEASES;CANCER;NEUROSCIENCES;PEDIATRIC;AUTOIMMUNE DISEASE;BIOTECHNOLOGY;DIABETES;DIGESTIVE DISEASES;LUNG;LUNG CANCER;NEUROBLASTOMA;PEDIATRIC RESEARCH INITIATIVE;STEM CELL RESEARCH;VACCINE RELATED","8;3;3;2;2;2;1;1;1;1;1;1;1;1;1;1","CANCER;INFLAMMATORY AND IMMUNE SYSTEM;GENERIC HEALTH RELEVANCE;METABOLIC AND ENDOCRINE;CARDIOVASCULAR;NEUROLOGICAL","5;3;2;2;1;1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;6.5 RADIOTHERAPY AND OTHER NON-INVASIVE THERAPIES;1.1 NORMAL BIOLOGICAL DEVELOPMENT AND FUNCTIONING;5.2 CELLULAR AND GENE THERAPIES","5;2;1;1","BIOMEDICAL;CLINICAL","7;1","CLINICAL MEDICINE AND SCIENCE;BASIC SCIENCE","12;9","LUNG CANCER;MELANOMA;NEUROBLASTOMA;NOT SITE-SPECIFIC CANCER","1;1;1;1",NA,NA
"IRCCS_GASLINI",2014,353,13.3399433427762,3.20396600566572,0.351274787535411,0.331444759206799,0.385269121813031,2.48678414096916,1.36263736263736,1.69565217391304,1.38775510204082,0.563739376770538,8,147,127,24,29,0.42,0.36,0.07,0.08,35.24,0.93257580530141,5.43231247225922,0.490084985835694,0.90084985835694,0.521,0.5,0.523,0.492,"ALBERTO MARTINI;ANGELO RAVELLI;NICOLINO RUPERTO;NICO WULFFRAAT;MARCO GATTORNO;JORDI ANTÓN;GIAN MARCO GHIGGERI;ANGELA PISTORIO;ALESSANDRO CONSOLARO;LORENZO MORETTA;FRANCO LOCATELLI;ANDREA ROSSI;PIERRE QUARTIER;VALERIA CAPRA;ISABELLE KONÉ‐PAUT;PAVLA DOLEŽALOVÁ;VITO PISTOIA;SEZA ÖZEN;ELIO CASTAGNOLA;YOSEF UZIEL","48;31;29;21;20;16;16;14;14;14;13;13;12;11;11;11;11;11;10;10","ALBERTO MARTINI;MARCO GATTORNO;NICOLINO RUPERTO;ANGELO RAVELLI;ELIO CASTAGNOLA;NICO WULFFRAAT;CARLO BELLINI;VITO PISTOIA;GIAN MARCO GHIGGERI;ANDREA ROSSI;SAMANTHA MASCELLI;ANGELA PISTORIO;ALESSANDRO CONSOLARO;GIORGIO CIPRANDI;LORENZO MORETTA;GINO TRIPODI;A. BARABINO;CLARA MALATTIA;PIETER VAN DIJKHUIZEN;ALESSANDRO RASO","4.24;3.53;3.17;2.57;2.14;2.13;2;1.79;1.72;1.39;1.35;1.22;1.22;1.2;1.2;1.12;1.11;1.09;1.09;1.05","ALBERTO MARTINI;ANGELO RAVELLI;NICOLINO RUPERTO;NICO WULFFRAAT;MARCO GATTORNO;JORDI ANTÓN;GIAN MARCO GHIGGERI;ANGELA PISTORIO;ALESSANDRO CONSOLARO;LORENZO MORETTA;ANDREA ROSSI;PIERRE QUARTIER;VALERIA CAPRA;ISABELLE KONÉ‐PAUT;PAVLA DOLEŽALOVÁ;VITO PISTOIA;SEZA ÖZEN;ELIO CASTAGNOLA;YOSEF UZIEL;MAJA DI ROCCO","48;31;29;21;20;16;16;14;14;14;13;12;11;11;11;11;11;10;10;10","ALBERTO MARTINI;MARCO GATTORNO;NICOLINO RUPERTO;ANGELO RAVELLI;ELIO CASTAGNOLA;NICO WULFFRAAT;CARLO BELLINI;VITO PISTOIA;GIAN MARCO GHIGGERI;ANDREA ROSSI;SAMANTHA MASCELLI;ANGELA PISTORIO;ALESSANDRO CONSOLARO;LORENZO MORETTA;GINO TRIPODI;A. BARABINO;CLARA MALATTIA;PIETER VAN DIJKHUIZEN;ALESSANDRO RASO;EDDI DI MARCO","4.24;3.53;3.17;2.57;2.14;2.13;2;1.79;1.72;1.39;1.35;1.22;1.22;1.2;1.12;1.11;1.09;1.09;1.05;1.03","ALBERTO MARTINI;LORENZO MORETTA;NICOLINO RUPERTO;A. BARABINO;ERASMO MIELE;PAOLO LIONETTI;ABRAHAM R. ELIAKIM;ANDERS PÆRREGAARD;ANNE M. GRIFFITHS;ARIE LEVINE;AXEL DIGNAß;B. WEIß;CHRISTIAN BRAEGGER;DAN TURNER;DANIELA ELENA SERBAN;DAVID C. WILSON;FRANK M. RUEMMELE;GIGI VEEREMAN;GÁBOR VERES;HARLAND S. WINTER","1751;1480;1311;1123;1068;1068;940;940;940;940;940;940;940;940;940;940;940;940;940;940","LORENZO MORETTA;ALBERTO MARTINI;NICOLINO RUPERTO;A. BARABINO;PAOLO PICCO;ANGELO RAVELLI;MICHELA FALCO;ANGELA PISTORIO;MARIA MARGHERITA MANCARDI;VITO PISTOIA;FRANCESCA BOVIS;MARCO GATTORNO;FEDERICO ZARA;E. CASTELLANO;GIAN MARCO GHIGGERI;FRANCESCA MINOIA;SERGIO DAVÌ;ELIO CASTAGNOLA;ANGELA ROBBIANO;CLAUDIO BRUNO","1480;1474;1310;1121;648;627;585;582;562;549;546;523;504;464;438;396;392;387;372;365","ALBERTO MARTINI;ANGELO RAVELLI;NICOLINO RUPERTO;MARCO GATTORNO;GIAN MARCO GHIGGERI;LORENZO MORETTA;ALESSANDRO CONSOLARO;ANGELA PISTORIO;ANDREA ROSSI;VITO PISTOIA;MAJA DI ROCCO;VALERIA CAPRA;ALBERTO GARAVENTA;CLAUDIO BRUNO;CARLO DUFOUR;ELIO CASTAGNOLA;RICCARDO HAUPT;MIRELLA FILOCAMO;CONCETTA MICALIZZI;A. BARABINO","39;28;26;19;16;14;14;13;11;11;10;10;9;9;9;9;9;9;8;8","MEDICINE;BIOLOGY;CHEMISTRY;PHYSICS;COMPUTER SCIENCE;PSYCHOLOGY;MATHEMATICS;ENGINEERING;POLITICAL SCIENCE;PHILOSOPHY;MATERIALS SCIENCE;SOCIOLOGY;ECONOMICS;GEOGRAPHY;GEOLOGY;HISTORY","300;205;46;20;17;10;9;7;6;5;3;3;2;2;2;2","INTERNAL MEDICINE;GENETICS;IMMUNOLOGY;PEDIATRICS;PATHOLOGY;BIOCHEMISTRY;SURGERY;CANCER RESEARCH;CELL BIOLOGY;GASTROENTEROLOGY;ENVIRONMENTAL HEALTH;INTENSIVE CARE MEDICINE;RADIOLOGY;PHYSICAL THERAPY;ENDOCRINOLOGY;ONCOLOGY;NEUROSCIENCE;PSYCHIATRY;PHARMACOLOGY;MOLECULAR BIOLOGY","218;144;93;67;62;56;41;36;36;35;29;23;23;22;21;19;18;18;17;16","GENE;DISEASE;RHEUMATOLOGY;ARTHRITIS;IMMUNE SYSTEM;JUVENILE;POPULATION;TRANSPLANTATION;ANTIBODY;CELL CULTURE;STEM CELL;CANCER;RECEPTOR;ANTIGEN;IN VITRO;CHEMOTHERAPY;PREGNANCY;COHORT;ALTERNATIVE MEDICINE;BONE MARROW","83;76;45;41;34;31;27;26;25;22;20;19;18;16;16;15;15;13;12;11","MUTATION;PHENOTYPE;NEUROBLASTOMA;HEMATOPOIETIC STEM CELL TRANSPLANTATION;ANAKINRA;MACROPHAGE ACTIVATION SYNDROME;HAEMATOPOIESIS;HUMAN LEUKOCYTE ANTIGEN;T CELL;CHROMOSOME;EXON;FETUS;CD8;GENE EXPRESSION;INFLAMMATORY BOWEL DISEASE;ALLELE;AUTOANTIBODY;CHEMOKINE;CYTOTOXIC T CELL;DNA REPAIR;METASTASIS;PLACEBO;RNA","24;24;18;14;13;11;10;10;9;8;8;8;7;7;7;6;6;6;6;6;6;6;6","CANAKINUMAB;EXOME SEQUENCING;FANCONI ANEMIA;MISSENSE MUTATION;FOCAL SEGMENTAL GLOMERULOSCLEROSIS;ACUTE LYMPHOCYTIC LEUKEMIA;ALTERNATIVE SPLICING;ANAPLASTIC LYMPHOMA KINASE;BONE MARROW FAILURE;COMPOUND HETEROZYGOSITY;COPY-NUMBER VARIATION;CRIZOTINIB;DONOR SPECIFIC ANTIBODIES;FLUORESCENCE IN SITU HYBRIDIZATION;HAPLOINSUFFICIENCY;INNATE LYMPHOID CELL;INTERLEUKIN 21;NKG2D;OLIGOARTHRITIS;PLACENTA;PROBAND;RNA INTERFERENCE;RNA SPLICING","12;6;6;6;5;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3","HUMANS;;FEMALE;MALE;CHILD;CHILD, PRESCHOOL;ADOLESCENT;ADULT;NEUROBLASTOMA;INFANT;MUTATION;TREATMENT OUTCOME;ITALY;YOUNG ADULT;INFANT, NEWBORN;MIDDLE AGED;KILLER CELLS, NATURAL;ANIMALS;RETROSPECTIVE STUDIES;ARTHRITIS, JUVENILE","209;137;136;124;94;78;75;53;52;50;37;32;31;29;28;28;27;25;25;23","HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS AND RELATED DISORDERS;NEUROBLASTOMA RESEARCH AND TREATMENT;MOLECULAR MECHANISMS OF INFLAMMASOME ACTIVATION AND REGULATION;NATURAL KILLER CELLS IN IMMUNITY;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;DIAGNOSIS AND MANAGEMENT OF FUNGAL INFECTIONS;HEMATOPOIETIC STEM CELL BIOLOGY;MOLECULAR MECHANISMS OF MUSCLE REGENERATION AND ATROPHY;THERAPEUTIC ADVANCES IN CYSTIC FIBROSIS RESEARCH;EPIDEMIOLOGY AND TREATMENT OF CHILDHOOD LEUKEMIA;GENOMIC REARRANGEMENTS AND COPY NUMBER VARIATIONS;GLIOMAS;MOLECULAR MECHANISMS OF DNA DAMAGE RESPONSE;PATHOPHYSIOLOGY OF GLOMERULAR DISEASES AND NEPHROTIC SYNDROMES;HIRSCHSPRUNG DISEASE AND ENTERIC NERVOUS SYSTEM DEVELOPMENT;IMMUNOLOGICAL MECHANISMS IN PREGNANCY AND FETAL-MATERNAL INTERFACE;KIDNEY TRANSPLANTATION;MOLECULAR MECHANISMS OF ION CHANNELS REGULATION;SUPPORTING HEALTH CARE TRANSITION FROM ADOLESCENCE TO ADULTHOOD;ALLERGIC RHINITIS AND ITS IMPACT ON ASTHMA","39;14;13;10;7;6;6;6;6;5;5;5;5;5;4;4;4;4;4;3","SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS;JUVENILE IDIOPATHIC ARTHRITIS;NEUROBLASTOMA;CANAKINUMAB;MACROPHAGE ACTIVATION SYNDROME;TREATMENT OUTCOMES;NK CELL ACTIVATION;NK CELL DEVELOPMENT;NK CELL RECOGNITION;HEMATOPOIETIC CELL TRANSPLANTATION;INFLAMMATION;TREATMENT;DIAGNOSIS;FANCA;HEMATOLOGY;NK CELL THERAPY;TOCILIZUMAB;APLASTIC ANEMIA;CFTR;CUMULATIVE INCIDENCE","38;37;13;12;12;12;8;8;8;7;7;7;6;6;6;5;5;4;4;4","IDIOPATHIC ARTHRITIS;JUVENILE IDIOPATHIC;SYSTEMIC JUVENILE;STEM CELL;ACTIVATION SYNDROME;MACROPHAGE ACTIVATION;CELL TRANSPLANTATION;BASED RECOMMENDATIONS;EVIDENCE BASED;ARTHRITIS PATIENTS;CYSTIC FIBROSIS;SHARE WORKPACKAGE;ACUTE LYMPHOBLASTIC;APLASTIC ANEMIA;LYMPHOBLASTIC LEUKEMIA;NK CELLS;ARTHRITIS TREATED;BONE MARROW;BOWEL DISEASE;CORD BLOOD;DE NOVO;DISEASE ACTIVITY;GENE EXPRESSION;GROWTH HORMONE;INFLAMMATORY BOWEL;ITALIAN ASSOCIATION;MULTICENTER STUDY;OBSERVATIONAL STUDY;PERIPHERAL BLOOD;ACID LIPASE","37;37;13;10;9;9;8;7;7;6;6;6;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4;4;3","PUBMED SCOPUS;CROSSREF PUBMED;CIK CELLS;NK CELLS;TARGET CELLS;CD CELLS;NEPHROTIC SYNDROME;CELL LINES;RENAL FAILURE;STEM CELL;IDIOPATHIC ARTHRITIS;JUVENILE IDIOPATHIC;NEPHROL -CROSSREF;STEROID-RESISTANT NEPHROTIC;FANCONI ANEMIA;INTERQUARTILE RANGE;NATURAL KILLER;WILMS TUMOR;BONE MARROW;HEMATOPOIETIC STEM;END-STAGE RENAL;KILLER CELLS;PERIPHERAL BLOOD;RHEUMATIC DISEASES;TARGET CELL;CELL TRANSPLANTATION;CIK-MEDIATED CYTOTOXICITY;RENAL DISEASE;ARTHRITIS JIA;REPLACEMENT THERAPY","122;86;44;44;31;30;28;25;25;24;23;23;22;22;21;18;18;18;17;17;16;16;16;16;16;15;15;15;14;14",133,0.38,5.7,5,2,2,2.5,1.75,3,0,1,5,0,1,3,1,4.5,1,2,2,1.5,0,0,70,70,3,0,0,2,0,0,0,1,0,0,0,0,1,1,1,0,3.66666666666667,0.97,2.33333333333333,0,2,3,0,1,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"PONZONI MIRCO;ALLEN THERESA M;CORTI ANGELO;GATTORNO MARCO;KONÉ-PAUT ISABELLE;PAGNAN GABRIELLA;PASTORINO FABIO;PERRI PATRIZIA;PIRAM MARYAM;RUPERTO NICOLINO","2;1;1;1;1;1;1;1;1;1","ISTITUTO GIANNINA GASLINI;ASSIST PUBL HOPITAUX DE PARIS;G GASLINI CHILDREN'S HOSPITAL;SAN RAFFAELE SRL;UNIV PARIS SUD;UNIVERSITY OF ALBERTA","2;1;1;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;3109 ZOOLOGY;3206 MEDICAL BIOTECHNOLOGY;42 HEALTH SCIENCES","2;1;1;1;1","BIOTECHNOLOGY;CANCER","1;1","5.1 PHARMACEUTICALS","1","A61K31/00;A61K31/704;A61K38/08;A61K38/10;A61K47/42;A61K9/127;A61K9/50;A61P35/00;G06F19/00","1;1;1;1;1;1;1;1;1","A61P35/00;A61K31/00;A61K31/704;A61K38/08;A61K38/10;A61K47/6851;A61K47/6913;A61K9/127;A61K9/1271;C07H21/02","2;1;1;1;1;1;1;1;1;1",11,4.5,3154.5,2.7,4,0.36,17.55,1,0,1,0,3,0,1,5,0,6,4,0,0,0,0,0,0,11,0,0,10,1,0,0,0,0,0,0,0,0,"United States;France;Netherlands;United Kingdom;Italy;Japan","3;2;2;2;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3204 IMMUNOLOGY;52 PSYCHOLOGY;31 BIOLOGICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;5202 BIOLOGICAL PSYCHOLOGY","11;7;2;2;1;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;PEDIATRIC;RARE DISEASES;PATIENT SAFETY;NEURODEGENERATIVE;NEUROSCIENCES;AUTOIMMUNE DISEASE;BIOMEDICAL IMAGING;PEDIATRIC RESEARCH INITIATIVE;PREVENTION;ARTHRITIS;BRAIN DISORDERS;CANCER;CARDIOVASCULAR;DENTAL/ORAL AND CRANIOFACIAL DISEASE;DIABETES;EPILEPSY;HEMATOLOGY;IMMUNIZATION","10;7;6;6;4;3;3;2;2;2;2;1;1;1;1;1;1;1;1;1","INFLAMMATORY AND IMMUNE SYSTEM;CARDIOVASCULAR","2;1","6.1 PHARMACEUTICALS;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES;5.1 PHARMACEUTICALS;6.4 SURGERY","7;2;1;1;1;1","NEUROBLASTOMA","1","4.4 RESOURCES AND INFRASTRUCTURE RELATED TO DETECTION, DIAGNOSIS, OR PROGNOSIS","1",5,313991.4,52875.82,4.4,19,3.4,1,25.6,1112011.99586746,0.317442618705413,"ISTITUTO GIANNINA GASLINI;CATHOLIC UNIVERSITY OF THE SACRED HEART;UNIVERSITY OF MESSINA;UNIVERSITY OF TURIN;BAMBINO GESÙ CHILDREN'S HOSPITAL;FONDAZIONE IRCCS CA' GRANDA OSPEDALE MAGGIORE POLICLINICO;FONDAZIONE ISTITUTO NEUROLOGICO NAZIONALE CASIMIRO MONDINO;FONDAZIONE STELLA MARIS;UNIVERSITY OF PADUA;ABBVIE (UNITED STATES);ADDENBROOKE'S HOSPITAL;ALDER HEY CHILDREN'S NHS FOUNDATION TRUST;BIRMINGHAM CHILDREN'S HOSPITAL;CENTRO CLINICO NEMO;CHARITÉ - UNIVERSITY MEDICINE BERLIN;CHARLES UNIVERSITY;CHILDHOOD ARTHRITIS AND RHEUMATOL­OGY RESEARCH ALLIANCE;CHILDREN’S ARTHRITIS ASSOCIATION;CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER;CITY, UNIVERSITY OF LONDON","5;3;3;3;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1","TELETHON FOUNDATION;MEDICAL RESEARCH COUNCIL","4;1","COALITION S;ICRP - INTERNATIONAL CANCER RESEARCH PARTNERSHIP;UKRI - UK RESEARCH AND INNOVATION","1;1;1","TELETHON - UILDM CLINICAL GRANT PROJECTS - 2013 (PROGRAM);RESEARCH GRANT (PROJECT CATEGORY);TELETHON GRANT PROJECTS - 2014 (PROGRAM);TELETHON SPECIAL PROJECTS - 2013 (PROGRAM)","2;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;3105 GENETICS;44 HUMAN SOCIETY","5;4;1;1;1","RARE DISEASES;BRAIN DISORDERS;PEDIATRIC;ARTHRITIS;CLINICAL RESEARCH;GENETICS;INTELLECTUAL AND DEVELOPMENTAL DISABILITIES (IDD);MUSCULAR DYSTROPHY;NEUROSCIENCES;PEDIATRIC RESEARCH INITIATIVE;AUTOIMMUNE DISEASE;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;CONGENITAL STRUCTURAL ANOMALIES;HEALTH SERVICES;NEURODEGENERATIVE;ORPHAN DRUG;SPINAL MUSCULAR ATROPHY","4;3;3;2;2;2;2;2;2;2;1;1;1;1;1;1;1","INFLAMMATORY AND IMMUNE SYSTEM;MUSCULOSKELETAL","2;2","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;5.1 PHARMACEUTICALS;4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;7.4 RESOURCES AND INFRASTRUCTURE (DISEASE MANAGEMENT)","4;2;1;1;1",NA,NA,NA,NA,"A01 CLINICAL MEDICINE;A03 ALLIED HEALTH PROFESSIONS, DENTISTRY, NURSING AND PHARMACY;A05 BIOLOGICAL SCIENCES","3;1;1",NA,NA,20,"PUBLIC LIBRARY OF SCIENCE","20","32 BIOMEDICAL AND CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;3102 BIOINFORMATICS AND COMPUTATIONAL BIOLOGY;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3204 IMMUNOLOGY;34 CHEMICAL SCIENCES;3404 MEDICINAL AND BIOMOLECULAR CHEMISTRY;37 EARTH SCIENCES;3705 GEOLOGY;38 ECONOMICS;3801 APPLIED ECONOMICS;4205 NURSING;46 INFORMATION AND COMPUTING SCIENCES","24;5;4;4;4;3;2;2;1;1;1;1;1;1;1;1;1","GENETICS;CANCER;CLINICAL RESEARCH;RARE DISEASES;PEDIATRIC;BIOENGINEERING;BRAIN DISORDERS;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;DUCHENNE/ BECKER MUSCULAR DYSTROPHY;INTELLECTUAL AND DEVELOPMENTAL DISABILITIES (IDD);LUNG;LUNG CANCER;MUSCULAR DYSTROPHY;NEUROBLASTOMA;NEUROSCIENCES;ORPHAN DRUG;PREVENTION;REGENERATIVE MEDICINE;TRANSPLANTATION;VACCINE RELATED","5;4;4;4;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CANCER","4","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES","1;1","BIOMEDICAL;CLINICAL","1;1","CLINICAL MEDICINE AND SCIENCE;BASIC SCIENCE","6;1","BREAST CANCER;NEUROBLASTOMA;LUNG CANCER;NOT SITE-SPECIFIC CANCER","3;2;1;1",NA,NA
"IRCCS_GASLINI",2015,398,13.2462311557789,3.40452261306533,0.379396984924623,0.374371859296482,0.462311557788945,2.84663865546218,1.51,1.93506493506494,1.54621848739496,0.525125628140704,7,193,125,36,32,0.48,0.31,0.09,0.08,36.62,0.982690546873894,5.43099875673435,0.464824120603015,0.914572864321608,0.528,0.454,0.485,0.455,"ALBERTO MARTINI;MARCO GATTORNO;CARLO DUFOUR;LORENZO MORETTA;GIAN MARCO GHIGGERI;ROBERTA CAORSI;ANGELO RAVELLI;VITO PISTOIA;FRANCO LOCATELLI;ANDREA ROSSI;NICOLINO RUPERTO;ISABELLA CECCHERINI;ANGELA PISTORIO;PASQUALE STRIANO;ALESSIA OMENETTI;ENRICO BERTINI;LUIS J. V. GALIETTA;SEZA ÖZEN;CLAUDIO BRUNO;JOOST FRENKEL","53;41;21;19;18;17;16;16;15;15;15;14;12;12;11;11;11;11;11;11","ALBERTO MARTINI;MARCO GATTORNO;DANIELA CAPRINO;LORENZO MORETTA;GIAN MARCO GHIGGERI;LUCA A. RAMENGHI;NICOLINO RUPERTO;ANDREA ROSSI;CLARA MALATTIA;MICHELA SILVESTRI;GIORGIO CIPRANDI;GIOVANNI A. ROSSI;ANGELO RAVELLI;ROBERTA CAORSI;VITO PISTOIA;CARLO DUFOUR;PASQUALE STRIANO;ENRICO VERRINA;ISABELLA CECCHERINI;ANGELA PISTORIO","4.75;4.55;2.7;2.56;2.32;2.08;1.98;1.97;1.85;1.78;1.77;1.66;1.62;1.62;1.48;1.45;1.44;1.41;1.39;1.39","ALBERTO MARTINI;MARCO GATTORNO;CARLO DUFOUR;LORENZO MORETTA;GIAN MARCO GHIGGERI;ROBERTA CAORSI;ANGELO RAVELLI;VITO PISTOIA;ANDREA ROSSI;NICOLINO RUPERTO;ISABELLA CECCHERINI;ANGELA PISTORIO;PASQUALE STRIANO;ALESSIA OMENETTI;LUIS J. V. GALIETTA;CLAUDIO BRUNO;GIOVANNI CANDIANO;LUCA A. RAMENGHI;ENRICO VERRINA;PAOLO PICCO","53;41;21;19;18;17;16;16;15;15;14;12;12;11;11;11;10;10;10;10","ALBERTO MARTINI;MARCO GATTORNO;DANIELA CAPRINO;LORENZO MORETTA;GIAN MARCO GHIGGERI;LUCA A. RAMENGHI;NICOLINO RUPERTO;ANDREA ROSSI;CLARA MALATTIA;MICHELA SILVESTRI;GIOVANNI A. ROSSI;ANGELO RAVELLI;ROBERTA CAORSI;VITO PISTOIA;CARLO DUFOUR;PASQUALE STRIANO;ENRICO VERRINA;ISABELLA CECCHERINI;ANGELA PISTORIO;FABRIZIO GINEVRI","4.75;4.55;2.7;2.56;2.32;2.08;1.98;1.97;1.85;1.78;1.66;1.62;1.62;1.48;1.45;1.44;1.41;1.39;1.39;1.24","ALBERTO MARTINI;NICOLINO RUPERTO;SEZA ÖZEN;LORENZO MORETTA;RICARDO RUSSO;NICOLA DISMA;ALEXEI A. GROM;MAJA DI ROCCO;NORMAN T. ILOWITE;CARLO DUFOUR;VITO PISTOIA;ANDREW DAVIDSON;ANNE M LYNN;ANTHONY ABSALOM;BRITTA S. VON UNGERN‐STERNBERG;BRUNO GUIDO LOCATELLI;CHARLES B. BERDE;DAVID C. BELLINGER;DAVID M. POLANER;DAVINIA E. WITHINGTON","1939;1273;1190;1155;1146;1077;1074;1067;1061;1049;1048;1046;1046;1046;1046;1046;1046;1046;1046;1046","ALBERTO MARTINI;NICOLINO RUPERTO;NICOLA DISMA;MAJA DI ROCCO;CARLO DUFOUR;VITO PISTOIA;GAIA GIRIBALDI;MARCO GATTORNO;ANGELA PISTORIO;ANGELO RAVELLI;LORENZO MORETTA;FEDERICO ZARA;SERGIO DAVÌ;FRANCESCA MINOIA;FRANCESCA BOVIS;IRMA AIROLDI;FABRIZIO LOIACONO;ANTONELLA TRIVELLI;LUCA A. RAMENGHI;GIAN MARCO GHIGGERI","1509;1273;1077;1067;1049;1048;1046;975;974;908;823;676;654;643;642;466;458;444;439;404","ALBERTO MARTINI;MARCO GATTORNO;CARLO DUFOUR;CLAUDIO BRUNO;GIAN MARCO GHIGGERI;ROBERTA CAORSI;VITO PISTOIA;ANDREA ROSSI;NICOLINO RUPERTO;ANGELO RAVELLI;LORENZO MORETTA;ANGELA PISTORIO;ISABELLA CECCHERINI;LUIS J. V. GALIETTA;SERENA ARRIGO;A. BARABINO;GIOVANNI CANDIANO;LUCA A. RAMENGHI;PAOLO PICCO;ENRICO VERRINA","42;38;22;16;16;16;16;15;15;14;13;12;11;11;10;10;10;10;10;10","MEDICINE;BIOLOGY;CHEMISTRY;PHYSICS;PSYCHOLOGY;COMPUTER SCIENCE;MATHEMATICS;ENGINEERING;PHILOSOPHY;POLITICAL SCIENCE;ECONOMICS;SOCIOLOGY;MATERIALS SCIENCE;GEOLOGY;ART;ENVIRONMENTAL SCIENCE;HISTORY","339;222;40;26;24;22;9;8;8;7;5;5;3;2;1;1;1","INTERNAL MEDICINE;GENETICS;IMMUNOLOGY;PEDIATRICS;PATHOLOGY;SURGERY;BIOCHEMISTRY;CANCER RESEARCH;CELL BIOLOGY;GASTROENTEROLOGY;RADIOLOGY;ENDOCRINOLOGY;ONCOLOGY;BIOINFORMATICS;ENVIRONMENTAL HEALTH;PSYCHIATRY;DERMATOLOGY;NEUROSCIENCE;PHARMACOLOGY;PHYSICAL THERAPY","245;154;89;76;68;65;63;47;41;31;31;26;24;23;22;22;21;18;18;18","GENE;DISEASE;RHEUMATOLOGY;IMMUNE SYSTEM;TRANSPLANTATION;ARTHRITIS;RECEPTOR;STEM CELL;CELL CULTURE;CANCER;IN VITRO;POPULATION;COHORT;MAGNETIC RESONANCE IMAGING;INFLAMMATION;ALTERNATIVE MEDICINE;ANTIBODY;BONE MARROW;CHEMOTHERAPY;PREGNANCY","120;65;35;33;28;26;24;23;21;20;20;20;17;17;16;15;15;15;15;15","MUTATION;PHENOTYPE;HEMATOPOIETIC STEM CELL TRANSPLANTATION;NEUROBLASTOMA;ANAKINRA;GENOTYPE;T CELL;GENE EXPRESSION;HAEMATOPOIESIS;CD34;CYTOTOXIC T CELL;GESTATIONAL AGE;HUMAN LEUKOCYTE ANTIGEN;DNA REPAIR;PROTEINURIA;ALLELE;EXON;INFLAMMASOME;JUVENILE DERMATOMYOSITIS;FAMILIAL MEDITERRANEAN FEVER;FETUS;INNATE IMMUNE SYSTEM;MUSCLE BIOPSY","41;33;19;17;13;13;13;10;10;9;9;9;9;8;8;7;7;7;7;6;6;6;6","CANAKINUMAB;FANCONI ANEMIA;MISSENSE MUTATION;COMPOUND HETEROZYGOSITY;GENETIC HETEROGENEITY;INTERLEUKIN 21;GERMLINE MUTATION;INNATE LYMPHOID CELL;INTERLEUKIN 12;PYRIN DOMAIN;RECEPTOR ANTAGONIST;SANGER SEQUENCING;SINGLE-NUCLEOTIDE POLYMORPHISM;BONE MARROW FAILURE;CD163;CD38;CLINICAL PHENOTYPE;CONGENITAL MYOPATHY;COPY-NUMBER VARIATION;GENE MUTATION;LOSS FUNCTION;NATURAL KILLER CELL;ONCOGENE;PENETRANCE;POLYARTERITIS NODOSA","11;7;7;6;5;5;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3","HUMANS;FEMALE;;MALE;CHILD;ADOLESCENT;CHILD, PRESCHOOL;NEUROBLASTOMA;INFANT;ADULT;ITALY;MIDDLE AGED;YOUNG ADULT;RETROSPECTIVE STUDIES;TREATMENT OUTCOME;ANIMALS;MUTATION;INFANT, NEWBORN;ANTINEOPLASTIC AGENTS;CYSTIC FIBROSIS","238;153;148;148;108;85;85;58;55;51;37;35;35;34;34;33;32;30;28;28","HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS AND RELATED DISORDERS;MOLECULAR MECHANISMS OF INFLAMMASOME ACTIVATION AND REGULATION;NATURAL KILLER CELLS IN IMMUNITY;NEUROBLASTOMA RESEARCH AND TREATMENT;HEMATOPOIETIC STEM CELL BIOLOGY;THERAPEUTIC ADVANCES IN CYSTIC FIBROSIS RESEARCH;EPIDEMIOLOGY, CLASSIFICATION, AND CLINICAL FEATURES OF INFLAMMATORY MYOPATHIES;GENOMIC REARRANGEMENTS AND COPY NUMBER VARIATIONS;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;MOLECULAR MECHANISMS OF DNA DAMAGE RESPONSE;MOLECULAR MECHANISMS OF MUSCLE REGENERATION AND ATROPHY;DIAGNOSIS AND MANAGEMENT OF FOOD ALLERGY;MOLECULAR BASIS OF RETT SYNDROME AND RELATED DISORDERS;MOLECULAR PHYSIOLOGY OF PURINERGIC SIGNALLING;NEONATAL LUNG DEVELOPMENT AND RESPIRATORY MORBIDITY;CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY;DEVELOPMENT AND DISORDERS OF FETAL BRAIN;DIAGNOSIS AND MANAGEMENT OF HYPERTROPHIC CARDIOMYOPATHY;EPILEPSY AND SEIZURES;EXOSOME BIOLOGY AND FUNCTION IN INTERCELLULAR COMMUNICATION","23;23;18;17;10;9;7;6;6;6;6;5;5;5;5;4;4;4;4;4","SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS;JUVENILE IDIOPATHIC ARTHRITIS;NEUROBLASTOMA;NK CELL RECOGNITION;HEMATOPOIETIC CELL TRANSPLANTATION;CANAKINUMAB;INFLAMMATION;NK CELL ACTIVATION;NK CELL DEVELOPMENT;NK CELL RECEPTORS;NK CELL THERAPY;CFTR;DIAGNOSIS;JUVENILE DERMATOMYOSITIS;PRETERM INFANTS;TREATMENT;TREATMENT OUTCOMES;COMPOUND HETEROZYGOSITY;DERMATOMYOSITIS;APLASTIC ANEMIA","21;19;16;14;12;11;11;11;11;10;9;7;7;7;7;7;7;6;6;5","IDIOPATHIC ARTHRITIS;JUVENILE IDIOPATHIC;STEM CELL;CYSTIC FIBROSIS;BONE MARROW;CELL TRANSPLANTATION;CORD BLOOD;GENE EXPRESSION;HEMATOPOIETIC STEM;APLASTIC ANAEMIA;JUVENILE DERMATOMYOSITIS;RISK FACTORS;AUTOINFLAMMATORY DISEASES;FANCONI ANEMIA;MARROW TRANSPLANTATION;NK CELLS;SYSTEMIC JUVENILE;NEPHROTIC SYNDROME;PERIODIC SYNDROMES;PRELIMINARY RESULTS;SEVERE APLASTIC;SYNDROMES CAPS;ACID LIPASE;ADA DEFICIENCY;DISEASE ACTIVITY;LIPASE DEFICIENCY;LYSOSOMAL ACID;MUSCULAR DYSTROPHY;NATURAL KILLER;NEUROBLASTOMA PATIENTS","18;18;16;11;10;10;8;8;8;7;7;7;6;6;6;6;6;5;5;5;5;5;4;4;4;4;4;4;4;4","PUBMED SCOPUS;CROSSREF PUBMED;NK CELLS;DE NOVO;STEM CELL;GENE EXPRESSION;CORD BLOOD;CELL LINES;GENOVA ITALY;PLATELET COUNT;SLCA MUTATIONS;BONE MARROW;MEDIAN RANGE;NEPHROL -CROSSREF;NK CELL;STEM CELLS;ATYPICAL HEMOLYTIC;HEMOLYTIC UREMIC;RENAL FUNCTION;GENOA ITALY;ITALY DEPARTMENT;KIDNEY DISEASE;NATURAL KILLER;UNRELATED DONOR;CHRONIC KIDNEY;GESTATIONAL AGE;GIANNINA GASLINI;HOMOZYGOUS DELETION;IMMUNE SYSTEM;PERIPHERAL BLOOD","110;86;47;22;21;20;19;17;17;16;16;15;15;15;15;15;14;14;14;13;13;13;13;13;12;12;12;12;12;12",174,0.44,5.19,6,2,1.75,1,4,2.25,1,1,7,1,1,4,3.5,2,1,2,4,3,0,0,86.75,86.75,1,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,3,1,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,NA,NA,"ASSIST PUBL HOPITAUX DE PARIS;ISTITUTO GIANNINA GASLINI;UNIV PARIS SUD","1;1;1",NA,NA,NA,NA,NA,NA,NA,NA,"G16H50/20","1",13,5.45,140.73,2.94,9,0.69,33.38,1,2,5,0,2,0,1,2,0,9,2,0,0,0,0,0,0,13,0,0,11,2,0,0,0,0,0,0,0,0,"United States;Switzerland;Australia;Germany;Netherlands","10;2;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3213 PAEDIATRICS;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;52 PSYCHOLOGY","12;9;2;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;PEDIATRIC;RARE DISEASES;PREVENTION;CANCER;PEDIATRIC CANCER;CHILDHOOD LEUKEMIA;COMPARATIVE EFFECTIVENESS RESEARCH;DIGESTIVE DISEASES;DRUG ABUSE (NIDA ONLY);EYE DISEASE AND DISORDERS OF VISION;HEALTH SERVICES;HEMATOLOGY;INFANT MORTALITY;LIVER DISEASE;NEURODEGENERATIVE;NEUROSCIENCES;ORPHAN DRUG;PATIENT SAFETY","10;7;5;5;3;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1","CANCER;RENAL AND UROGENITAL","2;2","6.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES","9;2","LEUKEMIA / LEUKAEMIA;NON-HODGKIN'S LYMPHOMA;NOT SITE-SPECIFIC CANCER","2;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES","2;1",3,92193.33,62763.33,3,1.33333333333333,1,0.333333333333333,8,1091448.44031191,0.364653047546856,"ISTITUTO GIANNINA GASLINI;IRCCS MATERNO INFANTILE BURLO GAROFOLO","3;1","TELETHON FOUNDATION","3",NA,NA,"TELETHON EXPLORATORY PROJECTS 2014 (PROGRAM);TELETHON GRANT PROJECTS - 2015 (PROGRAM)","2;1","31 BIOLOGICAL SCIENCES;3102 BIOINFORMATICS AND COMPUTATIONAL BIOLOGY;3105 GENETICS;32 BIOMEDICAL AND CLINICAL SCIENCES","3;2;2;2","GENETICS;BIOTECHNOLOGY;BRAIN DISORDERS;NEURODEGENERATIVE;NEUROSCIENCES;PEDIATRIC;AUTOIMMUNE DISEASE;CLINICAL RESEARCH;EPILEPSY;GENETIC TESTING;HUMAN GENOME;INTELLECTUAL AND DEVELOPMENTAL DISABILITIES (IDD);LUPUS;PREVENTION;RARE DISEASES","3;2;2;2;2;2;1;1;1;1;1;1;1;1;1","INFLAMMATORY AND IMMUNE SYSTEM;NEUROLOGICAL","1;1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;1.1 NORMAL BIOLOGICAL DEVELOPMENT AND FUNCTIONING;4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES","3;1;1",NA,NA,NA,NA,"A01 CLINICAL MEDICINE;A06 AGRICULTURE, VETERINARY AND FOOD SCIENCE","2;1",NA,NA,20,"PUBLIC LIBRARY OF SCIENCE;KARGER PUBLISHERS","19;1","32 BIOMEDICAL AND CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;3213 PAEDIATRICS;52 PSYCHOLOGY;3107 MICROBIOLOGY;3202 CLINICAL SCIENCES;3215 REPRODUCTIVE MEDICINE;3102 BIOINFORMATICS AND COMPUTATIONAL BIOLOGY;3103 ECOLOGY;3105 GENETICS;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3207 MEDICAL MICROBIOLOGY;44 HUMAN SOCIETY;4403 DEMOGRAPHY;5202 BIOLOGICAL PSYCHOLOGY;5204 COGNITIVE AND COMPUTATIONAL PSYCHOLOGY","26;10;5;5;3;3;2;1;1;1;1;1;1;1;1;1","CLINICAL RESEARCH;RARE DISEASES;CYSTIC FIBROSIS;LUNG;GENETICS;INFANT MORTALITY;PEDIATRIC;PERINATAL PERIOD - CONDITIONS ORIGINATING IN PERINATAL PERIOD;PRETERM, LOW BIRTH WEIGHT AND HEALTH OF THE NEWBORN;ARTHRITIS;AUTOIMMUNE DISEASE;BIOTECHNOLOGY;BRAIN DISORDERS;HEMATOLOGY;PNEUMONIA & INFLUENZA;REGENERATIVE MEDICINE;STEM CELL RESEARCH;STEM CELL RESEARCH - NONEMBRYONIC - HUMAN;STEM CELL RESEARCH - NONEMBRYONIC - NON-HUMAN;STEM CELL RESEARCH - UMBILICAL CORD BLOOD/ PLACENTA","8;4;3;3;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1","CONGENITAL;REPRODUCTIVE HEALTH AND CHILDBIRTH;INFECTION;INFLAMMATORY AND IMMUNE SYSTEM","3;3;1;1","2.2 FACTORS RELATING TO THE PHYSICAL ENVIRONMENT;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES;7.1 INDIVIDUAL CARE NEEDS","2;2;1;1;1","BIOMEDICAL;CLINICAL","2;2","CLINICAL MEDICINE AND SCIENCE;BASIC SCIENCE","8;1",NA,NA,"3 GOOD HEALTH AND WELL BEING","1"
"IRCCS_GASLINI",2016,324,15.2962962962963,3.39197530864198,0.320987654320988,0.33641975308642,0.419753086419753,2.37365010799136,1.22352941176471,1.67692307692308,1.28301886792453,0.549382716049383,7,178,77,20,25,0.55,0.24,0.06,0.08,32.88,1.01211504362062,5.24547206165704,0.398148148148148,0.910493827160494,0.506,0.429,0.446,0.441,"MARCO GATTORNO;ALBERTO MARTINI;ELIO CASTAGNOLA;GIOVANNI MORANA;FEDERICO ZARA;ANDREA ROSSI;LUCA A. RAMENGHI;ANGELO RAVELLI;NICOLINO RUPERTO;CARLO MINETTI;LORENZO MORETTA;FRANCO LOCATELLI;ANGELA PISTORIO;LUIS J. V. GALIETTA;GIULIANA CANGEMI;CHIARA FIORILLO;CARLO DUFOUR;PASQUALE STRIANO;GIROLAMO MATTIOLI;MARCO ZECCA","21;17;14;14;14;14;13;13;13;12;12;12;11;10;10;10;10;10;9;9","NICOLINO RUPERTO;MARCO GATTORNO;ELIO CASTAGNOLA;ANDREA ROSSI;LUCA A. RAMENGHI;VITO PISTOIA;CARLO BELLINI;FEDERICO ZARA;GIOVANNI MORANA;NICOLA DISMA;ROBERTO BANDETTINI;D. PALADINI;A. BARABINO;GIULIANA CANGEMI;MARIASAVINA SEVERINO;PAOLO NOZZA;CARLO MINETTI;ANGELO RAVELLI;LORENZO MORETTA;LUIS J. V. GALIETTA","2.42;2.11;1.95;1.6;1.55;1.54;1.37;1.35;1.32;1.24;1.21;1.21;1.2;1.18;1.14;1.09;1.07;1.05;1.04;1.02","MARCO GATTORNO;ALBERTO MARTINI;ELIO CASTAGNOLA;GIOVANNI MORANA;FEDERICO ZARA;ANDREA ROSSI;LUCA A. RAMENGHI;ANGELO RAVELLI;NICOLINO RUPERTO;CARLO MINETTI;ANGELA PISTORIO;LUIS J. V. GALIETTA;GIULIANA CANGEMI;CHIARA FIORILLO;CARLO DUFOUR;PASQUALE STRIANO;GIROLAMO MATTIOLI;MARIASAVINA SEVERINO;PAOLO NOZZA;MARIA LUISA GARRÈ","21;17;14;14;14;14;13;13;13;12;11;10;10;10;10;10;9;9;9;9","NICOLINO RUPERTO;MARCO GATTORNO;ELIO CASTAGNOLA;ANDREA ROSSI;LUCA A. RAMENGHI;VITO PISTOIA;CARLO BELLINI;FEDERICO ZARA;GIOVANNI MORANA;NICOLA DISMA;ROBERTO BANDETTINI;D. PALADINI;A. BARABINO;GIULIANA CANGEMI;MARIASAVINA SEVERINO;PAOLO NOZZA;CARLO MINETTI;ANGELO RAVELLI;LUIS J. V. GALIETTA;BARABINO AV","2.42;2.11;1.95;1.6;1.55;1.54;1.37;1.35;1.32;1.24;1.21;1.21;1.2;1.18;1.14;1.09;1.07;1.05;1.02;1","MARCO GATTORNO;ALBERTO MARTINI;SEZA ÖZEN;ERKAN DEMIRKAYA;NICOLINO RUPERTO;ANGELO RAVELLI;RICARDO RUSSO;ALEXEI A. GROM;FABRIZIO DE BENEDETTI;SERGIO DAVÌ;SIMONE CESARO;ANGELA PISTORIO;DANIEL L. KASTNER;LORENZO MORETTA;JANA PACHLOPNIK SCHMID;ELDAD BEN‐CHETRIT;JAROSLAV ŠTĚRBA;AVI LIVNEH;HURI ÖZDOĞAN;NORMAN T. ILOWITE","1630;1348;1252;1230;1041;909;826;811;795;701;681;660;630;627;608;602;600;580;580;567","MARCO GATTORNO;ALBERTO MARTINI;NICOLINO RUPERTO;ANGELO RAVELLI;SERGIO DAVÌ;ANGELA PISTORIO;GABRIELLA GIANCANE;FRANCESCA BOVIS;FEDERICO ZARA;CARLO DUFOUR;CLAUDIO BRUNO;FRANCESCA MINOIA;GIAN MARCO GHIGGERI;MARIA LUISA GARRÈ;ANDREA ROSSI;FABRIZIO LOIACONO;GIORGIO DINI;LUIS J. V. GALIETTA;ALESSANDRO RIMINI;LAURA CHIOSSONE","1630;1338;1041;909;701;647;553;549;540;511;483;421;379;378;332;307;301;298;290;287","MARCO GATTORNO;ALBERTO MARTINI;ELIO CASTAGNOLA;FEDERICO ZARA;ANDREA ROSSI;NICOLINO RUPERTO;CLAUDIO BRUNO;LUCA A. RAMENGHI;CARLO DUFOUR;ANGELO RAVELLI;GIOVANNI MORANA;GIULIANA CANGEMI;ANGELA PISTORIO;MARIA LUISA GARRÈ;ROBERTO BANDETTINI;CARLO MINETTI;CONCETTA MICALIZZI;ISABELLA CECCHERINI;LUIS J. V. GALIETTA;MARIASAVINA SEVERINO","21;16;14;14;13;13;13;13;12;12;11;10;10;9;9;8;8;8;8;8","MEDICINE;BIOLOGY;CHEMISTRY;PHYSICS;COMPUTER SCIENCE;MATHEMATICS;PSYCHOLOGY;ECONOMICS;POLITICAL SCIENCE;PHILOSOPHY;BUSINESS;MATERIALS SCIENCE;ENGINEERING;SOCIOLOGY;ENVIRONMENTAL SCIENCE;GEOGRAPHY;GEOLOGY","290;170;49;23;17;11;11;7;7;6;5;5;4;4;1;1;1","INTERNAL MEDICINE;GENETICS;IMMUNOLOGY;PEDIATRICS;PATHOLOGY;BIOCHEMISTRY;SURGERY;CANCER RESEARCH;CELL BIOLOGY;PSYCHIATRY;RADIOLOGY;ENDOCRINOLOGY;GASTROENTEROLOGY;ONCOLOGY;ENVIRONMENTAL HEALTH;BIOINFORMATICS;INTENSIVE CARE MEDICINE;PHARMACOLOGY;NURSING;PHYSICAL THERAPY","209;111;71;67;64;60;57;37;30;30;30;28;28;24;20;18;18;18;14;13","GENE;DISEASE;TRANSPLANTATION;CANCER;PREGNANCY;RECEPTOR;COHORT;IMMUNE SYSTEM;ARTHRITIS;BONE MARROW;POPULATION;IN VITRO;ADVERSE EFFECT;CHEMOTHERAPY;RETROSPECTIVE COHORT STUDY;ANTIBODY;CELL CULTURE;EPILEPSY;ALTERNATIVE MEDICINE;LUNG","75;47;27;25;23;23;21;20;19;18;18;17;16;16;15;14;14;14;13;13","MUTATION;HEMATOPOIETIC STEM CELL TRANSPLANTATION;NEUROBLASTOMA;FETUS;PHENOTYPE;ALLELE;ANAKINRA;CHROMOSOME;CUMULATIVE INCIDENCE;GENE EXPRESSION;HAEMATOPOIESIS;HUMAN LEUKOCYTE ANTIGEN;DOWNREGULATION AND UPREGULATION;FAMILIAL MEDITERRANEAN FEVER;INNATE IMMUNE SYSTEM;BREAST CANCER;CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR;GESTATIONAL AGE;PLACEBO;CYTOTOXIC T CELL;GENOME;GENOTYPE;KIDNEY TRANSPLANTATION;NEUTROPENIA","19;16;12;11;10;9;9;8;8;8;8;8;7;7;7;6;6;6;6;5;5;5;5;5","CANAKINUMAB;MISSENSE MUTATION;SANGER SEQUENCING;COMPOUND HETEROZYGOSITY;PRENATAL DIAGNOSIS;ANTIBODY-DEPENDENT CELL-MEDIATED CYTOTOXICITY;COPY-NUMBER VARIATION;DNA METHYLATION;DYSKINESIA;EXOME SEQUENCING;FAS RECEPTOR;GCLC;HEME OXYGENASE;INNATE LYMPHOID CELL;KARYOTYPE;MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION;RANKL;SINGLE-NUCLEOTIDE POLYMORPHISM;UBIQUITIN LIGASE;ABATACEPT;ACUTE LYMPHOCYTIC LEUKEMIA;ADENOSINE RECEPTOR;BONE MARROW FAILURE;BRONCHUS;CALPROTECTIN;COMPARATIVE GENOMIC HYBRIDIZATION;CYTOGENETICS;DONOR SPECIFIC ANTIBODIES;DOUBLE BLIND;FANCONI ANEMIA;FLUDARABINE;GENE EXPRESSION PROFILING;GROWTH HORMONE DEFICIENCY;HAPLOINSUFFICIENCY;HAPLOTYPE;HEMATOPOIETIC CELL;IDIOPATHIC SHORT STATURE;INTERLEUKIN 12;INTERLEUKIN 21;KRAS;MACROPHAGE POLARIZATION;MICROARRAY;MMP9;OFATUMUMAB;OSTEOCALCIN;PENETRANCE;PLACENTA;PODOCYTE;TOTAL BODY IRRADIATION;VANCOMYCIN","7;5;5;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HUMANS;FEMALE;MALE;CHILD;;ADOLESCENT;CHILD, PRESCHOOL;INFANT;ADULT;ITALY;INFANT, NEWBORN;YOUNG ADULT;NEUROBLASTOMA;RETROSPECTIVE STUDIES;MIDDLE AGED;ANIMALS;ARTHRITIS, JUVENILE;MAGNETIC RESONANCE IMAGING;BRAIN;MUTATION","224;149;145;107;92;84;80;60;53;48;40;40;37;37;31;30;29;27;26;26","HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS AND RELATED DISORDERS;NEUROBLASTOMA RESEARCH AND TREATMENT;MOLECULAR MECHANISMS OF INFLAMMASOME ACTIVATION AND REGULATION;NATURAL KILLER CELLS IN IMMUNITY;PEDIATRIC CANCER AND QUALITY OF LIFE;EPILEPSY AND SEIZURES;HEMATOPOIETIC STEM CELL BIOLOGY;THERAPEUTIC ADVANCES IN CYSTIC FIBROSIS RESEARCH;MOLECULAR MECHANISMS OF MUSCLE REGENERATION AND ATROPHY;ACUTE MYELOID LEUKEMIA;EPIDEMIOLOGY AND MANAGEMENT OF CONGENITAL HEART DISEASE;GENETIC BASIS OF NEUTROPENIA DISORDERS;GLIOMAS;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;NEONATAL BRAIN INJURY AND DEVELOPMENTAL CONSEQUENCES;GLYCOGEN METABOLISM AND MYOCLONIC DISORDERS;HIRSCHSPRUNG DISEASE AND ENTERIC NERVOUS SYSTEM DEVELOPMENT;SUPPORTING HEALTH CARE TRANSITION FROM ADOLESCENCE TO ADULTHOOD;DEVELOPMENT AND DISORDERS OF FETAL BRAIN;EPIDEMIOLOGY AND TREATMENT OF CHILDHOOD LEUKEMIA","16;16;12;11;8;7;7;7;6;5;5;5;5;5;5;4;4;4;3;3","SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS;JUVENILE IDIOPATHIC ARTHRITIS;NEUROBLASTOMA;HEMATOPOIETIC CELL TRANSPLANTATION;NK CELL RECOGNITION;CUMULATIVE INCIDENCE;NK CELL ACTIVATION;CANAKINUMAB;EPILEPSY;INFLAMMATION;NK CELL DEVELOPMENT;CFTR;PRENATAL DIAGNOSIS;SANGER SEQUENCING;SKELETAL MUSCLE ATROPHY;APLASTIC ANEMIA;CHILDHOOD CANCER SURVIVOR STUDY;CLINICAL ENDPOINT;COMPOUND HETEROZYGOSITY;DELPHI METHOD","19;18;14;10;9;8;8;7;7;7;7;5;5;5;5;4;4;4;4;4","IDIOPATHIC ARTHRITIS;JUVENILE IDIOPATHIC;CELL TRANSPLANTATION;STEM CELL;HEMATOPOIETIC STEM;BONE MARROW;SYSTEMIC JUVENILE;GAUCHER DISEASE;ITALIAN CHILDREN;PEDIATRIC PATIENTS;RETROSPECTIVE ANALYSIS;ACTIVATION SYNDROME;CYSTIC FIBROSIS;MACROPHAGE ACTIVATION;MUSCULAR DYSTROPHY;NEUROBLASTOMA PATIENTS;ACUTE LYMPHOBLASTIC;ALLOGENEIC HEMATOPOIETIC;APLASTIC ANEMIA;AUTOINFLAMMATORY DISEASE;BREAST CANCER;CHRONIC MYELOID;COMPLICATING SYSTEMIC;DE NOVO;FEVER SYNDROMES;GROWTH HORMONE;INNATE LYMPHOID;ITALIAN ASSOCIATION;ITALIAN PATIENTS;LYMPHOID CELLS","15;15;9;9;8;6;6;5;5;5;5;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3","PUBMED SCOPUS;CROSSREF PUBMED;PRIMARY CILIARY;NK CELLS;MSK DISEASE;GENOA ITALY;BREAST CANCER;CILIARY DYSKINESIA;STEM CELL;GENE EXPRESSION;BONE MARROW;MEDULLARY SPONGE;SPONGE KIDNEY;RISK FACTORS;ADVERSE EVENTS;DE NOVO;DIALYSIS THERAPY;BIOPSY SPECIMENS;CELL TRANSPLANTATION;CHILDHOOD CANCER;HEMATOPOIETIC STEM;CANCER CELLS;GIANNINA GASLINI;KIDNEY DISEASE;PREVIOUSLY REPORTED;SANGER SEQUENCING;GESTATIONAL AGE;ISTITUTO GIANNINA;ITALY DEPARTMENT;MED -CROSSREF","51;45;26;25;23;21;19;19;18;17;15;15;15;14;13;13;12;11;11;11;11;10;10;10;10;10;9;9;9;9",171,0.53,6.85,7,2,1,1,1,2.75,0,1,8,1,1,6,1,2,1,2,4,2,0,0,71.5,71.5,1,1,1,0,1,0,0,0,0,0,0,0,3,0,0,4,4,1.09,3.33333333333333,0,3,3,0,0,1,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"GATTORNO MARCO;KONÉ-PAUT ISABELLE;PIRAM MARYAM;RUPERTO NICOLINO","3;3;3;3","ASSISTANCE PUBLIQUE HOPITAUX DE PARIS APHP;ISTITUTO GIANNINA GASLINI;UNIVERSITE PARIS SUD PARIS 11;ST G GASLINI","3;3;3;1","31 BIOLOGICAL SCIENCES;3109 ZOOLOGY;32 BIOMEDICAL AND CLINICAL SCIENCES;42 HEALTH SCIENCES;3202 CLINICAL SCIENCES","2;2;2;2;1","CHRONIC PAIN;PAIN RESEARCH;RARE DISEASES","1;1;1",NA,NA,"G06F19/00","3","G16H50/20;G06F19/345","3;1",11,4.82,849.55,2.46,7,0.64,40.27,1,0,5,0,3,0,0,2,0,9,2,0,0,0,0,0,0,8,0,3,11,0,0,0,0,0,0,0,0,0,"Denmark;United States","1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;3107 MICROBIOLOGY;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3213 PAEDIATRICS;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY","11;10;1;1;1;1;1;1;1","CLINICAL RESEARCH;PEDIATRIC;RARE DISEASES;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;BRAIN DISORDERS;INTELLECTUAL AND DEVELOPMENTAL DISABILITIES (IDD);MUSCULAR DYSTROPHY;CANCER;NEURODEGENERATIVE;NEUROSCIENCES;PATIENT SAFETY;SPINAL MUSCULAR ATROPHY;DEPRESSION;DUCHENNE/ BECKER MUSCULAR DYSTROPHY;MAJOR DEPRESSIVE DISORDER;MENTAL HEALTH;ORPHAN DRUG;PREVENTION;REGENERATIVE MEDICINE;SERIOUS MENTAL ILLNESS","11;9;8;7;4;3;3;2;2;2;2;2;1;1;1;1;1;1;1;1","NEUROLOGICAL;CANCER;INFECTION;MENTAL HEALTH","2;1;1;1","6.1 PHARMACEUTICALS;6.4 SURGERY","8;1","SARCOMA;BONE CANCER, OSTEOSARCOMA / MALIGNANT FIBROUS HISTIOCYTOMA;KIDNEY CANCER;LEUKEMIA / LEUKAEMIA;NERVOUS SYSTEM;NOT SITE-SPECIFIC CANCER","2;1;1;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES","3;1",3,2448094,396466.42,4.33333333333333,6.33333333333333,2.33333333333333,1,11,1079243.51950383,0.300210280761247,"ISTITUTO GIANNINA GASLINI;BAMBINO GESÙ CHILDREN'S HOSPITAL;BIONEER (DENMARK);CATHOLIC UNIVERSITY OF THE SACRED HEART;CENTRO CLINICO NEMO;FONDAZIONE IRCCS CA' GRANDA OSPEDALE MAGGIORE POLICLINICO;FONDAZIONE ISTITUTO NEUROLOGICO NAZIONALE CASIMIRO MONDINO;FONDAZIONE STELLA MARIS;NATIONAL RESEARCH COUNCIL;OSPEDALE BELLARIA;OSPEDALE REGINA MARGHERITA;SPANISH NATIONAL RESEARCH COUNCIL;STEINBEIS FOUNDATION;UNIVERSITY HOSPITAL MÜNSTER;UNIVERSITY OF BURGOS;UNIVERSITY OF MESSINA;UNIVERSITY OF PADUA","3;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","DEUTSCHE FORSCHUNGSGEMEINSCHAFT;EUROPEAN COMMISSION;TELETHON FOUNDATION","1;1;1","COALITION S;EC & ERC - EUROPEAN UNION","1;1","H2020-EU.3.1. - SOCIETAL CHALLENGES - HEALTH, DEMOGRAPHIC CHANGE AND WELL-BEING (PROGRAMME);H2020-PHC-2015-TWO-STAGE (CALL FOR PROPOSAL);RESEARCH GRANTS (DFG PROGRAMME);RIA - RESEARCH AND INNOVATION ACTION (FUNDING SCHEME);TELETHON - UILDM CLINICAL GRANT PROJECTS - 2015 (PROGRAM)","1;1;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;3105 GENETICS;3202 CLINICAL SCIENCES;3208 MEDICAL PHYSIOLOGY","3;1;1;1;1","BIOTECHNOLOGY;CLINICAL RESEARCH;PEDIATRIC;RARE DISEASES;BRAIN DISORDERS;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;CYSTIC FIBROSIS;DUCHENNE/ BECKER MUSCULAR DYSTROPHY;GENETICS;HUMAN GENOME;INTELLECTUAL AND DEVELOPMENTAL DISABILITIES (IDD);LUNG;MUSCULAR DYSTROPHY;ORPHAN DRUG;PEDIATRIC RESEARCH INITIATIVE","2;2;2;2;1;1;1;1;1;1;1;1;1;1;1","CONGENITAL;MUSCULOSKELETAL","1;1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES;5.1 PHARMACEUTICALS;5.2 CELLULAR AND GENE THERAPIES","2;1;1;1",NA,NA,NA,NA,"A01 CLINICAL MEDICINE;A03 ALLIED HEALTH PROFESSIONS, DENTISTRY, NURSING AND PHARMACY;A05 BIOLOGICAL SCIENCES","1;1;1",NA,NA,26,"PUBLIC LIBRARY OF SCIENCE;AMERICAN ASSOCIATION FOR CANCER RESEARCH;SPRINGER NATURE","23;2;1","32 BIOMEDICAL AND CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;3202 CLINICAL SCIENCES;3101 BIOCHEMISTRY AND CELL BIOLOGY;3105 GENETICS;3102 BIOINFORMATICS AND COMPUTATIONAL BIOLOGY;3209 NEUROSCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;43 HISTORY, HERITAGE AND ARCHAEOLOGY;3107 MICROBIOLOGY;33 BUILT ENVIRONMENT AND DESIGN;3302 BUILDING;38 ECONOMICS;3803 ECONOMIC THEORY;4302 HERITAGE, ARCHIVE AND MUSEUM STUDIES;44 HUMAN SOCIETY;4403 DEMOGRAPHY","22;18;8;3;3;2;2;2;2;1;1;1;1;1;1;1;1","GENETICS;CLINICAL RESEARCH;NEUROSCIENCES;RARE DISEASES;BRAIN DISORDERS;CANCER;HUMAN GENOME;LUNG;NEURODEGENERATIVE;BIOTECHNOLOGY;BRAIN CANCER;CARDIOVASCULAR;CHRONIC PAIN;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;CYSTIC FIBROSIS;DIGESTIVE DISEASES;EPILEPSY;INFECTIOUS DISEASES;KIDNEY DISEASE;LUNG CANCER","5;4;4;4;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1","CANCER;NEUROLOGICAL;CARDIOVASCULAR;CONGENITAL;ORAL AND GASTROINTESTINAL","2;2;1;1;1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;1.1 NORMAL BIOLOGICAL DEVELOPMENT AND FUNCTIONING;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;6.1 PHARMACEUTICALS","4;1;1;1","BIOMEDICAL;CLINICAL;POPULATION & SOCIETY","5;3;1","BASIC SCIENCE;CLINICAL MEDICINE AND SCIENCE;PUBLIC HEALTH","6;5;1","NEUROBLASTOMA;LEUKEMIA / LEUKAEMIA;BRAIN TUMOR;LUNG CANCER","3;2;1;1","15 LIFE ON LAND","1"
"IRCCS_GASLINI",2017,313,17.9488817891374,3.50798722044728,0.332268370607029,0.345047923322684,0.431309904153355,2.46188340807175,1.35064935064935,1.52112676056338,1.36363636363636,0.597444089456869,1,163,83,26,22,0.52,0.27,0.08,0.07,39.01,1.32358757199762,5.23652365236524,0.498402555910543,0.939297124600639,0.489,0.458,0.398,0.443,"NICOLINO RUPERTO;ALBERTO MARTINI;GIROLAMO MATTIOLI;MARCO GATTORNO;MARIASAVINA SEVERINO;ANGELO RAVELLI;DOMENICO TORTORA;CARLO DUFOUR;PASQUALE STRIANO;ELIO CASTAGNOLA;FRANCO LOCATELLI;ALBERTO GARAVENTA;ANDREA ROSSI;ANGELA PISTORIO;ISABELLA CECCHERINI;LUCA A. RAMENGHI;LUCA PIO;GIOVANNI MORANA;MAURA FARACI;FEDERICO ZARA","19;18;17;17;16;14;13;13;13;12;12;12;12;11;11;11;11;10;10;10","LUCA A. RAMENGHI;MARIASAVINA SEVERINO;GIROLAMO MATTIOLI;ALESSANDRO CONSOLARO;ANDREA ROSSI;ELIO CASTAGNOLA;DOMENICO TORTORA;CARLO BELLINI;GIOVANNI MORANA;PASQUALE STRIANO;ISABELLA CECCHERINI;ALBERTO GARAVENTA;MARCO GATTORNO;NICOLINO RUPERTO;MAURA FARACI;LUCA PIO;PAOLO NOZZA;ALESSANDRO MORETTA;MARIA GRAZIA CALEVO;ALBERTO MARTINI","1.81;1.52;1.49;1.38;1.27;1.23;1.22;1.16;1.07;1;0.98;0.98;0.97;0.96;0.96;0.95;0.94;0.93;0.9;0.89","NICOLINO RUPERTO;ALBERTO MARTINI;GIROLAMO MATTIOLI;MARCO GATTORNO;MARIASAVINA SEVERINO;ANGELO RAVELLI;DOMENICO TORTORA;CARLO DUFOUR;PASQUALE STRIANO;ELIO CASTAGNOLA;ALBERTO GARAVENTA;ANDREA ROSSI;ANGELA PISTORIO;ISABELLA CECCHERINI;LUCA A. RAMENGHI;LUCA PIO;GIOVANNI MORANA;MAURA FARACI;FEDERICO ZARA;PAOLO NOZZA","19;18;17;17;16;14;13;13;13;12;12;12;11;11;11;11;10;10;10;10","LUCA A. RAMENGHI;MARIASAVINA SEVERINO;GIROLAMO MATTIOLI;ALESSANDRO CONSOLARO;ANDREA ROSSI;ELIO CASTAGNOLA;DOMENICO TORTORA;CARLO BELLINI;GIOVANNI MORANA;PASQUALE STRIANO;ISABELLA CECCHERINI;ALBERTO GARAVENTA;MARCO GATTORNO;NICOLINO RUPERTO;MAURA FARACI;LUCA PIO;PAOLO NOZZA;MARIA GRAZIA CALEVO;ALBERTO MARTINI;CARLO DUFOUR","1.81;1.52;1.49;1.38;1.27;1.23;1.22;1.16;1.07;1;0.98;0.98;0.97;0.96;0.96;0.95;0.94;0.9;0.89;0.88","MARCO GATTORNO;FRANCIS VEYCKEMANS;PASQUALE STRIANO;ANGELO RAVELLI;MARIASAVINA SEVERINO;NICOLINO RUPERTO;ALBERTO MARTINI;LUIGI VARESIO;BRIAN M. FELDMAN;DOMENICO TORTORA;NICOLA DISMA;MARIA CARLA BOSCO;FEDERICO ZARA;FRANCO LOCATELLI;ROBERTA CAORSI;A. DE VILLÉ;A. GUTMANN;ALIAKSANDRA PARASHCHANKA;ANNE VAN DE VELDE;BERNHARD ZIEGLER","1315;1228;1168;1107;959;959;915;807;756;726;710;688;685;680;641;614;614;614;614;614","MARCO GATTORNO;ANGELO RAVELLI;NICOLINO RUPERTO;MARIASAVINA SEVERINO;ALBERTO MARTINI;LUIGI VARESIO;DOMENICO TORTORA;MARIA CARLA BOSCO;FEDERICO ZARA;NICOLA DISMA;ROBERTA CAORSI;PAOLO PICCO;ISABELLA CECCHERINI;PAMELA BECHERINI;ALBERTO GARAVENTA;GENNY DEL ZOTTO;STEFANO VOLPI;FEDERICA PENCO;ANGELA PISTORIO;CARLO DUFOUR","1293;1107;959;923;892;807;690;688;685;679;641;602;559;559;543;532;532;500;477;465","NICOLINO RUPERTO;GIROLAMO MATTIOLI;ALBERTO MARTINI;MARCO GATTORNO;ANGELO RAVELLI;MARIASAVINA SEVERINO;ALBERTO GARAVENTA;CARLO DUFOUR;ISABELLA CECCHERINI;ANGELA PISTORIO;DOMENICO TORTORA;CLAUDIO BRUNO;LUCA A. RAMENGHI;ELIO CASTAGNOLA;FEDERICO ZARA;PAOLO NOZZA;ANDREA ROSSI;GIAN MARCO GHIGGERI;LUCA PIO;MAJA DI ROCCO","19;17;17;16;15;14;12;12;12;11;11;11;11;11;10;10;10;9;9;9","MEDICINE;BIOLOGY;CHEMISTRY;PHYSICS;ENGINEERING;PSYCHOLOGY;COMPUTER SCIENCE;MATHEMATICS;POLITICAL SCIENCE;SOCIOLOGY;MATERIALS SCIENCE;ECONOMICS;PHILOSOPHY;BUSINESS;GEOGRAPHY","261;155;31;24;13;13;12;10;10;6;5;4;3;2;1","INTERNAL MEDICINE;GENETICS;PEDIATRICS;SURGERY;IMMUNOLOGY;PATHOLOGY;BIOCHEMISTRY;GASTROENTEROLOGY;CANCER RESEARCH;CELL BIOLOGY;PSYCHIATRY;RADIOLOGY;ENVIRONMENTAL HEALTH;INTENSIVE CARE MEDICINE;ENDOCRINOLOGY;NEUROSCIENCE;ONCOLOGY;OPTICS;PHYSICAL THERAPY;ANATOMY","178;115;73;71;70;54;41;34;30;28;25;25;21;21;20;17;17;17;15;13","GENE;DISEASE;TRANSPLANTATION;CHEMOTHERAPY;RECEPTOR;COHORT;IN VITRO;POPULATION;IMMUNE SYSTEM;ANTIBODY;CELL CULTURE;PREGNANCY;EPILEPSY;INCIDENCE (GEOMETRY);CANCER;ARTHRITIS;MAGNETIC RESONANCE IMAGING;RETROSPECTIVE COHORT STUDY;STEM CELL;RHEUMATOLOGY","78;36;25;23;23;21;21;21;20;19;18;18;17;17;16;14;14;14;14;13","MUTATION;PHENOTYPE;HEMATOPOIETIC STEM CELL TRANSPLANTATION;NEUROBLASTOMA;CYTOTOXIC T CELL;GESTATIONAL AGE;CYCLOPHOSPHAMIDE;CUMULATIVE INCIDENCE;RITUXIMAB;T CELL;FETUS;GENE EXPRESSION;GENOME;GENOTYPE;HUMAN LEUKOCYTE ANTIGEN;IMMUNOTHERAPY;JUVENILE DERMATOMYOSITIS;MICRORNA;PERIPHERAL BLOOD MONONUCLEAR CELL;APLASTIC ANEMIA;CHEMOKINE;DIFFUSION MRI;HAEMATOPOIESIS;INNATE IMMUNE SYSTEM;MONOCLONAL ANTIBODY;NEURORADIOLOGY;PLACEBO;ZEBRAFISH","25;21;15;15;10;9;8;7;7;7;6;6;6;6;6;6;6;6;6;5;5;5;5;5;5;5;5;5","MISSENSE MUTATION;EXOME SEQUENCING;MICROVESICLES;CHEMOKINE RECEPTOR;COPY-NUMBER VARIATION;FLUDARABINE;FRAMESHIFT MUTATION;CANAKINUMAB;COMPARATIVE GENOMIC HYBRIDIZATION;COMPOUND HETEROZYGOSITY;CONGENITAL CENTRAL HYPOVENTILATION SYNDROME;INTERLEUKIN 12;INTERLEUKIN 21;INTRAVENTRICULAR HEMORRHAGE;METABOTROPIC GLUTAMATE RECEPTOR;METABOTROPIC RECEPTOR;PRENATAL DIAGNOSIS;ABATACEPT;BUSULFAN;CLINICAL PHENOTYPE;CORONAVIRUS DISEASE 2019 (COVID-19);DNA METHYLATION;DONOR SPECIFIC ANTIBODIES;EXCITOTOXICITY;FANCONI ANEMIA;FERTILITY PRESERVATION;HAPLOINSUFFICIENCY;IMATINIB MESYLATE;INEFFECTIVE ERYTHROPOIESIS;INNATE LYMPHOID CELL;LIMB-GIRDLE MUSCULAR DYSTROPHY;LOSS FUNCTION;MACROPHAGE POLARIZATION;MATURITY ONSET DIABETES OF THE YOUNG;MEROPENEM;MONOCLONAL;NKG2D;STIMULATOR OF INTERFERON GENES;TOTAL BODY IRRADIATION;TRACTOGRAPHY;VENTRICULOMEGALY;VINCRISTINE","13;6;5;4;4;4;4;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HUMANS;FEMALE;MALE;CHILD;ADOLESCENT;CHILD, PRESCHOOL;;INFANT;ITALY;ADULT;RETROSPECTIVE STUDIES;YOUNG ADULT;NEUROBLASTOMA;INFANT, NEWBORN;MUTATION;TREATMENT OUTCOME;ANIMALS;EPILEPSY;FOLLOW-UP STUDIES;MAGNETIC RESONANCE IMAGING","217;152;152;119;101;93;88;65;62;50;39;37;36;33;33;32;26;26;25;25","HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS AND RELATED DISORDERS;NEUROBLASTOMA RESEARCH AND TREATMENT;HEMATOPOIETIC STEM CELL BIOLOGY;NATURAL KILLER CELLS IN IMMUNITY;EPIDEMIOLOGY, CLASSIFICATION, AND CLINICAL FEATURES OF INFLAMMATORY MYOPATHIES;EPILEPSY AND SEIZURES;GLIOMAS;MOLECULAR MECHANISMS OF INFLAMMASOME ACTIVATION AND REGULATION;PATHOPHYSIOLOGY OF GLOMERULAR DISEASES AND NEPHROTIC SYNDROMES;DEVELOPMENT AND DISORDERS OF FETAL BRAIN;EXOSOME BIOLOGY AND FUNCTION IN INTERCELLULAR COMMUNICATION;NEONATAL BRAIN INJURY AND DEVELOPMENTAL CONSEQUENCES;THERAPEUTIC ADVANCES IN CYSTIC FIBROSIS RESEARCH;DIAGNOSIS AND MANAGEMENT OF FUNGAL INFECTIONS;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;MOLECULAR MECHANISMS OF SYNAPTIC PLASTICITY AND NEUROLOGICAL DISORDERS;NEONATAL LUNG DEVELOPMENT AND RESPIRATORY MORBIDITY;NEURAL MECHANISMS OF RESPIRATORY CONTROL AND HOMEOSTASIS;PANCREATIC ISLET DYSFUNCTION AND REGENERATION;EMERGENCY DEPARTMENT CROWDING","15;14;11;10;9;7;6;6;6;5;5;5;5;4;4;4;4;4;4;3","NEUROBLASTOMA;SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS;JUVENILE IDIOPATHIC ARTHRITIS;NK CELL ACTIVATION;NK CELL DEVELOPMENT;REGIMEN;EPILEPSY;HEMATOPOIETIC CELL TRANSPLANTATION;DERMATOMYOSITIS;NK CELL RECOGNITION;PRENATAL DIAGNOSIS;CUMULATIVE INCIDENCE;NK CELL THERAPY;PRETERM INFANTS;JUVENILE DERMATOMYOSITIS;TREATMENT OUTCOMES;APLASTIC ANEMIA;DISCONTINUATION;ETIOLOGY;FETAL MRI","17;15;12;12;11;10;9;9;8;8;8;7;7;7;6;6;5;5;5;5","STEM CELL;IDIOPATHIC ARTHRITIS;JUVENILE IDIOPATHIC;CELL TRANSPLANTATION;EUROPEAN SOCIETY;HEMATOPOIETIC STEM;JUVENILE DERMATOMYOSITIS;COHORT STUDY;NK CELLS;SEVERE APLASTIC;AMERICAN COLLEGE;APLASTIC ANEMIA;CELL TRANSPLANT;CLINICAL RESPONSE;CYSTIC FIBROSIS;HIGH-RISK NEUROBLASTOMA;MAJOR CLINICAL;MINIMAL MODERATE;PEDIATRIC PATIENTS;POLYARTICULAR-COURSE JUVENILE;RHEUMATISM CRITERIA;RHEUMATOLOGYEUROPEAN LEAGUE;ACUTE LEUKEMIA;ADULT DERMATOMYOSITIS;ALLOGENEIC HEMATOPOIETIC;APLASTIC ANAEMIA;ASSOCIAZIONE ITALIANA;CARDIAC DEFECTS;DISEASE ACTIVITY;EMATOLOGIA ONCOLOGIA","15;11;11;10;7;6;6;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3","PUBMED SCOPUS;NK CELLS;PERIODIC FEVER;CROSSREF PUBMED;APHTHOUS STOMATITIS;STOMATITIS PHARYNGITIS;GRANTRESEARCH SUPPORT;CORE SET;FEVER APHTHOUS;BRISTOL-MYERS SQUIBB;FLOW CYTOMETRY;SPEAKERS BUREAU;SET MEASURES;MGKG ATLG;NK CELL;PERIPHERAL BLOOD;BONE MARROW;CLINICAL RESPONSE;MAJOR IMPROVEMENT;FLOW CYTOMETER;RESPONSE CRITERIA;DISEASE ACTIVITY;MINIMAL MODERATE;PATIENTS AFFECTED;PEDIATR -ABSTRACT;CERVICAL ADENITIS;CLINICAL REMISSION;CONJOINT ANALYSIS;NB PATIENTS;PATIENTS RECEIVED","51;35;33;32;29;29;25;24;24;20;20;20;19;16;16;15;14;14;14;13;13;12;12;12;12;11;11;11;11;11",194,0.62,6.76,8,2,1,1,7,3,0,1,8.75,1,1,7,1,2,2,3,5,2,0,0,77,77,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,13,4.46,219.54,3.09,9,0.69,30.92,0,1,3,1,2,0,1,5,0,9,4,0,0,0,0,0,0,12,0,1,13,0,0,0,0,0,0,0,0,0,"United States;Australia;Japan","6;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3211 ONCOLOGY AND CARCINOGENESIS;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY","13;7;2;2;2;1;1","CLINICAL RESEARCH;PEDIATRIC;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;RARE DISEASES;LUNG;NEUROSCIENCES;HEMATOLOGY;BIOMEDICAL IMAGING;BRAIN DISORDERS;CANCER;COMPARATIVE EFFECTIVENESS RESEARCH;COMPLEMENTARY AND INTEGRATIVE HEALTH;CYSTIC FIBROSIS;GENETICS;INFECTIOUS DISEASES;INTELLECTUAL AND DEVELOPMENTAL DISABILITIES (IDD);LYMPHOMA;MUSCULAR DYSTROPHY;NEURODEGENERATIVE;NUTRITION","13;8;7;6;3;3;2;1;1;1;1;1;1;1;1;1;1;1;1;1","NEUROLOGICAL;CANCER;CONGENITAL;MENTAL HEALTH;RESPIRATORY","2;1;1;1;1","6.1 PHARMACEUTICALS;5.1 PHARMACEUTICALS;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;6.4 SURGERY;6.7 PHYSICAL","9;2;1;1;1","HODGKIN'S DISEASE;LEUKEMIA / LEUKAEMIA;LUNG CANCER","1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","1",1,227750,56937.5,3,4,1,1,6,967222.761928069,0.323606941772197,"BAMBINO GESÙ CHILDREN'S HOSPITAL;ISTITUTO GIANNINA GASLINI;UNIVERSITY OF MILAN;UNIVERSITY OF PADUA","1;1;1;1","TELETHON FOUNDATION","1",NA,NA,"TELETHON - UILDM CLINICAL GRANT PROJECTS - 2015 (PROGRAM)","1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3210 NUTRITION AND DIETETICS;42 HEALTH SCIENCES","1;1;1;1","DIGESTIVE DISEASES;LUNG;NEURODEGENERATIVE;NUTRITION;OBESITY;PEDIATRIC;PREVENTION;RARE DISEASES;SPINAL MUSCULAR ATROPHY","1;1;1;1;1;1;1;1;1","CARDIOVASCULAR;MUSCULOSKELETAL;ORAL AND GASTROINTESTINAL;STROKE","1;1;1;1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS","1",NA,NA,NA,NA,"A01 CLINICAL MEDICINE","1",NA,NA,6,"PUBLIC LIBRARY OF SCIENCE;AMERICAN CHEMICAL SOCIETY","5;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3208 MEDICAL PHYSIOLOGY;34 CHEMICAL SCIENCES","10;2;2;1;1","BIOTECHNOLOGY;RARE DISEASES;CANCER;GENETICS;KIDNEY DISEASE;LUNG;NEUROBLASTOMA;NEUROSCIENCES;PEDIATRIC","2;2;1;1;1;1;1;1;1","CANCER;RENAL AND UROGENITAL","1;1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;5.1 PHARMACEUTICALS","1;1","BIOMEDICAL;CLINICAL","2;1","CLINICAL MEDICINE AND SCIENCE;BASIC SCIENCE","2;1","NEUROBLASTOMA;NOT SITE-SPECIFIC CANCER","1;1",NA,NA
"IRCCS_GASLINI",2018,395,16.1569620253165,3.15189873417721,0.258227848101266,0.377215189873418,0.427848101265823,2.66595289079229,1.2289156626506,2.19117647058824,1.48245614035088,0.683544303797468,1,180,125,26,28,0.46,0.32,0.07,0.07,31.24,1.02408475068703,5.16420474063894,0.559493670886076,0.944303797468354,0.56,0.567,0.525,0.536,"NICOLINO RUPERTO;ALESSANDRO CONSOLARO;FRANCESCA BOVIS;ALBERTO MARTINI;ANGELO RAVELLI;CHIARA FIORILLO;ALBERTO GARAVENTA;CARLO DUFOUR;MARCO GATTORNO;ANGELA PISTORIO;JORDI ANTÓN;FABRIZIO DE BENEDETTI;CLAUDIO BRUNO;FRANCO LOCATELLI;MARIASAVINA SEVERINO;ANDREA ROSSI;PASQUALE STRIANO;CARLO MINETTI;VALERIA CAPRA;GIOVANNI MORANA","70;55;53;21;17;16;16;16;15;14;14;13;13;12;12;12;12;11;11;11","NICOLINO RUPERTO;ALESSANDRO CONSOLARO;FRANCESCA BOVIS;MARIA GRAZIA CALEVO;MARCO GATTORNO;ANDREA ACCOGLI;PASQUALE STRIANO;MATTEO BRUSCHETTINI;GIOVANNI MORANA;ALBERTO MARTINI;ELIO CASTAGNOLA;LUCA MORESCO;GIORGIO CIPRANDI;ALBERTO GARAVENTA;MARIASAVINA SEVERINO;CLAUDIO GRANATA;LUCA A. RAMENGHI;MICHELA SILVESTRI;ANGELA PISTORIO;ANGELO RAVELLI","7.62;6.96;6.49;1.82;1.61;1.49;1.33;1.33;1.33;1.3;1.3;1.25;1.23;1.17;1.17;1.14;1.11;1.1;1.05;1.04","NICOLINO RUPERTO;ALESSANDRO CONSOLARO;FRANCESCA BOVIS;ALBERTO MARTINI;ANGELO RAVELLI;CHIARA FIORILLO;ALBERTO GARAVENTA;CARLO DUFOUR;MARCO GATTORNO;ANGELA PISTORIO;JORDI ANTÓN;FABRIZIO DE BENEDETTI;CLAUDIO BRUNO;MARIASAVINA SEVERINO;ANDREA ROSSI;PASQUALE STRIANO;CARLO MINETTI;VALERIA CAPRA;GIOVANNI MORANA;NICO WULFFRAAT","70;55;53;21;17;16;16;16;15;14;14;13;13;12;12;12;11;11;11;11","NICOLINO RUPERTO;ALESSANDRO CONSOLARO;FRANCESCA BOVIS;MARIA GRAZIA CALEVO;MARCO GATTORNO;ANDREA ACCOGLI;PASQUALE STRIANO;GIOVANNI MORANA;ALBERTO MARTINI;ELIO CASTAGNOLA;ALBERTO GARAVENTA;MARIASAVINA SEVERINO;CLAUDIO GRANATA;LUCA A. RAMENGHI;MICHELA SILVESTRI;ANGELA PISTORIO;ANGELO RAVELLI;VALERIA CAPRA;CHIARA FIORILLO;MYRIAM SROUR","7.62;6.96;6.49;1.82;1.61;1.49;1.33;1.33;1.3;1.3;1.17;1.17;1.14;1.11;1.1;1.05;1.04;1.03;1.02;1.01","MARCO GATTORNO;NICOLINO RUPERTO;JORDI ANTÓN;ANGELO RAVELLI;ELIO CASTAGNOLA;NICO WULFFRAAT;CLAUDIO VISCOLI;ADILIA WARRIS;ANDREAS H. GROLL;ANDREW J. ULLMANN;ANNA SKIADA;ARUNALOKE CHAKRABARTI;BART JAN KULLBERG;C KIBBLER;CATHERINE BEIGELMAN‐AUBRY;CHRISTOPH LANGE;CLAUS PETER HEUßEL;CORNELIA LASS‐FLÖRL;DAVID W. DENNING;DIETER BUCHHEIDT","1419;1305;1301;1283;1227;1176;1151;1140;1140;1140;1140;1140;1140;1140;1140;1140;1140;1140;1140;1140","MARCO GATTORNO;ELIO CASTAGNOLA;ANGELO RAVELLI;ALBERTO MARTINI;NICOLINO RUPERTO;STEFANO VOLPI;ALBERTO GARAVENTA;CLAUDIO BRUNO;FEDERICO ZARA;TADEJ AVČIN;MICHELE IACOMINO;CARLO DUFOUR;CHIARA FIORILLO;RICCARDO HAUPT;CARLO MINETTI;ANDREA PETRETTO;GIAN MARCO GHIGGERI;FRANCESCA BAGNASCO;LUIGI VARESIO;MARIA LUISA GARRÈ","1419;1227;1017;981;912;493;480;449;408;393;390;372;360;334;320;289;280;277;277;252","NICOLINO RUPERTO;ALESSANDRO CONSOLARO;FRANCESCA BOVIS;ALBERTO MARTINI;CARLO DUFOUR;MARCO GATTORNO;CLAUDIO BRUNO;ALBERTO GARAVENTA;ANGELO RAVELLI;ANGELA PISTORIO;CHIARA FIORILLO;MARIASAVINA SEVERINO;ANDREA ROSSI;MARIA MARGHERITA MANCARDI;ELIO CASTAGNOLA;FEDERICO ZARA;GIOVANNI MORANA;MARIA LUISA GARRÈ;ANDREA ACCOGLI;MAURA FARACI","69;54;52;19;16;15;15;15;15;13;12;11;11;10;10;10;10;10;9;9","MEDICINE;BIOLOGY;CHEMISTRY;PHYSICS;COMPUTER SCIENCE;PSYCHOLOGY;MATHEMATICS;POLITICAL SCIENCE;PHILOSOPHY;ENGINEERING;SOCIOLOGY;ECONOMICS;MATERIALS SCIENCE;HISTORY;BUSINESS;ART","351;177;35;27;23;14;11;9;8;5;5;4;4;3;2;1","INTERNAL MEDICINE;GENETICS;PEDIATRICS;SURGERY;PHYSICAL THERAPY;IMMUNOLOGY;PATHOLOGY;CLINICAL PSYCHOLOGY;BIOCHEMISTRY;CANCER RESEARCH;PSYCHIATRY;ONCOLOGY;CELL BIOLOGY;GASTROENTEROLOGY;INTENSIVE CARE MEDICINE;ENDOCRINOLOGY;NEUROSCIENCE;FAMILY MEDICINE;RADIOLOGY;ENVIRONMENTAL HEALTH","264;121;82;74;65;60;60;50;48;38;31;28;27;27;27;26;26;23;23;19","GENE;ARTHRITIS;DISEASE;PSYCHOMETRICS;COHORT;CANCER;TRANSPLANTATION;CHEMOTHERAPY;RECEPTOR;IMMUNE SYSTEM;RHEUMATOLOGY;EPILEPSY;ANTIBODY;CELL CULTURE;POPULATION;BONE MARROW;PREGNANCY;STEM CELL;INCIDENCE (GEOMETRY);MAGNETIC RESONANCE IMAGING","79;61;59;49;28;25;25;23;23;20;20;18;17;17;17;16;16;16;14;14","CONSTRUCT VALIDITY;CRONBACH'S ALPHA;INTERNAL CONSISTENCY;POLYARTHRITIS;PHENOTYPE;MUTATION;HEMATOPOIETIC STEM CELL TRANSPLANTATION;NEUROBLASTOMA;FETUS;APLASTIC ANEMIA;GENOME;GENOTYPE;GESTATIONAL AGE;HAEMATOPOIESIS;ASTROCYTOMA;CD34;CHILDHOOD CANCER;CLINICAL ENDPOINT;CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR;ENZYME REPLACEMENT THERAPY;GENE EXPRESSION;GRAFT-VERSUS-HOST DISEASE;MICRORNA;RITUXIMAB;SYSTEMIC LUPUS ERYTHEMATOSUS","48;48;46;38;30;25;16;16;8;7;7;7;7;7;5;5;5;5;5;5;5;5;5;5;5","DISCRIMINANT VALIDITY;MISSENSE MUTATION;EXOME SEQUENCING;COPY-NUMBER VARIATION;COMPOUND HETEROZYGOSITY;FRAMESHIFT MUTATION;BONE MARROW FAILURE;BUSULFAN;CANAKINUMAB;CASPOFUNGIN;CD38;GENETIC HETEROGENEITY;HAPLOINSUFFICIENCY;HEMATOPOIETIC CELL;POSACONAZOLE;PRENATAL DIAGNOSIS;RNA SPLICING;SERRATIA MARCESCENS;SINGLE-NUCLEOTIDE POLYMORPHISM;VENTRICULOMEGALY","46;8;7;6;5;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3","HUMANS;MALE;FEMALE;CHILD;CHILD, PRESCHOOL;ADOLESCENT;;ARTHRITIS, JUVENILE;RHEUMATOLOGY;PROGNOSIS;CASE-CONTROL STUDIES;INFANT;PARENTS;QUALITY OF LIFE;REPRODUCIBILITY OF RESULTS;AGE OF ONSET;PATIENTS;PREDICTIVE VALUE OF TESTS;DISABILITY EVALUATION;TRANSLATING","280;208;205;166;144;140;107;99;65;62;61;59;57;55;55;54;53;51;50;50","HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS AND RELATED DISORDERS;NEUROBLASTOMA RESEARCH AND TREATMENT;HEMATOPOIETIC STEM CELL BIOLOGY;THERAPEUTIC ADVANCES IN CYSTIC FIBROSIS RESEARCH;NATURAL KILLER CELLS IN IMMUNITY;MOLECULAR MECHANISMS OF INFLAMMASOME ACTIVATION AND REGULATION;GLIOMAS;PEDIATRIC CANCER AND QUALITY OF LIFE;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;GENOMIC REARRANGEMENTS AND COPY NUMBER VARIATIONS;EPILEPSY AND SEIZURES;LYMPHOID NEOPLASMS;MOLECULAR MECHANISMS OF MUSCLE REGENERATION AND ATROPHY;DEVELOPMENT AND DISORDERS OF FETAL BRAIN;DIAGNOSIS AND MANAGEMENT OF FUNGAL INFECTIONS;EPIDEMIOLOGY AND TREATMENT OF BONE FRACTURES;MOLECULAR BASIS OF RETT SYNDROME AND RELATED DISORDERS;MOLECULAR PHYSIOLOGY OF PURINERGIC SIGNALLING;PATHOPHYSIOLOGY OF GLOMERULAR DISEASES AND NEPHROTIC SYNDROMES;SPINA BIFIDA","64;18;15;14;12;11;8;8;7;6;5;5;5;4;4;4;4;4;4;4","SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS;JUVENILE IDIOPATHIC ARTHRITIS;DISCRIMINANT VALIDITY;NEUROBLASTOMA;HEMATOPOIETIC CELL TRANSPLANTATION;NK CELL ACTIVATION;TUMOR MICROENVIRONMENT;CHILDHOOD CANCER SURVIVOR STUDY;NK CELL DEVELOPMENT;CYSTIC FIBROSIS;REGIMEN;APLASTIC ANEMIA;CHILDHOOD CANCER;DELPHI METHOD;NK CELL THERAPY;CFTR;NEUROSONOGRAPHY;NK CELL RECOGNITION;TREATMENT;TREATMENT OUTCOMES","71;68;46;17;13;10;10;9;9;8;8;7;7;7;7;6;6;6;6;6","JUVENILE ARTHRITIS;ARTHRITIS MULTIDIMENSIONAL;ASSESSMENT REPORT;MULTIDIMENSIONAL ASSESSMENT;REPORT JAMAR;IDIOPATHIC ARTHRITIS;JUVENILE IDIOPATHIC;CYSTIC FIBROSIS;CELL TRANSPLANTATION;STEM CELL;APLASTIC ANEMIA;SPANISH VERSION;CHILDHOOD CANCER;HEMATOPOIETIC STEM;ARABIC VERSION;MUSCULAR DYSTROPHY;PILOT STUDY;SYSTEMIC LUPUS;AUTOINFLAMMATORY DISEASES;BONE MARROW;CLASSIFICATION CRITERIA;DUCHENNE MUSCULAR;LUPUS ERYTHEMATOSUS;MAGNETIC RESONANCE;MARROW TRANSPLANTATION;PEDIATRIC PATIENTS;PHASE III;AIRWAY EPITHELIA;ALLOGENEIC HEMATOPOIETIC;CASE-CONTROL STUDY","50;49;49;49;49;18;18;13;12;9;7;7;6;6;5;5;5;5;4;4;4;4;4;4;4;4;4;3;3;3","JIA PATIENTS;HEALTHY CHILDREN;JAMAR COMPONENTS;IDIOPATHIC ARTHRITIS;JUVENILE IDIOPATHIC;ARTHRITIS JIA;HEALTHY SUBJECTS;JUVENILE ARTHRITIS;CONSTRUCT VALIDITY;DESCRIPTIVE STATISTICS;CLINICAL DATA;CLINICAL PRACTICE;CLINICAL RESEARCH;CRONBACHS ALPHA;DISEASE STATUS;ALPHA INTERSCALE;ARTHRITIS MULTIDIMENSIONAL;ASSESSMENT REPORT;ASSUMPTIONS FLOORCEILING;COMPONENTS REVEALED;CONSECUTIVE JIA;CONSECUTIVE PATIENTS;CONSISTENCY CRONBACHS;CROSS-CULTURAL ADAPTATION;DISCRIMINANT VALIDITY;EFFECTS INTERNAL;EXPLORED DESCRIPTIVE;FLOORCEILING EFFECTS;INTERNAL CONSISTENCY;INTERSCALE CORRELATIONS","163;107;97;63;63;62;61;53;51;51;50;50;50;50;50;49;49;49;49;49;49;49;49;49;49;49;49;49;49;49",205,0.52,8.5,9,2,1,1,4.75,3.75,0,1,10,0,1,8,0,2,2,2.25,7,4,0,0,69,69,3,0,0,0,2,1,0,0,0,0,0,0,2,1,0,0,7.33333333333333,1.77,3.33333333333333,0,3,2,0,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"BANDIERA TIZIANO;BERTOZZI FABIO;CACI EMANUELA;DI FRUSCIA PAOLO;FERRERA LORETTA;GALIETTA LUIS JUAN VICENTE;PEDEMONTE NICOLETTA;SORANA FEDERICO;BERTI FRANCESCO;GATTORNO MARCO","2;2;2;2;2;2;2;2;1;1","FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA;FONDAZIONE PER LA RICERCA SULLA FIBROSI CISTICA-ON-LUS;ISTITUTO GIANNINA GASLINI;ASSISTANCE PUBLIQUE HOPITAUX DE PARIS APHP;INSTITUTO GIANNINA GASLINI;ST G GASLINI;UNIVERSITE PARIS SUD PARIS 11","2;2;2;1;1;1;1","34 CHEMICAL SCIENCES;3404 MEDICINAL AND BIOMOLECULAR CHEMISTRY","4;2","CYSTIC FIBROSIS;LUNG;RARE DISEASES","2;2;2","5.1 PHARMACEUTICALS","2","A61P11/00;A61P3/00;C07D405/12;C07D405/14;C07D471/04;C07D498/04;A61K31/41;A61K31/4155;A61K31/4745;A61P27/00","2;2;2;2;2;2;1;1;1;1","A61P11/00;A61P3/00;C07D405/12;C07D405/14;C07D413/12;C07D471/04;C07D498/04;A61P27/00;C07D231/16;C07D403/12","2;2;2;2;2;2;2;1;1;1",16,4.8,547.53,4.04,7,0.44,46.94,0,1,3,0,7,0,0,5,0,11,4,0,0,0,0,0,0,15,0,1,15,1,0,0,0,0,0,0,0,0,"United States;Germany;Japan;United Kingdom","5;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;52 PSYCHOLOGY;31 BIOLOGICAL SCIENCES;3105 GENETICS;3211 ONCOLOGY AND CARCINOGENESIS;5202 BIOLOGICAL PSYCHOLOGY;3204 IMMUNOLOGY;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;42 HEALTH SCIENCES","16;9;3;3;2;2;2;2;1;1;1","CLINICAL RESEARCH;PEDIATRIC;RARE DISEASES;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;CANCER;AUTOIMMUNE DISEASE;ORPHAN DRUG;PEDIATRIC CANCER;ARTHRITIS;BRAIN DISORDERS;CYSTIC FIBROSIS;GENETICS;HEMATOLOGY;LUNG;NEUROSCIENCES;PEDIATRIC RESEARCH INITIATIVE;RHEUMATOID ARTHRITIS;STEM CELL RESEARCH;ATHEROSCLEROSIS;BIOMEDICAL IMAGING","12;11;10;7;4;3;3;3;2;2;2;2;2;2;2;2;2;2;1;1","CANCER;INFLAMMATORY AND IMMUNE SYSTEM;CONGENITAL;CARDIOVASCULAR;MUSCULOSKELETAL;ORAL AND GASTROINTESTINAL;RENAL AND UROGENITAL","3;3;2;1;1;1;1","6.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;5.1 PHARMACEUTICALS;2.4 SURVEILLANCE AND DISTRIBUTION;5.2 CELLULAR AND GENE THERAPIES","10;3;2;2;1;1","BONE CANCER, OSTEOSARCOMA / MALIGNANT FIBROUS HISTIOCYTOMA;LEUKEMIA / LEUKAEMIA;SARCOMA;NON-HODGKIN'S LYMPHOMA","2;2;2;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;2.2 ENDOGENOUS FACTORS IN THE ORIGIN AND CAUSE OF CANCER;4.1 TECHNOLOGY DEVELOPMENT AND/OR MARKER DISCOVERY;4.3 TECHNOLOGY AND/OR MARKER TESTING IN A CLINICAL SETTING;5.3 SYSTEMIC THERAPIES - DISCOVERY AND DEVELOPMENT","3;1;1;1;1",2,33560000,804444.44,5.5,23,8.5,0.5,14.5,924942.831192139,0.427053420686437,"ISTITUTO GIANNINA GASLINI;ARISTOTLE UNIVERSITY OF THESSALONIKI;AZIENDA SANITARIA UNIVERSITARIA FRIULI CENTRALE;BAMBINO GESÙ CHILDREN'S HOSPITAL;BAYER (GERMANY);CHARLES UNIVERSITY;CHILDREN'S MEMORIAL HEALTH INSTITUTE;CONSORZIO PER VALUTAZIONI BIOLOGICHE E FARMACOLOGICHE;DÉLÉGATION PARIS 11;ELI LILLY (UNITED KINGDOM);EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK - ERIC;EUROPEAN SOCIETY FOR PAEDIATRIC ONCOLOGY;FONDAZIONE IRCCS CA' GRANDA OSPEDALE MAGGIORE POLICLINICO;GENERAL UNIVERSITY HOSPITAL IN PRAGUE;GHENT UNIVERSITY;GIANNI BENZI PHARMACOLOGICAL RESEARCH FOUNDATION;GLAXOSMITHKLINE (UNITED KINGDOM);HAUKELAND UNIVERSITY HOSPITAL;HELIOS DR. HORST SCHMIDT KLINIKEN WIESBADEN;HOSPITAL CLÍNICO SAN CARLOS","2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","EUROPEAN COMMISSION;TELETHON FOUNDATION","1;1","COALITION S;EC & ERC - EUROPEAN UNION","1;1","H2020-EU.3.1. - SOCIETAL CHALLENGES - HEALTH, DEMOGRAPHIC CHANGE AND WELL-BEING (PROGRAMME);H2020-JTI-IMI2-2016-10-TWO-STAGE (CALL FOR PROPOSAL);RIA - RESEARCH AND INNOVATION ACTION (FUNDING SCHEME)","1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3208 MEDICAL PHYSIOLOGY;35 COMMERCE, MANAGEMENT, TOURISM AND SERVICES;3507 STRATEGY, MANAGEMENT AND ORGANISATIONAL BEHAVIOUR","2;1;1;1","BRAIN DISORDERS;CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;INTELLECTUAL AND DEVELOPMENTAL DISABILITIES (IDD);MUSCULAR DYSTROPHY;RARE DISEASES","1;1;1;1;1;1","MUSCULOSKELETAL","1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;5.1 PHARMACEUTICALS","1;1",NA,NA,NA,NA,"A05 BIOLOGICAL SCIENCES;B11 COMPUTER SCIENCE AND INFORMATICS","1;1",NA,NA,27,"FRONTIERS;PUBLIC LIBRARY OF SCIENCE;AMERICAN ASSOCIATION FOR CANCER RESEARCH;SPRINGER NATURE","15;8;3;1","32 BIOMEDICAL AND CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;3213 PAEDIATRICS;3105 GENETICS;3204 IMMUNOLOGY;3208 MEDICAL PHYSIOLOGY;34 CHEMICAL SCIENCES;3404 MEDICINAL AND BIOMOLECULAR CHEMISTRY;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS","35;13;6;5;5;4;2;2;1;1","BRAIN DISORDERS;NEUROSCIENCES;PEDIATRIC;CLINICAL RESEARCH;PERINATAL PERIOD - CONDITIONS ORIGINATING IN PERINATAL PERIOD;RARE DISEASES;GENETICS;CYSTIC FIBROSIS;LUNG;NEURODEGENERATIVE;ORPHAN DRUG;GENETIC TESTING;BIOTECHNOLOGY;EPILEPSY;HUMAN GENOME;STEM CELL RESEARCH;STEM CELL RESEARCH - UMBILICAL CORD BLOOD/ PLACENTA;STEM CELL RESEARCH - UMBILICAL CORD BLOOD/ PLACENTA - HUMAN;TRANSPLANTATION","7;7;7;6;6;6;5;4;4;3;3;2;1;1;1;1;1;1;1","NEUROLOGICAL;CONGENITAL;GENERIC HEALTH RELEVANCE","9;5;4","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;5.1 PHARMACEUTICALS;4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;1.1 NORMAL BIOLOGICAL DEVELOPMENT AND FUNCTIONING","13;3;2;2;1","BIOMEDICAL;CLINICAL","14;2","BASIC SCIENCE;CLINICAL MEDICINE AND SCIENCE","16;4","MELANOMA;NOT SITE-SPECIFIC CANCER","3;3","3 GOOD HEALTH AND WELL BEING","1"
"IRCCS_GASLINI",2019,415,17.033734939759,3.22409638554217,0.279518072289157,0.301204819277108,0.332530120481928,2.73415132924335,1.34883720930233,1.86567164179104,1.42268041237113,0.655421686746988,5,182,95,36,61,0.44,0.23,0.09,0.15,29.37,1.20774811302477,5.65028355387522,0.513253012048193,0.968674698795181,0.526,0.453,0.462,0.478,"ANGELO RAVELLI;MARCO GATTORNO;NICOLINO RUPERTO;PASQUALE STRIANO;ISABELLA CECCHERINI;ALESSANDRO CONSOLARO;MARIASAVINA SEVERINO;GIROLAMO MATTIOLI;ALBERTO MARTINI;ANGELA PISTORIO;MAURIZIO MIANO;ROBERTA CAORSI;GIAN MARCO GHIGGERI;FEDERICO ZARA;ALICE GROSSI;ALBERTO GARAVENTA;CARLO DUFOUR;ANDREA ROSSI;STEFANO VOLPI;GABRIELLA GIANCANE","31;30;25;20;19;18;16;15;15;14;14;14;14;14;14;14;14;14;13;12","NICOLINO RUPERTO;ANGELO RAVELLI;MARCO GATTORNO;GIORGIO CIPRANDI;ALESSANDRO CONSOLARO;ISABELLA CECCHERINI;ELIO CASTAGNOLA;ANDREA ROSSI;GIROLAMO MATTIOLI;CARLO BELLINI;GIAN MARCO GHIGGERI;SIMONE FERRERO;MARIASAVINA SEVERINO;ROBERTA CAORSI;PASQUALE STRIANO;ALBERTO GARAVENTA;FABIO BARRA;CAROLINA SCALA;VALERIO GAETANO VELLONE;ANGELA PISTORIO","2.61;2.58;2.35;2.13;1.8;1.54;1.46;1.46;1.42;1.34;1.34;1.33;1.31;1.29;1.28;1.27;1.22;1.22;1.19;1.17","ANGELO RAVELLI;MARCO GATTORNO;NICOLINO RUPERTO;PASQUALE STRIANO;ISABELLA CECCHERINI;ALESSANDRO CONSOLARO;MARIASAVINA SEVERINO;GIROLAMO MATTIOLI;ALBERTO MARTINI;ANGELA PISTORIO;MAURIZIO MIANO;ROBERTA CAORSI;GIAN MARCO GHIGGERI;FEDERICO ZARA;ALICE GROSSI;ALBERTO GARAVENTA;CARLO DUFOUR;ANDREA ROSSI;STEFANO VOLPI;GABRIELLA GIANCANE","31;30;25;20;19;18;16;15;15;14;14;14;14;14;14;14;14;14;13;12","NICOLINO RUPERTO;ANGELO RAVELLI;MARCO GATTORNO;ALESSANDRO CONSOLARO;ISABELLA CECCHERINI;ELIO CASTAGNOLA;ANDREA ROSSI;GIROLAMO MATTIOLI;CARLO BELLINI;GIAN MARCO GHIGGERI;MARIASAVINA SEVERINO;ROBERTA CAORSI;PASQUALE STRIANO;ALBERTO GARAVENTA;CAROLINA SCALA;ANGELA PISTORIO;MARIA GRAZIA CALEVO;ALICE GROSSI;E. VENESELLI;DOMENICO TORTORA","2.61;2.58;2.35;1.8;1.54;1.46;1.46;1.42;1.34;1.34;1.31;1.29;1.28;1.27;1.22;1.17;1.14;1.13;1.13;1.1","ELIO CASTAGNOLA;ADILIA WARRIS;ANDREAS H. GROLL;EMMANUEL ROILIDES;THOMAS LEHRNBECHER;SHARON CHEN;JOHAN MAERTENS;ANGELA M. CALIENDO;BARBARA D. ALEXANDER;BART JAN KULLBERG;BRIAN T. FISHER;C ORLA MORRISEY;CAROL A. KAUFFMAN;CATHERINE F. DECKER;CHRISTOPHER C. KIBBLER;CLAUDIO VISCOLI;CLAUS PETER HEUßEL;CORNELIA SCHAEFER PROKOP;CORNELIUS J. CLANCY;DAVID A. STEVENS","2131;2040;2040;2040;2040;2007;1846;1830;1830;1830;1830;1830;1830;1830;1830;1830;1830;1830;1830;1830","ELIO CASTAGNOLA;NICOLA DISMA;GAIA GIRIBALDI;GENNY DEL ZOTTO;ANGELO RAVELLI;PASQUALE STRIANO;GIAN MARCO GHIGGERI;FEDERICO ZARA;CARLO DUFOUR;MARCO GATTORNO;ANDREA PETRETTO;NICOLINO RUPERTO;MAURIZIO BRUSCHI;CLAUDIO BRUNO;VINCENZO SALPIETRO;MICHELE IACOMINO;STEFANO VOLPI;ALBERTO MARTINI;GIOVANNI CANDIANO;MARIASAVINA SEVERINO","2131;1194;1180;932;760;669;662;657;619;558;549;455;415;411;379;362;339;332;315;307","MARCO GATTORNO;NICOLINO RUPERTO;ANGELO RAVELLI;ISABELLA CECCHERINI;ALESSANDRO CONSOLARO;MARIASAVINA SEVERINO;PASQUALE STRIANO;CLAUDIO BRUNO;STEFANO VOLPI;ALBERTO GARAVENTA;FEDERICO ZARA;GIAN MARCO GHIGGERI;ANDREA ROSSI;GIROLAMO MATTIOLI;ALICE GROSSI;CARLO DUFOUR;ALBERTO MARTINI;GIOVANNI MORANA;ROBERTA CAORSI;ANGELA PISTORIO","28;25;25;18;16;16;15;15;15;14;14;14;14;13;13;12;12;12;12;11","MEDICINE;BIOLOGY;CHEMISTRY;PHYSICS;PSYCHOLOGY;COMPUTER SCIENCE;MATHEMATICS;ECONOMICS;ENGINEERING;POLITICAL SCIENCE;MATERIALS SCIENCE;BUSINESS;SOCIOLOGY;PHILOSOPHY;ART","360;209;49;31;26;24;9;7;7;7;6;4;3;2;1","INTERNAL MEDICINE;GENETICS;IMMUNOLOGY;PEDIATRICS;PATHOLOGY;SURGERY;BIOCHEMISTRY;PSYCHIATRY;GASTROENTEROLOGY;CELL BIOLOGY;CANCER RESEARCH;ENVIRONMENTAL HEALTH;NEUROSCIENCE;ONCOLOGY;RADIOLOGY;ENDOCRINOLOGY;BIOINFORMATICS;INTENSIVE CARE MEDICINE;PHYSICAL THERAPY;COMPUTATIONAL BIOLOGY;PHARMACOLOGY","259;159;93;93;81;81;59;46;41;38;31;27;27;27;26;21;18;18;18;15;15","GENE;DISEASE;ARTHRITIS;COHORT;CANCER;CHEMOTHERAPY;POPULATION;EPILEPSY;IMMUNE SYSTEM;PREGNANCY;ANTIBODY;CELL CULTURE;RHEUMATOLOGY;TRANSPLANTATION;CLINICAL TRIAL;ADVERSE EFFECT;RECEPTOR;RETROSPECTIVE COHORT STUDY;IN VITRO;BONE MARROW;INCIDENCE (GEOMETRY);JUVENILE;MAGNETIC RESONANCE IMAGING","122;93;35;34;29;27;27;26;22;22;21;20;20;20;18;16;16;16;15;14;14;14;14","MUTATION;PHENOTYPE;NEUROBLASTOMA;HEMATOPOIETIC STEM CELL TRANSPLANTATION;FETUS;GENE EXPRESSION;CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR;NEURORADIOLOGY;GENOTYPE;HAEMATOPOIESIS;IMMUNOTHERAPY;MICRORNA;NEUTROPENIA;RITUXIMAB;CLINICAL ENDPOINT;COLORECTAL CANCER;FAMILIAL MEDITERRANEAN FEVER;GENOME;APLASTIC ANEMIA;AUTOIMMUNITY;ETANERCEPT;EXON;INFLAMMATORY BOWEL DISEASE;MUTANT;POLYARTHRITIS","39;30;17;14;12;11;10;10;9;8;8;8;8;8;7;7;7;7;6;6;6;6;6;6;6","MISSENSE MUTATION;EXOME SEQUENCING;COMPOUND HETEROZYGOSITY;IVACAFTOR;MICROVESICLES;OLIGOARTHRITIS;COLONOSCOPY;COMPARATIVE GENOMIC HYBRIDIZATION;COPY-NUMBER VARIATION;DNA METHYLATION;GENE MUTATION;GERMLINE MUTATION;NIVOLUMAB;PLACENTA;AA AMYLOIDOSIS;BONE MARROW FAILURE;BRENTUXIMAB VEDOTIN;BUSULFAN;CHEMOKINE RECEPTOR;FAMILY PLANNING;FANCONI ANEMIA;FAS RECEPTOR;FRAMESHIFT MUTATION;GENETIC HETEROGENEITY;GROWTH HORMONE DEFICIENCY;MASS CYTOMETRY;PROBAND;RNA SPLICING;V600E","10;7;6;6;6;5;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3","HUMANS;FEMALE;;MALE;CHILD;CHILD, PRESCHOOL;ADOLESCENT;ADULT;INFANT;ITALY;RETROSPECTIVE STUDIES;NEUROBLASTOMA;YOUNG ADULT;MUTATION;EPILEPSY;INFANT, NEWBORN;ARTHRITIS, JUVENILE;CYSTIC FIBROSIS;MIDDLE AGED;ANIMALS","246;169;162;157;127;96;89;63;58;51;49;43;43;38;37;33;30;28;28;27","HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS AND RELATED DISORDERS;NEUROBLASTOMA RESEARCH AND TREATMENT;MOLECULAR MECHANISMS OF INFLAMMASOME ACTIVATION AND REGULATION;THERAPEUTIC ADVANCES IN CYSTIC FIBROSIS RESEARCH;GENETIC BASIS OF PRIMARY IMMUNODEFICIENCY DISORDERS;HIRSCHSPRUNG DISEASE AND ENTERIC NERVOUS SYSTEM DEVELOPMENT;GLYCOGEN METABOLISM AND MYOCLONIC DISORDERS;MITOCHONDRIAL DYNAMICS AND REACTIVE OXYGEN SPECIES REGULATION;MOLECULAR BASIS OF RETT SYNDROME AND RELATED DISORDERS;MOLECULAR MECHANISMS OF MUSCLE REGENERATION AND ATROPHY;NATURAL KILLER CELLS IN IMMUNITY;PATHOPHYSIOLOGY OF GLOMERULAR DISEASES AND NEPHROTIC SYNDROMES;GLIOMAS;NEONATAL BRAIN INJURY AND DEVELOPMENTAL CONSEQUENCES;SUPPORTING HEALTH CARE TRANSITION FROM ADOLESCENCE TO ADULTHOOD;ALLERGIC RHINITIS AND ITS IMPACT ON ASTHMA;DEVELOPMENT AND DISORDERS OF FETAL BRAIN;DIAGNOSIS AND MANAGEMENT OF ENDOMETRIOSIS;DIAGNOSIS AND MANAGEMENT OF FUNGAL INFECTIONS;EPILEPSY AND SEIZURES","27;19;13;11;9;7;6;6;6;6;6;6;5;5;5;4;4;4;4;4","SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS;JUVENILE IDIOPATHIC ARTHRITIS;NEUROBLASTOMA;TREATMENT;NEURORADIOLOGY;ETIOLOGY;REFRACTORY (PLANETARY SCIENCE);CLINICAL ENDPOINT;APLASTIC ANEMIA;BRAIN DEVELOPMENT;DIAGNOSIS;HIRSCHSPRUNG DISEASE;IMMUNE DYSREGULATION;INFLAMMATION;IVACAFTOR;NK CELL DEVELOPMENT;CFTR;COMPOUND HETEROZYGOSITY;CYSTIC FIBROSIS;CYTOPENIA","31;29;17;12;10;9;9;7;6;6;6;6;6;6;6;6;5;5;5;5","JUVENILE IDIOPATHIC;IDIOPATHIC ARTHRITIS;PEDIATRIC PATIENTS;CELL TRANSPLANTATION;CYSTIC FIBROSIS;AUTOINFLAMMATORY DISEASES;APLASTIC ANEMIA;EUROPEAN SOCIETY;ITALIAN PATIENTS;STEM CELL;BOWEL DISEASE;COHORT STUDY;DISEASE ACTIVITY;INACTIVE DISEASE;INFLAMMATORY BOWEL;KIDNEY DISEASE;NATURAL HISTORY;NEUROBLASTOMA PATIENTS;SYSTEMIC JUVENILE;ACUTE LYMPHOBLASTIC;CLINICAL PRACTICE;GROWTH HORMONE;JUVENILE DERMATOMYOSITIS;LYMPHOBLASTIC LEUKEMIA;MARROW TRANSPLANTATION;MOUSE MODEL;MULTICENTER STUDY;MUSCULAR DYSTROPHY;MYOCLONIC EPILEPSY;NEPHROTIC SYNDROME","25;24;10;9;8;7;6;6;6;6;5;5;5;5;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4","BRISTOL-MYERS SQUIBB;GRANTRESEARCH SUPPORT;NOVARTIS PFIZER;ARTICLECROSSREF GOOGLE;SPEAKERS BUREAU;PUBMED SCOPUS;AMP JOHNSON;JOHNSON AMP;DISEASE ACTIVITY;HOFFMANN-LA ROCHE;SQUIBB JOHNSON;ABBVIE BRISTOL-MYERS;ANGELINI ABBVIE;JOHNSON NOVARTIS;PFIZER RECKITT;RECKITT BENKISER;ROCHE JANSSEN;CROSSREF PUBMED;IDIOPATHIC ARTHRITIS;JUVENILE IDIOPATHIC;BIOGEN BOEHRINGER;EMD SERONO;GASLINI HOSPITAL;ABBVIE ASTRAZENECA-MEDIMMUNE;ABLYNX ABBVIE;ASTRAZENECA-MEDIMMUNE BIOGEN;BOEHRINGER BRISTOL-MYERS;BUREAUS LT;ELI-LILLY EMD;GLAXOSMITHKLINE HOFFMANN-LA","121;105;103;70;61;60;49;49;48;48;46;45;45;45;45;45;45;44;41;41;37;37;36;30;30;30;30;30;30;30",203,0.49,9.47,9.5,1,1,0,2,1.25,1,1,11,2,1,9.75,0,2,2,3,7,4,0,0,57.5,57.5,1,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,4,0.3,4,0,1,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"GATTORNO MARCO;KONE-PAUT ISABELLE;PIRAM MARYAM;RUPERTO NICOLINO","1;1;1;1","ASSISTANCE PUBLIQUE HOPITAUX DE PARIS APHP;ISTITUTO GIANNINA GASLINI;ST G GASLINI;UNIVERSITE PARIS SUD PARIS 11","1;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES","2;1","CHRONIC PAIN;CLINICAL RESEARCH;PAIN RESEARCH","1;1;1",NA,NA,"G16H50/20","1","G16H50/20","1",16,6.13,261,3.6,8,0.5,49,1,0,2,0,9,0,0,3,1,11,4,0,0,0,0,0,0,16,0,0,14,1,1,0,0,0,0,0,0,0,"United States;Italy;France;Germany","5;2;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;31 BIOLOGICAL SCIENCES;3105 GENETICS;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3212 OPHTHALMOLOGY AND OPTOMETRY;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;3213 PAEDIATRICS;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY","15;5;5;2;2;2;2;2;2;1;1;1","CLINICAL RESEARCH;RARE DISEASES;PEDIATRIC;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;CANCER;HEMATOLOGY;PATIENT SAFETY;ARTHRITIS;AUTOIMMUNE DISEASE;LUNG;NEUROSCIENCES;RHEUMATOID ARTHRITIS;CHRONIC PAIN;CYSTIC FIBROSIS;EYE DISEASE AND DISORDERS OF VISION;GENETICS;NEUROBLASTOMA;ORPHAN DRUG;PAIN RESEARCH;PREVENTION","14;13;12;9;5;5;5;4;4;3;3;3;2;2;2;2;2;2;2;2","INFLAMMATORY AND IMMUNE SYSTEM;CANCER;CONGENITAL;METABOLIC AND ENDOCRINE;REPRODUCTIVE HEALTH AND CHILDBIRTH;RESPIRATORY","4;2;2;1;1;1","6.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;5.2 CELLULAR AND GENE THERAPIES;6.5 RADIOTHERAPY AND OTHER NON-INVASIVE THERAPIES","13;3;1;1;1","LEUKEMIA / LEUKAEMIA;NEUROBLASTOMA;NON-HODGKIN'S LYMPHOMA","2;2;2","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES;5.5 COMBINATIONS OF LOCALIZED AND SYSTEMIC THERAPIES","3;3;1",1,3999873,307682.54,5,13,9,1,7,374749.90083456,1.10740522966331,"DANISH CANCER SOCIETY;EUROPEAN SOCIETY FOR PAEDIATRIC ONCOLOGY;ISTITUTO GIANNINA GASLINI;KU LEUVEN;LUND UNIVERSITY;NETHERLANDS INSTITUTE FOR HEALTH SERVICES RESEARCH;NEWCASTLE UNIVERSITY;PINTAIL (IRELAND);PRINCESS MÁXIMA CENTER;RADBOUD UNIVERSITY NIJMEGEN;RADBOUD UNIVERSITY NIJMEGEN MEDICAL CENTRE;ST. ANNE´S UNIVERSITY HOSPITAL;UNIVERSITY OF LUCERNE","1;1;1;1;1;1;1;1;1;1;1;1;1","EUROPEAN COMMISSION","1","COALITION S;EC & ERC - EUROPEAN UNION","1;1","H2020-EU.3.1. - SOCIETAL CHALLENGES - HEALTH, DEMOGRAPHIC CHANGE AND WELL-BEING (PROGRAMME);RIA - RESEARCH AND INNOVATION ACTION (FUNDING SCHEME)","1;1","42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;4205 NURSING","1;1;1","CANCER;CLINICAL RESEARCH;COMPARATIVE EFFECTIVENESS RESEARCH;HEALTH SERVICES;PEDIATRIC;PREVENTION","1;1;1;1;1;1","CANCER","1","7.1 INDIVIDUAL CARE NEEDS;7.3 MANAGEMENT AND DECISION MAKING","1;1","LEUKEMIA / LEUKAEMIA;NON-HODGKIN'S LYMPHOMA;NOT SITE-SPECIFIC CANCER","1;1;1","6.1 PATIENT CARE AND SURVIVORSHIP ISSUES;6.4 COST ANALYSES AND HEALTH CARE DELIVERY","1;1","A02 PUBLIC HEALTH, HEALTH SERVICES AND PRIMARY CARE","1","3 GOOD HEALTH AND WELL BEING","1",35,"FRONTIERS;PUBLIC LIBRARY OF SCIENCE;SPRINGER NATURE;ZENODO;AMERICAN CHEMICAL SOCIETY;ORDA - THE UNIVERSITY OF SHEFFIELD RESEARCH DATA CATALOGUE AND REPOSITORY","24;4;3;2;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;3105 GENETICS;3204 IMMUNOLOGY;3211 ONCOLOGY AND CARCINOGENESIS;40 ENGINEERING;4003 BIOMEDICAL ENGINEERING;49 MATHEMATICAL SCIENCES;3101 BIOCHEMISTRY AND CELL BIOLOGY;3208 MEDICAL PHYSIOLOGY;3213 PAEDIATRICS;34 CHEMICAL SCIENCES;3404 MEDICINAL AND BIOMOLECULAR CHEMISTRY;42 HEALTH SCIENCES;4201 ALLIED HEALTH AND REHABILITATION SCIENCE;4207 SPORTS SCIENCE AND EXERCISE;46 INFORMATION AND COMPUTING SCIENCES;4904 PURE MATHEMATICS","40;25;11;9;9;5;5;3;2;2;2;2;2;2;1;1;1;1","GENETICS;CANCER;IMMUNIZATION;RARE DISEASES;VACCINE RELATED;PEDIATRIC;CLINICAL RESEARCH;INFECTIOUS DISEASES;NEUROSCIENCES;CHARCOT-MARIE-TOOTH DISEASE;CONGENITAL STRUCTURAL ANOMALIES;NEURODEGENERATIVE;PERIPHERAL NEUROPATHY;STEM CELL RESEARCH;STEM CELL RESEARCH - NONEMBRYONIC - NON-HUMAN;BIOTECHNOLOGY;DIGESTIVE DISEASES;GENE THERAPY;HEMATOLOGY;ARTHRITIS","12;11;9;9;9;8;7;7;7;6;6;6;6;5;5;2;2;2;2;1","CANCER;INFLAMMATORY AND IMMUNE SYSTEM;NEUROLOGICAL;MUSCULOSKELETAL;INFECTION;ORAL AND GASTROINTESTINAL;REPRODUCTIVE HEALTH AND CHILDBIRTH","9;7;7;5;2;1;1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;5.1 PHARMACEUTICALS;5.2 CELLULAR AND GENE THERAPIES","17;9;7","BIOMEDICAL;CLINICAL","25;1","BASIC SCIENCE;CLINICAL MEDICINE AND SCIENCE;PUBLIC HEALTH","19;10;1","LEUKEMIA / LEUKAEMIA;NOT SITE-SPECIFIC CANCER;NON-HODGKIN'S LYMPHOMA;COLON AND RECTAL CANCER;LIVER CANCER","9;8;7;1;1",NA,NA
"IRCCS_GASLINI",2020,519,16.6531791907514,2.93063583815029,0.269749518304432,0.275529865125241,0.325626204238921,2.77049180327869,1.4,2.04285714285714,1.56481481481481,0.651252408477842,3,252,110,45,33,0.49,0.21,0.09,0.06,21.34,0.846761932370273,6.23363688104725,0.435452793834297,0.973025048169557,0.548,0.458,0.442,0.445,"MARIASAVINA SEVERINO;PASQUALE STRIANO;ANGELO RAVELLI;NICOLINO RUPERTO;SIMONE FERRERO;GIORGIO CIPRANDI;ELIO CASTAGNOLA;LUCA A. RAMENGHI;GIAN LUIGI MARSEGLIA;MARCO GATTORNO;CAROLINA SCALA;MAJA DI ROCCO;FABIO BARRA;DOMENICO TORTORA;EUGENIO MERCURI;LINO NOBILI;ANDREA ROSSI;CLAUDIO BRUNO;HERMINE I. BRUNNER;VALERIA CAPRA","31;24;22;22;20;20;18;18;18;18;18;16;16;15;15;15;14;14;13;13","SIMONE FERRERO;GIORGIO CIPRANDI;CAROLINA SCALA;CARLO CASTELLANI;FABIO BARRA;ANGELO RAVELLI;MARIASAVINA SEVERINO;GIAN LUIGI MARSEGLIA;CARLO BELLINI;ELIO CASTAGNOLA;AMELIA LICARI;LUCA A. RAMENGHI;GIROLAMO MATTIOLI;PASQUALE STRIANO;MARZIA OGNIBENE;ANNALISA PEZZOLO;VALERIO GAETANO VELLONE;LINO NOBILI;MAJA DI ROCCO;MARIA ANGELA TOSCA","3.81;3.37;3.31;3.03;2.94;2.51;2.39;2.11;2.09;1.94;1.85;1.82;1.63;1.62;1.6;1.6;1.41;1.38;1.36;1.35","MARIASAVINA SEVERINO;PASQUALE STRIANO;ANGELO RAVELLI;NICOLINO RUPERTO;ELIO CASTAGNOLA;LUCA A. RAMENGHI;GIAN LUIGI MARSEGLIA;MARCO GATTORNO;CAROLINA SCALA;MAJA DI ROCCO;DOMENICO TORTORA;LINO NOBILI;ANDREA ROSSI;CLAUDIO BRUNO;VALERIA CAPRA;GIOVANNI MORANA;MAURA FARACI;CARLO DUFOUR;MOHAMAD MAGHNIE;GIROLAMO MATTIOLI","31;24;22;22;18;18;18;18;18;16;15;15;14;14;13;13;13;13;12;12","CAROLINA SCALA;CARLO CASTELLANI;ANGELO RAVELLI;MARIASAVINA SEVERINO;GIAN LUIGI MARSEGLIA;CARLO BELLINI;ELIO CASTAGNOLA;LUCA A. RAMENGHI;GIROLAMO MATTIOLI;PASQUALE STRIANO;MARZIA OGNIBENE;ANNALISA PEZZOLO;LINO NOBILI;MAJA DI ROCCO;MARIA ANGELA TOSCA;GIAN MARCO GHIGGERI;NICOLINO RUPERTO;MARIA ANGELA TOSCA;DOMENICO TORTORA;MASSIMILIANO SERAFINO","3.31;3.03;2.51;2.39;2.11;2.09;1.94;1.82;1.63;1.62;1.6;1.6;1.38;1.36;1.35;1.26;1.23;1.15;1.12;1.12","MARCO GATTORNO;GANNA BALAGURA;FABIAN HAUCK;STEFANO VOLPI;ROLAND KRAUSE;MARKUS G. SEIDEL;AMY BROWER;ANA RATH;AVI Z. ROSENBERG;CHRIS MUNGALL;CHRISTINA RAPP;CHRISTOPH KLEIN;CHRISTOPHER G. CHUTE;DAMIAN SMEDLEY;DANIEL DANIŠ;DAVID LAGORCE;DAVID LEWIS‐SMITH;GARETH BAYNAM;GERHARD KINDLE;HUGH KEARNEY","1088;946;942;927;920;901;866;866;866;866;866;866;866;866;866;866;866;866;866;866","MARCO GATTORNO;GANNA BALAGURA;STEFANO VOLPI;ANGELO RAVELLI;MARIASAVINA SEVERINO;PASQUALE STRIANO;LINO NOBILI;CLAUDIO BRUNO;NICOLINO RUPERTO;GIULIA TUO;ELIO CASTAGNOLA;GIULIA BORDIN;DOMENICO TORTORA;NICOLA DISMA;D. PALADINI;FRANCESCA MANUNZA;MARIA ANGELA TOSCA;MARIA MARGHERITA MANCARDI;ANDRIUS MACAS;CHRISTIAN BRESCHAN","1088;931;914;764;620;544;423;422;420;371;369;306;288;262;247;235;222;210;209;209","MARIASAVINA SEVERINO;NICOLINO RUPERTO;PASQUALE STRIANO;CAROLINA SCALA;ANGELO RAVELLI;MARIA ANGELA TOSCA;ELIO CASTAGNOLA;LUCA A. RAMENGHI;MARCO GATTORNO;MAJA DI ROCCO;CLAUDIO BRUNO;LINO NOBILI;CARLO DUFOUR;DOMENICO TORTORA;ANDREA ROSSI;ENRICO VERRINA;GIAN MARCO GHIGGERI;MAURA FARACI;MOHAMAD MAGHNIE;VALERIA CAPRA","29;22;20;18;18;18;17;17;17;16;15;14;13;13;12;12;12;12;12;12","MEDICINE;BIOLOGY;CHEMISTRY;PSYCHOLOGY;PHYSICS;COMPUTER SCIENCE;MATHEMATICS;POLITICAL SCIENCE;ENGINEERING;SOCIOLOGY;ECONOMICS;MATERIALS SCIENCE;PHILOSOPHY;HISTORY;BUSINESS;GEOGRAPHY","479;212;41;35;34;32;24;18;15;11;7;7;7;5;2;2","INTERNAL MEDICINE;GENETICS;PEDIATRICS;SURGERY;PATHOLOGY;IMMUNOLOGY;PSYCHIATRY;BIOCHEMISTRY;INTENSIVE CARE MEDICINE;RADIOLOGY;ENVIRONMENTAL HEALTH;ONCOLOGY;CANCER RESEARCH;GASTROENTEROLOGY;CELL BIOLOGY;NEUROSCIENCE;ENDOCRINOLOGY;VIROLOGY;PHYSICAL THERAPY;BIOINFORMATICS","323;161;123;120;110;82;64;55;52;52;45;41;38;38;34;32;30;29;26;25","DISEASE;GENE;POPULATION;COHORT;EPILEPSY;CANCER;PREGNANCY;MAGNETIC RESONANCE IMAGING;TRANSPLANTATION;CHEMOTHERAPY;OUTBREAK;IMMUNE SYSTEM;ADVERSE EFFECT;RANDOMIZED CONTROLLED TRIAL;RETROSPECTIVE COHORT STUDY;CELL CULTURE;NEUROLOGY;PROSPECTIVE COHORT STUDY;IN VITRO;ALTERNATIVE MEDICINE;ANTIBODY;ARTHRITIS;BONE MARROW;CYSTIC FIBROSIS","130;97;43;36;31;30;29;28;28;26;26;24;23;23;23;21;20;20;19;18;18;18;18;18","INFECTIOUS DISEASE (MEDICAL SPECIALTY);PHENOTYPE;MUTATION;2019-20 CORONAVIRUS OUTBREAK;HEMATOPOIETIC STEM CELL TRANSPLANTATION;NEUROBLASTOMA;CLINICAL ENDPOINT;GENOTYPE;NEURORADIOLOGY;FETUS;CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR;PLACEBO;SPINAL MUSCULAR ATROPHY;HAEMATOPOIESIS;RITUXIMAB;T CELL;CUMULATIVE INCIDENCE;GENE EXPRESSION;GESTATIONAL AGE;IMMUNOTHERAPY","41;28;27;23;20;18;13;13;12;11;10;10;10;9;9;9;8;8;8;8","CORONAVIRUS DISEASE 2019 (COVID-19);MISSENSE MUTATION;EXOME SEQUENCING;PRENATAL DIAGNOSIS;CANAKINUMAB;COMPOUND HETEROZYGOSITY;INTERLEUKIN 21;SINGLE-NUCLEOTIDE POLYMORPHISM;BONE MARROW FAILURE;BUSULFAN;INTRAVENTRICULAR HEMORRHAGE;NIVOLUMAB;SANGER SEQUENCING;ALLERGEN IMMUNOTHERAPY;COLONOSCOPY;FANCONI ANEMIA;GLOBAL DEVELOPMENTAL DELAY;HAPLOINSUFFICIENCY;INTERLEUKIN 12;IVACAFTOR;MEMBRANOUS NEPHROPATHY;OTOTOXICITY;PHARMACOGENETICS;PROBAND;RESPONSE EVALUATION CRITERIA IN SOLID TUMORS;STEREOELECTROENCEPHALOGRAPHY","41;12;7;6;5;5;5;5;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3",";HUMANS;FEMALE;MALE;CHILD;ADOLESCENT;CHILD, PRESCHOOL;ITALY;ADULT;RETROSPECTIVE STUDIES;INFANT;COVID-19;CORONAVIRUS INFECTIONS;NEUROBLASTOMA;PNEUMONIA, VIRAL;YOUNG ADULT;ARTHRITIS, JUVENILE;MUTATION;INFANT, NEWBORN;BRAIN","271;246;146;138;134;86;85;60;55;53;52;38;37;37;37;36;34;32;30;29","HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS AND RELATED DISORDERS;NEUROBLASTOMA RESEARCH AND TREATMENT;THERAPEUTIC ADVANCES IN CYSTIC FIBROSIS RESEARCH;DIAGNOSIS AND MANAGEMENT OF ENDOMETRIOSIS;GENE THERAPY FOR SPINAL MUSCULAR ATROPHY;HEMATOPOIETIC STEM CELL BIOLOGY;ASTHMA;EPILEPSY AND SEIZURES;GLIOMAS;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;PATHOPHYSIOLOGY OF GLOMERULAR DISEASES AND NEPHROTIC SYNDROMES;DEVELOPMENT AND DISORDERS OF FETAL BRAIN;EPIDEMIOLOGY AND MANAGEMENT OF CONGENITAL HEART DISEASE;NEONATAL LUNG DEVELOPMENT AND RESPIRATORY MORBIDITY;MOLECULAR BASIS OF RETT SYNDROME AND RELATED DISORDERS;NATURAL KILLER CELLS IN IMMUNITY;NEUROFIBROMATOSIS TYPE 1 AND TYPE 2;PEDIATRIC CANCER AND QUALITY OF LIFE;ALLERGIC RHINITIS AND ITS IMPACT ON ASTHMA;DIAGNOSIS AND MANAGEMENT OF KAWASAKI DISEASE","23;19;19;17;12;11;9;9;9;9;9;8;7;7;6;6;6;6;5;5","PANDEMIC;2019-20 CORONAVIRUS OUTBREAK;SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS;JUVENILE IDIOPATHIC ARTHRITIS;NEUROBLASTOMA;CLINICAL ENDPOINT;NEURORADIOLOGY;TREATMENT;EPILEPSY;PRENATAL DIAGNOSIS;ASTHMA;HEMATOPOIETIC CELL TRANSPLANTATION;SPINAL MUSCULAR ATROPHY;CFTR;CYSTIC FIBROSIS;CUMULATIVE INCIDENCE;REGIMEN;DIAGNOSIS;FETAL MRI;POTENTIATOR","27;23;20;19;18;14;12;12;11;11;10;10;10;9;9;8;8;7;7;7","IDIOPATHIC ARTHRITIS;JUVENILE IDIOPATHIC;STEM CELL;CELL TRANSPLANTATION;PEDIATRIC PATIENTS;CYSTIC FIBROSIS;HEMATOPOIETIC STEM;COVID- PANDEMIC;MUSCULAR ATROPHY;SPINAL MUSCULAR;RETROSPECTIVE STUDY;DE NOVO;DISEASE ACTIVITY;FIBRODYSPLASIA OSSIFICANS;MAGNETIC RESONANCE;MARROW TRANSPLANTATION;NEUROFIBROMATOSIS TYPE;OSSIFICANS PROGRESSIVA;EMERGENCY DEPARTMENT;EUROPEAN SOCIETY;ITALIAN ASSOCIATION;LUPUS ERYTHEMATOSUS;MULTICENTER STUDY;NATURAL HISTORY;PAEDIATRIC PATIENTS;RANDOMIZED CONTROLLED;RECTOSIGMOID ENDOMETRIOSIS;SEVERE APLASTIC;SYSTEMIC LUPUS;ACUTE LEUKEMIA","19;19;14;12;12;10;10;9;8;8;7;6;6;6;6;6;6;6;5;5;5;5;5;5;5;5;5;5;5;4","SPEAKERS BUREAU;PUBMED SCOPUS;CYSTIC FIBROSIS;ADVISORY COMMITTEES;ENTITYS BOARD;NOVARTIS PFIZER;BONE MARROW;BRISTOL-MYERS SQUIBB;DISEASE ACTIVITY;CROSSREF PUBMED;RISK FACTORS;MEDIAN AGE;RESEARCH FUNDING;COVID- PANDEMIC;NK CELLS;INTENSIVE CARE;PATHOGENIC VARIANTS;CLINICAL PRACTICE;CYST FIBROS;GRANTRESEARCH SUPPORT;LOGISTIC REGRESSION;EMD SERONO;EPUB AHEAD;HOFFMANN-LA ROCHE;PEDIATRIC PATIENTS;PRINT DOI;RECTOSIGMOID ENDOMETRIOSIS;ELI LILY;PROSPECTIVE STUDY;STEM CELL","57;56;48;33;33;28;27;27;27;26;24;22;22;21;21;20;20;18;18;18;18;17;17;17;17;17;17;16;16;16",291,0.56,9.5,9,1.25,1,0,3.75,1.5,1,1,10,1,1,8.5,1,1,2,3,7,4,0,0,49.5,49.5,5,0,5,0,2,1,0,0,0,0,0,0,7,1,0,1.5,9.125,4.8,2.75,0,7,3,0,2,2,0,0,4,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"BANDIERA TIZIANO;BERTOZZI FABIO;CACI EMANUELA;FERRERA LORETTA;PEDEMONTE NICOLETTA;SORANA FEDERICO;DI FRUSCIA PAOLO;GALIETTA LUIS JUAN VICENTE;BERTI FRANCESCO;RODRIGUEZ GIMENO ALEJANDRA","8;8;8;8;8;8;6;5;4;4","FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA;ISTITUTO GIANNINA GASLINI;FONDAZIONE PER LA RICERCA SULLA FIBROSI CISTICA - ONLUS;FONDAZIONE PER LA RICERCA SULLA FIBROSI CISTICA ONLUS;FONDAZIONE PER LA RICERCA SULLA FIBROSI CISTICA-ON-LUS","8;7;3;2;2","34 CHEMICAL SCIENCES;3404 MEDICINAL AND BIOMOLECULAR CHEMISTRY;3402 INORGANIC CHEMISTRY","16;6;2","CYSTIC FIBROSIS;LUNG;RARE DISEASES;BRAIN DISORDERS","6;6;6;4","5.1 PHARMACEUTICALS","6","C07D405/12;C07D471/04;A61P11/00;C07D405/14;C07D413/12;C07D498/04;C07D413/14;A61P3/00;C07D231/16;C07D409/12","6;6;4;4;4;4;3;2;2;2","A61P11/00;C07D471/04;C07D405/12;C07D405/14;C07D498/04;A61P3/00;C07D413/12;C07D471/18;C07D413/14;C07D519/00","8;7;6;6;6;5;5;5;4;4",14,3.08,1415.15,2.71,3,0.21,39.71,1,0,3,0,1,0,0,9,0,5,8,0,0,0,0,0,0,13,0,1,13,1,0,0,0,0,0,0,0,0,"United States;Netherlands;Switzerland;France;Italy;United Kingdom;Germany;Japan;Austria;Belgium;Canada;Czechia;Denmark;Poland;Spain;Sweden","8;5;5;4;4;3;2;2;1;1;1;1;1;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;30 AGRICULTURAL, VETERINARY AND FOOD SCIENCES;3009 VETERINARY SCIENCES;31 BIOLOGICAL SCIENCES;3105 GENETICS;3206 MEDICAL BIOTECHNOLOGY;3211 ONCOLOGY AND CARCINOGENESIS;3213 PAEDIATRICS","14;7;2;1;1;1;1;1;1;1","CLINICAL RESEARCH;PEDIATRIC;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;LUNG;RARE DISEASES;CANCER;EMERGING INFECTIOUS DISEASES;GENETICS;HEMATOLOGY;INFECTIOUS DISEASES;PATIENT SAFETY;PERINATAL PERIOD - CONDITIONS ORIGINATING IN PERINATAL PERIOD;PREVENTION;ACUTE RESPIRATORY DISTRESS SYNDROME;BIOTECHNOLOGY;BRAIN DISORDERS;CARDIOVASCULAR;DRUG ABUSE (NIDA ONLY);GENE THERAPY;HEALTH SERVICES","12;8;6;4;4;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1","INFECTION;BLOOD;CANCER;REPRODUCTIVE HEALTH AND CHILDBIRTH","2;1;1;1","6.1 PHARMACEUTICALS;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;5.2 CELLULAR AND GENE THERAPIES;6.2 CELLULAR AND GENE THERAPIES","4;1;1;1","BONE CANCER, OSTEOSARCOMA / MALIGNANT FIBROUS HISTIOCYTOMA;LEUKEMIA / LEUKAEMIA;NEUROBLASTOMA;NON-HODGKIN'S LYMPHOMA;NOT SITE-SPECIFIC CANCER;SARCOMA","1;1;1;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","3",3,122986,35887.33,2.66666666666667,3.66666666666667,3.66666666666667,0.333333333333333,6,322710.982439782,1.60825019364454,"ISTITUTO GIANNINA GASLINI;ARISTOTLE UNIVERSITY OF THESSALONIKI;CHILDREN'S MEMORIAL HEALTH INSTITUTE;GENERAL UNIVERSITY HOSPITAL IN PRAGUE;HOSPITAL OF LITHUANIAN UNIVERSITY OF HEALTH SCIENCES KAUNAS CLINICS;LJUBLJANA UNIVERSITY MEDICAL CENTRE;UNIVERSITY MEDICAL CENTER FREIBURG;UNIVERSITY MEDICAL CENTER UTRECHT;UNIVERSITY OF LATVIA","3;1;1;1;1;1;1;1;1","EUROPEAN COMMISSION;ITALIAN ASSOCIATION FOR CANCER RESEARCH;TELETHON FOUNDATION","1;1;1","COALITION S;EC & ERC - EUROPEAN UNION;ICRP - INTERNATIONAL CANCER RESEARCH PARTNERSHIP","1;1;1","3RD HEALTH PROGRAMME (PROGRAMME)","1","32 BIOMEDICAL AND CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;3208 MEDICAL PHYSIOLOGY;3211 ONCOLOGY AND CARCINOGENESIS;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS","3;1;1;1;1;1","GENETICS;NEUROSCIENCES;RARE DISEASES;BIOENGINEERING;BIOTECHNOLOGY;BRAIN DISORDERS;CANCER;CLINICAL RESEARCH;GENE THERAPY;NANOTECHNOLOGY;NEUROBLASTOMA;NEURODEGENERATIVE;ORPHAN DRUG;PEDIATRIC;PEDIATRIC CANCER;PEDIATRIC RESEARCH INITIATIVE","2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1","CANCER;NEUROLOGICAL","1;1","1.1 NORMAL BIOLOGICAL DEVELOPMENT AND FUNCTIONING;5.1 PHARMACEUTICALS;5.2 CELLULAR AND GENE THERAPIES","1;1;1","NEUROBLASTOMA","1","5.3 SYSTEMIC THERAPIES - DISCOVERY AND DEVELOPMENT","1","A01 CLINICAL MEDICINE;A03 ALLIED HEALTH PROFESSIONS, DENTISTRY, NURSING AND PHARMACY","2;1",NA,NA,29,"PUBLIC LIBRARY OF SCIENCE;FRONTIERS;SPRINGER NATURE;AMERICAN ASSOCIATION FOR CANCER RESEARCH;AMERICAN CHEMICAL SOCIETY;ORDA - THE UNIVERSITY OF SHEFFIELD RESEARCH DATA CATALOGUE AND REPOSITORY;THE UNIVERSITY OF SHEFFIELD","13;8;4;1;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;42 HEALTH SCIENCES;3105 GENETICS;3202 CLINICAL SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;4201 ALLIED HEALTH AND REHABILITATION SCIENCE;49 MATHEMATICAL SCIENCES;30 AGRICULTURAL, VETERINARY AND FOOD SCIENCES;3101 BIOCHEMISTRY AND CELL BIOLOGY;3204 IMMUNOLOGY;4203 HEALTH SERVICES AND SYSTEMS;4207 SPORTS SCIENCE AND EXERCISE;3009 VETERINARY SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3215 REPRODUCTIVE MEDICINE;41 ENVIRONMENTAL SCIENCES;4102 ECOLOGICAL APPLICATIONS;4202 EPIDEMIOLOGY;4205 NURSING","26;14;11;6;5;4;4;3;2;2;2;2;2;1;1;1;1;1;1;1","PEDIATRIC;GENETICS;BRAIN DISORDERS;CLINICAL RESEARCH;RARE DISEASES;INTELLECTUAL AND DEVELOPMENTAL DISABILITIES (IDD);NEUROSCIENCES;BIOENGINEERING;CANCER;CARDIOVASCULAR;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;DUCHENNE/ BECKER MUSCULAR DYSTROPHY;GENETIC TESTING;HEART DISEASE;MUSCULAR DYSTROPHY;ARTHRITIS;AUTISM;LUNG;MENTAL HEALTH;PREVENTION","13;8;7;7;7;5;4;3;3;3;3;3;3;3;3;2;2;2;2;2","CANCER;NEUROLOGICAL;CARDIOVASCULAR;CONGENITAL;EYE;GENERIC HEALTH RELEVANCE;INFLAMMATORY AND IMMUNE SYSTEM;RENAL AND UROGENITAL","2;2;1;1;1;1;1;1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;5.1 PHARMACEUTICALS;6.1 PHARMACEUTICALS","4;2;2;2","BIOMEDICAL;CLINICAL;HEALTH SERVICES & SYSTEMS","4;4;1","CLINICAL MEDICINE AND SCIENCE;BASIC SCIENCE;HEALTH SERVICES RESEARCH","11;4;1","BRAIN TUMOR;HODGKIN'S DISEASE;LEUKEMIA / LEUKAEMIA;LUNG CANCER;NEUROBLASTOMA;NON-HODGKIN'S LYMPHOMA","2;1;1;1;1;1","3 GOOD HEALTH AND WELL BEING","2"
"IRCCS_GASLINI",2021,532,17.6184210526316,3.3984962406015,0.31203007518797,0.280075187969925,0.347744360902256,2.98842975206612,1.56603773584906,1.83950617283951,1.46825396825397,0.712406015037594,1,236,135,45,31,0.44,0.25,0.08,0.06,14.09,0.91372084862749,6.40730408318538,0.460526315789474,0.983082706766917,0.557,0.439,0.482,0.482,"PASQUALE STRIANO;FEDERICO ZARA;GIAN MARCO GHIGGERI;LINO NOBILI;ANGELO RAVELLI;ISABELLA CECCHERINI;MARCO GATTORNO;GIORGIO CIPRANDI;CLAUDIO BRUNO;ELIO CASTAGNOLA;DOMENICO TORTORA;MARIASAVINA SEVERINO;ROBERTA CAORSI;ENRICO BERTINI;ANDREA PETRETTO;ANDREA ANGELETTI;MOHAMAD MAGHNIE;LUCA A. RAMENGHI;NICOLINO RUPERTO;MARCELLO SCALA","48;29;28;25;24;23;21;20;20;18;18;18;16;16;16;15;15;15;15;14","GIORGIO CIPRANDI;PASQUALE STRIANO;GIAN MARCO GHIGGERI;MARIA ANGELA TOSCA;LINO NOBILI;ANGELO RAVELLI;IRENE SCHIAVETTI;ELIO CASTAGNOLA;FEDERICO ZARA;MARIA ANGELA TOSCA;ANDREA ANGELETTI;MARCO GATTORNO;ISABELLA CECCHERINI;LUCA A. RAMENGHI;FILIPPO M. SÉNÈS;DOMENICO TORTORA;ANDREA PETRETTO;GIAN LUIGI MARSEGLIA;CARLO BELLINI;AMELIA LICARI","4.56;3.86;2.4;2.24;2.17;2.12;1.94;1.91;1.82;1.8;1.75;1.74;1.7;1.53;1.46;1.45;1.43;1.41;1.33;1.29","PASQUALE STRIANO;FEDERICO ZARA;GIAN MARCO GHIGGERI;LINO NOBILI;ANGELO RAVELLI;ISABELLA CECCHERINI;MARCO GATTORNO;CLAUDIO BRUNO;ELIO CASTAGNOLA;DOMENICO TORTORA;MARIASAVINA SEVERINO;ROBERTA CAORSI;ANDREA PETRETTO;ANDREA ANGELETTI;MOHAMAD MAGHNIE;LUCA A. RAMENGHI;NICOLINO RUPERTO;MARCELLO SCALA;MARIA MARGHERITA MANCARDI;ENRICO VERRINA","48;29;28;25;24;23;21;20;18;18;18;16;16;15;15;15;15;14;13;13","PASQUALE STRIANO;GIAN MARCO GHIGGERI;MARIA ANGELA TOSCA;LINO NOBILI;ANGELO RAVELLI;ELIO CASTAGNOLA;FEDERICO ZARA;MARIA ANGELA TOSCA;ANDREA ANGELETTI;MARCO GATTORNO;ISABELLA CECCHERINI;LUCA A. RAMENGHI;FILIPPO M. SÉNÈS;DOMENICO TORTORA;ANDREA PETRETTO;CARLO BELLINI;ROBERTA CAORSI;ENRICO VERRINA;FRANCESCA LUGANI;MARIA GRAZIA CALEVO","3.86;2.4;2.24;2.17;2.12;1.91;1.82;1.8;1.75;1.74;1.7;1.53;1.46;1.45;1.43;1.33;1.25;1.23;1.22;1.22","PASQUALE STRIANO;FEDERICO ZARA;CLAUDIO BRUNO;GIAN MARCO GHIGGERI;FRANCIS VEYCKEMANS;NICOLA DISMA;ANGELO RAVELLI;ELIO CASTAGNOLA;FRANCO LOCATELLI;ROBERTA CAORSI;ARASH AFSHARI;MERJA KOKKI;TOM G. HANSEN;RENZO GUERRINI;MARIASAVINA SEVERINO;BASIL T. DARRAS;LINO NOBILI;ENRICO BERTINI;CONCETTA MICALIZZI;DOMENICO TORTORA","946;614;547;490;447;403;383;358;356;350;331;311;311;310;305;294;294;292;290;288","PASQUALE STRIANO;CLAUDIO BRUNO;FEDERICO ZARA;GIAN MARCO GHIGGERI;NICOLA DISMA;ANGELO RAVELLI;ELIO CASTAGNOLA;ROBERTA CAORSI;MARIASAVINA SEVERINO;DOMENICO TORTORA;CONCETTA MICALIZZI;LINO NOBILI;MARCO GATTORNO;ISABELLA CECCHERINI;ALESSANDRO CONSOLARO;RICCARDO HAUPT;NICOLINO RUPERTO;ANDREA PETRETTO;D. PALADINI;MARIA LUISA GARRÈ","843;547;543;490;396;377;358;344;305;288;284;277;266;242;240;236;225;206;200;190","PASQUALE STRIANO;FEDERICO ZARA;GIAN MARCO GHIGGERI;CLAUDIO BRUNO;ANGELO RAVELLI;LINO NOBILI;ISABELLA CECCHERINI;MARCO GATTORNO;MARIASAVINA SEVERINO;DOMENICO TORTORA;ELIO CASTAGNOLA;MARIA ANGELA TOSCA;ANDREA PETRETTO;ROBERTA CAORSI;NICOLINO RUPERTO;MOHAMAD MAGHNIE;ANDREA ANGELETTI;LUCA A. RAMENGHI;MARCELLO SCALA;ENRICO VERRINA","44;27;26;24;23;22;20;19;19;18;18;16;16;15;15;15;14;13;13;12","MEDICINE;BIOLOGY;PSYCHOLOGY;CHEMISTRY;COMPUTER SCIENCE;PHYSICS;MATHEMATICS;ENGINEERING;POLITICAL SCIENCE;SOCIOLOGY;ECONOMICS;BUSINESS;PHILOSOPHY;MATERIALS SCIENCE;HISTORY;ART;GEOGRAPHY;GEOLOGY","477;228;52;47;47;40;26;15;14;14;11;10;8;6;2;1;1;1","INTERNAL MEDICINE;GENETICS;PEDIATRICS;PATHOLOGY;SURGERY;IMMUNOLOGY;PSYCHIATRY;BIOCHEMISTRY;INTENSIVE CARE MEDICINE;CANCER RESEARCH;CELL BIOLOGY;ENVIRONMENTAL HEALTH;NEUROSCIENCE;RADIOLOGY;ENDOCRINOLOGY;GASTROENTEROLOGY;BIOINFORMATICS;ANESTHESIA;PHYSICAL THERAPY;ONCOLOGY","325;169;162;116;103;88;74;60;58;40;34;34;34;33;32;31;28;27;26;25","GENE;DISEASE;EPILEPSY;COHORT;POPULATION;CANCER;CHEMOTHERAPY;TRANSPLANTATION;RETROSPECTIVE COHORT STUDY;ARTHRITIS;IMMUNE SYSTEM;PREGNANCY;ALTERNATIVE MEDICINE;ANTIBODY;CYSTIC FIBROSIS;INCIDENCE (GEOMETRY);KIDNEY;ASTHMA;MAGNETIC RESONANCE IMAGING;RECEPTOR","129;116;45;44;32;30;30;27;25;24;23;23;20;20;20;20;19;17;17;17","PHENOTYPE;MUTATION;INFECTIOUS DISEASE (MEDICAL SPECIALTY);GENOTYPE;NEUROBLASTOMA;GENE EXPRESSION;HEMATOPOIETIC STEM CELL TRANSPLANTATION;RITUXIMAB;CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR;2019-20 CORONAVIRUS OUTBREAK;FETUS;ALLELE;CYCLOPHOSPHAMIDE;EXON;INFLAMMATORY BOWEL DISEASE;MICRORNA;SPINAL MUSCULAR ATROPHY;ANAKINRA;CHROMOSOME;PROTEINURIA","51;34;31;13;13;12;12;12;11;10;10;9;9;9;9;9;9;8;8;8","CORONAVIRUS DISEASE 2019 (COVID-19);MISSENSE MUTATION;EXOME SEQUENCING;MICROVESICLES;IVACAFTOR;ADENOSINE DEAMINASE DEFICIENCY;FANCONI ANEMIA;PROBAND;SANGER SEQUENCING;SINGLE-NUCLEOTIDE POLYMORPHISM;DNA METHYLATION;FAS RECEPTOR;FOCAL SEGMENTAL GLOMERULOSCLEROSIS;GENETIC HETEROGENEITY;GROWTH HORMONE DEFICIENCY;KARYOTYPE;LOSS FUNCTION;ABATACEPT;COMPOUND HETEROZYGOSITY;COPY-NUMBER VARIATION;FRAMESHIFT MUTATION;GENOTYPE-PHENOTYPE DISTINCTION;GERMLINE MUTATION;MITOCHONDRIAL DISEASE;MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION;OFATUMUMAB;OLIGOARTHRITIS;ONCOGENE;ORAL FOOD CHALLENGE;PENETRANCE;PODOCYTE;RNA SPLICING;TRANSCRIPTOME;VINCRISTINE","31;18;15;7;6;5;5;5;5;5;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3","HUMANS;;CHILD;FEMALE;MALE;ADOLESCENT;CHILD, PRESCHOOL;ITALY;INFANT;RETROSPECTIVE STUDIES;COVID-19;ADULT;MUTATION;EPILEPSY;ARTHRITIS, JUVENILE;TREATMENT OUTCOME;NEUROBLASTOMA;YOUNG ADULT;ANIMALS;ASTHMA","302;225;143;141;125;74;70;66;64;60;50;49;44;36;33;30;26;25;24;24","HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS AND RELATED DISORDERS;THERAPEUTIC ADVANCES IN CYSTIC FIBROSIS RESEARCH;NEUROBLASTOMA RESEARCH AND TREATMENT;EPILEPSY AND SEIZURES;GENE THERAPY FOR SPINAL MUSCULAR ATROPHY;PATHOPHYSIOLOGY OF GLOMERULAR DISEASES AND NEPHROTIC SYNDROMES;ASTHMA;MOLECULAR BASIS OF RETT SYNDROME AND RELATED DISORDERS;PEDIATRIC CANCER AND QUALITY OF LIFE;IMPACT OF COVID-19 ON CANCER PATIENTS AND CARE;DIAGNOSIS AND MANAGEMENT OF KAWASAKI DISEASE;MITOCHONDRIAL DYNAMICS AND REACTIVE OXYGEN SPECIES REGULATION;MOLECULAR MECHANISMS OF INFLAMMASOME ACTIVATION AND REGULATION;MOLECULAR MECHANISMS OF MUSCLE REGENERATION AND ATROPHY;STANDARDS AND GUIDELINES FOR GENETIC VARIANT INTERPRETATION;GENETIC BASIS OF PRIMARY IMMUNODEFICIENCY DISORDERS;HETEROTOPIC OSSIFICATION AND FIBRODYSPLASIA OSSIFICANS PROGRESSIVA;DEVELOPMENT AND DISORDERS OF FETAL BRAIN;DIAGNOSIS AND MANAGEMENT OF FUNGAL INFECTIONS;GENETIC AND CLINICAL ASPECTS OF HEMOGLOBIN DISORDERS","19;18;16;14;14;14;12;11;9;8;7;7;7;7;7;6;6;5;5;5","SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS;PANDEMIC;JUVENILE IDIOPATHIC ARTHRITIS;NEUROBLASTOMA;CYSTIC FIBROSIS;EPILEPSY;SPINAL MUSCULAR ATROPHY;2019-20 CORONAVIRUS OUTBREAK;ADOLESCENT AND YOUNG ADULT ONCOLOGY;ASTHMA;CHILDHOOD CANCER SURVIVOR STUDY;INTERQUARTILE RANGE;CHILDHOOD CANCER;CLINICAL ENDPOINT;DIAGNOSIS;NK CELL THERAPY;SLEEP (SYSTEM CALL);DELPHI METHOD;DIFFUSE PULMONARY OSSIFICATION;DRUG RESISTANT EPILEPSY","21;19;18;16;13;12;12;10;10;10;10;9;8;7;7;7;7;6;6;6","CYSTIC FIBROSIS;IDIOPATHIC ARTHRITIS;JUVENILE IDIOPATHIC;MUSCULAR ATROPHY;NEPHROTIC SYNDROME;SPINAL MUSCULAR;STEM CELL;PEDIATRIC PATIENTS;SARS-COV- INFECTION;CANCER SURVIVORS;CHILDHOOD CANCER;FIBRODYSPLASIA OSSIFICANS;OBSERVATIONAL STUDY;OSSIFICANS PROGRESSIVA;BOWEL DISEASE;DE NOVO;INFLAMMATORY BOWEL;ACUTE LYMPHOBLASTIC;ADENOSINE DEAMINASE;AUTOIMMUNE LYMPHOPROLIFERATIVE;BIALLELIC VARIANTS;CELL TRANSPLANT;CELL TRANSPLANTATION;CLINICAL FEATURES;CLINICAL PRACTICE;CONTROLLED TRIAL;CROSS-SECTIONAL STUDY;EMERGENCY DEPARTMENT;FOCAL SEGMENTAL;GATING MUTATIONS","17;17;17;10;10;10;8;7;7;6;6;6;6;6;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4;4","PRIMARY CARE;ASTHMA CONTROL;GRANTRESEARCH SUPPORT;SPEAKERS BUREAU;MEDLINE GOOGLE;CROSSREF MEDLINE;MEDIAN AGE;NOVARTIS PFIZER;ADVERSE EVENTS;BRISTOL MYERS;CLINICAL FEATURES;RESEARCH FUNDING;RISK FACTORS;SARS-COV- INFECTION;SOBI SWEDISH;STEM CELL;INTENSIVE CARE;MILAN ITALY;MYERS SQUIBB;SLEEP LATENCY;LUNG FUNCTION;PEDIATRIC PATIENTS;SCIENCEGOOGLE SCHOLAR;STATISTICALLY SIGNIFICANT;ASTHMA MANAGEMENT;BONE MARROW;CLINICAL PRACTICE;DISEASE ACTIVITY;MULTIVARIATE ANALYSIS;NEPHROTIC SYNDROME","48;46;38;37;29;27;24;24;23;23;23;22;21;21;21;20;19;19;19;19;18;18;18;18;17;17;17;17;17;17",309,0.58,8.08,9,1,1,0,3,1,1,1,10,1,1,8,3,1,1,2,6,3,0,0,35,35,4,0,2,0,2,1,0,0,0,0,0,0,4,1,0,0,7.6,2.1,3,0,5,3,0,1,2,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"FERRERA LORETTA;BANDIERA TIZIANO;BERTOZZI FABIO;CACI EMANUELA;PEDEMONTE NICOLETTA;SORANA FEDERICO;GALIETTA LUIS JUAN VICENTE;GIACOMINA FRANCESCA;GIOVANI SIMONE;BERTI FRANCESCO","5;4;4;4;4;4;3;2;2;1","FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA;ISTITUTO GIANNINA GASLINI;FONDAZIONE PER LA RICERCA SULLA FIBROSI CISTICA ONLUS;FONDAZIONE PER LA RICERCA SULLA FIBROSI CISTICA - ONLUS;INSTITUTO GIANNINA GASLINI;UNIVERSITA DEGLI STUDI DI ROMA LA SAPIENZA","4;4;3;2;1;1","34 CHEMICAL SCIENCES;3402 INORGANIC CHEMISTRY;32 BIOMEDICAL AND CLINICAL SCIENCES;3208 MEDICAL PHYSIOLOGY;3404 MEDICINAL AND BIOMOLECULAR CHEMISTRY","8;3;2;1;1","CYSTIC FIBROSIS;LUNG;RARE DISEASES;BRAIN DISORDERS;GENETICS","3;3;3;2;1","5.1 PHARMACEUTICALS","2","A61P11/00;C07D471/04;A61P43/00;C07D471/18;A61K31/437;A61K31/5377;A61K38/17;A61P1/10;A61P27/02;C07D405/12","3;3;2;2;1;1;1;1;1;1","A61P11/00;C07D471/04;C07D471/18;A61P43/00;C07D451/00;A61K38/1703;A61P1/10;A61P27/02;C07D231/56;C07D401/12","5;3;3;2;2;1;1;1;1;1",19,4.11,147.16,3.28,8,0.42,38.53,1,2,1,1,9,0,0,5,0,14,5,0,0,0,0,0,0,18,1,0,19,0,0,0,0,0,0,0,0,0,"Denmark;United States;France;Japan;Netherlands;United Kingdom","2;2;1;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;31 BIOLOGICAL SCIENCES;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY;3105 GENETICS;3107 MICROBIOLOGY;3203 DENTISTRY;3208 MEDICAL PHYSIOLOGY;3215 REPRODUCTIVE MEDICINE","19;15;4;2;2;2;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;PEDIATRIC;RARE DISEASES;BRAIN DISORDERS;CANCER;NEUROSCIENCES;PATIENT SAFETY;PREVENTION;CYSTIC FIBROSIS;LUNG;ORPHAN DRUG;PEDIATRIC CANCER;PEDIATRIC RESEARCH INITIATIVE;CHRONIC PAIN;HEADACHES;HEMATOLOGY;INFECTIOUS DISEASES;MIGRAINES;PAIN RESEARCH","19;13;13;9;4;4;4;4;4;3;3;3;3;3;2;2;2;2;2;2","CANCER;CONGENITAL;INFECTION;INFLAMMATORY AND IMMUNE SYSTEM;MENTAL HEALTH;NEUROLOGICAL","3;3;1;1;1;1","6.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;5.1 PHARMACEUTICALS;6.4 SURGERY","14;2;1;1;1","BONE CANCER, OSTEOSARCOMA / MALIGNANT FIBROUS HISTIOCYTOMA;LEUKEMIA / LEUKAEMIA;SARCOMA;NON-HODGKIN'S LYMPHOMA","2;2;2;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;5.2 LOCALIZED THERAPIES - CLINICAL APPLICATIONS;5.3 SYSTEMIC THERAPIES - DISCOVERY AND DEVELOPMENT;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES","4;1;1;1",9,899666,203454.69,3.77777777777778,7.11111111111111,2.55555555555556,0.555555555555556,3.83333333333333,722387.212802013,0.736447144373536,"ISTITUTO GIANNINA GASLINI;BAMBINO GESÙ CHILDREN'S HOSPITAL;CENTRO CLINICO NEMO;FONDAZIONE IRCCS CA' GRANDA OSPEDALE MAGGIORE POLICLINICO;UNIVERSITY OF MESSINA;AGOSTINO GEMELLI UNIVERSITY POLYCLINIC;CINECA;EUROPEAN SOCIETY FOR PAEDIATRIC ONCOLOGY;FONDAZIONE ISTITUTO NEUROLOGICO NAZIONALE CASIMIRO MONDINO;FONDAZIONE STELLA MARIS;IRCCS OSPEDALE SAN RAFFAELE;ISTITUTO DELLE SCIENZE NEUROLOGICHE DI BOLOGNA;PRINCESS MÁXIMA CENTER;ST ANNA CHILDREN'S HOSPITAL;UNIVERSITY OF CAMPANIA ""LUIGI VANVITELLI"";UNIVERSITY OF PADUA;UNIVERSITY OF TURIN;VILNIUS UNIVERSITY;AUSTRIAN INSTITUTE OF TECHNOLOGY;CAPITAL REGION OF DENMARK","9;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1","TELETHON FOUNDATION;EUROPEAN COMMISSION;ITALIAN ASSOCIATION FOR CANCER RESEARCH","6;2;1","COALITION S;EC & ERC - EUROPEAN UNION;ICRP - INTERNATIONAL CANCER RESEARCH PARTNERSHIP","2;2;1","TELETHON-UILDM CLINICAL PROJECTS 2021 (PROGRAM);CSA - COORDINATION AND SUPPORT ACTION (FUNDING SCHEME);H2020-EU.3.1. - SOCIETAL CHALLENGES - HEALTH, DEMOGRAPHIC CHANGE AND WELL-BEING (PROGRAMME);H2020-EU.4.B. - TWINNING OF RESEARCH INSTITUTIONS (PROGRAMME);RIA - RESEARCH AND INNOVATION ACTION (FUNDING SCHEME);TELETHON SPECIAL PROJECTS - 2020 (PROGRAM)","2;1;1;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;4205 NURSING","3;2;1;1;1;1","CANCER;CLINICAL RESEARCH;NEUROSCIENCES;PEDIATRIC;RARE DISEASES;BIOENGINEERING;BIOTECHNOLOGY;BRAIN DISORDERS;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;DUCHENNE/ BECKER MUSCULAR DYSTROPHY;INTELLECTUAL AND DEVELOPMENTAL DISABILITIES (IDD);MUSCULAR DYSTROPHY;NANOTECHNOLOGY;NEUROBLASTOMA;ORPHAN DRUG;PEDIATRIC CANCER;PEDIATRIC RESEARCH INITIATIVE","2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1","CANCER;MUSCULOSKELETAL","3;1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;5.1 PHARMACEUTICALS;7.3 MANAGEMENT AND DECISION MAKING","1;1;1","NEUROBLASTOMA;BRAIN TUMOR;NOT SITE-SPECIFIC CANCER","2;1;1","5.3 SYSTEMIC THERAPIES - DISCOVERY AND DEVELOPMENT;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES;6.4 COST ANALYSES AND HEALTH CARE DELIVERY","1;1;1","A01 CLINICAL MEDICINE;A02 PUBLIC HEALTH, HEALTH SERVICES AND PRIMARY CARE;A03 ALLIED HEALTH PROFESSIONS, DENTISTRY, NURSING AND PHARMACY","2;1;1","3 GOOD HEALTH AND WELL BEING;4 QUALITY EDUCATION","1;1",47,"FRONTIERS;PUBLIC LIBRARY OF SCIENCE;ZENODO;UNIVERSITY COLLEGE LONDON;SPRINGER NATURE;KARGER PUBLISHERS","22;9;8;5;2;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;52 PSYCHOLOGY;3105 GENETICS;46 INFORMATION AND COMPUTING SCIENCES;34 CHEMICAL SCIENCES;42 HEALTH SCIENCES;3204 IMMUNOLOGY;4203 HEALTH SERVICES AND SYSTEMS;5202 BIOLOGICAL PSYCHOLOGY;3205 MEDICAL BIOCHEMISTRY AND METABOLOMICS;3211 ONCOLOGY AND CARCINOGENESIS;3212 OPHTHALMOLOGY AND OPTOMETRY;3401 ANALYTICAL CHEMISTRY;44 HUMAN SOCIETY;4611 MACHINE LEARNING;51 PHYSICAL SCIENCES;5107 PARTICLE AND HIGH ENERGY PHYSICS;3102 BIOINFORMATICS AND COMPUTATIONAL BIOLOGY","64;20;15;8;5;5;4;4;3;3;3;2;2;2;2;2;2;2;2;1","CLINICAL RESEARCH;NEUROSCIENCES;BRAIN DISORDERS;NEURODEGENERATIVE;PEDIATRIC;EPILEPSY;GENETICS;RARE DISEASES;PATIENT SAFETY;BEHAVIORAL AND SOCIAL SCIENCE;CANCER;GENETIC TESTING;HUMAN GENOME;KIDNEY DISEASE;MIND AND BODY;PREVENTION;BASIC BEHAVIORAL AND SOCIAL SCIENCE;BIOMEDICAL IMAGING;BIOTECHNOLOGY;CYSTIC FIBROSIS","23;17;16;12;12;10;6;6;5;4;3;3;3;3;3;3;2;2;2;2","NEUROLOGICAL;CONGENITAL;INFLAMMATORY AND IMMUNE SYSTEM;MENTAL HEALTH;GENERIC HEALTH RELEVANCE;METABOLIC AND ENDOCRINE;RENAL AND UROGENITAL;CANCER;EYE;INFECTION;REPRODUCTIVE HEALTH AND CHILDBIRTH","13;4;3;3;2;2;2;1;1;1;1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;6.1 PHARMACEUTICALS;1.1 NORMAL BIOLOGICAL DEVELOPMENT AND FUNCTIONING;2.4 SURVEILLANCE AND DISTRIBUTION;4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES;7.1 INDIVIDUAL CARE NEEDS","12;5;3;1;1;1;1","CLINICAL;BIOMEDICAL;POPULATION & SOCIETY","16;10;2","CLINICAL MEDICINE AND SCIENCE;BASIC SCIENCE;PUBLIC HEALTH","30;3;2","KIDNEY CANCER;NOT SITE-SPECIFIC CANCER;BRAIN TUMOR","2;2;1",NA,NA
"IRCCS_GASLINI",2022,525,18.3695238095238,3.44761904761905,0.304761904761905,0.293333333333333,0.361904761904762,3.10463121783877,1.40350877192982,1.65591397849462,1.54471544715447,0.754285714285714,4,243,107,30,25,0.46,0.2,0.06,0.05,8.47,0.948667316154344,5.92286973555338,0.497142857142857,0.979047619047619,0.523,0.452,0.435,0.469,"PASQUALE STRIANO;MOHAMAD MAGHNIE;MARIA LUISA GARRÈ;MARCO GATTORNO;FEDERICO ZARA;MARIASAVINA SEVERINO;ANDREA ROSSI;ELIO CASTAGNOLA;STEFANO VOLPI;CLAUDIA MILANACCIO;NICOLINO RUPERTO;ANTONIO VERRICO;GIAN MARCO GHIGGERI;DOMENICO COVIELLO;MAURA FARACI;GIANLUCA PICCOLO;MARCELLO SCALA;ANGELO RAVELLI;LINO NOBILI;DOMENICO TORTORA","44;23;23;21;20;20;19;18;18;18;18;17;17;16;16;16;15;15;15;14","PASQUALE STRIANO;NICOLETTA PEDEMONTE;CARLO BELLINI;ELIO CASTAGNOLA;MOHAMAD MAGHNIE;GIORGIO CIPRANDI;MARIA LUISA GARRÈ;MARIA ANGELA TOSCA;ANDREA ROSSI;D. PALADINI;HALKAWT NURI;CLAUDIA MILANACCIO;ANDREA PETRETTO;MARIASAVINA SEVERINO;GIANLUCA PIATELLI;NICOLINO RUPERTO;FEDERICO ZARA;ANTONIO VERRICO;MARCO GATTORNO;GIAN MARCO GHIGGERI","2.36;2.14;2.11;1.95;1.91;1.91;1.73;1.6;1.55;1.46;1.42;1.4;1.39;1.39;1.38;1.36;1.35;1.33;1.33;1.31","PASQUALE STRIANO;MOHAMAD MAGHNIE;MARIA LUISA GARRÈ;MARCO GATTORNO;FEDERICO ZARA;MARIASAVINA SEVERINO;ANDREA ROSSI;ELIO CASTAGNOLA;STEFANO VOLPI;CLAUDIA MILANACCIO;NICOLINO RUPERTO;ANTONIO VERRICO;GIAN MARCO GHIGGERI;DOMENICO COVIELLO;MAURA FARACI;GIANLUCA PICCOLO;MARCELLO SCALA;ANGELO RAVELLI;LINO NOBILI;DOMENICO TORTORA","44;23;23;21;20;20;19;18;18;18;18;17;17;16;16;16;15;15;15;14","PASQUALE STRIANO;NICOLETTA PEDEMONTE;CARLO BELLINI;ELIO CASTAGNOLA;MOHAMAD MAGHNIE;MARIA LUISA GARRÈ;MARIA ANGELA TOSCA;ANDREA ROSSI;D. PALADINI;HALKAWT NURI;CLAUDIA MILANACCIO;ANDREA PETRETTO;MARIASAVINA SEVERINO;GIANLUCA PIATELLI;NICOLINO RUPERTO;FEDERICO ZARA;ANTONIO VERRICO;MARCO GATTORNO;GIAN MARCO GHIGGERI;LINO NOBILI","2.36;2.14;2.11;1.95;1.91;1.73;1.6;1.55;1.46;1.42;1.4;1.39;1.39;1.38;1.36;1.35;1.33;1.33;1.31;1.29","PASQUALE STRIANO;MARCO GATTORNO;STEFANO VOLPI;ANDREA MOSCATELLI;D. PALADINI;NICOLETTA PEDEMONTE;AUSTEN WORTH;MARIASAVINA SEVERINO;MOHAMAD MAGHNIE;CARLO DUFOUR;WINNIE IP;FEDERICO PREFUMO;CARLO CASTELLANI;G. MALINGER;VALERIA CAPURRO;AMENEH KHATAMI;ANDREW B. GAINEY;ANNE BROWN;BAILEY E. SMITH;BRENDAN MCMULLAN","544;276;268;240;215;214;213;209;198;197;196;187;184;182;176;174;174;174;174;174","PASQUALE STRIANO;MARCO GATTORNO;STEFANO VOLPI;D. PALADINI;NICOLETTA PEDEMONTE;ANDREA MOSCATELLI;MARIASAVINA SEVERINO;CARLO DUFOUR;MOHAMAD MAGHNIE;CARLO CASTELLANI;VALERIA CAPURRO;NICOLINO RUPERTO;ELENA PALMISANI;CLAUDIO BRUNO;FEDERICO ZARA;MARCELLO SCALA;ANGELO RAVELLI;MARIA MARGHERITA MANCARDI;VALERIA CAPRA;PAOLO UVA","484;269;268;215;214;209;209;197;195;184;176;173;166;164;159;142;130;130;130;126","PASQUALE STRIANO;MARIA LUISA GARRÈ;MOHAMAD MAGHNIE;MARIASAVINA SEVERINO;MARCO GATTORNO;ANDREA ROSSI;FEDERICO ZARA;CLAUDIA MILANACCIO;ELIO CASTAGNOLA;NICOLINO RUPERTO;STEFANO VOLPI;ANTONIO VERRICO;CLAUDIO BRUNO;MAURA FARACI;GIAN MARCO GHIGGERI;DOMENICO COVIELLO;LINO NOBILI;NICOLETTA PEDEMONTE;ANGELO RAVELLI;ANDREA PETRETTO","46;23;22;21;20;19;19;18;18;18;18;17;17;16;16;16;15;14;14;13","MEDICINE;BIOLOGY;CHEMISTRY;PSYCHOLOGY;PHYSICS;COMPUTER SCIENCE;ECONOMICS;MATHEMATICS;ENGINEERING;SOCIOLOGY;PHILOSOPHY;POLITICAL SCIENCE;MATERIALS SCIENCE;BUSINESS;HISTORY;ART;GEOGRAPHY","458;243;45;45;36;35;23;22;15;13;11;11;6;3;3;1;1","INTERNAL MEDICINE;GENETICS;PEDIATRICS;SURGERY;PATHOLOGY;IMMUNOLOGY;PSYCHIATRY;BIOCHEMISTRY;INTENSIVE CARE MEDICINE;CANCER RESEARCH;ENVIRONMENTAL HEALTH;RADIOLOGY;ENDOCRINOLOGY;GASTROENTEROLOGY;ONCOLOGY;CELL BIOLOGY;ANESTHESIA;FAMILY MEDICINE;BIOINFORMATICS;NEUROSCIENCE","323;164;135;103;93;91;70;58;43;41;40;39;36;35;35;34;30;30;29;29","GENE;DISEASE;COHORT;CANCER;EPILEPSY;POPULATION;IMMUNE SYSTEM;ANTIBODY;PREGNANCY;CHEMOTHERAPY;RETROSPECTIVE COHORT STUDY;CELL CULTURE;RECEPTOR;STEM CELL;MAGNETIC RESONANCE IMAGING;CYSTIC FIBROSIS;HEALTH CARE;TRANSPLANTATION;ARTHRITIS;INCIDENCE (GEOMETRY)","118;106;55;46;39;38;32;27;27;26;26;24;24;22;21;20;19;19;18;18","PHENOTYPE;MUTATION;INFECTIOUS DISEASE (MEDICAL SPECIALTY);NEUROBLASTOMA;FETUS;HEMATOPOIETIC STEM CELL TRANSPLANTATION;CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR;GENE EXPRESSION;HAEMATOPOIESIS;NEURORADIOLOGY;RITUXIMAB;2019-20 CORONAVIRUS OUTBREAK;CLINICAL ENDPOINT;GENOTYPE;IMMUNOTHERAPY;PROTEOMICS;ANAKINRA;AUTISM SPECTRUM DISORDER;CUMULATIVE INCIDENCE;METASTATIC MELANOMA;TYPE 1 DIABETES","31;29;28;22;19;14;13;10;10;10;9;8;8;8;8;8;7;7;7;7;7","CORONAVIRUS DISEASE 2019 (COVID-19);EXOME SEQUENCING;MISSENSE MUTATION;BONE MARROW FAILURE;IVACAFTOR;PRENATAL DIAGNOSIS;VEMURAFENIB;GROWTH HORMONE DEFICIENCY;HAPLOINSUFFICIENCY;DNA METHYLATION;FRAMESHIFT MUTATION;INDUCED PLURIPOTENT STEM CELL;KLEBSIELLA PNEUMONIAE;VANCOMYCIN;ALTERNATIVE SPLICING;CONGENITAL NEUTROPENIA;DYSKERATOSIS CONGENITA;ENTHESITIS;GLOBAL DEVELOPMENTAL DELAY;IDIOPATHIC SHORT STATURE;KARYOTYPE;LOSS FUNCTION;LYMPHOBLASTIC LYMPHOMA;UBIQUITIN LIGASE;VENTRICULOMEGALY","28;10;8;7;7;7;7;5;5;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3","HUMANS;;CHILD;FEMALE;CYSTIC FIBROSIS;RETROSPECTIVE STUDIES;MUTATION;COVID-19;MALE;CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR;ADOLESCENT;EPILEPSY;ADULT;ARTHRITIS, JUVENILE;INTELLECTUAL DISABILITY;MAGNETIC RESONANCE IMAGING;SEIZURES;NEOPLASMS;NEUROBLASTOMA;CHILD, PRESCHOOL","308;212;108;63;50;48;46;45;43;36;34;34;33;30;27;26;23;22;22;21","NEUROBLASTOMA RESEARCH AND TREATMENT;HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS AND RELATED DISORDERS;THERAPEUTIC ADVANCES IN CYSTIC FIBROSIS RESEARCH;EPILEPSY AND SEIZURES;GLIOMAS;GENE THERAPY FOR SPINAL MUSCULAR ATROPHY;MOLECULAR BASIS OF RETT SYNDROME AND RELATED DISORDERS;GENETIC BASIS OF PRIMARY IMMUNODEFICIENCY DISORDERS;DIAGNOSIS AND MANAGEMENT OF KAWASAKI DISEASE;MOLECULAR MECHANISMS OF INFLAMMASOME ACTIVATION AND REGULATION;PATHOPHYSIOLOGY OF GLOMERULAR DISEASES AND NEPHROTIC SYNDROMES;NATURAL KILLER CELLS IN IMMUNITY;PEDIATRIC CANCER AND QUALITY OF LIFE;GENOMIC IMPRINTING AND PARENTAL GENE EXPRESSION CONTROL;MANAGEMENT OF DIABETES MELLITUS AND HYPOGLYCEMIA;DEVELOPMENT AND DISORDERS OF FETAL BRAIN;EPIDEMIOLOGY AND MANAGEMENT OF CONGENITAL HEART DISEASE;EPIDEMIOLOGY AND TREATMENT OF CHILDHOOD LEUKEMIA;GENETIC AND CLINICAL ASPECTS OF HEMOGLOBIN DISORDERS;GENETIC BASIS OF NEUTROPENIA DISORDERS","24;21;19;14;14;10;10;9;8;8;8;7;7;6;6;5;5;5;5;5","NEUROBLASTOMA;PANDEMIC;JUVENILE IDIOPATHIC ARTHRITIS;SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS;CYSTIC FIBROSIS;CFTR;NEURORADIOLOGY;2019-20 CORONAVIRUS OUTBREAK;DELPHI METHOD;REFRACTORY (PLANETARY SCIENCE);CHILDHOOD CANCER SURVIVOR STUDY;CLINICAL ENDPOINT;CONCOMITANT;EPILEPSY;FETAL DNA ANALYSIS;SPINAL MUSCULAR ATROPHY;TYPE 1 DIABETES;BONE MARROW FAILURE;CUMULATIVE INCIDENCE;DIABETES","26;22;18;17;14;10;10;9;9;9;8;8;8;8;8;8;8;7;7;7","CYSTIC FIBROSIS;JUVENILE IDIOPATHIC;IDIOPATHIC ARTHRITIS;PEDIATRIC PATIENTS;STEM CELL;CELL TRANSPLANTATION;COVID- PANDEMIC;INFLAMMATORY SYNDROME;MULTISYSTEM INFLAMMATORY;MUSCULAR ATROPHY;SPINAL MUSCULAR;TYPE DIABETES;ACUTE LYMPHOBLASTIC;ADULT PATIENTS;DISEASE TYPE;HEMATOPOIETIC STEM;MUSCULAR DYSTROPHY;NEPHROTIC SYNDROME;OBSERVATIONAL STUDY;SEVERE APLASTIC;ANTIMICROBIAL PROPHYLAXIS;APPROPRIATENESS METHOD;BONE MARROW;CARE UNIT;CHILDHOOD CANCER;COHORT STUDY;CONSENSUS STUDY;DE NOVO;GROWTH HORMONE;HODGKIN LYMPHOMA","15;14;13;11;11;10;8;6;6;6;6;6;5;5;5;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4","ANTI-RITUXIMAB ANTIBODIES;SPEAKERS BUREAU;GIANNINA GASLINI;GASLINI GENOA;MEDIAN AGE;ISTITUTO GIANNINA;IRCCS ISTITUTO;RESEARCH CENTRE;RIYADH SAUDI;SAUDI ARABIASEARCH;GRANTRESEARCH SUPPORT;ADVERSE EVENTS;CENTRE RIYADH;FAISAL SPECIALIST;KING FAISAL;SPECIALIST HOSPITAL;STEM CELL;NOVARTIS PFIZER;CHILDRENS HOSPITAL;PUBMED SCOPUS;ELI LILLY;GENOA ITALYSEARCH;HR CI;RISK FACTORS;BONE MARROW;NK CELLS;CARE UNIT;CYSTIC FIBROSIS;INTENSIVE CARE;UNIT IRCCS","54;52;46;41;41;40;39;38;38;36;35;33;32;32;32;32;32;31;30;30;29;28;28;28;27;27;26;26;26;26",297,0.57,7.2,9,1,1,0,8.75,1,1,1,10,2,1,8,1.5,1,2,3,6,3.25,0,0,21,21,3,0,0,0,2,1,0,0,0,0,0,0,2,1,0,0,6.66666666666667,1.1,3.66666666666667,0,3,2,0,0,2,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"FERRERA LORETTA;BANDIERA TIZIANO;BERTOZZI FABIO;CACI EMANUELA;GALIETTA LUIS JUAN VICENTE;PEDEMONTE NICOLETTA;BERTI FRANCESCO;DI FRUSCIA PAOLO;MANGONI MARIA LUISA;RODRIGUEZ GIMENO ALEJANDRA","3;2;2;2;2;2;1;1;1;1","ISTITUTO GIANNINA GASLINI;FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA;FONDAZIONE PER LA RICERCA SULLA FIBROSI CISTICA ONLUS;FOND PER LA RICERCA SULLA FIBROSI CISTICA ONLUS;FONDAZIONE PER LA RICERCA SULLA FIBROSI CISTICA - ONLUS;ST GIANNINA GASLINI;UNIVERSITA DEGLI STUDI DI ROMA LA SAPIENZA","3;2;2;1;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;34 CHEMICAL SCIENCES;3208 MEDICAL PHYSIOLOGY;3402 INORGANIC CHEMISTRY","2;2;1;1","BRAIN DISORDERS;CYSTIC FIBROSIS;LUNG;RARE DISEASES","1;1;1;1","5.1 PHARMACEUTICALS","1","A61P11/00;A61K31/4745;A61K38/17;A61P27/00;A61P3/00;C07D405/12;C07D405/14;C07D413/04;C07D413/14;C07D471/04","2;1;1;1;1;1;1;1;1;1","A61P11/00;C07D413/14;A61K38/1703;A61P1/10;A61P27/00;A61P27/02;A61P3/00;C07D405/12;C07D405/14;C07D413/04","3;2;1;1;1;1;1;1;1;1",22,3.67,182.57,4.01,10,0.45,44.64,1,1,2,1,13,0,0,4,0,19,2,0,0,0,0,0,0,21,0,1,21,1,0,0,0,0,0,0,0,0,"United States;Germany;Hungary;Japan","5;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;3101 BIOCHEMISTRY AND CELL BIOLOGY;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3208 MEDICAL PHYSIOLOGY;42 HEALTH SCIENCES;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY;30 AGRICULTURAL, VETERINARY AND FOOD SCIENCES;3009 VETERINARY SCIENCES;3204 IMMUNOLOGY;3207 MEDICAL MICROBIOLOGY;3211 ONCOLOGY AND CARCINOGENESIS;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;3215 REPRODUCTIVE MEDICINE;35 COMMERCE, MANAGEMENT, TOURISM AND SERVICES;3505 HUMAN RESOURCES AND INDUSTRIAL RELATIONS;4201 ALLIED HEALTH AND REHABILITATION SCIENCE;4207 SPORTS SCIENCE AND EXERCISE","22;10;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;PEDIATRIC;RARE DISEASES;NEURODEGENERATIVE;NEUROSCIENCES;CYSTIC FIBROSIS;LUNG;AUTOIMMUNE DISEASE;BRAIN DISORDERS;KIDNEY DISEASE;SPINAL MUSCULAR ATROPHY;ARTHRITIS;EPILEPSY;GENETICS;INFECTIOUS DISEASES;PEDIATRIC RESEARCH INITIATIVE;PREVENTION;STEM CELL RESEARCH;TRANSPLANTATION","20;18;15;12;6;6;4;4;3;3;3;3;2;2;2;2;2;2;2;2","CONGENITAL;NEUROLOGICAL;CANCER;INFECTION;INFLAMMATORY AND IMMUNE SYSTEM;MUSCULOSKELETAL;RENAL AND UROGENITAL;CARDIOVASCULAR","3;3;2;2;2;2;2;1","6.1 PHARMACEUTICALS;5.1 PHARMACEUTICALS;1.1 NORMAL BIOLOGICAL DEVELOPMENT AND FUNCTIONING;2.4 SURVEILLANCE AND DISTRIBUTION;5.2 CELLULAR AND GENE THERAPIES;6.2 CELLULAR AND GENE THERAPIES","15;2;1;1;1;1","NOT SITE-SPECIFIC CANCER;LEUKEMIA / LEUKAEMIA;NON-HODGKIN'S LYMPHOMA;BLOOD CANCER;MYELOMA","3;2;2;1;1","5.3 SYSTEMIC THERAPIES - DISCOVERY AND DEVELOPMENT;5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","3;3",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,43,"FRONTIERS;ZENODO;UNIVERSITY COLLEGE LONDON","35;6;2","32 BIOMEDICAL AND CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;3202 CLINICAL SCIENCES;3102 BIOINFORMATICS AND COMPUTATIONAL BIOLOGY;34 CHEMICAL SCIENCES;3105 GENETICS;52 PSYCHOLOGY;3213 PAEDIATRICS;3205 MEDICAL BIOCHEMISTRY AND METABOLOMICS;3206 MEDICAL BIOTECHNOLOGY;3401 ANALYTICAL CHEMISTRY;3404 MEDICINAL AND BIOMOLECULAR CHEMISTRY;36 CREATIVE ARTS AND WRITING;42 HEALTH SCIENCES;46 INFORMATION AND COMPUTING SCIENCES;5202 BIOLOGICAL PSYCHOLOGY;3212 OPHTHALMOLOGY AND OPTOMETRY;3215 REPRODUCTIVE MEDICINE;40 ENGINEERING;4003 BIOMEDICAL ENGINEERING","50;31;14;12;8;6;4;3;2;2;2;2;2;2;2;2;1;1;1;1","PEDIATRIC;CLINICAL RESEARCH;GENETICS;PREVENTION;NEUROSCIENCES;AUTOIMMUNE DISEASE;BRAIN DISORDERS;DIABETES;CANCER;HEMATOLOGY;KIDNEY DISEASE;PEDIATRIC CANCER;RARE DISEASES;ORGAN TRANSPLANTATION;TRANSPLANTATION;UROLOGIC DISEASES;BIOMEDICAL IMAGING;CARDIOVASCULAR;CHILDHOOD LEUKEMIA;EPILEPSY","24;21;15;12;10;8;8;6;5;5;5;5;5;4;4;4;3;3;3;3","NEUROLOGICAL;INFLAMMATORY AND IMMUNE SYSTEM;METABOLIC AND ENDOCRINE;CANCER;RENAL AND UROGENITAL;CARDIOVASCULAR;MUSCULOSKELETAL;INFECTION;REPRODUCTIVE HEALTH AND CHILDBIRTH;STROKE","10;7;6;5;5;3;2;1;1;1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;2.6 RESOURCES AND INFRASTRUCTURE (AETIOLOGY);5.2 CELLULAR AND GENE THERAPIES","16;8;4;2;1","CLINICAL;BIOMEDICAL;HEALTH SERVICES & SYSTEMS","17;15;1","CLINICAL MEDICINE AND SCIENCE;BASIC SCIENCE;HEALTH SERVICES RESEARCH","20;10;1","LEUKEMIA / LEUKAEMIA;NEUROBLASTOMA","3;2","3 GOOD HEALTH AND WELL BEING","1"
"IRCCS_GASLINI",2023,540,17.9203703703704,3.58888888888889,0.290740740740741,0.32962962962963,0.35,2.69262865090403,1.35344827586207,1.66355140186916,1.4,0.703703703703704,1,207,109,39,48,0.38,0.2,0.07,0.09,3.84,0.875418377273267,5.50931248562885,0.47037037037037,0.990740740740741,0.555,0.468,0.46,0.482,"PASQUALE STRIANO;FEDERICO ZARA;MARCO GATTORNO;GIAN MARCO GHIGGERI;MARIASAVINA SEVERINO;MOHAMAD MAGHNIE;FRANCESCA LUGANI;LINO NOBILI;ANDREA ROSSI;NICOLINO RUPERTO;ANDREA ANGELETTI;MARCELLO SCALA;ANGELO RAVELLI;ROBERTA CAORSI;DOMENICO TORTORA;ENRICO VERRINA;ALEXANDER FUCHS;RICCARDO HAUPT;MARIA GRAZIA CALEVO;ANTONELLA RIVA","41;29;22;21;21;19;17;16;16;16;15;15;14;14;13;13;13;13;13;13","PASQUALE STRIANO;ANDREA ROSSI;ALEXANDER FUCHS;THOMAS RIVA;MARCO GATTORNO;ROBERT GREIF;MARIA ANGELA TOSCA;ANGELO RAVELLI;ASTRID HERZUM;GIORGIO CIPRANDI;FEDERICO ZARA;MOHAMAD MAGHNIE;GIANMARIA VIGLIZZO;C. OCCELLA;GIAN MARCO GHIGGERI;LINO NOBILI;CAROLINA S. ROMERO;LODOVICA GARIAZZO;ANDREA ANGELETTI;MARIASAVINA SEVERINO","2.53;2.08;1.99;1.96;1.96;1.93;1.82;1.82;1.77;1.73;1.71;1.69;1.67;1.66;1.61;1.51;1.49;1.47;1.46;1.43","PASQUALE STRIANO;FEDERICO ZARA;MARCO GATTORNO;GIAN MARCO GHIGGERI;MARIASAVINA SEVERINO;MOHAMAD MAGHNIE;FRANCESCA LUGANI;LINO NOBILI;ANDREA ROSSI;NICOLINO RUPERTO;ANDREA ANGELETTI;MARCELLO SCALA;ANGELO RAVELLI;ROBERTA CAORSI;DOMENICO TORTORA;ENRICO VERRINA;ALEXANDER FUCHS;RICCARDO HAUPT;MARIA GRAZIA CALEVO;ANTONELLA RIVA","41;29;22;21;21;19;17;16;16;16;15;15;14;14;13;13;13;13;13;13","PASQUALE STRIANO;ANDREA ROSSI;ALEXANDER FUCHS;THOMAS RIVA;MARCO GATTORNO;MARIA ANGELA TOSCA;ANGELO RAVELLI;ASTRID HERZUM;FEDERICO ZARA;MOHAMAD MAGHNIE;GIANMARIA VIGLIZZO;C. OCCELLA;GIAN MARCO GHIGGERI;LINO NOBILI;CAROLINA S. ROMERO;LODOVICA GARIAZZO;ANDREA ANGELETTI;MARIASAVINA SEVERINO;MARIA GRAZIA CALEVO;FRANCESCA LUGANI","2.53;2.08;1.99;1.96;1.96;1.82;1.82;1.77;1.71;1.69;1.67;1.66;1.61;1.51;1.49;1.47;1.46;1.43;1.29;1.24","MIRCO PONZONI;LOREDANA AMOROSO;MARIA VALERIA CORRIAS;PASQUALE STRIANO;AITOR BLANCO‐MÍGUEZ;FABIO CUMBO;FEDERICA ARMANINI;FEDERICA PINTO;FRANCESCO ASNICAR;MIREIA VALLÈS-COLOMER;NICOLA SEGATA;PAOLO MANGHI;DAVIDE GOLZATO;EDOARDO PASOLLI;KUN D. HUANG;MARTA SELMA‐ROYO;MARÍA CARMEN COLLADO;SERENA MANARA;GIULIA MASETTI;MICHAL PUNČOCHÁŘ","218;217;214;210;209;209;209;209;209;209;209;209;205;205;205;205;205;205;197;197","MIRCO PONZONI;LOREDANA AMOROSO;MARIA VALERIA CORRIAS;PASQUALE STRIANO;CLAUDIO BRUNO;GIAN MARCO GHIGGERI;FEDERICO ZARA;FRANCESCA LUGANI;MARIA LUISA GARRÈ;MOHAMAD MAGHNIE;ELIO CASTAGNOLA;D. PALADINI;GIANLUCA CARIDI;FEDERICO PREFUMO;MARCO GATTORNO;NICOLA DISMA;MARIASAVINA SEVERINO;ALEXANDER FUCHS;LINO NOBILI;CARLO CASTELLANI","218;217;214;183;154;114;98;95;85;84;82;73;70;69;67;67;66;63;59;53","PASQUALE STRIANO;FEDERICO ZARA;GIAN MARCO GHIGGERI;MARCO GATTORNO;MARIASAVINA SEVERINO;CLAUDIO BRUNO;MOHAMAD MAGHNIE;FRANCESCA LUGANI;NICOLINO RUPERTO;CARLO DUFOUR;ANDREA ANGELETTI;LINO NOBILI;ANGELO RAVELLI;MARIA GRAZIA CALEVO;MARCELLO SCALA;ALEXANDER FUCHS;ANDREA ROSSI;DOMENICO TORTORA;ENRICO VERRINA;SERENA ARRIGO","38;28;21;21;21;19;19;17;16;15;15;14;14;13;13;13;13;13;13;13","MEDICINE;BIOLOGY;COMPUTER SCIENCE;CHEMISTRY;PHYSICS;PSYCHOLOGY;MATHEMATICS;ECONOMICS;POLITICAL SCIENCE;ENGINEERING;SOCIOLOGY;BUSINESS;MATERIALS SCIENCE;PHILOSOPHY;GEOGRAPHY;HISTORY;ENVIRONMENTAL SCIENCE","495;232;50;47;46;38;30;13;13;12;12;11;7;7;3;3;1","INTERNAL MEDICINE;GENETICS;PEDIATRICS;PATHOLOGY;SURGERY;IMMUNOLOGY;PSYCHIATRY;BIOCHEMISTRY;ENVIRONMENTAL HEALTH;INTENSIVE CARE MEDICINE;BIOINFORMATICS;RADIOLOGY;NEUROSCIENCE;GASTROENTEROLOGY;CANCER RESEARCH;ONCOLOGY;ANESTHESIA;ENDOCRINOLOGY;CELL BIOLOGY;PHARMACOLOGY","327;174;138;104;98;80;63;56;43;43;38;38;37;34;33;31;30;29;25;25","GENE;DISEASE;COHORT;POPULATION;CANCER;EPILEPSY;PREGNANCY;RETROSPECTIVE COHORT STUDY;CHEMOTHERAPY;IMMUNE SYSTEM;ANTIBODY;CYSTIC FIBROSIS;TRANSPLANTATION;ARTHRITIS;ADVERSE EFFECT;INFLAMMATION;ALTERNATIVE MEDICINE;INCIDENCE (GEOMETRY);MAGNETIC RESONANCE IMAGING;CELL CULTURE;KIDNEY","136;104;49;43;38;36;33;31;20;20;19;19;19;18;17;17;15;15;15;14;14","PHENOTYPE;MUTATION;FETUS;CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR;GENOTYPE;HEMATOPOIETIC STEM CELL TRANSPLANTATION;NEUROBLASTOMA;GESTATIONAL AGE;INFECTIOUS DISEASE (MEDICAL SPECIALTY);TRACHEAL INTUBATION;AIRWAY MANAGEMENT;GENE EXPRESSION;NEUTROPENIA;SPINAL MUSCULAR ATROPHY;HAEMATOPOIESIS;HUMAN GENETICS;INFLAMMATORY BOWEL DISEASE;NEURODEVELOPMENTAL DISORDER;RITUXIMAB;ALLELE;CD8;CUMULATIVE INCIDENCE;GESTATION;MONOCLONAL ANTIBODY;TOLERABILITY","47;33;15;14;14;12;12;11;10;9;8;8;8;8;7;7;7;7;7;6;6;6;6;6;6","EXOME SEQUENCING;MISSENSE MUTATION;CORONAVIRUS DISEASE 2019 (COVID-19);IVACAFTOR;LOSS FUNCTION;FRAMESHIFT MUTATION;GROWTH HORMONE DEFICIENCY;PENETRANCE;PRENATAL DIAGNOSIS;PROBAND;SINGLE-NUCLEOTIDE POLYMORPHISM;TRANSCRIPTOME;CONGENITAL NEUTROPENIA;FANCONI ANEMIA;FOCAL SEGMENTAL GLOMERULOSCLEROSIS;INTRAVENTRICULAR HEMORRHAGE;SANGER SEQUENCING;ABATACEPT;BONE MARROW FAILURE;COMPARATIVE GENOMIC HYBRIDIZATION;DNA METHYLATION;FAS RECEPTOR;HPV INFECTION;NIVOLUMAB;PLACENTA;VANCOMYCIN","24;21;10;8;7;5;5;5;5;5;5;5;4;4;4;4;4;3;3;3;3;3;3;3;3;3","HUMANS;;CHILD;FEMALE;RETROSPECTIVE STUDIES;MALE;ADOLESCENT;ADULT;CHILD, PRESCHOOL;INFANT;MUTATION;CYSTIC FIBROSIS;INFANT, NEWBORN;EPILEPSY;PHENOTYPE;ITALY;COVID-19;TREATMENT OUTCOME;ANIMALS;SEIZURES","296;237;131;71;56;48;45;41;34;34;32;29;29;28;27;26;24;24;22;21","THERAPEUTIC ADVANCES IN CYSTIC FIBROSIS RESEARCH;HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS AND RELATED DISORDERS;NEUROBLASTOMA RESEARCH AND TREATMENT;PEDIATRIC CANCER AND QUALITY OF LIFE;EPILEPSY AND SEIZURES;MANAGEMENT OF DIFFICULT AIRWAY IN ANESTHESIA PRACTICE;STANDARDS AND GUIDELINES FOR GENETIC VARIANT INTERPRETATION;DEVELOPMENT AND DISORDERS OF FETAL BRAIN;GENE THERAPY FOR SPINAL MUSCULAR ATROPHY;GENETIC BASIS OF NEUTROPENIA DISORDERS;MOLECULAR BASIS OF RETT SYNDROME AND RELATED DISORDERS;GENETIC BASIS OF PRIMARY IMMUNODEFICIENCY DISORDERS;MOLECULAR MECHANISMS OF INFLAMMASOME ACTIVATION AND REGULATION;NEONATAL BRAIN INJURY AND DEVELOPMENTAL CONSEQUENCES;PATHOPHYSIOLOGY OF GLOMERULAR DISEASES AND NEPHROTIC SYNDROMES;DIAGNOSIS AND MANAGEMENT OF CELIAC DISEASE;ASTHMA;DIAGNOSIS AND MANAGEMENT OF KAWASAKI DISEASE;GENETIC AND MOLECULAR STUDIES OF CONNECTIVE TISSUE DISORDERS;GENETICS AND TREATMENT OF INFLAMMATORY BOWEL DISEASE","20;15;15;13;12;11;10;9;9;8;8;7;7;7;7;6;5;5;5;5","JUVENILE IDIOPATHIC ARTHRITIS;SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS;ETIOLOGY;NEUROBLASTOMA;CHILDHOOD CANCER SURVIVOR STUDY;CYSTIC FIBROSIS;SPINAL MUSCULAR ATROPHY;DISCONTINUATION;MICROCEPHALY;PHENOTYPE ANALYSIS;TREATMENT;CFTR;EXOME;EXOME SEQUENCING;FETAL MRI;IVACAFTOR;NEURODEVELOPMENTAL DISORDER;PATHOGENESIS;PEDIATRIC INTUBATION;PRETERM INFANTS","16;15;14;14;13;13;12;10;9;9;9;8;8;8;8;8;8;8;8;8","CYSTIC FIBROSIS;IDIOPATHIC ARTHRITIS;JUVENILE IDIOPATHIC;DISEASE ACTIVITY;MUSCULAR ATROPHY;PEDIATRIC PATIENTS;SPINAL MUSCULAR;APNEIC OXYGENATION;CANCER SURVIVORS;CELL TRANSPLANTATION;CHILDHOOD CANCER;COHORT STUDY;CLINICAL PRACTICE;DE NOVO;PEDIATRIC TRACHEAL;STEM CELL;TRACHEAL INTUBATION;CELIAC DISEASE;OBSERVATIONAL STUDY;RETROSPECTIVE STUDY;RISK FACTORS;EUROPEAN SOCIETY;EXOME SEQUENCING;ITALIAN SOCIETY;ALLERGIC RHINITIS;ATOPIC DERMATITIS;CASE-CONTROL STUDY;CHILDHOOD LUPUS;EYELID MYOCLONIA;GROWTH HORMONE","16;12;12;9;9;9;9;8;8;8;8;8;7;7;7;7;7;6;6;6;6;5;5;5;4;4;4;4;4;4","DISEASE ACTIVITY;REGENERON PHARMACEUTICALS;RISK FACTORS;MEDIAN AGE;CYSTIC FIBROSIS;PATIENTS TREATED;SPEAKERS BUREAU;STEM CELL;CELL TRANSPLANTATION;BONE MARROW;DE NOVO;PATHOGENIC VARIANTS;PEDIATRIC PATIENTS;TRACHEAL INTUBATION;CANCER SURVIVORS;CLINICAL PRACTICE;FOUR-CHAMBER VIEW;JUVENILE IDIOPATHIC;ADVERSE EVENTS;DISEASE ONSET;EXOME SEQUENCING;GRANTRESEARCH SUPPORT;IDIOPATHIC ARTHRITIS;STATISTICALLY SIGNIFICANT;AIRWAY MANAGEMENT;CARDIAC SCREENING;CLINICAL DATA;ELI LILLY;INCREASED RISK;MAGNETIC RESONANCE","47;29;29;26;22;21;20;20;19;18;18;18;18;18;16;16;16;16;15;15;15;15;15;15;14;14;14;14;14;14",246,0.46,6.91,8.75,1,2,0,8,0,1,1,10,1,1,8,1,1.5,2,3,6,5,0,0,8.75,8.75,4,0,0,0,1,7,0,0,0,0,0,0,1,5,2,0,8.5,3.51,2.875,0,8,3,0,0,5,0,0,2,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,3,0,1,1,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"BANDIERA TIZIANO;BERTOZZI FABIO;CACI EMANUELA;FERRERA LORETTA;GALIETTA LUIS JUAN VICENTE;PEDEMONTE NICOLETTA;SORANA FEDERICO;DI FRUSCIA PAOLO;GIACOMINA FRANCESCA;GIOVANI SIMONE","8;8;8;8;8;8;8;5;2;2","FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA;ISTITUTO GIANNINA GASLINI;FONDAZIONE PER LA RICERCA SULLA FIBROSI CISTICA ONLUS;FOND PER LA RICERCA SULLA FIBROSI CISTICA ONLUS;FONDAZIONE PER LA RICERCA SULLA FIBROSI CISTICA - ONLUS;FONDAZIONE PER LA RICERCA SULLA FIBROSI CISTICA ETS;FONDAZIONE PER LA RICERCA SULLA FIBROSI CRISTICA ONLUS;ISTITUTO GIANNINA GASIINI;ST GIANNINA GASLINI","8;7;2;1;1;1;1;1;1","34 CHEMICAL SCIENCES;3404 MEDICINAL AND BIOMOLECULAR CHEMISTRY;46 INFORMATION AND COMPUTING SCIENCES;4613 THEORY OF COMPUTATION","5;2;1;1","BRAIN DISORDERS;CYSTIC FIBROSIS;LUNG;RARE DISEASES","2;1;1;1","5.1 PHARMACEUTICALS","2","A61P11/00;C07D405/12;C07D471/04;C07D231/16;C07D409/12;C07D413/12;A61P3/00;C07D405/14;C07D498/04;A61K31/41","6;5;5;4;4;4;3;3;3;2","A61P11/00;C07D471/04;A61P3/00;C07D405/12;C07D405/14;C07D413/12;C07D498/04;C07D231/16;C07D403/12;C07D403/14","8;7;5;5;5;5;5;4;4;4",15,3,212.21,2.26,1,0.07,18.13,1,0,3,0,5,0,0,6,0,10,4,0,0,0,0,0,0,15,0,0,14,1,0,0,0,0,0,0,0,0,"Germany;Switzerland;United States;Canada;Denmark;Italy","2;2;2;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3204 IMMUNOLOGY;3211 ONCOLOGY AND CARCINOGENESIS;3207 MEDICAL MICROBIOLOGY;3213 PAEDIATRICS;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY","14;7;3;2;1;1;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;PEDIATRIC;PREVENTION;AUTOIMMUNE DISEASE;HEMATOLOGY;NEUROSCIENCES;RARE DISEASES;BRAIN DISORDERS;PATIENT SAFETY;BIOMEDICAL IMAGING;BIOTECHNOLOGY;CANCER;CHRONIC PAIN;COMPARATIVE EFFECTIVENESS RESEARCH;GENETICS;HEADACHES;INFANT MORTALITY;INFECTIOUS DISEASES;LUPUS","13;8;6;4;3;3;3;3;2;2;1;1;1;1;1;1;1;1;1;1","CANCER;INFLAMMATORY AND IMMUNE SYSTEM;INFECTION;NEUROLOGICAL;REPRODUCTIVE HEALTH AND CHILDBIRTH","3;3;2;2;1","6.1 PHARMACEUTICALS;5.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES;7.1 INDIVIDUAL CARE NEEDS","7;2;2;1;1;1","LEUKEMIA / LEUKAEMIA;BRAIN TUMOR;NON-HODGKIN'S LYMPHOMA;NOT SITE-SPECIFIC CANCER","2;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;5.3 SYSTEMIC THERAPIES - DISCOVERY AND DEVELOPMENT;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES;6.4 COST ANALYSES AND HEALTH CARE DELIVERY","3;1;1;1",1,1999369,117609.94,2,17,12,1,0,751572.486420551,0.718493571487444,"CENTRE LÉON BÉRARD;CENTRUM MEDYCZNE KSZTAŁCENIA PODYPLOMOWEGO;CHILDREN'S HEALTH IRELAND AT CRUMLIN;CINECA;COMENIUS UNIVERSITY;ESSEN UNIVERSITY HOSPITAL;EUROPA DONNA;EUROPEAN CANCER ORGANISATION;EUROPEAN INSTITUTE OF ONCOLOGY;EUROPEAN SOCIETY FOR PAEDIATRIC ONCOLOGY;INSTITUTE OF ONCOLOGY LJUBLJANA;ISTITUTO GIANNINA GASLINI;PRINCESS MÁXIMA CENTER;ST ANNA CHILDREN'S HOSPITAL;ST. ANNE´S UNIVERSITY HOSPITAL;TURKU UNIVERSITY OF APPLIED SCIENCES;UNIVERSITY MEDICAL CENTER OF THE JOHANNES GUTENBERG UNIVERSITY MAINZ","1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","EUROPEAN COMMISSION","1","COALITION S;EC & ERC - EUROPEAN UNION","1;1","EU4HEALTH PROGRAMME (EU4H) (PROGRAMME)","1","42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;4205 NURSING","1;1;1","CANCER","1","CANCER","1","7.1 INDIVIDUAL CARE NEEDS","1","COLON AND RECTAL CANCER;NOT SITE-SPECIFIC CANCER","1;1","6.1 PATIENT CARE AND SURVIVORSHIP ISSUES","1","A03 ALLIED HEALTH PROFESSIONS, DENTISTRY, NURSING AND PHARMACY","1",NA,NA,36,"FRONTIERS;ZENODO;AMERICAN CHEMICAL SOCIETY;PUBLIC LIBRARY OF SCIENCE","24;6;4;2","32 BIOMEDICAL AND CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;3105 GENETICS;34 CHEMICAL SCIENCES;3202 CLINICAL SCIENCES;3404 MEDICINAL AND BIOMOLECULAR CHEMISTRY;3102 BIOINFORMATICS AND COMPUTATIONAL BIOLOGY;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3212 OPHTHALMOLOGY AND OPTOMETRY;46 INFORMATION AND COMPUTING SCIENCES;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;3204 IMMUNOLOGY;3206 MEDICAL BIOTECHNOLOGY;3213 PAEDIATRICS;3402 INORGANIC CHEMISTRY;37 EARTH SCIENCES;4608 HUMAN-CENTRED COMPUTING;52 PSYCHOLOGY;5204 COGNITIVE AND COMPUTATIONAL PSYCHOLOGY","41;18;10;9;5;4;3;3;3;3;2;2;1;1;1;1;1;1;1;1","CLINICAL RESEARCH;PEDIATRIC;NEUROSCIENCES;BRAIN DISORDERS;GENETICS;PREVENTION;HUMAN GENOME;RARE DISEASES;CARDIOVASCULAR;HEART DISEASE;BIOTECHNOLOGY;CONGENITAL STRUCTURAL ANOMALIES;LUNG;CYSTIC FIBROSIS;ORPHAN DRUG;PERINATAL PERIOD - CONDITIONS ORIGINATING IN PERINATAL PERIOD;AUTOIMMUNE DISEASE;INFANT MORTALITY;INTELLECTUAL AND DEVELOPMENTAL DISABILITIES (IDD);NEURODEGENERATIVE","18;17;14;12;12;10;9;9;7;7;6;6;6;4;4;4;3;3;3;3","CARDIOVASCULAR;CONGENITAL;NEUROLOGICAL;INFLAMMATORY AND IMMUNE SYSTEM;GENERIC HEALTH RELEVANCE;METABOLIC AND ENDOCRINE;REPRODUCTIVE HEALTH AND CHILDBIRTH","7;4;4;2;1;1;1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;5.1 PHARMACEUTICALS;7.1 INDIVIDUAL CARE NEEDS;2.4 SURVEILLANCE AND DISTRIBUTION;4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES;5.2 CELLULAR AND GENE THERAPIES;6.1 PHARMACEUTICALS;7.3 MANAGEMENT AND DECISION MAKING","19;6;5;2;1;1;1;1;1","BIOMEDICAL;CLINICAL;POPULATION & SOCIETY","13;12;1","CLINICAL MEDICINE AND SCIENCE;BASIC SCIENCE","18;7","LEUKEMIA / LEUKAEMIA;NON-HODGKIN'S LYMPHOMA;NOT SITE-SPECIFIC CANCER","1;1;1","3 GOOD HEALTH AND WELL BEING","3"
"IRCCS_GASLINI",2024,521,18.6717850287908,3.35124760076775,0.291746641074856,0.295585412667946,0.320537428023033,2.83306320907618,1.25619834710744,1.65591397849462,1.29457364341085,0.63531669865643,5,238,104,34,32,0.46,0.2,0.07,0.06,0.83,0.869614011440822,4.61902530459233,0.445297504798464,0.986564299424184,0.529,0.453,0.447,0.46,"PASQUALE STRIANO;MARCO GATTORNO;LINO NOBILI;ELIO CASTAGNOLA;NICOLINO RUPERTO;ANDREA ANGELETTI;MARCELLO SCALA;FEDERICO ZARA;ANDREA ROSSI;ROBERTA CAORSI;MAURA FARACI;MARIASAVINA SEVERINO;VALERIA CAPRA;GIAN MARCO GHIGGERI;DOMENICO TORTORA;ANDREA MOSCATELLI;NICOLA MINUTO;EUGENIO MERCURI;MARIKA PANE;ANDREA PETRETTO","28;23;21;20;20;19;17;17;17;16;16;16;15;15;14;13;13;13;13;13","PASQUALE STRIANO;GABRIELE GAGGERO;ANDREA ROSSI;ANDREA ANGELETTI;VALERIO GAETANO VELLONE;LINO NOBILI;ELIO CASTAGNOLA;GIORGIO CIPRANDI;GIAN MARCO GHIGGERI;FEDERICO PREFUMO;ANDREA MOSCATELLI;MARCO GATTORNO;D. PALADINI;PAOLO CRAVEDI;FEDERICO ZARA;DOMENICO TORTORA;GIROLAMO MATTIOLI;GIANLUCA PIATELLI;MARCO PAVANELLO;LUCA A. RAMENGHI","2.77;2.36;2.1;2.09;1.94;1.92;1.79;1.67;1.63;1.59;1.49;1.48;1.43;1.38;1.3;1.3;1.25;1.25;1.25;1.21","PASQUALE STRIANO;MARCO GATTORNO;LINO NOBILI;ELIO CASTAGNOLA;NICOLINO RUPERTO;ANDREA ANGELETTI;MARCELLO SCALA;FEDERICO ZARA;ANDREA ROSSI;ROBERTA CAORSI;MAURA FARACI;MARIASAVINA SEVERINO;VALERIA CAPRA;GIAN MARCO GHIGGERI;DOMENICO TORTORA;ANDREA MOSCATELLI;NICOLA MINUTO;ANDREA PETRETTO;FEDERICO PREFUMO;ENRICO VERRINA","28;23;21;20;20;19;17;17;17;16;16;16;15;15;14;13;13;13;12;12","PASQUALE STRIANO;GABRIELE GAGGERO;ANDREA ROSSI;ANDREA ANGELETTI;VALERIO GAETANO VELLONE;LINO NOBILI;ELIO CASTAGNOLA;GIAN MARCO GHIGGERI;FEDERICO PREFUMO;ANDREA MOSCATELLI;MARCO GATTORNO;D. PALADINI;FEDERICO ZARA;DOMENICO TORTORA;GIROLAMO MATTIOLI;GIANLUCA PIATELLI;MARCO PAVANELLO;LUCA A. RAMENGHI;ANGELO RAVELLI;GIANLUCA CARIDI","2.77;2.36;2.1;2.09;1.94;1.92;1.79;1.63;1.59;1.49;1.48;1.43;1.3;1.3;1.25;1.25;1.25;1.21;1.21;1.17","ANDREA ANGELETTI;ENRICO VERRINA;MAURIZIO BRUSCHI;PAOLO CRAVEDI;EDOARDO LA PORTA;FRANCESCA LUGANI;GIAN MARCO GHIGGERI;GIOVANNI CANDIANO;DANIELA VERZOLA;FRANCESCA VIAZZI;PASQUALE ESPOSITO;PASQUALE STRIANO;CLAUDIA CABONI;CRISTINA ARTINI;GIANLUIGI ZAZA;GIOVANNI STALLONE;MATTEO SANTOSTEFANO;MICAELA GENTILE;NICOLETTA MANCIANTI;NOEMI RUMEO","37;37;37;36;35;35;35;35;32;32;32;32;31;31;31;31;31;31;31;31","ANDREA ANGELETTI;ENRICO VERRINA;MAURIZIO BRUSCHI;FRANCESCA LUGANI;GIAN MARCO GHIGGERI;GIOVANNI CANDIANO;PASQUALE STRIANO;NOEMI RUMEO;CARLO CASTELLANI;MARCO GATTORNO;ANDREA PETRETTO;CHIARA REBUFFI;MARIASAVINA SEVERINO;ELIO CASTAGNOLA;ANTONELLA RIVA;MARCELLO MARIANI;STEFANO VOLPI;VALERIA CAPRA;FEDERICO PREFUMO;NICOLINO RUPERTO","37;37;37;35;35;35;32;31;25;25;24;21;21;19;17;17;16;16;15;15","PASQUALE STRIANO;MARCO GATTORNO;NICOLINO RUPERTO;ELIO CASTAGNOLA;ANDREA ANGELETTI;LINO NOBILI;FEDERICO ZARA;MARIASAVINA SEVERINO;MAURA FARACI;ANDREA ROSSI;GIAN MARCO GHIGGERI;ROBERTA CAORSI;DOMENICO TORTORA;VALERIA CAPRA;ANDREA PETRETTO;MARCELLO SCALA;NICOLA MINUTO;STEFANO VOLPI;ANDREA MOSCATELLI;FEDERICO PREFUMO","30;22;20;19;19;18;17;16;16;15;15;15;14;14;13;13;13;13;12;12","MEDICINE;BIOLOGY;PSYCHOLOGY;COMPUTER SCIENCE;CHEMISTRY;PHYSICS;MATHEMATICS;POLITICAL SCIENCE;ECONOMICS;SOCIOLOGY;ENGINEERING;PHILOSOPHY;BUSINESS;MATERIALS SCIENCE;GEOGRAPHY;GEOLOGY;ART;HISTORY","468;222;61;52;50;44;29;18;17;17;14;14;9;8;4;3;2;1","INTERNAL MEDICINE;GENETICS;PEDIATRICS;IMMUNOLOGY;PATHOLOGY;SURGERY;PSYCHIATRY;INTENSIVE CARE MEDICINE;BIOCHEMISTRY;NEUROSCIENCE;ENVIRONMENTAL HEALTH;RADIOLOGY;CANCER RESEARCH;CELL BIOLOGY;ENDOCRINOLOGY;PHYSICAL THERAPY;ANESTHESIA;ONCOLOGY;GASTROENTEROLOGY;CARDIOLOGY;NURSING","290;155;117;88;86;86;65;61;54;41;37;36;32;29;27;25;24;24;23;22;22","GENE;DISEASE;COHORT;EPILEPSY;CANCER;POPULATION;PREGNANCY;RETROSPECTIVE COHORT STUDY;ANTIBODY;TRANSPLANTATION;IMMUNE SYSTEM;INCIDENCE (GEOMETRY);CHEMOTHERAPY;ARTHRITIS;CELL CULTURE;KIDNEY;CYSTIC FIBROSIS;DIABETES MELLITUS;IN VITRO;JUVENILE;MAGNETIC RESONANCE IMAGING;RECEPTOR","95;87;37;37;31;30;29;27;26;23;21;20;19;18;18;18;16;16;16;16;16;16","PHENOTYPE;MUTATION;FETUS;HEMATOPOIETIC STEM CELL TRANSPLANTATION;NEUROBLASTOMA;INFECTIOUS DISEASE (MEDICAL SPECIALTY);INFLAMMATORY BOWEL DISEASE;PROTEINURIA;SPINAL MUSCULAR ATROPHY;CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR;RITUXIMAB;TYPE 2 DIABETES;AUTISM SPECTRUM DISORDER;CHILDHOOD CANCER;EPILEPSY SURGERY;HAEMATOPOIESIS;IMMUNOTHERAPY;MICRORNA;TYPE 1 DIABETES;CUMULATIVE INCIDENCE;GENE EXPRESSION;GENOTYPE;INFLAMMASOME;MACROPHAGE ACTIVATION SYNDROME;NEURORADIOLOGY;STAPHYLOCOCCUS AUREUS;SYSTEMIC LUPUS ERYTHEMATOSUS","38;20;16;15;13;12;9;9;9;8;8;8;7;7;7;7;7;7;7;6;6;6;6;6;6;6;6","CORONAVIRUS DISEASE 2019 (COVID-19);EXOME SEQUENCING;MISSENSE MUTATION;INFLAMMATORY BOWEL DISEASES;PODOCYTE;IVACAFTOR;FRAMESHIFT MUTATION;HAPLOINSUFFICIENCY;HEMATOPOIETIC CELL;LOSS FUNCTION;MICROVESICLES;VANCOMYCIN;BONE MARROW FAILURE;COPY-NUMBER VARIATION;DARATUMUMAB;GENE MUTATION;GENETIC HETEROGENEITY;GLOBAL DEVELOPMENTAL DELAY;IDIOPATHIC NEPHROTIC SYNDROME;IMPAIRED GLUCOSE TOLERANCE;TRANSCRIPTOME","12;7;7;6;6;5;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3",";HUMANS;CHILD;FEMALE;MALE;ADOLESCENT;CHILD, PRESCHOOL;INFANT;RETROSPECTIVE STUDIES;ADULT;ITALY;YOUNG ADULT;TREATMENT OUTCOME;INFANT, NEWBORN;ANIMALS;MIDDLE AGED;EPILEPSY;EUROPE;HEMATOPOIETIC STEM CELL TRANSPLANTATION;PHENOTYPE","286;234;134;125;116;81;73;56;56;48;31;24;23;22;20;17;16;13;12;12","HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS AND RELATED DISORDERS;EPILEPSY AND SEIZURES;PATHOPHYSIOLOGY OF GLOMERULAR DISEASES AND NEPHROTIC SYNDROMES;PEDIATRIC CANCER AND QUALITY OF LIFE;THERAPEUTIC ADVANCES IN CYSTIC FIBROSIS RESEARCH;NEUROBLASTOMA RESEARCH AND TREATMENT;GENE THERAPY FOR SPINAL MUSCULAR ATROPHY;MOLECULAR BASIS OF RETT SYNDROME AND RELATED DISORDERS;MANAGEMENT OF DIABETES MELLITUS AND HYPOGLYCEMIA;MOLECULAR MECHANISMS OF INFLAMMASOME ACTIVATION AND REGULATION;EXOSOME BIOLOGY AND FUNCTION IN INTERCELLULAR COMMUNICATION;GENOMIC IMPRINTING AND PARENTAL GENE EXPRESSION CONTROL;GLIOMAS;HIRSCHSPRUNG DISEASE AND ENTERIC NERVOUS SYSTEM DEVELOPMENT;DEVELOPMENT AND DISORDERS OF FETAL BRAIN;MANAGEMENT OF VASCULAR MALFORMATIONS IN THE BRAIN;MINIMALLY INVASIVE REPAIR OF PECTUS EXCAVATUM;PATHOPHYSIOLOGY AND MANAGEMENT OF PREECLAMPSIA;DIAGNOSIS AND MANAGEMENT OF CELIAC DISEASE;EPIDEMIOLOGY AND MANAGEMENT OF CONGENITAL HEART DISEASE","19;16;15;14;14;13;12;9;8;8;7;7;7;7;6;6;6;6;5;5","SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS;JUVENILE IDIOPATHIC ARTHRITIS;EPILEPSY;CHILDHOOD CANCER SURVIVOR STUDY;NEUROBLASTOMA;DIABETES;TREATMENT;BRAIN DEVELOPMENT;CYSTIC FIBROSIS;HEMATOPOIETIC CELL TRANSPLANTATION;PRENATAL DIAGNOSIS;SPINAL MUSCULAR ATROPHY;TYPE 1 DIABETES;CONTINUOUS GLUCOSE MONITORING;ADOLESCENT AND YOUNG ADULT ONCOLOGY;CHILDHOOD CANCER;MACROPHAGE ACTIVATION SYNDROME;ANTIEPILEPTIC DRUGS;CUMULATIVE INCIDENCE;DELPHI METHOD","19;18;16;14;13;11;11;9;9;9;9;9;9;8;7;7;7;6;6;6","IDIOPATHIC ARTHRITIS;JUVENILE IDIOPATHIC;ITALIAN SOCIETY;PEDIATRIC PATIENTS;CELL TRANSPLANTATION;STEM CELL;NEPHROTIC SYNDROME;CYSTIC FIBROSIS;DISEASE ACTIVITY;INFLAMMATORY BOWEL;MUSCULAR ATROPHY;RETROSPECTIVE STUDY;SPINAL MUSCULAR;TYPE DIABETES;COHORT STUDY;RETROSPECTIVE ANALYSIS;ALLOGENEIC HEMATOPOIETIC;CANCER SURVIVORS;CENTRAL NERVOUS;CHILDHOOD CANCER;EXTRACELLULAR VESICLES;HEMATOPOIETIC CELL;HEMATOPOIETIC STEM;HIGH-RISK NEUROBLASTOMA;MULTICENTER STUDY;NERVOUS SYSTEM;PILOT STUDY;SYSTEMIC JUVENILE;ADVERSE EVENTS;BOWEL DISEASES","14;14;13;13;11;11;10;9;7;7;7;7;7;7;6;6;5;5;5;5;5;5;5;5;5;5;5;5;4;4","MEDIAN AGE;PEDIATRIC PATIENTS;CHILDHOOD CANCER;DISEASE ACTIVITY;INTELLECTUAL DISABILITY;OXIDATIVE STRESS;VASA PREVIA;ANTI-NEPHRIN ANTIBODIES;CANCER SURVIVORS;RETROSPECTIVE STUDY;NERVOUS SYSTEM;BONE MARROW;CELL LINES;ITALIAN SOCIETY;IDIOPATHIC ARTHRITIS;JUVENILE IDIOPATHIC;MOTOR FUNCTION;STEM CELL;GENE EXPRESSION;INTENSIVE CARE;AFFECTED INDIVIDUALS;CLINICAL FEATURES;CLINICAL TRIALS;CTRL PEP;EPILEPSY SURGERY;NEPHROTIC SYNDROME;OBSERVATIONAL STUDY;PATIENTS RECEIVED;ABSTRACT OBJECTIVE;CLINICAL CHARACTERISTICS","27;18;16;16;16;16;16;15;15;15;14;13;13;13;12;12;12;12;11;11;10;10;10;10;10;10;10;10;9;9",9,0.02,1.25,4,1,1,0,4,0,0,0,4,0,0,4,0,0,0,1.5,3.25,2.5,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,0.5,57500,0.35,0,0,10.5,0,0,0,0,0,0,0,2,0,0,2,0,0,0,0,0,0,2,0,0,2,0,0,0,0,0,0,0,0,0,"United States;Australia;Canada;Germany;Netherlands;Switzerland","2;1;1;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;4205 NURSING","1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;LUNG;PATIENT SAFETY;PEDIATRIC","2;1;1;1;1","GENERIC HEALTH RELEVANCE","1",NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,4,"FRONTIERS;TAYLOR & FRANCIS GROUP","3;1","32 BIOMEDICAL AND CLINICAL SCIENCES;42 HEALTH SCIENCES;3202 CLINICAL SCIENCES;4203 HEALTH SERVICES AND SYSTEMS","4;4;3;1","AUTOIMMUNE DISEASE;CLINICAL RESEARCH;DIABETES;PEDIATRIC;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;PEDIATRIC RESEARCH INITIATIVE;CANCER;HEMATOLOGY;PREVENTION","4;4;4;4;3;3;1;1;1","METABOLIC AND ENDOCRINE","4",NA,NA,"POPULATION & SOCIETY;CLINICAL","3;1","HEALTH SERVICES RESEARCH;CLINICAL MEDICINE AND SCIENCE","3;1","LEUKEMIA / LEUKAEMIA","1",NA,NA
